data_2k53_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2k53 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 mm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.064 0.459 . . . . 75.32 112.135 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.458 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.8 p -122.81 155.12 37.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.472 -0.331 . . . . 75.53 110.526 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.534 ' HB3' HG23 ' A' ' 56' ' ' VAL . 10.4 ptpp? -69.62 -17.65 63.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.917 -0.489 . . . . 70.11 111.969 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.98 -17.61 60.51 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.933 0.397 . . . . 73.22 111.221 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.458 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 66.0 mtt -66.38 149.82 49.82 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.139 0.495 . . . . 74.53 111.841 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -79.11 133.19 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.245 -0.434 . . . . 71.41 111.317 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.7 mt -55.55 -48.88 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.848 0.356 . . . . 72.11 111.367 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.51 69.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.046 0.387 . . . . 73.44 112.046 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.18 -38.97 60.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.742 0.306 . . . . 54.04 111.323 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.08 -40.04 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.523 . . . . 63.21 110.24 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.46 HD21 ' OG1' ' A' ' 19' ' ' THR . 95.8 mt -61.43 -25.44 67.21 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.934 -0.575 . . . . 75.32 111.63 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -73.7 -32.26 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.814 0.34 . . . . 71.13 111.098 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mtt -71.24 -39.48 71.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 74.31 110.129 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB3' HG22 ' A' ' 19' ' ' THR . 40.0 t0 -160.05 130.22 5.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.275 -0.875 . . . . 74.41 111.018 176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.91 -22.68 62.22 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.082 0.467 . . . . 63.24 110.637 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.69 2.16 49.52 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.284 -0.416 . . . . 63.21 113.755 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.46 ' OG1' HD21 ' A' ' 13' ' ' LEU . 68.1 p -82.59 -19.01 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.288 -0.537 . . . . 73.11 111.585 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.96 -51.13 77.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.72 0.637 . . . . 52.45 112.72 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.6 Cg_endo -59.4 -21.41 60.99 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.039 1.826 . . . . 72.41 112.897 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.39 -46.32 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 74.34 110.376 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -59.27 -45.27 91.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.188 0.518 . . . . 74.31 110.32 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.66 -37.03 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.112 -0.494 . . . . 74.42 111.13 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -56.43 -42.18 77.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.031 0.443 . . . . 74.35 111.457 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.54 -1.36 57.02 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.823 0.675 . . . . 64.45 112.823 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.49 17.52 15.09 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.224 0.85 . . . . 52.41 115.224 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.472 0.673 0 CA-C-N 118.093 0.947 . . . . 74.4 111.813 176.182 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.29 0.848 . . . . 74.31 113.29 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 24.3 m -72.19 159.73 33.62 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.126 -0.943 . . . . 45.42 111.5 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.7 mt -52.97 -52.55 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.959 0.355 . . . . 73.23 111.959 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.09 -40.36 85.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.831 0.348 . . . . 64.15 111.732 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.402 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.2 t70 -63.34 -51.13 67.23 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.246 -0.434 . . . . 63.43 110.804 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.05 -0.523 . . . . 61.23 111.685 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.2 m -62.21 -48.53 79.62 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 72.35 111.433 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.61 -37.44 65.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.962 0.356 . . . . 37.32 111.962 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 43' ' ' ASP . 56.1 t -57.74 -53.98 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.91 0.386 . . . . 74.2 111.65 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -92.65 6.64 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.226 0.454 . . . . 72.43 112.226 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.34 83.56 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.285 -0.483 . . . . 61.15 112.968 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.43 150.04 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.207 0.527 . . . . 71.45 111.555 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -80.92 84.23 6.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.104 -0.498 . . . . 72.15 110.433 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.403 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -60.84 -30.3 70.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.545 -0.298 . . . . 74.54 111.771 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 33.2 t70 -58.75 -47.3 85.12 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.715 0.293 . . . . 61.2 110.864 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -71.83 -44.16 64.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.763 0.316 . . . . 70.12 111.432 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp -54.73 -51.61 65.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.323 -0.398 . . . . 64.42 111.703 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 5' ' ' LYS . 90.1 t -60.56 -42.28 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.608 -0.269 . . . . 75.25 111.614 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 98.9 mttt -57.16 -48.0 79.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.591 0.234 . . . . 73.42 111.375 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.57 -39.71 89.02 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.601 0.238 . . . . 70.42 111.45 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 56' ' ' VAL . 91.0 mt -59.26 -48.54 81.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.618 0.247 . . . . 74.21 111.185 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -58.62 -61.7 2.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.608 -0.269 . . . . 74.5 111.373 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -46.17 -46.06 17.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.197 -0.456 . . . . 63.54 111.153 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -52.09 -58.66 5.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.383 0.512 . . . . 73.25 112.383 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.832 0.349 . . . . 73.32 111.309 178.789 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.451 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 120.647 0.26 . . . . 72.03 111.235 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.48 159.32 25.4 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.413 -0.358 . . . . 72.05 110.851 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.604 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.1 pttp -71.01 -11.29 60.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.94 0.4 . . . . 72.22 111.356 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.87 -25.41 53.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.895 -0.593 . . . . 65.31 110.96 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.7 mtt -66.75 154.14 41.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.298 0.571 . . . . 61.41 112.071 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.51 136.52 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.955 -0.566 . . . . 64.32 111.334 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.4 mt -56.11 -52.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.847 0.356 . . . . 71.05 111.696 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.34 65.67 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.97 0.414 . . . . 38.58 111.631 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.0 -41.12 60.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.908 0.385 . . . . 72.22 110.822 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.37 -37.96 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.204 0.526 . . . . 74.21 110.524 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.1 -30.08 70.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.05 -0.523 . . . . 62.43 111.59 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.69 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.929 0.395 . . . . 73.45 111.042 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.8 mtt -72.35 -49.03 37.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.374 0.607 . . . . 74.33 109.744 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -158.18 138.14 12.28 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.491 -0.777 . . . . 71.34 111.364 173.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -77.18 -20.59 55.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.257 0.551 . . . . 75.22 110.771 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.87 -2.42 23.36 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.864 -0.607 . . . . 71.11 113.525 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.8 p -81.59 -20.69 39.31 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.43 -0.453 . . . . 74.43 111.67 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.496 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.58 -50.65 82.03 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 113.027 0.751 . . . . 74.23 113.027 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.9 Cg_endo -59.46 -21.35 61.13 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.298 1.999 . . . . 73.03 113.025 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.98 -45.62 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.147 0.499 . . . . 75.23 110.474 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HG3' ' A' ' 28' ' ' MET . 68.6 m-85 -57.52 -44.73 85.29 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.211 0.529 . . . . 73.11 110.105 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.74 -38.61 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.314 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -55.37 -29.19 57.96 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.278 0.561 . . . . 72.21 111.613 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.419 ' ND2' HD13 ' A' ' 55' ' ' LEU . 37.7 m-80 -98.8 4.1 47.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.244 0.461 . . . . 63.13 112.244 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.85 26.25 11.93 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.752 0.661 . . . . 42.4 114.752 172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' A' ' 23' ' ' PHE . 22.0 mmt . . . . . 0 CA--C 1.537 0.469 0 CA-C-N 117.803 0.801 . . . . 75.2 112.209 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.013 0.435 . . . . 75.4 111.704 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.6 m -63.86 145.81 55.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.323 -0.399 . . . . 74.34 110.588 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.7 mt -47.92 -50.62 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 113.06 0.763 . . . . 73.23 113.06 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 7.9 pt-20 -63.69 -37.87 88.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.383 . . . . 75.15 112.033 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.67 -42.13 78.32 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.912 0.387 . . . . 55.54 110.747 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.04 75.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.235 -0.438 . . . . 72.52 111.15 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -57.79 -43.66 85.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.868 0.366 . . . . 73.5 110.789 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.36 62.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.189 -0.459 . . . . 73.24 112.061 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.03 -42.66 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 111.993 0.368 . . . . 62.14 111.993 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -105.1 3.07 29.98 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.992 0.425 . . . . 74.44 111.618 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 30.85 63.16 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.795 -0.716 . . . . 64.22 112.979 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.6 mt -81.82 155.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.894 0.478 . . . . 74.52 111.171 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -93.89 106.69 18.65 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.971 0.415 . . . . 73.13 110.349 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 42' ' ' GLU . . . -64.42 -33.04 74.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.316 0.487 . . . . 72.22 112.316 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -54.04 -47.86 71.14 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.95 0.405 . . . . 72.14 111.067 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -70.27 -47.54 60.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.262 -0.426 . . . . 65.22 111.479 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' ND2' ' A' ' 26' ' ' ASN . 27.6 tp -55.53 -51.58 66.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.933 0.397 . . . . 73.21 111.973 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HA ' HD13 ' A' ' 59' ' ' LEU . 92.5 t -58.4 -38.89 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.019 0.438 . . . . 73.24 111.648 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.08 -43.5 91.99 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.541 -0.3 . . . . 73.22 111.434 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -56.9 -42.59 80.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.802 0.334 . . . . 75.23 111.134 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -57.18 -52.81 63.81 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.252 -0.431 . . . . 64.43 111.751 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -55.88 -50.22 71.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.652 0.263 . . . . 73.42 111.689 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.57 -32.69 65.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.95 0.405 . . . . 71.41 111.845 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -65.81 -52.15 53.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.129 -0.487 . . . . 74.3 111.458 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.414 -0.357 . . . . 74.03 111.426 178.15 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.577 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.6 mm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 113.373 0.879 . . . . 72.23 113.373 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -121.69 160.39 24.57 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.752 -0.658 . . . . 74.31 110.287 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.5 pttp -66.45 -16.54 64.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.963 0.411 . . . . 72.13 111.353 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.24 -19.64 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.765 -0.652 . . . . 75.05 111.663 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.577 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.5 mtt -69.11 153.82 43.1 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.133 0.492 . . . . 65.33 111.911 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.2 mm -85.22 129.97 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.399 -0.364 . . . . 54.51 111.24 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.8 -53.56 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.477 0.547 . . . . 74.55 112.477 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.07 72.13 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.043 0.386 . . . . 64.24 112.043 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.72 -40.27 76.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.914 0.388 . . . . 71.04 110.674 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -60.49 -39.96 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.26 0.552 . . . . 73.43 110.59 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.98 -32.24 70.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.972 -0.558 . . . . 72.31 111.393 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.603 ' HA ' HH12 ' A' ' 17' ' ' ARG . 15.8 mm-40 -67.21 -31.76 72.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.339 . . . . 71.24 111.583 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.4 mtt -65.78 -54.83 21.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.556 0.693 . . . . 73.11 109.816 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -150.73 121.59 7.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.364 -0.834 . . . . 63.32 110.58 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.603 HH12 ' HA ' ' A' ' 14' ' ' GLN . 81.9 mmt-85 -60.12 -21.56 61.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.999 0.428 . . . . 73.24 111.673 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.76 -3.38 27.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.502 -0.38 . . . . 73.45 113.656 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -82.32 -16.24 50.04 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.425 -0.456 . . . . 75.42 111.671 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.49 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.94 -51.41 79.61 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 112.724 0.638 . . . . 72.11 112.724 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 12.4 Cg_endo -55.62 -29.19 69.23 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.161 1.908 . . . . 74.33 112.673 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.3 mt -69.12 -45.57 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.047 0.451 . . . . 75.11 110.888 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 -45.89 91.08 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.909 0.385 . . . . 74.11 110.679 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.05 -42.69 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 73.43 111.348 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -50.72 -50.03 56.31 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.1 0.476 . . . . 75.11 111.508 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -75.27 -4.31 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.492 0.552 . . . . 64.21 112.492 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.98 16.85 12.63 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.821 0.688 . . . . 41.14 114.821 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 118.039 0.919 . . . . 54.22 111.016 175.369 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 55.4 111.817 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.6 p -75.74 164.63 26.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.126 0.489 . . . . 62.11 112.254 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 mt -55.04 -50.64 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.889 -0.596 . . . . 71.22 112.356 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.769 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 10.1 pt-20 -66.62 -37.13 84.22 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.247 -0.283 . . . . 70.24 111.724 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 47' ' ' VAL . 24.1 t0 -64.76 -49.97 68.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.138 0.495 . . . . 63.12 110.146 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.79 99.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.858 -0.61 . . . . 71.04 111.896 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -52.1 -52.97 48.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.593 -0.276 . . . . 62.32 111.467 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.73 68.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.214 0.45 . . . . 45.32 112.214 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 43' ' ' ASP . 66.7 t -59.88 -42.48 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.914 0.388 . . . . 63.22 111.794 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -97.61 -0.27 46.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.786 0.327 . . . . 71.22 111.467 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.71 82.31 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.477 -0.392 . . . . 72.0 113.45 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.5 mt -74.42 154.68 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 122.581 -0.364 . . . . 74.34 111.273 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -97.38 113.79 25.5 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.977 0.417 . . . . 64.11 110.529 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -68.34 -32.62 72.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.211 0.449 . . . . 64.41 112.211 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.49 -40.29 82.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.886 0.374 . . . . 71.32 111.658 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -70.57 -49.46 47.73 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.212 0.53 . . . . 63.13 111.043 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.41 -47.31 85.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.799 -0.637 . . . . 73.33 112.406 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 52' ' ' ALA . 98.4 t -61.75 -38.9 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.149 0.426 . . . . 73.42 112.149 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -61.95 -45.35 94.05 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.176 -0.327 . . . . 73.13 110.798 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.53 -42.52 74.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.153 0.501 . . . . 63.33 111.36 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.3 -53.4 55.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.239 -0.437 . . . . 61.04 111.745 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -55.0 -50.44 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.038 0.384 . . . . 72.32 112.038 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.06 -42.3 69.11 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.763 -0.199 . . . . 74.33 111.346 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.58 -49.41 77.55 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 63.03 112.188 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.771 0.319 . . . . 75.52 111.618 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.446 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.9 mm . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 120.529 0.204 . . . . 73.41 110.602 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 28.5 p -116.66 155.88 28.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 70.31 111.134 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HB3' HG23 ' A' ' 56' ' ' VAL . 14.0 ptpt -69.27 -10.5 58.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.01 0.374 . . . . 74.01 112.01 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.28 -14.95 45.04 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.088 0.47 . . . . 71.3 111.347 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.492 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 65.5 mtt -69.41 157.29 37.36 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.435 0.531 . . . . 73.53 112.435 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 48.9 mm -85.39 141.55 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.043 -0.526 . . . . 62.13 111.552 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.6 mt -55.44 -52.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 120.76 0.314 . . . . 71.34 111.798 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.22 71.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.961 0.41 . . . . 62.44 111.616 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.75 -42.08 98.5 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.303 -0.408 . . . . 64.15 111.044 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.97 -40.93 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.037 0.446 . . . . 72.44 110.933 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.5 HD21 ' OG1' ' A' ' 19' ' ' THR . 97.0 mt -61.22 -31.74 71.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.892 0.377 . . . . 73.44 111.348 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -70.1 -15.17 62.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.455 -0.339 . . . . 63.13 111.9 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.4 mtt -86.69 -43.44 12.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.208 0.528 . . . . 64.15 110.044 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.08 133.79 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.568 -0.742 . . . . 71.54 110.814 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.8 mmt-85 -69.68 -25.0 63.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.874 0.368 . . . . 74.21 111.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.49 -1.41 10.83 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.608 -0.33 . . . . 73.02 113.728 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.5 ' OG1' HD21 ' A' ' 13' ' ' LEU . 73.3 p -82.84 -21.43 34.41 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.469 -0.43 . . . . 74.52 111.704 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.78 -51.08 82.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 112.396 0.517 . . . . 63.35 112.396 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 22.6 Cg_endo -60.93 -25.15 80.91 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.885 1.724 . . . . 74.04 112.613 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.2 mt -71.05 -43.18 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.969 0.414 . . . . 73.51 110.785 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -58.64 -48.72 80.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.131 0.491 . . . . 72.21 110.249 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 28' ' ' MET . 66.5 mt -60.71 -37.84 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.99 -0.55 . . . . 70.34 111.221 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -56.06 -32.95 64.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.275 -0.421 . . . . 71.25 112.089 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.417 ' ND2' HD13 ' A' ' 55' ' ' LEU . 34.0 m-80 -90.93 -7.5 51.93 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.453 0.538 . . . . 71.22 112.453 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 -7.47 6.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.624 -0.798 . . . . 61.4 114.605 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 50.0 mtt . . . . . 0 N--CA 1.473 0.687 0 CA-C-N 117.877 0.838 . . . . 74.24 111.082 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 121.087 0.47 . . . . 63.23 112.054 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 54.3 m -70.31 149.45 47.37 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.577 -0.283 . . . . 75.12 110.578 172.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 mt -51.51 -55.61 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.655 0.613 . . . . 73.33 112.655 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.6 pt-20 -62.1 -36.28 81.23 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.038 0.447 . . . . 74.14 111.684 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.93 -52.68 22.5 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.071 -0.513 . . . . 71.14 111.117 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.88 91.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.303 -0.408 . . . . 73.1 111.504 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -57.49 -45.53 84.79 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.53 -0.304 . . . . 60.01 110.938 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.88 75.05 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.016 0.376 . . . . 61.43 112.016 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.8 t -55.65 -41.27 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.927 0.394 . . . . 73.1 112.052 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.541 ' HB3' HG13 ' A' ' 50' ' ' ILE . 8.8 t60 -91.33 -22.96 20.26 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 73.25 111.299 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.75 24.53 17.56 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.546 -0.359 . . . . 73.22 112.439 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.541 HG13 ' HB3' ' A' ' 48' ' ' HIS . 63.8 mt -79.69 155.23 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.92 0.488 . . . . 73.11 112.058 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.76 101.74 12.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.166 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -71.44 -21.88 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.454 0.538 . . . . 73.03 112.454 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -43.1 77.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.361 . . . . 60.34 110.467 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.61 -46.78 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.312 -0.404 . . . . 63.42 110.992 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.417 HD13 ' ND2' ' A' ' 26' ' ' ASN . 30.1 tp -56.29 -54.84 40.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.223 -0.444 . . . . 62.15 112.046 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 5' ' ' LYS . 87.4 t -56.51 -41.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.965 0.412 . . . . 71.31 112.011 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -37.21 80.63 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.73 0.27 . . . . 72.45 111.73 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -59.91 -42.57 94.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 64.02 110.692 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -58.6 -52.32 66.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.28 -0.418 . . . . 74.44 111.381 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -54.19 -57.36 11.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.695 0.283 . . . . 74.22 111.59 177.543 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -52.42 -40.9 62.71 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.217 -0.447 . . . . 71.13 111.789 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -56.45 -48.56 76.81 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.894 0.378 . . . . 74.51 111.663 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.612 0.244 . . . . 75.14 111.499 179.313 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.828 0.347 . . . . 71.42 111.412 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.475 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.3 p -118.06 170.23 9.02 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.861 0.362 . . . . 70.21 110.973 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.515 ' HB3' HG23 ' A' ' 56' ' ' VAL . 16.8 ptpt -80.87 -11.78 59.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.865 0.364 . . . . 71.34 111.282 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.52 -25.43 38.72 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.012 -0.54 . . . . 60.34 111.141 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.475 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 64.3 mtt -65.11 161.07 19.75 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.181 0.515 . . . . 73.55 112.203 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.0 mm -86.91 129.76 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.062 -0.517 . . . . 73.04 110.716 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . 0.485 HG12 HG13 ' A' ' 41' ' ' ILE . 57.3 mt -54.66 -45.96 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 112.211 0.448 . . . . 72.15 112.211 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -63.15 -34.68 78.15 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.195 0.521 . . . . 61.42 111.078 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.4 t70 -65.06 -41.84 94.74 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.913 -0.585 . . . . 54.1 110.344 177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.88 -37.96 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.219 0.533 . . . . 62.44 110.997 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.64 -29.87 70.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.472 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 77.0 mt-30 -68.34 -25.45 65.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.953 0.406 . . . . 71.14 111.042 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.0 mtt -75.62 -53.91 7.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.208 0.528 . . . . 73.42 110.02 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -154.3 124.45 6.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.956 -0.566 . . . . 75.44 111.127 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.41 -18.12 65.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 74.31 112.556 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.434 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -68.1 -6.44 46.17 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.274 -0.489 . . . . 73.52 113.2 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.1 p -80.91 -23.14 39.15 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.644 -0.327 . . . . 73.44 111.455 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.47 -51.79 77.11 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.528 0.566 . . . . 73.44 112.528 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.46 -26.03 76.29 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.901 1.734 . . . . 72.13 112.335 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 64.1 mt -72.48 -41.76 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.02 0.438 . . . . 72.15 110.583 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -61.9 -49.93 74.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.041 0.448 . . . . 75.22 110.497 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.0 mt -59.12 -37.55 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 72.43 111.099 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 27.4 t30 -52.09 -46.4 65.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.992 0.425 . . . . 64.31 111.678 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -81.21 1.69 31.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.312 0.486 . . . . 72.43 112.312 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.33 13.84 14.32 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.203 0.841 . . . . 62.44 115.203 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.543 0.703 0 CA-C-N 117.952 0.876 . . . . 65.22 112.147 176.36 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.4 . . . . 73.4 111.413 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 7' ' ' MET . 49.2 m -68.54 153.06 44.48 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.415 -0.357 . . . . 72.0 111.024 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 52' ' ' ALA . 4.0 mp -51.93 -51.24 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 111.791 0.293 . . . . 74.4 111.791 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.6 pt-20 -69.05 -33.9 74.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.903 0.382 . . . . 75.42 111.724 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.88 -47.25 75.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.103 0.478 . . . . 70.11 111.238 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.73 56.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 75.02 111.788 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.88 -42.08 75.39 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.72 0.295 . . . . 72.53 111.679 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.67 65.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.272 0.471 . . . . 53.11 112.272 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.2 -51.18 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.816 0.341 . . . . 71.43 111.914 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -87.6 -19.82 27.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.873 0.368 . . . . 74.31 111.386 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.59 27.04 12.07 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.19 -0.528 . . . . 74.31 112.655 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mt -76.57 148.28 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.751 0.31 . . . . 70.31 111.298 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.8 93.84 5.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.202 0.525 . . . . 70.24 110.283 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB2' HG22 ' A' ' 41' ' ' ILE . . . -65.7 -24.05 66.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.165 -0.47 . . . . 64.32 112.105 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.15 -45.76 92.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.792 0.329 . . . . 70.03 110.962 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.85 -46.44 75.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.893 0.377 . . . . 54.34 111.126 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 41' ' ' ILE . 26.2 tp -53.19 -51.73 61.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.002 -0.545 . . . . 72.21 111.624 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 5' ' ' LYS . 80.2 t -57.41 -45.28 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 73.43 111.524 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.63 -45.0 85.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.515 0.198 . . . . 74.22 111.395 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -58.97 -40.85 86.02 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.937 0.398 . . . . 74.41 111.281 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 80.9 mt -60.13 -50.46 73.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.854 0.359 . . . . 74.24 111.38 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -57.57 -55.13 38.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.395 -0.366 . . . . 73.4 111.418 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -50.11 -41.77 49.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.891 0.377 . . . . 74.01 111.031 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.434 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 87.4 t80 -58.74 -53.23 60.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.17 -0.468 . . . . 73.11 112.084 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.591 0.234 . . . . 75.2 111.117 178.424 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.47 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.4 mm . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.174 0.435 . . . . 64.32 112.174 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.475 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.2 p -116.42 158.9 22.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.282 -0.417 . . . . 75.21 110.307 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -72.98 -15.55 61.54 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.106 -0.371 . . . . 73.13 111.959 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.06 -14.11 58.14 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.794 0.331 . . . . 74.35 111.48 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.475 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 62.8 mtt -63.95 134.92 55.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.28 0.562 . . . . 72.01 111.575 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.49 136.01 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.901 -0.59 . . . . 73.2 111.405 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.6 mt -52.13 -52.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.838 0.31 . . . . 73.25 111.838 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.11 -36.85 73.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.934 0.397 . . . . 72.31 111.627 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.12 -37.54 87.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.208 -0.451 . . . . 64.24 110.902 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.94 -41.31 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.072 0.463 . . . . 73.04 110.99 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -59.22 -31.24 68.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.341 -0.391 . . . . 74.42 111.709 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 79.3 mt-30 -62.95 -37.06 85.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.73 0.3 . . . . 70.23 111.532 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.9 mtt -65.76 -48.25 72.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 60.4 110.225 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.85 120.25 3.4 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.445 -0.798 . . . . 74.32 110.7 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -62.24 -20.8 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.459 0.54 . . . . 74.22 112.459 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -3.49 22.86 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.418 -0.42 . . . . 61.13 113.65 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.7 p -83.08 -19.79 36.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.916 0.358 . . . . 70.43 111.833 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.469 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.29 -50.99 81.72 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 112.478 0.547 . . . . 74.41 112.478 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.1 Cg_endo -59.13 -29.1 89.61 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.899 1.733 . . . . 72.0 112.613 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.88 -42.17 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.094 0.474 . . . . 75.14 110.613 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -62.38 -53.44 55.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.155 0.502 . . . . 73.12 110.648 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.7 -35.35 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.136 -0.484 . . . . 44.31 111.322 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -57.6 -48.84 78.28 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.021 -0.536 . . . . 72.35 111.511 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.92 -5.11 39.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.355 0.502 . . . . 62.35 112.355 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.89 17.47 7.89 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.653 -0.784 . . . . 75.32 114.831 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 CA--C 1.537 0.469 0 CA-C-N 117.961 0.881 . . . . 65.41 111.717 175.651 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.351 0.596 . . . . 72.32 112.042 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 87.7 p -76.76 162.02 28.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.739 -0.664 . . . . 70.4 112.248 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.15 -44.08 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.14 111.91 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.14 -40.78 90.87 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.562 0.208 . . . . 71.33 111.562 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.01 -48.61 65.24 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.008 0.432 . . . . 71.34 111.132 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.75 94.08 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.881 0.372 . . . . 61.2 111.632 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -56.27 -39.49 72.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.709 0.29 . . . . 60.14 111.355 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.69 69.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.067 0.395 . . . . 37.56 112.067 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -48.08 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.018 0.437 . . . . 63.34 111.346 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -92.47 -10.27 38.46 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.388 -0.369 . . . . 75.13 111.989 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.42 35.44 23.1 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.35 -0.452 . . . . 61.22 113.233 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -91.95 152.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.646 0.378 . . . . 74.15 111.286 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.32 99.43 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.411 -0.589 . . . . 71.25 109.411 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -65.07 -30.1 71.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.154 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.54 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.8 t70 -59.7 -44.29 93.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.68 0.276 . . . . 61.02 110.677 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.63 -49.1 67.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 75.5 111.079 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.87 -45.09 67.29 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 73.24 111.354 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 52' ' ' ALA . 75.9 t -61.56 -37.47 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.169 -0.469 . . . . 73.41 111.453 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.4 mttm -60.37 -48.83 80.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.743 0.306 . . . . 72.21 110.649 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.69 -38.19 71.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.241 -0.436 . . . . 60.04 111.484 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 56' ' ' VAL . 87.0 mt -65.2 -51.25 62.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.505 -0.316 . . . . 73.01 111.364 174.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -53.57 -55.02 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.647 -0.251 . . . . 72.12 111.445 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 45.0 mt-10 -47.51 -50.46 23.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.059 0.457 . . . . 75.44 110.773 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -55.15 -49.12 72.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.765 -0.652 . . . . 71.42 112.292 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.875 0.369 . . . . 73.32 111.722 -179.857 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.403 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 47.1 mm . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 112.727 0.64 . . . . 71.22 112.727 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.5 p -122.34 153.7 38.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.941 -0.572 . . . . 64.53 110.367 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.9 pttp -68.45 -13.46 62.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.959 0.409 . . . . 72.53 111.606 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.24 -22.67 59.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.205 0.526 . . . . 71.12 111.048 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.439 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.3 mtt -68.59 159.67 31.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.268 0.556 . . . . 61.32 111.718 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.27 135.87 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.031 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.8 mt -56.81 -50.88 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 111.892 0.33 . . . . 73.24 111.892 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.02 -37.33 74.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.942 0.401 . . . . 63.02 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.81 -44.48 96.78 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.162 -0.472 . . . . 75.44 110.62 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.13 -39.71 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.116 0.484 . . . . 72.34 110.837 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.464 HD21 ' OG1' ' A' ' 19' ' ' THR . 97.1 mt -62.69 -33.81 75.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.216 -0.447 . . . . 74.4 111.62 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 88.1 mt-30 -69.28 -20.83 63.91 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.7 0.286 . . . . 74.1 111.538 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.5 mtt -75.95 -56.45 4.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.374 0.607 . . . . 74.42 109.896 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -145.8 125.45 13.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.683 -0.69 . . . . 72.33 110.571 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.422 HH11 ' HB3' ' A' ' 13' ' ' LEU . 41.1 mmt180 -69.57 -19.53 63.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.516 -0.311 . . . . 75.14 111.591 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.07 -1.8 43.28 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.318 -0.467 . . . . 64.52 113.304 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.464 ' OG1' HD21 ' A' ' 13' ' ' LEU . 81.5 p -82.28 -17.21 46.7 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.461 -0.435 . . . . 53.15 111.183 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.491 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.21 -51.82 76.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.497 0.554 . . . . 74.42 112.497 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -56.95 -26.43 67.86 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.108 1.872 . . . . 72.31 112.612 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.14 -46.98 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.034 0.445 . . . . 70.12 110.672 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -58.98 -40.97 86.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.022 0.439 . . . . 75.22 110.504 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.97 -46.57 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.131 -0.486 . . . . 74.31 111.097 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -51.68 -48.61 63.41 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.181 0.515 . . . . 73.35 111.495 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.406 ' ND2' HD13 ' A' ' 55' ' ' LEU . 32.6 m-80 -77.63 -6.8 55.06 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.176 -0.465 . . . . 75.15 112.16 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.6 39.05 3.75 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.251 0.86 . . . . 64.14 115.251 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 CA--C 1.541 0.616 0 CA-C-N 117.806 0.803 . . . . 75.14 111.654 174.278 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 121.123 0.487 . . . . 74.34 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.6 m -67.03 157.78 32.65 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.364 -0.38 . . . . 74.53 111.437 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.3 mt -54.81 -54.93 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.867 0.321 . . . . 74.15 111.867 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.3 pt-20 -63.49 -30.68 71.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.707 0.289 . . . . 54.1 111.689 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.3 t70 -64.32 -61.84 1.98 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.919 0.39 . . . . 73.32 109.971 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.72 65.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.157 0.503 . . . . 65.15 111.588 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 81.4 m -57.57 -40.83 79.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.989 -0.55 . . . . 75.31 111.43 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.5 69.03 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.013 0.435 . . . . 63.12 111.627 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.4 t -69.98 -39.91 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.784 0.326 . . . . 74.52 111.831 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.511 ' HD1' HD13 ' A' ' 50' ' ' ILE . 8.7 t-160 -105.39 4.57 30.92 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.089 -0.382 . . . . 74.23 112.007 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.2 27.97 72.15 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.538 -0.363 . . . . 61.3 113.958 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.511 HD13 ' HD1' ' A' ' 48' ' ' HIS . 53.3 mt -85.53 153.73 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.973 0.416 . . . . 70.54 111.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.34 102.2 11.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.672 0.389 . . . . 52.44 111.675 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.42 85.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 71.43 111.417 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -51.43 -44.93 62.44 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.961 -0.563 . . . . 73.23 111.41 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.21 -39.1 34.12 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.224 -0.444 . . . . 72.22 111.969 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.406 HD13 ' ND2' ' A' ' 26' ' ' ASN . 26.4 tp -61.82 -52.81 62.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.918 0.39 . . . . 74.42 111.98 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.523 ' HA ' HD13 ' A' ' 59' ' ' LEU . 90.1 t -57.46 -37.01 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.956 0.354 . . . . 72.04 111.956 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -64.41 -42.22 96.19 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.625 -0.261 . . . . 71.31 111.354 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.98 -42.13 97.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.994 0.426 . . . . 70.22 110.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.523 HD13 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -58.37 -52.66 64.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.33 -0.396 . . . . 75.43 111.678 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -56.11 -54.5 44.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.744 0.307 . . . . 74.13 111.444 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.09 -31.65 52.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.537 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -69.34 -46.66 66.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.896 0.379 . . . . 74.43 111.696 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 CA--C 1.535 0.383 0 O-C-N 122.171 -0.33 . . . . 72.52 111.15 177.424 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.454 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 49.6 mm . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.994 0.426 . . . . 75.21 111.828 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 p -121.18 161.8 21.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.744 0.307 . . . . 73.44 110.996 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.857 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.9 pttp -69.34 -21.23 63.84 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.869 0.366 . . . . 74.34 111.658 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.66 -21.65 59.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.177 -0.465 . . . . 72.01 111.731 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -63.08 152.02 38.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.388 0.613 . . . . 73.12 112.125 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.88 130.5 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.97 -0.559 . . . . 73.54 111.107 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.41 -47.18 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 111.923 0.342 . . . . 74.45 111.923 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -60.45 -35.78 76.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.97 0.414 . . . . 37.9 111.338 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.58 -39.95 80.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.349 -0.387 . . . . 73.03 110.704 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.93 -41.79 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.277 0.56 . . . . 50.33 110.128 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.451 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.0 mt -64.19 -21.24 66.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.974 -0.557 . . . . 72.23 111.735 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 83.9 mm-40 -77.44 -30.72 53.47 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.719 0.295 . . . . 72.45 111.149 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.1 mtt -69.88 -45.89 66.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.317 0.58 . . . . 74.13 109.894 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.33 127.25 4.94 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.202 -0.908 . . . . 71.34 111.141 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -65.55 -26.34 67.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.285 -0.416 . . . . 73.43 111.686 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.62 -1.24 5.85 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 114.179 0.431 . . . . 61.32 114.179 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.451 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.4 p -85.86 -13.19 48.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.166 0.483 . . . . 72.34 111.589 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.68 -51.35 74.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.699 0.629 . . . . 72.04 112.699 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -56.93 -31.95 91.12 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.112 1.874 . . . . 64.33 112.628 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.07 -48.67 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.032 0.444 . . . . 65.04 110.836 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -60.25 -47.55 85.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.715 0.293 . . . . 64.41 111.263 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.33 -41.97 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.814 0.34 . . . . 71.21 111.428 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -58.15 -44.07 87.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.255 -0.43 . . . . 63.44 111.533 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -75.5 -9.9 58.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.282 0.475 . . . . 52.44 112.282 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.28 1.53 11.17 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 115.424 0.93 . . . . 74.34 115.424 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.471 0.589 0 CA-C-N 118.345 1.073 . . . . 74.24 111.762 179.316 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 112.3 0.481 . . . . 75.02 112.3 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -64.2 150.86 44.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.339 -0.391 . . . . 71.11 110.89 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mt -51.7 -56.29 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.466 0.543 . . . . 74.42 112.466 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.857 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.3 pt-20 -62.41 -39.75 94.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.813 0.339 . . . . 74.34 111.717 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 47' ' ' VAL . 35.7 t70 -64.64 -54.84 25.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.348 -0.387 . . . . 72.32 110.924 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.35 75.8 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.945 0.402 . . . . 52.33 111.235 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' GLY . 90.3 m -58.76 -52.75 64.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.377 -0.374 . . . . 72.51 111.123 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -42.88 81.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.714 0.264 . . . . 75.53 111.714 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 43' ' ' ASP . 60.6 t -60.58 -44.37 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.175 0.512 . . . . 73.21 111.342 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.459 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.5 t-80 -89.4 -2.7 58.5 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-N 116.257 -0.429 . . . . 62.14 111.505 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 67.77 29.87 74.1 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.65 -0.309 . . . . 54.31 113.519 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.459 HG13 ' HB3' ' A' ' 48' ' ' HIS . 45.5 mt -89.02 151.82 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 122.879 0.471 . . . . 72.2 111.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.03 102.7 9.44 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.81 0.338 . . . . 71.32 110.759 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.3 -23.64 61.21 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.201 0.445 . . . . 75.35 112.201 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.8 -51.07 71.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.959 0.409 . . . . 73.43 110.634 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 59.9 mtpt -63.66 -50.5 69.03 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.185 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 36.3 tp -56.19 -54.34 46.35 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.928 -0.578 . . . . 70.21 112.198 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.4 t -59.01 -43.83 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 111.818 0.303 . . . . 72.11 111.818 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.13 -42.82 99.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.679 0.276 . . . . 71.24 111.458 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 96.4 mt-10 -63.69 -39.93 95.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.832 0.349 . . . . 73.41 111.338 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 90.8 mt -59.06 -48.26 82.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.776 0.322 . . . . 71.53 111.322 174.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -54.63 -58.63 6.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.489 -0.323 . . . . 74.41 111.283 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -48.7 -41.4 31.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.944 0.402 . . . . 71.24 111.627 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -62.08 -54.85 35.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.213 -0.449 . . . . 74.22 112.158 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 111.778 0.288 . . . . 73.33 111.778 179.682 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.479 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 44.4 mm . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.682 0.277 . . . . 75.4 111.406 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.521 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 18.3 p -115.34 154.05 29.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.707 0.289 . . . . 75.22 110.771 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.778 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 49.9 pttt -68.95 -14.84 63.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.86 0.362 . . . . 73.14 111.844 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.9 -22.75 52.94 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.08 -0.509 . . . . 74.55 111.314 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.521 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 60.7 mtt -62.43 150.57 39.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.604 0.716 . . . . 74.21 112.873 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.65 133.77 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 73.4 111.185 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -51.01 -50.91 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 120.73 0.3 . . . . 74.22 111.806 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.494 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.03 -40.94 82.13 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.837 0.31 . . . . 73.32 111.837 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.3 -38.89 88.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.948 0.404 . . . . 64.23 111.026 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.532 ' HA ' ' HE1' ' A' ' 15' ' ' MET . 59.2 t -65.32 -44.92 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.134 0.492 . . . . 75.43 110.953 174.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.8 -33.16 71.36 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.041 -0.527 . . . . 72.11 111.987 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 82.5 mm-40 -61.42 -29.02 69.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.977 0.418 . . . . 73.44 111.618 177.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.532 ' HE1' ' HA ' ' A' ' 12' ' ' VAL . 31.0 mtm -84.15 -41.39 17.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.169 0.509 . . . . 72.11 110.346 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.22 120.96 3.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.002 -0.545 . . . . 74.43 111.325 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -69.83 -16.96 63.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 72.53 112.082 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -66.02 -7.75 38.79 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.236 -0.506 . . . . 53.24 113.144 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.2 p -80.24 -19.49 46.72 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.568 -0.372 . . . . 73.1 111.573 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.463 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.75 -51.78 77.56 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.501 0.556 . . . . 44.11 112.501 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 17.7 Cg_endo -59.12 -21.68 60.52 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.115 1.877 . . . . 71.4 112.634 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.4 mt -77.07 -41.7 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.974 0.416 . . . . 74.44 110.579 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -60.79 -45.85 92.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.139 0.495 . . . . 72.01 110.229 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.87 -39.11 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.988 -0.551 . . . . 74.14 110.991 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.93 -37.37 63.78 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.046 0.451 . . . . 74.25 111.782 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.483 ' ND2' HD13 ' A' ' 55' ' ' LEU . 33.6 m-80 -89.82 -2.29 58.19 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.31 0.485 . . . . 73.41 112.31 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 37.6 5.44 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.927 -0.654 . . . . 63.31 114.706 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 117.363 0.582 . . . . 71.4 111.656 173.439 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.156 0.503 . . . . 74.25 111.863 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -75.77 154.98 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.884 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -53.36 -58.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.702 0.63 . . . . 74.23 112.702 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.778 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.4 pt-20 -64.97 -33.55 76.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.863 0.364 . . . . 70.52 111.604 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 47' ' ' VAL . 25.7 t70 -64.49 -54.17 36.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.821 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.084 -0.507 . . . . 73.21 111.038 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.5 m -56.4 -49.21 75.13 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.431 -0.35 . . . . 75.12 110.913 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.0 67.54 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.902 0.334 . . . . 36.86 111.902 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 43' ' ' ASP . 61.8 t -67.41 -39.14 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.872 0.368 . . . . 72.55 111.552 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.01 9.76 24.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.774 0.321 . . . . 75.44 111.839 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.31 31.54 81.19 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.522 -0.371 . . . . 72.31 113.329 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.74 153.28 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.538 0.335 . . . . 60.42 111.646 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.38 107.09 16.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.944 0.402 . . . . 73.44 110.298 175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -28.74 56.8 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.011 0.374 . . . . 65.14 112.011 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.44 -47.16 84.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.862 0.363 . . . . 62.14 110.776 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.35 -45.93 52.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.586 -0.279 . . . . 74.32 111.594 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.483 HD13 ' ND2' ' A' ' 26' ' ' ASN . 25.0 tp -53.18 -51.4 62.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.996 0.427 . . . . 75.51 111.694 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 5' ' ' LYS . 88.0 t -59.91 -41.81 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.686 0.279 . . . . 65.53 111.602 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.04 -39.47 90.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.545 0.202 . . . . 74.44 111.545 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.76 -37.03 80.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 73.42 110.723 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 79.8 mt -65.83 -51.14 61.4 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.454 -0.339 . . . . 73.23 111.764 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.479 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 40.5 m-80 -56.21 -51.66 67.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.926 0.343 . . . . 71.34 111.926 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.62 -34.83 69.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.813 0.34 . . . . 64.32 111.632 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.466 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 94.3 t80 -59.35 -48.31 82.11 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.84 0.352 . . . . 63.22 111.181 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 15' ' ' MET . 57.0 m-85 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 116.649 -0.251 . . . . 72.42 111.253 177.032 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.553 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.7 mm . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 112.717 0.636 . . . . 61.43 112.717 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -122.28 156.87 32.94 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.274 -0.421 . . . . 73.55 110.725 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.5 ptpt -66.76 -14.07 62.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.796 0.331 . . . . 73.14 111.809 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.7 -19.33 41.77 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.227 -0.442 . . . . 62.1 111.279 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.553 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 53.6 mtt -63.19 151.39 40.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.283 0.563 . . . . 73.24 112.05 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 42.0 mm -82.62 138.24 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.879 -0.6 . . . . 64.21 110.518 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -53.5 -49.21 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 120.865 0.364 . . . . 64.12 111.825 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -62.16 -32.01 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.867 0.365 . . . . 71.34 111.718 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.75 -43.7 88.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.039 0.447 . . . . 73.12 110.637 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.67 -36.3 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.211 0.529 . . . . 74.14 110.793 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.403 HD22 ' OG1' ' A' ' 19' ' ' THR . 96.6 mt -65.61 -24.44 67.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.119 -0.491 . . . . 72.2 111.778 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 73.8 mt-30 -69.48 -32.96 72.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.158 0.504 . . . . 51.33 110.909 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.5 mtt -71.21 -50.46 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.812 -0.631 . . . . 70.44 110.674 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.88 135.96 13.87 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.821 -0.627 . . . . 64.32 110.632 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -72.72 -21.86 60.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.836 0.35 . . . . 75.21 111.909 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.77 3.18 45.16 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.251 -0.432 . . . . 52.23 113.807 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.403 ' OG1' HD22 ' A' ' 13' ' ' LEU . 71.4 p -81.31 -21.29 39.37 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.387 -0.478 . . . . 73.54 111.674 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.81 -51.41 80.62 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 112.741 0.645 . . . . 72.15 112.741 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.7 Cg_endo -57.31 -26.01 68.25 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.201 1.934 . . . . 71.2 112.785 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -69.2 -47.07 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.079 0.466 . . . . 71.32 110.7 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.95 -44.55 82.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.157 0.503 . . . . 64.45 110.3 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.8 mt -60.78 -40.62 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.982 -0.554 . . . . 64.21 111.475 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -55.55 -36.02 66.34 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.131 0.491 . . . . 74.1 111.803 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.424 ' ND2' HD13 ' A' ' 55' ' ' LEU . 35.0 m-80 -91.25 1.41 57.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.443 0.534 . . . . 72.41 112.443 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.07 18.54 17.14 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.097 0.799 . . . . 73.23 115.097 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 118.109 0.954 . . . . 64.21 111.543 175.119 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.17 0.509 . . . . 74.02 111.775 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.4 p -78.05 162.96 26.32 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.107 0.48 . . . . 72.12 112.201 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.92 -52.74 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.898 -0.592 . . . . 64.44 112.101 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 17.2 pt-20 -62.95 -37.22 86.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.833 0.349 . . . . 73.24 111.752 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -67.53 -49.81 61.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.345 -0.389 . . . . 72.42 110.778 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.97 93.96 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.035 0.445 . . . . 73.53 111.72 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -59.28 -51.22 70.9 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.408 -0.36 . . . . 62.45 111.458 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.52 69.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.987 0.366 . . . . 72.32 111.987 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.29 -48.59 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.93 0.395 . . . . 53.43 111.477 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HB3' HG13 ' A' ' 50' ' ' ILE . 65.2 t-80 -82.27 -11.88 58.38 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.369 -0.378 . . . . 74.02 111.596 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.28 40.8 15.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.52 -0.371 . . . . 72.43 113.031 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.404 HG13 ' HB3' ' A' ' 48' ' ' HIS . 18.9 mt -103.63 152.16 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.708 0.403 . . . . 63.04 111.177 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -80.48 97.65 7.22 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.073 0.463 . . . . 65.53 109.879 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -60.74 -37.48 81.93 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.604 0.594 . . . . 73.31 112.604 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 12.4 t70 -64.1 -39.75 94.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.657 -0.417 . . . . 72.12 110.493 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.02 -41.43 90.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.785 0.326 . . . . 73.53 111.218 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.424 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.0 tp -61.85 -50.05 73.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.958 0.409 . . . . 72.31 111.405 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 52' ' ' ALA . 93.4 t -55.86 -35.23 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.371 -0.377 . . . . 73.25 111.875 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 58.0 mttm -57.06 -54.96 40.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.664 0.269 . . . . 71.04 110.982 176.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -56.85 -39.6 74.57 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.433 -0.349 . . . . 73.53 111.335 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 56' ' ' VAL . 89.1 mt -60.19 -51.93 67.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.507 -0.315 . . . . 63.22 111.494 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -56.59 -50.03 73.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.508 0.194 . . . . 72.14 111.453 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.447 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 63.7 mt-10 -54.75 -42.11 71.22 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.46 -0.336 . . . . 75.11 111.143 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -54.45 -44.72 72.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.868 0.366 . . . . 74.32 111.744 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.863 0.363 . . . . 73.55 110.975 177.359 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 48.4 mm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 112.814 0.672 . . . . 71.34 112.814 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.459 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 43.1 p -117.35 156.2 28.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.745 -0.661 . . . . 74.52 110.403 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.667 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 21.2 pttp -68.94 -13.46 62.45 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.007 0.432 . . . . 60.31 111.557 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.03 -22.51 45.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.27 -0.423 . . . . 62.32 111.284 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.459 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 67.2 mtt -64.73 153.98 38.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.295 0.569 . . . . 54.33 112.102 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -82.25 139.83 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.983 -0.553 . . . . 75.52 111.659 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.3 -55.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.189 0.44 . . . . 62.42 112.189 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.83 -35.61 73.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.737 0.303 . . . . 72.21 111.517 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.56 -43.8 89.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.047 0.451 . . . . 74.32 111.065 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.19 -43.72 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.775 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.24 -27.91 69.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.094 -0.503 . . . . 71.53 111.912 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 18.5 mm-40 -63.18 -27.98 69.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.8 0.334 . . . . 75.41 111.397 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.78 -49.15 7.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.029 0.442 . . . . 74.03 110.879 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -148.21 119.84 8.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.226 -0.443 . . . . 62.13 111.396 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 17' ' ' ARG . 12.6 mmt180 -75.48 -8.34 56.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.382 0.512 . . . . 71.03 112.382 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.02 -8.23 68.64 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.227 -0.511 . . . . 72.24 112.459 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.4 p -81.05 -18.04 48.09 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.696 -0.297 . . . . 72.3 111.45 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.91 -52.1 75.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 112.178 0.436 . . . . 53.34 112.178 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -59.52 -28.16 86.78 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.03 1.82 . . . . 74.14 112.318 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.71 -46.63 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.057 0.456 . . . . 71.14 110.894 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 58.5 m-85 -56.75 -48.97 76.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.088 0.47 . . . . 73.34 110.529 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.34 -36.15 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.013 -0.539 . . . . 74.43 111.568 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -57.38 -33.11 67.48 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.081 0.467 . . . . 62.55 111.203 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -92.58 -4.4 53.49 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.197 -0.456 . . . . 74.43 112.068 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.42 -13.34 11.03 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.74 -0.743 . . . . 71.52 114.559 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.488 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.7 mmt . . . . . 0 N--CA 1.476 0.827 0 CA-C-N 117.559 0.679 . . . . 53.12 111.746 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.065 0.46 . . . . 63.32 111.911 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.3 m -66.6 147.44 53.27 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.224 -0.444 . . . . 72.13 110.252 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.449 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.7 mt -50.49 -56.95 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.642 0.608 . . . . 73.51 112.642 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.2 pt-20 -62.99 -35.99 82.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.847 0.356 . . . . 73.42 111.791 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 t70 -65.29 -52.0 57.01 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.064 -0.517 . . . . 73.41 110.767 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.3 79.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.169 -0.469 . . . . 73.21 111.484 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 41' ' ' ILE . 85.8 m -58.27 -54.93 41.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.469 -0.332 . . . . 73.43 111.163 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -37.26 64.24 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.838 0.352 . . . . 73.41 111.841 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -59.72 -52.2 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.392 -0.367 . . . . 73.52 111.839 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -92.12 -0.67 57.44 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.109 0.411 . . . . 73.15 112.109 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.55 46.33 40.65 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.443 -0.408 . . . . 64.43 113.283 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mt -101.91 151.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 122.704 0.401 . . . . 75.34 111.264 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -85.14 98.52 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.035 0.445 . . . . 71.21 110.654 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.35 66.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.429 -0.35 . . . . 73.22 111.78 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.46 -51.82 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.585 -0.279 . . . . 62.33 111.159 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -76.91 -40.16 48.26 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.04 0.385 . . . . 64.23 112.04 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 tp -55.63 -53.69 53.36 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.783 0.325 . . . . 70.11 111.747 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 5' ' ' LYS . 59.8 t -61.16 -39.93 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.659 0.266 . . . . 72.33 111.595 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.4 mttt -60.8 -45.78 93.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.802 -0.181 . . . . 71.24 111.315 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.15 -40.0 88.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.751 0.31 . . . . 72.24 111.453 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 56' ' ' VAL . 87.9 mt -59.24 -52.72 64.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.813 0.339 . . . . 72.2 111.51 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 3' ' ' ILE . 52.9 m-80 -57.74 -49.94 74.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.429 -0.351 . . . . 73.11 111.745 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.416 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 46.7 mt-10 -52.57 -44.43 65.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.462 -0.336 . . . . 63.14 110.782 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -57.69 -54.15 50.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.336 -0.393 . . . . 72.15 112.054 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.993 0.368 . . . . 74.4 111.993 -179.665 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.47 HG21 HG12 ' A' ' 56' ' ' VAL . 50.9 mm . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.944 0.72 . . . . 75.31 112.944 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.8 p -125.82 158.58 34.64 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.69 -0.686 . . . . 63.34 109.939 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.4 pttp -71.92 -15.17 62.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.015 -0.428 . . . . 41.14 111.252 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.84 -23.56 61.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.04 -0.527 . . . . 74.44 111.192 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.42 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.9 mtt -67.64 165.33 17.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.397 0.518 . . . . 74.2 112.397 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 12' ' ' VAL . 47.2 mm -93.75 135.53 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.992 -0.549 . . . . 61.42 111.581 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.7 -51.31 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.821 0.343 . . . . 65.0 111.849 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.13 -41.52 83.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.805 0.336 . . . . 64.42 111.73 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.66 -45.01 90.28 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.407 -0.361 . . . . 74.31 110.95 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.518 ' HA ' ' HE1' ' A' ' 15' ' ' MET . 88.7 t -57.53 -43.42 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.957 0.408 . . . . 73.43 111.2 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.412 HD21 ' OG1' ' A' ' 19' ' ' THR . 94.9 mt -62.68 -34.4 77.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.321 -0.399 . . . . 71.42 111.395 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 78.8 mt-30 -67.61 -30.16 69.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.386 -0.37 . . . . 63.51 111.661 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.518 ' HE1' ' HA ' ' A' ' 12' ' ' VAL . 37.2 mtm -74.45 -43.2 57.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.3 0.572 . . . . 65.0 109.949 175.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -159.49 124.67 4.11 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.614 -0.721 . . . . 73.52 111.756 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -69.47 -14.7 63.02 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.992 -0.549 . . . . 72.54 111.766 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.502 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -65.51 -9.75 45.54 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.067 -0.587 . . . . 73.32 113.178 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.412 ' OG1' HD21 ' A' ' 13' ' ' LEU . 80.7 p -82.43 -13.85 56.11 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.44 -0.447 . . . . 70.23 111.757 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.496 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.03 -51.07 80.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.604 0.594 . . . . 75.31 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.5 Cg_endo -58.92 -26.45 81.13 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.169 1.913 . . . . 74.12 112.677 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -71.41 -44.1 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.97 0.414 . . . . 74.33 110.789 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -63.76 -46.03 87.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.972 0.415 . . . . 73.53 110.55 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.56 -39.16 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.205 -0.452 . . . . 64.01 111.259 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.43 -40.7 71.83 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.076 0.465 . . . . 72.5 111.541 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.74 0.42 43.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.14 -0.482 . . . . 75.2 112.041 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 9.51 45.31 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 114.826 0.69 . . . . 71.53 114.826 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 118.093 0.946 . . . . 74.15 111.817 179.279 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 121.253 0.549 . . . . 75.23 112.344 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.7 m -70.29 151.53 45.19 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.041 -0.527 . . . . 72.31 111.899 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.0 mt -52.67 -57.66 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.376 0.509 . . . . 74.22 112.376 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.6 pt-20 -58.61 -35.56 72.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.912 0.387 . . . . 74.24 111.78 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.412 ' O ' HG22 ' A' ' 47' ' ' VAL . 17.9 t70 -68.85 -53.61 20.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.202 -0.454 . . . . 73.22 111.144 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.41 79.16 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.267 -0.424 . . . . 72.22 111.245 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -60.22 -52.25 66.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 74.11 110.825 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.0 -47.94 64.69 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.411 -0.358 . . . . 38.22 111.871 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 43' ' ' ASP . 59.9 t -51.94 -38.27 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 52.42 111.928 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -103.18 0.51 31.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.294 0.479 . . . . 73.35 112.294 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.57 74.07 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.161 -0.543 . . . . 44.41 113.501 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.6 153.13 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.899 0.38 . . . . 72.32 111.307 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -86.07 105.09 16.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.872 0.368 . . . . 72.15 110.877 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.5 -36.07 68.29 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.045 0.387 . . . . 72.23 112.045 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.74 -44.73 77.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.029 0.442 . . . . 75.34 111.003 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -69.2 -52.02 32.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.343 -0.39 . . . . 75.21 111.469 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -55.09 -49.62 71.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.21 0.448 . . . . 73.33 112.21 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 5' ' ' LYS . 75.2 t -60.31 -42.1 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 111.978 0.362 . . . . 73.45 111.978 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.71 -35.39 77.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.818 0.342 . . . . 74.45 111.217 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.63 -38.25 86.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.921 0.391 . . . . 73.05 110.999 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.42 -45.0 73.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.204 -0.453 . . . . 73.41 111.971 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -53.58 -56.4 17.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.794 0.294 . . . . 73.15 111.794 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -46.68 -52.53 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 75.52 111.327 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.502 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 80.4 t80 -50.43 -55.36 16.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.54 0.57 . . . . 74.41 112.54 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.51 ' CZ ' ' HE3' ' A' ' 15' ' ' MET . 56.2 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.244 0.461 . . . . 73.44 112.244 -178.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.512 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 120.71 0.291 . . . . 75.14 111.435 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 p -121.61 154.69 36.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.841 0.353 . . . . 74.44 111.287 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 18.3 ptpt -53.54 -33.34 54.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.185 0.809 . . . . 75.42 113.185 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.09 -3.39 42.06 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.883 0.697 . . . . 61.45 112.883 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.2 mtt -73.38 150.79 41.52 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.122 0.487 . . . . 71.15 111.67 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.6 mm -79.78 131.04 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.237 -0.438 . . . . 72.33 111.444 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.8 mt -56.25 -51.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 111.89 0.329 . . . . 72.04 111.89 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -56.38 -40.11 74.06 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.891 0.377 . . . . 72.3 111.385 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -43.4 96.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.261 -0.427 . . . . 75.13 110.709 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.1 -41.55 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.089 0.471 . . . . 75.2 110.986 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD21 ' OG1' ' A' ' 19' ' ' THR . 94.7 mt -61.42 -35.89 78.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.033 0.444 . . . . 72.35 111.163 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mt-30 -67.66 -22.21 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.257 -0.429 . . . . 64.04 111.598 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -74.2 -58.56 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.254 0.549 . . . . 74.53 109.643 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -146.83 127.51 14.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.612 -0.722 . . . . 74.23 110.825 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . 0.433 HH12 ' HA ' ' A' ' 14' ' ' GLN . 77.8 mmt-85 -69.18 -17.59 63.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.783 0.29 . . . . 73.11 111.783 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.2 -6.75 41.18 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.211 -0.519 . . . . 71.13 113.217 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.431 ' HA ' HD11 ' A' ' 22' ' ' ILE . 80.9 p -81.62 -21.27 38.38 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.557 -0.378 . . . . 70.53 111.251 174.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.489 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -57.09 -51.14 83.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 112.181 0.438 . . . . 73.14 112.181 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.79 -25.44 76.16 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.941 1.761 . . . . 74.22 112.281 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . 0.431 HD11 ' HA ' ' A' ' 19' ' ' THR . 59.9 mt -73.22 -45.43 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.013 0.435 . . . . 72.11 110.72 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -57.01 -52.17 66.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.056 0.455 . . . . 64.04 110.522 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.81 -37.32 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.272 -0.422 . . . . 63.33 111.368 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -55.9 -33.64 64.83 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.137 0.494 . . . . 74.1 111.251 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -91.43 -4.12 55.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.241 0.459 . . . . 72.11 112.241 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.18 19.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.984 -0.627 . . . . 74.31 114.438 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.47 0.565 0 CA-C-N 117.593 0.696 . . . . 54.33 111.807 176.19 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.685 0.755 . . . . 75.23 112.772 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 94.1 p -78.84 164.13 24.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.526 -0.761 . . . . 70.4 112.011 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.07 -48.79 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.593 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 8.0 pt-20 -62.56 -37.18 85.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.982 0.364 . . . . 60.04 111.982 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 47' ' ' VAL . 22.2 t70 -66.01 -58.99 4.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.71 0.29 . . . . 74.14 110.703 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.37 65.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.778 0.323 . . . . 74.15 111.65 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.819 0.342 . . . . 72.4 110.753 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.12 68.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.835 0.309 . . . . 75.4 111.835 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 43' ' ' ASP . 76.7 t -66.45 -54.58 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.939 0.4 . . . . 71.41 111.747 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.75 -18.69 30.52 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.881 0.372 . . . . 64.12 111.748 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.18 53.15 2.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 121.178 0.321 . . . . 72.02 113.066 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.9 mt -110.88 153.15 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.01 0.524 . . . . 60.03 111.107 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . 0.422 ' OD2' ' HG3' ' A' ' 54' ' ' LYS . 14.6 t70 -84.74 103.06 13.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.946 0.403 . . . . 72.02 110.243 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.14 -34.15 75.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.377 0.51 . . . . 74.14 112.377 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.65 -45.01 90.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.749 0.309 . . . . 73.4 111.181 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 92.0 mttt -66.42 -49.06 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.955 0.407 . . . . 74.15 111.036 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.17 -52.87 63.75 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.112 -0.495 . . . . 73.13 111.819 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.442 ' HA ' HD13 ' A' ' 59' ' ' LEU . 96.2 t -58.57 -40.02 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.731 0.3 . . . . 65.15 111.639 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.47 -44.92 95.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.538 0.209 . . . . 74.13 111.39 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -62.96 -35.6 80.68 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.847 0.356 . . . . 60.42 111.314 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 56' ' ' VAL . 90.8 mt -64.09 -51.4 64.18 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.468 -0.333 . . . . 73.44 111.619 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -58.31 -49.92 75.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.676 0.274 . . . . 72.54 111.571 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.29 -46.88 55.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.568 -0.287 . . . . 72.51 110.9 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -54.31 -51.77 63.62 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.305 0.483 . . . . 73.14 112.305 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.547 0.213 . . . . 70.34 111.429 179.379 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 mm . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.828 0.347 . . . . 63.22 111.324 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 p -127.33 154.07 45.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.711 0.291 . . . . 64.33 110.719 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.46 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 10.2 ptpp? -64.46 -15.79 61.32 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.157 0.504 . . . . 71.24 111.237 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.44 -25.2 63.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.591 -0.731 . . . . 63.43 111.287 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.7 mtt -71.71 149.41 45.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.237 0.828 . . . . 64.11 113.237 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mm -78.76 133.37 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.405 -0.816 . . . . 73.22 110.928 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.67 -42.04 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 111.896 0.332 . . . . 63.52 111.896 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.0 94.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.964 0.357 . . . . 61.12 111.964 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.65 -45.99 88.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.093 0.473 . . . . 74.52 110.957 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HA ' ' HE2' ' A' ' 15' ' ' MET . 42.7 t -57.51 -37.52 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 74.04 111.249 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.36 -37.17 86.23 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.323 -0.399 . . . . 74.44 111.235 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -65.26 -21.83 66.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.365 -0.38 . . . . 72.41 111.428 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 12' ' ' VAL . 29.7 mtm -84.68 -52.15 6.29 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.157 0.503 . . . . 74.13 110.091 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -146.55 128.81 15.76 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.919 -0.582 . . . . 73.55 111.042 176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -73.04 -22.75 60.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.299 0.481 . . . . 71.31 112.299 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.55 -2.84 51.96 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.447 -0.406 . . . . 36.26 113.56 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 p -80.26 -24.39 40.13 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.502 -0.411 . . . . 61.24 111.762 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.46 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.7 -52.5 66.81 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.715 0.635 . . . . 74.53 112.715 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.0 Cg_endo -58.88 -24.57 73.04 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.117 1.878 . . . . 71.25 112.706 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -71.82 -44.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.928 0.394 . . . . 64.51 110.633 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.96 -49.9 76.11 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.185 0.517 . . . . 75.01 110.288 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -61.22 -34.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.111 -0.495 . . . . 55.22 111.265 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -57.76 -34.42 69.53 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.912 0.387 . . . . 64.52 111.326 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -93.73 12.94 23.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.398 0.518 . . . . 73.35 112.398 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.22 38.1 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.707 -0.758 . . . . 40.22 114.846 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 117.82 0.81 . . . . 65.51 111.32 176.608 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.079 0.466 . . . . 72.44 111.65 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -68.96 153.45 43.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.411 -0.358 . . . . 62.55 111.063 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 5' ' ' LYS . 22.5 mt -52.16 -52.53 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 72.15 112.583 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 11.2 pt-20 -61.08 -33.1 72.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.964 0.412 . . . . 62.35 111.886 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 47' ' ' VAL . 39.0 t70 -75.87 -59.19 2.87 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 72.53 110.953 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.48 -43.0 83.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.308 -0.405 . . . . 64.51 111.916 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.06 -49.04 77.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.364 -0.21 . . . . 74.44 111.438 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.15 73.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.008 0.432 . . . . 65.23 111.642 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 43' ' ' ASP . 87.0 t -61.05 -45.48 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.197 -0.456 . . . . 61.03 111.815 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -90.03 -10.38 45.09 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.716 0.293 . . . . 72.53 111.787 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.31 35.94 25.24 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.47 -0.395 . . . . 50.11 113.308 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.64 152.89 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.986 0.422 . . . . 72.11 111.721 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -82.24 97.42 8.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.026 0.441 . . . . 72.32 109.865 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -65.31 -31.55 72.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.524 0.565 . . . . 53.13 112.524 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 35.6 t70 -60.93 -45.31 95.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.898 0.38 . . . . 73.13 110.716 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.24 -40.42 77.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.784 0.326 . . . . 75.21 111.501 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 41' ' ' ILE . 23.2 tp -58.88 -49.89 76.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.056 0.455 . . . . 74.11 111.433 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 52' ' ' ALA . 92.4 t -57.48 -38.78 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.269 -0.423 . . . . 70.04 111.805 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.2 mttm -56.58 -53.68 54.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.769 0.319 . . . . 75.12 111.37 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.05 -36.51 75.16 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.46 -0.336 . . . . 75.43 111.638 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.93 -49.44 74.76 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 111.84 0.311 . . . . 73.31 111.84 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -59.09 -52.4 65.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.657 0.265 . . . . 62.1 111.397 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -54.2 -41.28 68.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.221 -0.445 . . . . 72.31 111.53 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.16 -51.78 66.75 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.18 0.437 . . . . 74.53 112.18 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.442 ' CZ ' ' HE1' ' A' ' 15' ' ' MET . 55.1 m-85 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 120.617 0.246 . . . . 71.45 111.455 178.289 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.523 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.1 mm . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.738 0.304 . . . . 53.45 111.652 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.408 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 36.4 p -121.69 162.92 19.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.847 0.356 . . . . 75.43 110.902 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.04 -14.94 62.5 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.892 0.377 . . . . 74.11 111.506 178.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.73 -15.93 57.85 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.101 0.476 . . . . 70.23 111.403 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 65.0 mtt -72.82 154.29 40.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.428 0.632 . . . . 61.33 112.206 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -81.87 133.72 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.65 -0.705 . . . . 75.14 111.485 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.19 -51.45 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.173 0.434 . . . . 52.41 112.173 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -32.97 65.94 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 74.43 111.621 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.02 -45.13 71.25 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.724 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.7 -37.21 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.259 0.552 . . . . 71.23 110.744 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.94 -31.13 72.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.115 -0.493 . . . . 74.43 111.919 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -71.6 -29.45 64.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.921 0.391 . . . . 73.15 111.061 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.0 mtt -66.52 -52.12 49.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.344 0.592 . . . . 72.22 110.03 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -154.77 135.3 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.786 -0.643 . . . . 74.1 111.225 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -68.84 -24.92 64.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.339 -0.391 . . . . 74.42 111.69 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.438 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -69.06 -1.37 25.82 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.379 -0.373 . . . . 70.35 113.874 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.9 p -82.58 -22.88 34.68 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.607 -0.349 . . . . 72.12 111.518 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.96 -51.39 79.83 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 112.59 0.589 . . . . 73.02 112.59 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -59.61 -26.36 81.84 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 121.896 1.731 . . . . 60.45 112.637 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -44.78 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.925 0.393 . . . . 75.32 110.846 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -56.59 -50.4 72.09 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.057 0.456 . . . . 75.24 110.173 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.93 -39.69 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.118 -0.492 . . . . 73.41 111.337 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.86 -39.73 68.93 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.052 -0.522 . . . . 72.41 111.849 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.61 -3.53 58.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.184 0.438 . . . . 64.41 112.184 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.44 0.72 11.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.476 0.95 . . . . 71.33 115.476 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.474 0.737 0 CA-C-N 118.285 1.042 . . . . 63.5 111.815 178.84 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 121.307 0.575 . . . . 63.54 112.024 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.7 m -72.26 151.26 42.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.97 -0.559 . . . . 63.4 112.24 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -51.35 -48.88 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.793 0.664 . . . . 61.32 112.793 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 14.9 pt-20 -63.17 -35.34 79.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.852 0.358 . . . . 55.03 111.642 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 47' ' ' VAL . 36.8 t0 -69.72 -53.56 17.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.189 -0.46 . . . . 75.44 110.751 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.75 71.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.212 0.53 . . . . 75.23 111.297 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 84.0 m -59.67 -52.92 63.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.948 -0.569 . . . . 62.35 111.199 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -39.68 69.85 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.252 0.464 . . . . 75.42 112.252 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 43' ' ' ASP . 91.9 t -59.56 -42.31 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.837 0.351 . . . . 75.01 111.446 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -104.23 9.81 35.93 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.306 0.484 . . . . 74.1 112.306 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.21 18.31 71.05 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 114.279 0.472 . . . . 61.34 114.279 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 45' ' ' CYS . 56.7 mt -73.59 154.86 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 122.526 0.33 . . . . 73.24 111.475 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.28 96.48 10.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.14 0.495 . . . . 74.33 110.61 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -67.48 -34.79 77.89 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.336 -0.393 . . . . 73.01 111.894 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 30.2 t70 -58.42 -42.5 87.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.613 -0.267 . . . . 72.23 111.494 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.54 -39.28 67.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.943 0.402 . . . . 72.41 111.288 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.3 tp -59.84 -49.47 77.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 73.44 111.636 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.514 ' HA ' HD13 ' A' ' 59' ' ' LEU . 92.3 t -57.38 -36.73 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.371 -0.377 . . . . 73.5 111.816 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.4 mttm -56.32 -55.24 35.84 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.851 0.357 . . . . 63.33 111.171 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.83 -35.29 74.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.388 -0.369 . . . . 74.24 111.964 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 56' ' ' VAL . 93.0 mt -60.64 -52.9 63.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.645 0.259 . . . . 64.13 111.449 175.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -58.92 -51.81 68.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.82 0.343 . . . . 52.1 111.721 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.06 -30.18 65.98 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.029 0.381 . . . . 62.01 112.029 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.438 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 90.0 t80 -64.02 -44.91 91.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.938 0.399 . . . . 72.0 111.359 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 CA--C 1.538 0.496 0 O-C-N 122.224 -0.297 . . . . 72.23 111.133 177.896 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.535 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.4 mm . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.77 0.655 . . . . 72.11 112.77 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -120.76 159.37 25.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.195 -0.457 . . . . 64.03 110.953 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.627 ' HZ2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -64.26 -15.92 61.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.087 0.47 . . . . 73.51 111.319 176.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.2 -26.37 56.06 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.654 -0.703 . . . . 74.41 111.552 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.535 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -65.57 158.42 27.15 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.423 0.63 . . . . 72.44 112.686 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 49.8 mm -84.54 134.96 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.926 -0.579 . . . . 70.33 111.329 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -56.66 -49.51 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.42 . . . . 71.45 111.312 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.92 68.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.307 -0.406 . . . . 71.32 111.516 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 13.2 t70 -72.59 -40.78 66.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.487 -0.324 . . . . 72.35 110.807 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 8' ' ' ILE . 57.9 t -57.72 -37.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.148 0.499 . . . . 73.13 110.335 173.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.15 -36.04 82.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.139 -0.482 . . . . 63.35 110.983 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.33 -29.3 70.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.727 0.298 . . . . 71.32 111.174 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -71.47 -49.29 42.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.224 0.535 . . . . 73.13 110.035 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -160.43 130.98 5.42 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.496 -0.775 . . . . 74.32 110.893 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -72.04 -20.28 61.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.959 0.355 . . . . 74.11 111.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.65 -1.44 45.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.56 -0.353 . . . . 74.33 113.476 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -19.55 46.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.521 -0.4 . . . . 75.32 111.721 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.09 -49.91 87.31 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.353 0.501 . . . . 72.01 112.353 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 76.7 Cg_exo -48.99 -42.08 38.92 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.399 2.066 . . . . 64.35 112.826 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.94 -45.31 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.403 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -58.67 -46.88 86.23 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 71.5 110.508 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -58.96 -39.07 77.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.019 -0.537 . . . . 73.41 111.387 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.62 -36.29 73.83 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.312 -0.404 . . . . 64.4 111.571 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -86.68 4.46 40.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.637 0.606 . . . . 74.02 112.637 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.54 39.97 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.672 -0.775 . . . . 74.52 114.499 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 117.677 0.739 . . . . 73.35 111.419 175.347 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.303 0.573 . . . . 73.31 112.349 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 92.5 p -78.63 161.54 26.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.391 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.8 mt -56.67 -47.81 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.493 -0.321 . . . . 75.51 111.781 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.07 -43.27 99.19 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.698 0.258 . . . . 74.03 111.698 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.14 -52.05 66.98 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.05 0.389 . . . . 74.54 112.05 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.49 88.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.777 0.322 . . . . 71.31 111.614 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.6 m -53.52 -46.46 70.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.68 -0.236 . . . . 73.41 111.166 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.04 67.61 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.987 0.365 . . . . 74.31 111.987 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.2 -46.14 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.976 0.417 . . . . 63.11 111.504 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -89.04 -10.02 49.07 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.456 -0.338 . . . . 64.14 111.73 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.26 37.87 30.83 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.106 -0.568 . . . . 72.15 112.795 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.8 mt -93.03 151.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.663 0.385 . . . . 75.24 111.293 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -80.88 102.01 9.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.958 0.409 . . . . 74.33 110.383 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.99 65.14 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.153 0.427 . . . . 74.15 112.153 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.22 -50.91 71.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.88 0.371 . . . . 71.33 110.446 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -70.26 -47.93 59.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.525 . . . . 73.03 112.032 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.5 tp -52.76 -52.64 55.75 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.952 0.406 . . . . 65.44 111.725 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.499 HG12 HG21 ' A' ' 3' ' ' ILE . 88.1 t -61.05 -40.52 85.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 74.35 111.78 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 98.7 mttt -69.72 -29.45 66.84 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.22 -0.3 . . . . 64.44 111.745 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.61 -39.4 73.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.879 0.371 . . . . 62.32 110.794 171.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 56' ' ' VAL . 87.8 mt -58.12 -46.83 84.9 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.378 -0.374 . . . . 73.14 110.674 172.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -54.2 -55.97 22.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.251 -0.431 . . . . 73.21 111.595 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . 0.487 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 46.0 mt-10 -46.05 -48.82 16.85 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.075 0.464 . . . . 75.55 111.201 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -54.21 -52.4 61.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.87 -0.605 . . . . 74.24 112.384 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.723 0.297 . . . . 71.1 111.352 179.406 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.4 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 44.4 mm . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 120.69 0.281 . . . . 73.55 111.496 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 27.3 p -119.27 155.31 32.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.66 0.267 . . . . 74.34 110.862 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 17.0 ptpt -64.67 -14.66 59.24 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.177 0.513 . . . . 71.01 111.415 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.55 -16.07 55.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.691 -0.686 . . . . 73.2 111.669 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.43 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.4 mtt -75.39 164.87 25.95 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.506 0.67 . . . . 73.1 112.582 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -88.57 138.06 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.568 -0.742 . . . . 74.52 111.513 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.1 mt -54.5 -53.28 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.994 0.426 . . . . 70.22 111.699 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.84 75.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.833 0.349 . . . . 74.33 111.796 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.77 -39.63 94.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.802 0.334 . . . . 75.44 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.38 -39.73 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.044 0.45 . . . . 60.34 110.844 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.492 HD21 ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -61.43 -34.53 75.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.149 0.5 . . . . 74.43 111.096 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -68.89 -18.77 64.17 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.056 -0.52 . . . . 51.2 111.485 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.4 mtt -81.23 -50.35 9.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.38 0.61 . . . . 73.1 109.791 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.5 132.5 14.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.965 -0.561 . . . . 70.34 111.716 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -74.17 -16.25 60.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.606 0.595 . . . . 72.25 112.606 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.57 -2.21 79.59 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.14 -0.552 . . . . 71.12 113.415 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.492 ' OG1' HD21 ' A' ' 13' ' ' LEU . 74.3 p -80.51 -22.1 41.26 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.114 0.413 . . . . 74.42 112.114 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.83 -50.64 84.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 112.722 0.638 . . . . 74.45 112.722 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 75.7 Cg_exo -49.86 -41.24 47.71 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.198 1.932 . . . . 72.3 112.657 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.41 -44.98 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.167 -0.47 . . . . 72.4 111.492 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -58.24 -51.56 69.23 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 63.13 110.936 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.51 -38.98 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.928 0.394 . . . . 75.54 111.107 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -51.86 -41.87 62.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.979 -0.555 . . . . 71.43 111.536 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -85.48 -4.26 59.11 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.277 0.473 . . . . 73.11 112.277 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.5 -5.35 9.31 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.662 -0.78 . . . . 62.55 114.972 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 118.208 1.004 . . . . 74.35 111.833 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 120.977 0.418 . . . . 74.15 111.788 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.7 p -73.14 158.11 35.94 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.309 0.576 . . . . 73.33 112.503 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mt -54.79 -56.03 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.812 -0.631 . . . . 75.23 112.476 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.1 pt-20 -60.81 -44.72 96.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.13 0.419 . . . . 63.04 112.13 -176.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -65.59 -45.21 84.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.971 0.415 . . . . 73.41 110.987 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.73 81.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.429 . . . . 61.4 111.455 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.35 -49.59 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.413 -0.358 . . . . 75.03 111.26 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.88 -36.21 62.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.121 0.415 . . . . 74.33 112.121 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.19 -37.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.993 0.425 . . . . 74.24 111.854 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.92 18.09 16.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.403 0.519 . . . . 75.11 112.403 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.19 27.83 68.1 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 72.05 113.79 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.33 150.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.895 0.379 . . . . 70.14 111.117 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.66 97.27 10.79 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.821 0.344 . . . . 75.0 110.215 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -67.29 -36.55 81.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.105 0.409 . . . . 75.01 112.105 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -42.87 83.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.149 0.5 . . . . 64.41 111.072 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.65 -44.11 57.73 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.249 -0.432 . . . . 64.22 111.529 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -55.36 -49.34 72.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.959 0.409 . . . . 72.21 111.951 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 5' ' ' LYS . 93.0 t -59.32 -38.28 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.395 -0.366 . . . . 64.03 111.837 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.69 -43.84 98.09 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.719 0.295 . . . . 73.24 110.638 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -60.17 -37.9 81.57 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 71.23 111.359 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 56' ' ' VAL . 84.8 mt -63.36 -53.98 44.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.484 -0.325 . . . . 75.35 111.517 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -56.71 -54.22 48.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.918 0.34 . . . . 73.4 111.918 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -52.96 -38.51 62.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.612 -0.267 . . . . 75.52 111.334 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.86 -49.29 78.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.876 0.37 . . . . 72.42 111.762 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 120.741 0.305 . . . . 72.12 110.897 177.349 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.066 0.46 . . . . 62.54 111.785 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -122.99 153.13 40.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.417 -0.356 . . . . 70.22 110.748 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.78 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 46.2 pttt -63.36 -15.51 57.67 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.903 0.382 . . . . 74.44 111.98 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.5 -29.83 63.98 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.97 -0.559 . . . . 73.04 111.409 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 65.2 mtt -63.6 150.51 43.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.728 0.64 . . . . 75.53 112.728 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mm -78.37 136.06 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.683 -0.69 . . . . 64.51 111.116 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.44 -48.75 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.762 0.315 . . . . 73.21 111.771 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -59.72 -33.5 71.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.897 0.332 . . . . 75.04 111.897 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.17 -41.73 85.47 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.823 0.344 . . . . 72.22 111.184 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.2 t -60.44 -39.24 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.105 0.479 . . . . 75.13 110.945 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . 0.447 HD21 ' OG1' ' A' ' 19' ' ' THR . 88.1 mt -62.22 -31.01 71.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.26 -0.427 . . . . 73.04 111.519 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 84.3 mm-40 -67.34 -27.01 66.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.941 0.401 . . . . 73.22 111.321 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.2 mtt -75.0 -48.38 24.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.34 0.59 . . . . 73.55 110.064 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -154.99 132.54 11.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.722 -0.672 . . . . 54.13 110.761 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -70.15 -28.41 65.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.093 0.473 . . . . 62.44 111.611 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.04 2.09 14.94 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.078 -0.51 . . . . 74.45 113.807 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . 0.447 ' OG1' HD21 ' A' ' 13' ' ' LEU . 72.6 p -82.72 -19.24 38.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.514 -0.403 . . . . 75.33 111.384 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.35 -51.41 78.17 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.654 0.613 . . . . 62.14 112.654 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.5 Cg_endo -57.84 -31.03 91.42 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.953 1.768 . . . . 61.2 112.59 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.97 -46.65 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.98 0.419 . . . . 72.2 110.914 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -57.52 -46.82 83.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.204 0.525 . . . . 74.33 110.266 171.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 28' ' ' MET . 73.6 mt -58.05 -36.67 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.958 -0.565 . . . . 75.43 111.668 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -61.73 -32.96 73.23 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.973 0.416 . . . . 65.44 111.574 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.7 1.38 55.51 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.242 0.46 . . . . 74.32 112.242 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.78 10.3 16.81 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.425 -0.893 . . . . 42.44 114.896 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 22.2 mmt . . . . . 0 N--CA 1.469 0.524 0 O-C-N 121.85 -0.794 . . . . 54.45 111.435 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 121.247 0.546 . . . . 73.53 112.156 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.0 m -67.5 156.22 37.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.915 0.709 . . . . 73.02 112.915 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -55.11 -60.24 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.615 0.598 . . . . 74.43 112.615 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.78 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.5 pt-20 -61.95 -36.01 80.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.873 0.368 . . . . 73.53 111.847 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.44 -48.43 72.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.888 0.375 . . . . 60.24 110.918 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.14 77.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.065 0.459 . . . . 61.52 111.538 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.4 m -58.81 -44.59 90.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.442 -0.345 . . . . 74.21 111.22 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.54 62.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.007 0.373 . . . . 74.23 112.007 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.67 -41.75 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 111.821 0.304 . . . . 73.45 111.821 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -112.31 17.11 19.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 71.14 111.862 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.97 23.11 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.123 -0.561 . . . . 74.41 113.763 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.1 150.27 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.905 0.383 . . . . 71.43 111.639 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.57 108.3 17.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.125 0.488 . . . . 54.33 110.203 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -75.08 -25.05 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 73.22 111.962 -176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 13.9 t70 -60.92 -47.86 84.47 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.017 0.436 . . . . 74.35 110.621 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.76 -39.78 66.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.87 -50.47 72.38 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.08 0.466 . . . . 75.3 111.077 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.468 ' HA ' HD13 ' A' ' 59' ' ' LEU . 78.6 t -59.27 -38.5 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.442 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.0 mttm -57.82 -50.38 73.47 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.544 0.201 . . . . 74.31 111.544 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -58.53 -38.44 77.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.826 0.346 . . . . 73.04 111.577 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 56' ' ' VAL . 85.2 mt -61.64 -50.97 70.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.734 0.302 . . . . 75.14 111.534 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -59.0 -55.78 30.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.932 0.345 . . . . 73.34 111.932 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -52.81 -36.79 58.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.728 0.299 . . . . 73.24 111.577 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -58.27 -51.68 68.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.367 . . . . 74.12 111.495 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 120.729 0.299 . . . . 74.23 111.31 178.192 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 mm . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.716 0.293 . . . . 74.53 111.66 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 41.8 p -119.84 160.81 21.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.554 -0.294 . . . . 72.15 110.553 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.3 pttp -73.71 -16.77 61.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.069 -0.394 . . . . 72.33 111.414 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.19 -25.05 62.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.086 -0.506 . . . . 75.53 111.102 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.43 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.0 mtt -62.41 139.86 58.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.438 0.637 . . . . 70.05 111.832 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 44.9 mm -69.53 137.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.772 -0.649 . . . . 62.33 110.953 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -54.04 -46.21 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.851 0.357 . . . . 62.21 111.273 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -60.2 -36.37 77.52 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.802 0.335 . . . . 64.34 111.426 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.467 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 12.0 t70 -63.18 -43.98 96.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.041 0.448 . . . . 73.14 110.516 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 41' ' ' ILE . 51.6 t -61.19 -40.1 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.141 0.496 . . . . 72.13 110.722 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.23 -33.12 74.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.243 -0.435 . . . . 63.24 111.304 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 74.0 mt-30 -64.21 -30.33 71.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.362 . . . . 54.41 111.242 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.6 mtt -71.89 -51.59 21.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.283 0.563 . . . . 71.15 110.072 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.29 125.66 5.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.55 -0.75 . . . . 73.24 110.693 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -71.72 -15.47 62.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.006 0.373 . . . . 73.51 112.006 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.58 -1.75 39.29 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.212 -0.518 . . . . 44.21 113.157 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.0 p -82.64 -17.87 43.09 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.698 -0.295 . . . . 74.2 111.573 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.488 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.25 -51.06 82.89 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.223 0.453 . . . . 63.1 112.223 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -58.58 -25.76 75.97 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.957 1.772 . . . . 72.13 112.554 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.74 -44.77 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.995 0.426 . . . . 54.12 110.812 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -58.19 -45.82 86.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 73.12 110.406 173.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.96 -40.81 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.192 0.52 . . . . 63.51 110.911 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -56.86 -30.06 63.47 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.622 -0.717 . . . . 72.34 112.001 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -96.82 1.47 50.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.553 0.575 . . . . 74.2 112.553 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -3.0 22.84 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.476 -0.869 . . . . 35.46 115.11 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 118.251 1.026 . . . . 53.42 112.287 -178.887 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.434 0.635 . . . . 72.52 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 90.2 p -75.55 160.12 30.5 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.928 -0.578 . . . . 54.23 112.207 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . 0.44 HD12 HG22 ' A' ' 12' ' ' VAL . 22.3 mt -54.74 -52.57 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.093 -0.503 . . . . 64.14 111.901 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.695 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.0 pt-20 -62.97 -40.33 97.38 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.877 0.325 . . . . 64.22 111.877 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 47' ' ' VAL . 6.7 t70 -62.58 -51.14 68.51 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 54.44 110.499 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.07 94.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.01 -0.541 . . . . 52.34 111.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -58.49 -45.82 87.94 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.561 -0.29 . . . . 72.31 111.307 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -35.8 74.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.753 0.311 . . . . 74.54 111.656 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 43' ' ' ASP . 61.2 t -65.98 -43.24 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.192 0.52 . . . . 63.15 111.364 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.466 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.3 t-80 -86.59 -14.82 41.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.2 -0.454 . . . . 75.03 111.435 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 38.61 23.44 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 116.455 -0.339 . . . . 71.21 113.13 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.466 HG13 ' HB3' ' A' ' 48' ' ' HIS . 27.9 mt -98.02 153.36 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 122.927 0.491 . . . . 73.41 111.284 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.55 101.92 8.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.018 0.437 . . . . 75.25 109.904 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.69 77.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.444 0.535 . . . . 63.24 112.444 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.01 -45.5 82.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.829 0.347 . . . . 72.22 111.066 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.26 -47.03 75.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.4 -0.363 . . . . 73.2 111.254 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.51 -50.83 71.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.244 -0.435 . . . . 75.13 111.306 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 5' ' ' LYS . 85.4 t -60.79 -39.62 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.508 -0.314 . . . . 71.11 111.615 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.65 -41.67 98.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.454 0.168 . . . . 64.22 111.454 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.82 -40.53 95.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.706 0.289 . . . . 62.14 111.043 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 56' ' ' VAL . 91.1 mt -59.6 -52.24 66.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.617 -0.265 . . . . 55.03 110.971 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -54.67 -57.97 9.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.622 -0.263 . . . . 44.01 111.537 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.07 -37.78 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.552 -0.295 . . . . 72.31 111.667 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -58.4 -51.3 70.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.842 0.353 . . . . 64.12 111.31 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.695 0.283 . . . . 73.44 110.971 176.755 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' ILE . . . . . 0.515 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.8 mm . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 112.426 0.528 . . . . 75.44 112.426 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.6 p -120.21 167.21 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.95 -0.568 . . . . 62.24 110.336 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.9 ptpt -74.28 -8.79 57.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.134 0.492 . . . . 65.32 110.873 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.91 -24.9 32.92 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.898 -0.592 . . . . 53.24 111.818 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.3 mtt -66.23 156.92 32.82 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.653 0.612 . . . . 73.12 112.653 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.8 133.78 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.871 -0.604 . . . . 74.13 111.165 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.89 -50.49 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.207 0.447 . . . . 73.22 112.207 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.07 80.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 70.04 111.655 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.38 -44.3 92.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 74.14 110.772 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' VAL . . . . . 0.516 ' HA ' ' HE1' ' A' ' 15' ' ' MET . 60.5 t -60.4 -42.16 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.112 -0.495 . . . . 73.54 111.105 175.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.39 -34.14 73.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.214 -0.448 . . . . 70.11 111.91 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -69.23 -22.87 63.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.77 0.319 . . . . 74.41 111.719 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' MET . . . . . 0.516 ' HE1' ' HA ' ' A' ' 12' ' ' VAL . 28.6 mtm -83.3 -45.51 13.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.048 0.451 . . . . 75.02 110.193 177.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -152.08 112.93 4.2 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.901 -0.59 . . . . 73.33 110.889 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.3 -11.91 53.42 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.832 0.679 . . . . 74.0 112.832 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -70.16 -9.53 63.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.175 -0.536 . . . . 74.13 112.916 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -78.67 -16.36 57.39 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.566 -0.373 . . . . 74.14 111.707 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . 0.579 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -56.62 -52.01 76.86 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 112.391 0.515 . . . . 70.41 112.391 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 52.2 Cg_exo -52.63 -38.22 75.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.011 1.807 . . . . 70.12 112.438 175.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.66 -46.49 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.096 -0.502 . . . . 73.13 111.162 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 54.4 m-85 -59.03 -46.22 88.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.849 0.357 . . . . 74.31 110.836 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.83 -37.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.913 0.387 . . . . 70.33 111.206 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -56.14 -40.31 73.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.059 -0.519 . . . . 74.53 111.337 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.44 ' ND2' HD12 ' A' ' 55' ' ' LEU . 39.9 m-80 -87.79 -2.37 58.57 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.389 0.515 . . . . 71.45 112.389 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.7 11.44 30.66 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 115.011 0.764 . . . . 71.22 115.011 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' MET . . . . . 0.514 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 25.4 mmt . . . . . 0 N--CA 1.473 0.719 0 CA-C-N 117.984 0.892 . . . . 62.03 110.975 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.199 0.524 . . . . 62.34 112.231 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 m -72.41 147.65 45.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.864 -0.607 . . . . 64.2 111.805 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.3 mt -51.41 -52.36 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.291 0.478 . . . . 73.44 112.291 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.9 pt-20 -62.61 -34.81 77.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.741 0.275 . . . . 65.54 111.741 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.0 t70 -65.57 -52.39 52.66 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 72.1 110.633 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.91 77.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.23 0.538 . . . . 72.22 111.077 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' CYS . . . . . 0.457 ' SG ' ' HB1' ' A' ' 52' ' ' ALA . 93.0 m -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.129 -0.487 . . . . 63.34 111.392 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.07 52.27 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.264 0.468 . . . . 73.31 112.264 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 43' ' ' ASP . 48.0 t -65.07 -52.1 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.984 0.421 . . . . 65.13 111.716 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' HIS . . . . . 0.43 ' HB2' HG13 ' A' ' 50' ' ' ILE . 85.4 m-70 -98.87 3.19 47.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.021 0.378 . . . . 63.44 112.021 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.01 67.12 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.008 -0.615 . . . . 73.14 112.944 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 48' ' ' HIS . 50.5 mt -73.45 150.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.884 0.373 . . . . 65.21 111.291 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.5 97.28 10.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.197 0.522 . . . . 72.33 109.766 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . 0.486 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -64.74 -31.28 72.44 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.407 0.521 . . . . 73.41 112.407 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 2.9 t70 -63.63 -40.35 96.66 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.663 0.268 . . . . 75.42 110.879 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.32 -47.5 84.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.052 0.453 . . . . 72.32 110.668 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.44 HD12 ' ND2' ' A' ' 26' ' ' ASN . 20.9 tp -58.05 -48.5 79.92 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.804 -0.635 . . . . 72.23 111.262 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 52' ' ' ALA . 89.6 t -57.12 -42.58 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.219 -0.446 . . . . 54.42 111.754 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.5 mttm -56.5 -52.96 62.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.853 0.359 . . . . 73.21 110.812 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -55.11 -40.32 70.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.081 -0.509 . . . . 54.44 111.622 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.0 -55.41 22.53 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.114 0.413 . . . . 73.45 112.114 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 51.6 m-80 -55.47 -51.47 66.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.72 0.295 . . . . 72.23 111.58 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.56 -27.84 66.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.434 -0.348 . . . . 54.42 111.68 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.467 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 85.8 t80 -69.66 -47.12 64.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.627 -0.261 . . . . 74.45 111.318 175.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.406 ' CZ ' ' HE3' ' A' ' 15' ' ' MET . 45.4 m-85 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.763 0.315 . . . . 72.24 111.23 177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.33 -0.248 . . . . 72.21 110.33 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.639 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.3 tppt? -128.77 104.79 7.83 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.961 0.41 . . . . 72.54 111.52 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.53 142.08 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.966 0.506 . . . . 75.32 112.135 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.458 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.8 p -122.81 155.12 37.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.472 -0.331 . . . . 75.53 110.526 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.534 ' HB3' HG23 ' A' ' 56' ' ' VAL . 10.4 ptpp? -69.62 -17.65 63.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.917 -0.489 . . . . 70.11 111.969 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.98 -17.61 60.51 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.933 0.397 . . . . 73.22 111.221 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.458 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 66.0 mtt -66.38 149.82 49.82 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.139 0.495 . . . . 74.53 111.841 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -79.11 133.19 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.245 -0.434 . . . . 71.41 111.317 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.7 mt -55.55 -48.88 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.848 0.356 . . . . 72.11 111.367 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.51 69.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.046 0.387 . . . . 73.44 112.046 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.18 -38.97 60.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.742 0.306 . . . . 54.04 111.323 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.6 t -60.08 -40.04 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.523 . . . . 63.21 110.24 173.353 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.46 HD21 ' OG1' ' A' ' 19' ' ' THR . 95.8 mt -61.43 -25.44 67.21 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.934 -0.575 . . . . 75.32 111.63 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -73.7 -32.26 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.814 0.34 . . . . 71.13 111.098 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mtt -71.24 -39.48 71.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 74.31 110.129 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.418 ' HB3' HG22 ' A' ' 19' ' ' THR . 40.0 t0 -160.05 130.22 5.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.275 -0.875 . . . . 74.41 111.018 176.252 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.91 -22.68 62.22 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.082 0.467 . . . . 63.24 110.637 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.69 2.16 49.52 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.284 -0.416 . . . . 63.21 113.755 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.46 ' OG1' HD21 ' A' ' 13' ' ' LEU . 68.1 p -82.59 -19.01 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.288 -0.537 . . . . 73.11 111.585 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.483 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.96 -51.13 77.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.72 0.637 . . . . 52.45 112.72 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.483 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.6 Cg_endo -59.4 -21.41 60.99 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.039 1.826 . . . . 72.41 112.897 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.39 -46.32 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 74.34 110.376 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -59.27 -45.27 91.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.188 0.518 . . . . 74.31 110.32 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.66 -37.03 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.112 -0.494 . . . . 74.42 111.13 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -56.43 -42.18 77.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.031 0.443 . . . . 74.35 111.457 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.54 -1.36 57.02 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.823 0.675 . . . . 64.45 112.823 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.49 17.52 15.09 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.224 0.85 . . . . 52.41 115.224 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 mmt -72.09 147.18 46.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.093 0.947 . . . . 74.4 111.813 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -110.02 97.62 7.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.311 -0.404 . . . . 74.44 110.718 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.2 p -64.27 103.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.247 0.546 . . . . 74.53 111.561 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.675 HD13 ' SG ' ' A' ' 33' ' ' CYS . 1.3 tm? -148.61 153.19 37.99 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.589 -0.523 . . . . 71.23 109.589 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.66 ' N ' HD12 ' A' ' 31' ' ' LEU . . . -66.38 70.53 0.15 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 121.145 0.303 . . . . 41.54 113.096 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.675 ' SG ' HD13 ' A' ' 31' ' ' LEU . 62.8 m -145.19 152.3 50.41 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 122.639 0.375 . . . . 74.31 111.295 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.409 ' C ' ' H ' ' A' ' 36' ' ' SER . 48.5 Cg_exo -57.96 -47.03 22.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.257 1.971 . . . . 72.23 112.315 173.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -69.7 20.61 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.52 0.933 . . . . 74.34 113.52 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.409 ' H ' ' C ' ' A' ' 34' ' ' PRO . 80.6 p -146.69 -46.42 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.088 0.47 . . . . 74.42 111.345 -179.872 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.52 ' HE3' ' HA ' ' A' ' 37' ' ' MET . 2.7 mmt -109.16 -48.08 3.32 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.642 0.608 . . . . 72.1 112.642 -179.301 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.82 -40.26 52.96 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.147 0.819 . . . . 73.54 115.147 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.49 173.97 11.81 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.29 0.848 . . . . 74.31 113.29 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.495 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 24.3 m -72.19 159.73 33.62 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.126 -0.943 . . . . 45.42 111.5 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.7 mt -52.97 -52.55 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.959 0.355 . . . . 73.23 111.959 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.09 -40.36 85.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.831 0.348 . . . . 64.15 111.732 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.402 ' O ' HG22 ' A' ' 47' ' ' VAL . 4.2 t70 -63.34 -51.13 67.23 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.246 -0.434 . . . . 63.43 110.804 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.05 -0.523 . . . . 61.23 111.685 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.2 m -62.21 -48.53 79.62 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 72.35 111.433 177.829 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.61 -37.44 65.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.962 0.356 . . . . 37.32 111.962 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.402 HG22 ' O ' ' A' ' 43' ' ' ASP . 56.1 t -57.74 -53.98 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.91 0.386 . . . . 74.2 111.65 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -92.65 6.64 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.226 0.454 . . . . 72.43 112.226 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.34 83.56 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.285 -0.483 . . . . 61.15 112.968 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.43 150.04 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.207 0.527 . . . . 71.45 111.555 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -80.92 84.23 6.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.104 -0.498 . . . . 72.15 110.433 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.403 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -60.84 -30.3 70.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.545 -0.298 . . . . 74.54 111.771 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.419 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 33.2 t70 -58.75 -47.3 85.12 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.715 0.293 . . . . 61.2 110.864 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -71.83 -44.16 64.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.763 0.316 . . . . 70.12 111.432 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp -54.73 -51.61 65.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.323 -0.398 . . . . 64.42 111.703 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.534 HG23 ' HB3' ' A' ' 5' ' ' LYS . 90.1 t -60.56 -42.28 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.608 -0.269 . . . . 75.25 111.614 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.419 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 98.9 mttt -57.16 -48.0 79.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.591 0.234 . . . . 73.42 111.375 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.57 -39.71 89.02 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.601 0.238 . . . . 70.42 111.45 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.426 HD13 ' HA ' ' A' ' 56' ' ' VAL . 91.0 mt -59.26 -48.54 81.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.618 0.247 . . . . 74.21 111.185 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.589 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 53.2 m-80 -58.62 -61.7 2.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.608 -0.269 . . . . 74.5 111.373 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.654 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 51.8 mt-10 -46.17 -46.06 17.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.197 -0.456 . . . . 63.54 111.153 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -52.09 -58.66 5.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.383 0.512 . . . . 73.25 112.383 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -60.46 -43.23 97.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.832 0.349 . . . . 73.32 111.309 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.47 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 27.6 mt-10 -68.4 -19.82 64.63 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.266 -0.425 . . . . 73.25 111.622 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.654 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 74.9 mmtt -70.12 -45.76 66.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.269 0.557 . . . . 74.14 110.058 168.533 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.4 mtpt -61.05 -39.18 88.86 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.887 -0.597 . . . . 70.21 111.515 179.901 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -62.27 -11.21 13.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.944 0.402 . . . . 73.41 111.532 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.21 -50.81 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.069 0.462 . . . . 74.3 111.272 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -59.81 -53.3 59.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.65 0.611 . . . . 72.25 112.65 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.458 -0.782 . . . . 74.22 112.054 -178.878 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.603 0.24 . . . . 53.54 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.2 tppp? -62.0 104.29 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.995 0.426 . . . . 44.34 110.983 175.455 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.451 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm -66.23 136.62 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.11 -0.495 . . . . 72.03 111.235 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.48 159.32 25.4 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.413 -0.358 . . . . 72.05 110.851 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.604 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.1 pttp -71.01 -11.29 60.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.94 0.4 . . . . 72.22 111.356 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.87 -25.41 53.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.895 -0.593 . . . . 65.31 110.96 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.451 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.7 mtt -66.75 154.14 41.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.298 0.571 . . . . 61.41 112.071 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.51 136.52 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.955 -0.566 . . . . 64.32 111.334 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.4 mt -56.11 -52.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.847 0.356 . . . . 71.05 111.696 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.34 65.67 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.97 0.414 . . . . 38.58 111.631 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.0 -41.12 60.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.908 0.385 . . . . 72.22 110.822 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.37 -37.96 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.204 0.526 . . . . 74.21 110.524 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.1 -30.08 70.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.05 -0.523 . . . . 62.43 111.59 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.69 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.929 0.395 . . . . 73.45 111.042 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.8 mtt -72.35 -49.03 37.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.374 0.607 . . . . 74.33 109.744 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.421 ' CG ' ' HZ2' ' A' ' 66' ' ' LYS . 54.9 t0 -158.18 138.14 12.28 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.491 -0.777 . . . . 71.34 111.364 173.74 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -77.18 -20.59 55.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.257 0.551 . . . . 75.22 110.771 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.87 -2.42 23.36 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.864 -0.607 . . . . 71.11 113.525 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.8 p -81.59 -20.69 39.31 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.43 -0.453 . . . . 74.43 111.67 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.58 -50.65 82.03 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 113.027 0.751 . . . . 74.23 113.027 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.9 Cg_endo -59.46 -21.35 61.13 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.298 1.999 . . . . 73.03 113.025 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.98 -45.62 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.147 0.499 . . . . 75.23 110.474 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.537 ' HB3' ' HG3' ' A' ' 28' ' ' MET . 68.6 m-85 -57.52 -44.73 85.29 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.211 0.529 . . . . 73.11 110.105 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.74 -38.61 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.314 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -55.37 -29.19 57.96 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.278 0.561 . . . . 72.21 111.613 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.419 ' ND2' HD13 ' A' ' 55' ' ' LEU . 37.7 m-80 -98.8 4.1 47.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.244 0.461 . . . . 63.13 112.244 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.85 26.25 11.93 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.752 0.661 . . . . 42.4 114.752 172.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.537 ' HG3' ' HB3' ' A' ' 23' ' ' PHE . 22.0 mmt -74.18 145.66 44.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.803 0.801 . . . . 75.2 112.209 175.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -127.28 29.08 5.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.744 -0.662 . . . . 74.21 110.732 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.464 ' SG ' ' HE2' ' A' ' 37' ' ' MET . 26.4 p -62.32 135.1 57.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.947 -0.57 . . . . 75.32 111.737 -179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.71 97.74 2.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.638 0.256 . . . . 72.24 110.984 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.1 -66.49 1.49 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 114.977 0.751 . . . . 43.24 114.977 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 68.2 m -57.27 137.85 80.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.087 0.773 . . . . 75.31 113.087 -172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_exo -56.83 -29.56 81.74 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.974 2.45 . . . . 63.42 112.577 179.106 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -64.03 1.58 0.67 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.369 0.507 . . . . 75.03 112.369 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.6 p -133.5 -50.28 0.85 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.189 0.518 . . . . 74.14 111.107 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.464 ' HE2' ' SG ' ' A' ' 30' ' ' CYS . 0.6 OUTLIER -77.31 -39.45 47.77 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.555 0.576 . . . . 61.13 112.555 179.902 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.75 2.13 87.16 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.106 -0.569 . . . . 38.58 114.062 -173.604 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -87.93 154.48 20.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.177 0.489 . . . . 75.4 111.704 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.6 m -63.86 145.81 55.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.323 -0.399 . . . . 74.34 110.588 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.7 mt -47.92 -50.62 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 113.06 0.763 . . . . 73.23 113.06 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.604 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 7.9 pt-20 -63.69 -37.87 88.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.383 . . . . 75.15 112.033 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.67 -42.13 78.32 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.912 0.387 . . . . 55.54 110.747 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.04 75.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.235 -0.438 . . . . 72.52 111.15 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -57.79 -43.66 85.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.868 0.366 . . . . 73.5 110.789 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.36 62.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.189 -0.459 . . . . 73.24 112.061 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.03 -42.66 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 111.993 0.368 . . . . 62.14 111.993 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -105.1 3.07 29.98 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.992 0.425 . . . . 74.44 111.618 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 30.85 63.16 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.795 -0.716 . . . . 64.22 112.979 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.6 mt -81.82 155.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.894 0.478 . . . . 74.52 111.171 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 16.8 t70 -93.89 106.69 18.65 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.971 0.415 . . . . 73.13 110.349 175.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.494 ' HB1' ' HA ' ' A' ' 42' ' ' GLU . . . -64.42 -33.04 74.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.316 0.487 . . . . 72.22 112.316 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.5 t70 -54.04 -47.86 71.14 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.95 0.405 . . . . 72.14 111.067 178.806 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -70.27 -47.54 60.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.262 -0.426 . . . . 65.22 111.479 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' ND2' ' A' ' 26' ' ' ASN . 27.6 tp -55.53 -51.58 66.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.933 0.397 . . . . 73.21 111.973 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HA ' HD13 ' A' ' 59' ' ' LEU . 92.5 t -58.4 -38.89 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.019 0.438 . . . . 73.24 111.648 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.08 -43.5 91.99 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.541 -0.3 . . . . 73.22 111.434 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -56.9 -42.59 80.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.802 0.334 . . . . 75.23 111.134 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD13 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -57.18 -52.81 63.81 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.252 -0.431 . . . . 64.43 111.751 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.496 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.0 m-80 -55.88 -50.22 71.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.652 0.263 . . . . 73.42 111.689 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.48 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 40.6 mt-10 -56.57 -32.69 65.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.95 0.405 . . . . 71.41 111.845 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -65.81 -52.15 53.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.129 -0.487 . . . . 74.3 111.458 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -57.5 -35.11 69.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.414 -0.357 . . . . 74.03 111.426 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.496 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 37.1 mt-10 -57.72 -43.71 85.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.024 0.44 . . . . 72.5 111.028 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.48 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 45.8 mmtm -62.75 -36.71 83.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.095 0.474 . . . . 74.31 111.363 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.421 ' HZ2' ' CG ' ' A' ' 16' ' ' ASP . 41.9 mtpt -62.36 -36.02 80.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.25 -0.432 . . . . 65.25 111.225 177.936 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.9 -28.41 66.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.288 0.565 . . . . 74.53 111.256 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.7 t -78.67 -52.45 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.947 -0.569 . . . . 75.14 110.967 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.09 -59.64 4.77 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.587 0.588 . . . . 50.14 112.587 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.698 -0.667 . . . . 71.45 112.705 -176.279 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.478 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.891 0.377 . . . . 75.35 111.692 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.47 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 17.2 tppt? -98.91 95.61 7.29 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.178 -0.675 . . . . 75.14 109.178 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.577 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.6 mm -67.01 140.32 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.373 0.879 . . . . 72.23 113.373 -168.383 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -121.69 160.39 24.57 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.752 -0.658 . . . . 74.31 110.287 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.769 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.5 pttp -66.45 -16.54 64.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.963 0.411 . . . . 72.13 111.353 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.24 -19.64 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.765 -0.652 . . . . 75.05 111.663 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.577 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.5 mtt -69.11 153.82 43.1 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.133 0.492 . . . . 65.33 111.911 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.2 mm -85.22 129.97 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.399 -0.364 . . . . 54.51 111.24 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.8 -53.56 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.477 0.547 . . . . 74.55 112.477 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.07 72.13 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.043 0.386 . . . . 64.24 112.043 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.72 -40.27 76.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.914 0.388 . . . . 71.04 110.674 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -60.49 -39.96 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.26 0.552 . . . . 73.43 110.59 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.98 -32.24 70.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.972 -0.558 . . . . 72.31 111.393 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.603 ' HA ' HH12 ' A' ' 17' ' ' ARG . 15.8 mm-40 -67.21 -31.76 72.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.339 . . . . 71.24 111.583 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.4 mtt -65.78 -54.83 21.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.556 0.693 . . . . 73.11 109.816 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -150.73 121.59 7.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.364 -0.834 . . . . 63.32 110.58 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.603 HH12 ' HA ' ' A' ' 14' ' ' GLN . 81.9 mmt-85 -60.12 -21.56 61.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.999 0.428 . . . . 73.24 111.673 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.76 -3.38 27.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.502 -0.38 . . . . 73.45 113.656 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -82.32 -16.24 50.04 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.425 -0.456 . . . . 75.42 111.671 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.49 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.94 -51.41 79.61 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 112.724 0.638 . . . . 72.11 112.724 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.49 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 12.4 Cg_endo -55.62 -29.19 69.23 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.161 1.908 . . . . 74.33 112.673 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.3 mt -69.12 -45.57 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.047 0.451 . . . . 75.11 110.888 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 -45.89 91.08 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.909 0.385 . . . . 74.11 110.679 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.05 -42.69 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 73.43 111.348 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -50.72 -50.03 56.31 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.1 0.476 . . . . 75.11 111.508 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -75.27 -4.31 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.492 0.552 . . . . 64.21 112.492 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.98 16.85 12.63 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.821 0.688 . . . . 41.14 114.821 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.81 142.77 54.78 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.039 0.919 . . . . 54.22 111.016 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.471 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 22.7 t-80 -134.91 97.5 3.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.969 0.414 . . . . 73.11 111.632 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.3 t -75.27 73.91 2.38 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.187 0.518 . . . . 72.44 111.493 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.471 ' HB3' ' CE1' ' A' ' 29' ' ' HIS . 2.8 tm? -177.0 107.78 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.834 -0.621 . . . . 74.34 109.327 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.17 -72.86 0.36 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.075 -0.583 . . . . 54.0 112.581 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.421 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.9 m -122.46 123.87 26.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.92 0.391 . . . . 74.31 111.577 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 25.5 Cg_exo -63.18 -27.45 72.81 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.072 2.515 . . . . 73.24 113.676 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.9 t -58.18 -24.49 59.18 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.551 0.575 . . . . 63.3 112.551 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 m -56.96 -22.77 40.7 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.987 0.366 . . . . 74.45 111.987 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.554 ' HE1' ' HA ' ' A' ' 37' ' ' MET . 9.5 mmt -89.71 -19.42 24.83 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.809 0.338 . . . . 74.2 111.678 176.328 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.47 -14.34 38.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.382 -0.437 . . . . 73.14 113.736 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 55.4 111.817 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.6 p -75.74 164.63 26.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.126 0.489 . . . . 62.11 112.254 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 mt -55.04 -50.64 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.889 -0.596 . . . . 71.22 112.356 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.769 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 10.1 pt-20 -66.62 -37.13 84.22 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.247 -0.283 . . . . 70.24 111.724 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.406 ' O ' HG23 ' A' ' 47' ' ' VAL . 24.1 t0 -64.76 -49.97 68.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.138 0.495 . . . . 63.12 110.146 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.79 99.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.858 -0.61 . . . . 71.04 111.896 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -52.1 -52.97 48.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.593 -0.276 . . . . 62.32 111.467 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.73 68.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.214 0.45 . . . . 45.32 112.214 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.406 HG23 ' O ' ' A' ' 43' ' ' ASP . 66.7 t -59.88 -42.48 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.914 0.388 . . . . 63.22 111.794 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -97.61 -0.27 46.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.786 0.327 . . . . 71.22 111.467 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.71 82.31 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.477 -0.392 . . . . 72.0 113.45 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.5 mt -74.42 154.68 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 122.581 -0.364 . . . . 74.34 111.273 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -97.38 113.79 25.5 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.977 0.417 . . . . 64.11 110.529 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.431 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -68.34 -32.62 72.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.211 0.449 . . . . 64.41 112.211 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.49 -40.29 82.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.886 0.374 . . . . 71.32 111.658 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -70.57 -49.46 47.73 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.212 0.53 . . . . 63.13 111.043 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.41 -47.31 85.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.799 -0.637 . . . . 73.33 112.406 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.431 HG21 ' O ' ' A' ' 52' ' ' ALA . 98.4 t -61.75 -38.9 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.149 0.426 . . . . 73.42 112.149 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -61.95 -45.35 94.05 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.176 -0.327 . . . . 73.13 110.798 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.53 -42.52 74.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.153 0.501 . . . . 63.33 111.36 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.3 -53.4 55.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.239 -0.437 . . . . 61.04 111.745 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.47 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 47.3 m-80 -55.0 -50.44 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.038 0.384 . . . . 72.32 112.038 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.06 -42.3 69.11 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.763 -0.199 . . . . 74.33 111.346 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.58 -49.41 77.55 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 63.03 112.188 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.411 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 71.8 m-85 -59.52 -36.78 76.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.771 0.319 . . . . 75.52 111.618 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.15 -34.0 70.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.825 0.345 . . . . 74.51 111.126 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -65.07 -29.11 69.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.712 -0.222 . . . . 72.34 111.46 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.411 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 26.9 mtpp -51.47 -45.27 62.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.964 0.411 . . . . 74.52 111.331 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.14 -21.58 66.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.148 -0.478 . . . . 75.44 112.05 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.37 -54.92 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.99 0.424 . . . . 63.4 111.48 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -67.32 -59.2 3.61 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.625 0.602 . . . . 73.41 112.625 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.689 -0.672 . . . . 65.22 112.682 -176.063 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.965 0.412 . . . . 73.34 111.586 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -131.3 140.78 49.84 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.509 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.446 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.9 mm -66.44 133.25 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.529 0.204 . . . . 73.41 110.602 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.492 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 28.5 p -116.66 155.88 28.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 70.31 111.134 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HB3' HG23 ' A' ' 56' ' ' VAL . 14.0 ptpt -69.27 -10.5 58.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.01 0.374 . . . . 74.01 112.01 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.28 -14.95 45.04 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.088 0.47 . . . . 71.3 111.347 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.492 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 65.5 mtt -69.41 157.29 37.36 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.435 0.531 . . . . 73.53 112.435 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.43 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 48.9 mm -85.39 141.55 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.043 -0.526 . . . . 62.13 111.552 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.6 mt -55.44 -52.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 120.76 0.314 . . . . 71.34 111.798 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.52 ' HB3' ' HB3' ' A' ' 37' ' ' MET . . . -57.23 -37.22 71.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.961 0.41 . . . . 62.44 111.616 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.75 -42.08 98.5 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.303 -0.408 . . . . 64.15 111.044 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.97 -40.93 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.037 0.446 . . . . 72.44 110.933 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.5 HD21 ' OG1' ' A' ' 19' ' ' THR . 97.0 mt -61.22 -31.74 71.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.892 0.377 . . . . 73.44 111.348 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -70.1 -15.17 62.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.455 -0.339 . . . . 63.13 111.9 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.4 mtt -86.69 -43.44 12.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.208 0.528 . . . . 64.15 110.044 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.08 133.79 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.568 -0.742 . . . . 71.54 110.814 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.8 mmt-85 -69.68 -25.0 63.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.874 0.368 . . . . 74.21 111.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.49 -1.41 10.83 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.608 -0.33 . . . . 73.02 113.728 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.5 ' OG1' HD21 ' A' ' 13' ' ' LEU . 73.3 p -82.84 -21.43 34.41 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.469 -0.43 . . . . 74.52 111.704 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.78 -51.08 82.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 112.396 0.517 . . . . 63.35 112.396 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 22.6 Cg_endo -60.93 -25.15 80.91 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.885 1.724 . . . . 74.04 112.613 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.2 mt -71.05 -43.18 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.969 0.414 . . . . 73.51 110.785 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -58.64 -48.72 80.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.131 0.491 . . . . 72.21 110.249 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.458 ' HA ' ' O ' ' A' ' 28' ' ' MET . 66.5 mt -60.71 -37.84 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.99 -0.55 . . . . 70.34 111.221 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -56.06 -32.95 64.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.275 -0.421 . . . . 71.25 112.089 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.417 ' ND2' HD13 ' A' ' 55' ' ' LEU . 34.0 m-80 -90.93 -7.5 51.93 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.453 0.538 . . . . 71.22 112.453 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 -7.47 6.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.624 -0.798 . . . . 61.4 114.605 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 50.0 mtt -75.81 176.39 7.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.877 0.838 . . . . 74.24 111.082 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.84 174.23 10.84 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.994 0.426 . . . . 64.33 111.665 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.4 p -73.2 -164.34 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.017 -0.538 . . . . 73.34 111.777 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -72.39 74.71 1.02 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.417 0.627 . . . . 55.53 111.241 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.63 -23.55 28.16 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.216 -0.754 . . . . 42.43 111.216 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -146.4 134.43 10.62 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.112 0.565 . . . . 70.11 109.862 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.11 -32.27 79.04 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.646 2.231 . . . . 75.14 113.054 -176.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.54 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 30.6 t -55.73 -36.05 66.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.487 0.551 . . . . 75.3 112.487 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 t -48.14 -31.52 5.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.467 0.914 . . . . 61.33 113.467 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.543 ' HE1' ' HA ' ' A' ' 37' ' ' MET . 3.3 mmt -84.9 -32.72 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.321 0.489 . . . . 75.23 112.321 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.95 -11.9 80.59 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.13 -0.557 . . . . 70.44 114.136 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.54 ' HG2' ' O ' ' A' ' 35' ' ' SER . 8.9 mm-40 -75.56 144.65 41.75 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.282 0.541 . . . . 63.23 112.054 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.43 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 54.3 m -70.31 149.45 47.37 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.577 -0.283 . . . . 75.12 110.578 172.851 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 mt -51.51 -55.61 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.655 0.613 . . . . 73.33 112.655 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.507 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.6 pt-20 -62.1 -36.28 81.23 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.038 0.447 . . . . 74.14 111.684 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.93 -52.68 22.5 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.071 -0.513 . . . . 71.14 111.117 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.88 91.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.303 -0.408 . . . . 73.1 111.504 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -57.49 -45.53 84.79 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.53 -0.304 . . . . 60.01 110.938 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.88 75.05 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.016 0.376 . . . . 61.43 112.016 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.8 t -55.65 -41.27 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.927 0.394 . . . . 73.1 112.052 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.541 ' HB3' HG13 ' A' ' 50' ' ' ILE . 8.8 t60 -91.33 -22.96 20.26 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 73.25 111.299 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.75 24.53 17.56 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.546 -0.359 . . . . 73.22 112.439 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.541 HG13 ' HB3' ' A' ' 48' ' ' HIS . 63.8 mt -79.69 155.23 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.92 0.488 . . . . 73.11 112.058 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.76 101.74 12.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.183 -0.462 . . . . 74.11 110.166 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -71.44 -21.88 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.454 0.538 . . . . 73.03 112.454 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -43.1 77.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.361 . . . . 60.34 110.467 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.61 -46.78 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.312 -0.404 . . . . 63.42 110.992 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.417 HD13 ' ND2' ' A' ' 26' ' ' ASN . 30.1 tp -56.29 -54.84 40.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.223 -0.444 . . . . 62.15 112.046 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.525 HG23 ' HB3' ' A' ' 5' ' ' LYS . 87.4 t -56.51 -41.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.965 0.412 . . . . 71.31 112.011 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -37.21 80.63 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.73 0.27 . . . . 72.45 111.73 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -59.91 -42.57 94.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 64.02 110.692 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -58.6 -52.32 66.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.28 -0.418 . . . . 74.44 111.381 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 43.5 m-80 -54.19 -57.36 11.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.695 0.283 . . . . 74.22 111.59 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.478 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 48.3 mt-10 -52.42 -40.9 62.71 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.217 -0.447 . . . . 71.13 111.789 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -56.45 -48.56 76.81 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.894 0.378 . . . . 74.51 111.663 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -64.55 -38.44 91.03 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.612 0.244 . . . . 75.14 111.499 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.483 ' O ' HG21 ' A' ' 68' ' ' VAL . 33.9 mt-10 -63.47 -40.7 97.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.822 0.344 . . . . 70.02 111.116 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.478 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.0 mmtp -56.5 -41.36 76.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.919 0.39 . . . . 73.24 111.26 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.8 -50.27 72.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.299 -0.41 . . . . 74.35 111.241 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.12 -29.15 68.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.765 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.483 HG21 ' O ' ' A' ' 64' ' ' GLU . 65.4 t -74.05 -54.37 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.962 0.41 . . . . 73.34 111.494 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.2 mt -71.12 -56.88 5.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.496 0.554 . . . . 72.44 112.496 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.847 -0.597 . . . . 73.43 112.543 -176.262 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.554 0.216 . . . . 74.32 110.459 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -117.73 140.74 49.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.231 0.539 . . . . 74.21 112.425 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.48 143.8 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.8 -0.637 . . . . 71.42 111.412 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.475 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.3 p -118.06 170.23 9.02 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.861 0.362 . . . . 70.21 110.973 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.515 ' HB3' HG23 ' A' ' 56' ' ' VAL . 16.8 ptpt -80.87 -11.78 59.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.865 0.364 . . . . 71.34 111.282 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.52 -25.43 38.72 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.012 -0.54 . . . . 60.34 111.141 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.475 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 64.3 mtt -65.11 161.07 19.75 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.181 0.515 . . . . 73.55 112.203 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.425 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.0 mm -86.91 129.76 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.062 -0.517 . . . . 73.04 110.716 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . 0.485 HG12 HG13 ' A' ' 41' ' ' ILE . 57.3 mt -54.66 -45.96 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 112.211 0.448 . . . . 72.15 112.211 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.405 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -63.15 -34.68 78.15 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.195 0.521 . . . . 61.42 111.078 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.403 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.4 t70 -65.06 -41.84 94.74 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.913 -0.585 . . . . 54.1 110.344 177.787 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.88 -37.96 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.219 0.533 . . . . 62.44 110.997 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.64 -29.87 70.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.472 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.405 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 77.0 mt-30 -68.34 -25.45 65.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.953 0.406 . . . . 71.14 111.042 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.0 mtt -75.62 -53.91 7.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.208 0.528 . . . . 73.42 110.02 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -154.3 124.45 6.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.956 -0.566 . . . . 75.44 111.127 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.41 -18.12 65.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 74.31 112.556 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.434 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -68.1 -6.44 46.17 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.274 -0.489 . . . . 73.52 113.2 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.1 p -80.91 -23.14 39.15 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.644 -0.327 . . . . 73.44 111.455 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.461 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.47 -51.79 77.11 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.528 0.566 . . . . 73.44 112.528 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.461 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.46 -26.03 76.29 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.901 1.734 . . . . 72.13 112.335 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.401 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 64.1 mt -72.48 -41.76 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.02 0.438 . . . . 72.15 110.583 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 62.0 m-85 -61.9 -49.93 74.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.041 0.448 . . . . 75.22 110.497 173.094 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.0 mt -59.12 -37.55 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 72.43 111.099 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.401 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 27.4 t30 -52.09 -46.4 65.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.992 0.425 . . . . 64.31 111.678 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -81.21 1.69 31.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.312 0.486 . . . . 72.43 112.312 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.33 13.84 14.32 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.203 0.841 . . . . 62.44 115.203 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mmt -73.67 163.32 28.14 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 117.952 0.876 . . . . 65.22 112.147 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.48 138.52 23.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.073 -0.512 . . . . 65.55 110.6 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.405 ' SG ' ' SD ' ' A' ' 37' ' ' MET . 39.4 t -166.66 128.74 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.191 0.811 . . . . 63.24 113.191 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.7 34.41 5.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.498 -1.297 . . . . 71.14 107.498 167.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.02 41.16 5.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.202 -0.908 . . . . 53.43 111.229 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 57.5 m -102.07 132.09 21.94 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 111.843 0.312 . . . . 73.42 111.843 -172.389 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 50.3 Cg_exo -55.36 -60.32 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.973 2.449 . . . . 64.35 113.587 179.863 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.472 ' O ' ' HB2' ' A' ' 36' ' ' SER . 65.5 m -67.23 76.8 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.276 0.473 . . . . 74.25 112.276 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.472 ' HB2' ' O ' ' A' ' 35' ' ' SER . 41.0 t 156.36 -30.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.54 1.136 . . . . 61.24 110.135 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.53 ' HA ' ' HE1' ' A' ' 37' ' ' MET . 3.6 mmt -103.6 -68.33 0.85 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.325 -0.398 . . . . 73.24 111.809 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.02 3.86 6.44 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.536 0.574 . . . . 75.34 114.536 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -106.35 161.6 14.42 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.304 0.552 . . . . 73.4 111.413 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.468 ' HA ' ' O ' ' A' ' 7' ' ' MET . 49.2 m -68.54 153.06 44.48 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.415 -0.357 . . . . 72.0 111.024 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.506 HG22 ' HB2' ' A' ' 52' ' ' ALA . 4.0 mp -51.93 -51.24 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 111.791 0.293 . . . . 74.4 111.791 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.497 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.6 pt-20 -69.05 -33.9 74.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.903 0.382 . . . . 75.42 111.724 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.88 -47.25 75.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.103 0.478 . . . . 70.11 111.238 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.73 56.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 75.02 111.788 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.88 -42.08 75.39 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.72 0.295 . . . . 72.53 111.679 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.67 65.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.272 0.471 . . . . 53.11 112.272 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.2 -51.18 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.816 0.341 . . . . 71.43 111.914 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -87.6 -19.82 27.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.873 0.368 . . . . 74.31 111.386 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.59 27.04 12.07 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.19 -0.528 . . . . 74.31 112.655 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mt -76.57 148.28 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.751 0.31 . . . . 70.31 111.298 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.8 93.84 5.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.202 0.525 . . . . 70.24 110.283 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.506 ' HB2' HG22 ' A' ' 41' ' ' ILE . . . -65.7 -24.05 66.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.165 -0.47 . . . . 64.32 112.105 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.15 -45.76 92.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.792 0.329 . . . . 70.03 110.962 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.85 -46.44 75.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.893 0.377 . . . . 54.34 111.126 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.442 HD22 HG21 ' A' ' 41' ' ' ILE . 26.2 tp -53.19 -51.73 61.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.002 -0.545 . . . . 72.21 111.624 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.515 HG23 ' HB3' ' A' ' 5' ' ' LYS . 80.2 t -57.41 -45.28 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 73.43 111.524 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.63 -45.0 85.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.515 0.198 . . . . 74.22 111.395 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -58.97 -40.85 86.02 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.937 0.398 . . . . 74.41 111.281 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 80.9 mt -60.13 -50.46 73.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.854 0.359 . . . . 74.24 111.38 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.479 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.2 m-80 -57.57 -55.13 38.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.395 -0.366 . . . . 73.4 111.418 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.632 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.6 mt-10 -50.11 -41.77 49.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.891 0.377 . . . . 74.01 111.031 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.434 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 87.4 t80 -58.74 -53.23 60.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.17 -0.468 . . . . 73.11 112.084 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.88 -39.01 87.65 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.591 0.234 . . . . 75.2 111.117 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.531 ' O ' HG22 ' A' ' 68' ' ' VAL . 33.3 mt-10 -58.41 -40.88 83.65 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.56 0.219 . . . . 73.34 111.055 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.632 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 33.1 mmtp -54.62 -42.81 71.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.017 0.437 . . . . 70.25 110.587 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.82 -47.44 83.4 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.048 -0.524 . . . . 75.34 111.145 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -65.47 -17.3 64.45 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.342 -0.39 . . . . 63.01 111.758 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.531 HG22 ' O ' ' A' ' 64' ' ' GLU . 92.4 t -90.88 -56.62 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.015 0.436 . . . . 72.32 111.575 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -54.82 10.66 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.984 0.735 . . . . 72.44 112.984 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.746 -0.645 . . . . 73.13 112.502 -175.458 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.531 0.205 . . . . 62.41 111.402 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.74 125.09 25.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.932 0.396 . . . . 75.13 110.575 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.47 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.4 mm -74.01 139.97 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 112.174 0.435 . . . . 64.32 112.174 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.475 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.2 p -116.42 158.9 22.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.282 -0.417 . . . . 75.21 110.307 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -72.98 -15.55 61.54 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.106 -0.371 . . . . 73.13 111.959 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.06 -14.11 58.14 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.794 0.331 . . . . 74.35 111.48 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.475 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 62.8 mtt -63.95 134.92 55.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.28 0.562 . . . . 72.01 111.575 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.7 mm -68.49 136.01 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.901 -0.59 . . . . 73.2 111.405 -179.301 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.6 mt -52.13 -52.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.838 0.31 . . . . 73.25 111.838 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.456 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.11 -36.85 73.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.934 0.397 . . . . 72.31 111.627 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.12 -37.54 87.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.208 -0.451 . . . . 64.24 110.902 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.94 -41.31 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.072 0.463 . . . . 73.04 110.99 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -59.22 -31.24 68.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.341 -0.391 . . . . 74.42 111.709 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.456 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 79.3 mt-30 -62.95 -37.06 85.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.73 0.3 . . . . 70.23 111.532 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.9 mtt -65.76 -48.25 72.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 60.4 110.225 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . 0.409 ' HB2' ' HZ2' ' A' ' 66' ' ' LYS . 8.1 t70 -158.85 120.25 3.4 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.445 -0.798 . . . . 74.32 110.7 177.312 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -62.24 -20.8 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.459 0.54 . . . . 74.22 112.459 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -3.49 22.86 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.418 -0.42 . . . . 61.13 113.65 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.7 p -83.08 -19.79 36.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.916 0.358 . . . . 70.43 111.833 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.469 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.29 -50.99 81.72 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 112.478 0.547 . . . . 74.41 112.478 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.469 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.1 Cg_endo -59.13 -29.1 89.61 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.899 1.733 . . . . 72.0 112.613 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.88 -42.17 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.094 0.474 . . . . 75.14 110.613 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -62.38 -53.44 55.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.155 0.502 . . . . 73.12 110.648 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.7 -35.35 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.136 -0.484 . . . . 44.31 111.322 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -57.6 -48.84 78.28 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.021 -0.536 . . . . 72.35 111.511 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.92 -5.11 39.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.355 0.502 . . . . 62.35 112.355 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.89 17.47 7.89 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.653 -0.784 . . . . 75.32 114.831 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.87 143.16 49.49 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.961 0.881 . . . . 65.41 111.717 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -138.36 -179.37 5.76 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.029 -0.532 . . . . 75.55 110.73 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 44.3 t 59.8 20.42 9.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.143 0.497 . . . . 75.0 111.362 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.26 110.19 1.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.845 -0.616 . . . . 74.24 110.704 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.33 -28.45 3.15 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.315 -0.469 . . . . 73.33 112.748 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 74.3 m -72.88 143.83 84.75 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.638 -0.331 . . . . 74.41 111.519 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -44.57 -54.97 3.59 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.375 2.717 . . . . 74.21 114.439 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -58.63 -55.67 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.425 0.155 . . . . 74.43 111.415 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -55.8 -29.28 59.45 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.184 0.439 . . . . 71.1 112.184 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.57 ' HA ' ' HE2' ' A' ' 37' ' ' MET . 6.2 mmt -79.77 -35.14 39.13 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.667 0.27 . . . . 71.32 111.421 177.432 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.39 10.98 69.2 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.843 0.697 . . . . 72.2 114.843 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.22 161.72 16.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.759 0.779 . . . . 72.32 112.042 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 87.7 p -76.76 162.02 28.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.739 -0.664 . . . . 70.4 112.248 -175.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.15 -44.08 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.14 111.91 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.14 -40.78 90.87 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.562 0.208 . . . . 71.33 111.562 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.01 -48.61 65.24 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.008 0.432 . . . . 71.34 111.132 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.75 94.08 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.881 0.372 . . . . 61.2 111.632 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -56.27 -39.49 72.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.709 0.29 . . . . 60.14 111.355 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.69 69.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.067 0.395 . . . . 37.56 112.067 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -48.08 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.018 0.437 . . . . 63.34 111.346 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -92.47 -10.27 38.46 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.388 -0.369 . . . . 75.13 111.989 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.42 35.44 23.1 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.35 -0.452 . . . . 61.22 113.233 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -91.95 152.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.646 0.378 . . . . 74.15 111.286 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.32 99.43 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.411 -0.589 . . . . 71.25 109.411 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.438 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -65.07 -30.1 71.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.154 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.54 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.8 t70 -59.7 -44.29 93.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.68 0.276 . . . . 61.02 110.677 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.63 -49.1 67.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 75.5 111.079 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.87 -45.09 67.29 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 73.24 111.354 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.438 HG21 ' O ' ' A' ' 52' ' ' ALA . 75.9 t -61.56 -37.47 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.169 -0.469 . . . . 73.41 111.453 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.54 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.4 mttm -60.37 -48.83 80.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.743 0.306 . . . . 72.21 110.649 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.69 -38.19 71.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.241 -0.436 . . . . 60.04 111.484 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.407 HD13 ' HA ' ' A' ' 56' ' ' VAL . 87.0 mt -65.2 -51.25 62.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.505 -0.316 . . . . 73.01 111.364 174.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.514 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.4 m-80 -53.57 -55.02 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.647 -0.251 . . . . 72.12 111.445 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.558 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.0 mt-10 -47.51 -50.46 23.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.059 0.457 . . . . 75.44 110.773 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -55.15 -49.12 72.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.765 -0.652 . . . . 71.42 112.292 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -65.73 -37.1 85.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.875 0.369 . . . . 73.32 111.722 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.514 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 33.0 mt-10 -70.4 -24.57 62.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.948 0.404 . . . . 72.41 111.199 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.558 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.7 mmtp -75.72 -31.27 59.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.438 -0.346 . . . . 73.11 111.315 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.409 ' HZ2' ' HB2' ' A' ' 16' ' ' ASP . 48.9 mtpt -52.69 -42.78 65.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.715 0.293 . . . . 60.41 111.767 179.361 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.36 -28.99 65.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.155 0.502 . . . . 74.14 111.535 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.19 -44.4 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.019 -0.537 . . . . 75.43 111.465 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.51 -62.24 2.03 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.064 -0.517 . . . . 60.31 111.689 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.566 -0.73 . . . . 75.41 112.054 -179.142 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.715 0.293 . . . . 73.11 111.452 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -88.78 96.04 10.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.431 -0.581 . . . . 73.11 109.431 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.403 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 47.1 mm -74.02 144.64 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.727 0.64 . . . . 71.22 112.727 -171.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.439 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.5 p -122.34 153.7 38.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.941 -0.572 . . . . 64.53 110.367 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.561 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.9 pttp -68.45 -13.46 62.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.959 0.409 . . . . 72.53 111.606 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.24 -22.67 59.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.205 0.526 . . . . 71.12 111.048 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.439 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.3 mtt -68.59 159.67 31.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.268 0.556 . . . . 61.32 111.718 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.9 mm -86.27 135.87 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.031 -179.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.8 mt -56.81 -50.88 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 111.892 0.33 . . . . 73.24 111.892 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.522 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.02 -37.33 74.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.942 0.401 . . . . 63.02 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.81 -44.48 96.78 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.162 -0.472 . . . . 75.44 110.62 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.13 -39.71 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.116 0.484 . . . . 72.34 110.837 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.464 HD21 ' OG1' ' A' ' 19' ' ' THR . 97.1 mt -62.69 -33.81 75.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.216 -0.447 . . . . 74.4 111.62 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.522 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 88.1 mt-30 -69.28 -20.83 63.91 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.7 0.286 . . . . 74.1 111.538 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.5 mtt -75.95 -56.45 4.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.374 0.607 . . . . 74.42 109.896 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -145.8 125.45 13.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.683 -0.69 . . . . 72.33 110.571 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.422 HH11 ' HB3' ' A' ' 13' ' ' LEU . 41.1 mmt180 -69.57 -19.53 63.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.516 -0.311 . . . . 75.14 111.591 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.07 -1.8 43.28 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.318 -0.467 . . . . 64.52 113.304 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.464 ' OG1' HD21 ' A' ' 13' ' ' LEU . 81.5 p -82.28 -17.21 46.7 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.461 -0.435 . . . . 53.15 111.183 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.491 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.21 -51.82 76.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.497 0.554 . . . . 74.42 112.497 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.491 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -56.95 -26.43 67.86 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.108 1.872 . . . . 72.31 112.612 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.14 -46.98 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.034 0.445 . . . . 70.12 110.672 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -58.98 -40.97 86.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.022 0.439 . . . . 75.22 110.504 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.97 -46.57 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.131 -0.486 . . . . 74.31 111.097 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -51.68 -48.61 63.41 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.181 0.515 . . . . 73.35 111.495 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.406 ' ND2' HD13 ' A' ' 55' ' ' LEU . 32.6 m-80 -77.63 -6.8 55.06 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.176 -0.465 . . . . 75.15 112.16 -178.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.6 39.05 3.75 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.251 0.86 . . . . 64.14 115.251 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 mmt -90.23 158.1 17.37 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.806 0.803 . . . . 75.14 111.654 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.27 92.0 3.76 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.137 0.494 . . . . 74.24 110.947 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.06 -9.12 59.68 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.912 0.708 . . . . 73.22 112.912 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.46 79.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.456 0.539 . . . . 73.33 112.456 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.65 8.48 27.12 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 114.591 0.596 . . . . 63.32 114.591 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -88.59 117.27 68.16 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 117.168 0.484 . . . . 64.41 111.595 -178.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 12.4 Cg_endo -54.93 -32.36 77.89 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.686 2.258 . . . . 64.21 112.248 179.686 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.0 m -50.64 -54.41 23.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.786 -0.643 . . . . 74.54 112.228 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -90.98 -5.1 55.87 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.42 0.526 . . . . 74.02 112.42 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.579 ' HE3' ' HA ' ' A' ' 37' ' ' MET . 16.3 mmt -100.15 -71.66 0.69 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.823 0.675 . . . . 73.21 112.823 179.897 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.22 -21.92 59.87 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.019 -0.61 . . . . 71.23 114.426 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -79.87 160.92 25.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.123 0.487 . . . . 74.34 111.87 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.6 m -67.03 157.78 32.65 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.364 -0.38 . . . . 74.53 111.437 176.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.3 mt -54.81 -54.93 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.867 0.321 . . . . 74.15 111.867 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.561 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.3 pt-20 -63.49 -30.68 71.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.707 0.289 . . . . 54.1 111.689 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.446 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.3 t70 -64.32 -61.84 1.98 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.919 0.39 . . . . 73.32 109.971 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.72 65.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.157 0.503 . . . . 65.15 111.588 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.412 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 81.4 m -57.57 -40.83 79.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.989 -0.55 . . . . 75.31 111.43 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.5 69.03 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.013 0.435 . . . . 63.12 111.627 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.446 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.4 t -69.98 -39.91 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.784 0.326 . . . . 74.52 111.831 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.511 ' HD1' HD13 ' A' ' 50' ' ' ILE . 8.7 t-160 -105.39 4.57 30.92 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.089 -0.382 . . . . 74.23 112.007 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.2 27.97 72.15 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.538 -0.363 . . . . 61.3 113.958 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.511 HD13 ' HD1' ' A' ' 48' ' ' HIS . 53.3 mt -85.53 153.73 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.973 0.416 . . . . 70.54 111.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.34 102.2 11.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.672 0.389 . . . . 52.44 111.675 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.42 85.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 71.43 111.417 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -51.43 -44.93 62.44 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.961 -0.563 . . . . 73.23 111.41 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.21 -39.1 34.12 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.224 -0.444 . . . . 72.22 111.969 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.406 HD13 ' ND2' ' A' ' 26' ' ' ASN . 26.4 tp -61.82 -52.81 62.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.918 0.39 . . . . 74.42 111.98 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.523 ' HA ' HD13 ' A' ' 59' ' ' LEU . 90.1 t -57.46 -37.01 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.956 0.354 . . . . 72.04 111.956 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -64.41 -42.22 96.19 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.625 -0.261 . . . . 71.31 111.354 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.98 -42.13 97.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.994 0.426 . . . . 70.22 110.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.523 HD13 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -58.37 -52.66 64.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.33 -0.396 . . . . 75.43 111.678 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.6 m-80 -56.11 -54.5 44.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.744 0.307 . . . . 74.13 111.444 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.604 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.4 mt-10 -54.09 -31.65 52.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.537 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -69.34 -46.66 66.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.896 0.379 . . . . 74.43 111.696 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -61.54 -32.62 72.69 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.171 -0.33 . . . . 72.52 111.15 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.437 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 69.0 mt-10 -66.57 -32.94 74.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.913 0.387 . . . . 52.34 111.15 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.604 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 44.6 mmtm -63.44 -39.83 95.52 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.195 -0.316 . . . . 73.42 110.877 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.42 -37.61 70.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.989 0.423 . . . . 65.42 111.158 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.3 -21.18 66.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.219 -0.446 . . . . 71.33 111.496 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.63 -50.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.001 0.429 . . . . 74.14 111.792 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.78 -58.16 6.99 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.384 0.512 . . . . 73.35 112.384 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.911 -0.566 . . . . 62.13 111.909 -178.313 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.48 0.181 . . . . 72.45 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -76.92 102.59 6.44 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.996 0.427 . . . . 74.31 110.106 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.454 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 49.6 mm -70.94 139.06 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.049 -0.523 . . . . 75.21 111.828 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 p -121.18 161.8 21.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.744 0.307 . . . . 73.44 110.996 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.857 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.9 pttp -69.34 -21.23 63.84 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.869 0.366 . . . . 74.34 111.658 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.66 -21.65 59.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.177 -0.465 . . . . 72.01 111.731 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.454 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -63.08 152.02 38.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.388 0.613 . . . . 73.12 112.125 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.88 130.5 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.97 -0.559 . . . . 73.54 111.107 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.41 -47.18 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 111.923 0.342 . . . . 74.45 111.923 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.427 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -60.45 -35.78 76.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.97 0.414 . . . . 37.9 111.338 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.58 -39.95 80.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.349 -0.387 . . . . 73.03 110.704 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.93 -41.79 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.277 0.56 . . . . 50.33 110.128 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.451 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.0 mt -64.19 -21.24 66.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.974 -0.557 . . . . 72.23 111.735 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.427 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 83.9 mm-40 -77.44 -30.72 53.47 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.719 0.295 . . . . 72.45 111.149 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.1 mtt -69.88 -45.89 66.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.317 0.58 . . . . 74.13 109.894 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.33 127.25 4.94 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.202 -0.908 . . . . 71.34 111.141 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -65.55 -26.34 67.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.285 -0.416 . . . . 73.43 111.686 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.62 -1.24 5.85 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 114.179 0.431 . . . . 61.32 114.179 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.451 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.4 p -85.86 -13.19 48.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.166 0.483 . . . . 72.34 111.589 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.68 -51.35 74.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.699 0.629 . . . . 72.04 112.699 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -56.93 -31.95 91.12 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.112 1.874 . . . . 64.33 112.628 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.07 -48.67 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.032 0.444 . . . . 65.04 110.836 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -60.25 -47.55 85.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.715 0.293 . . . . 64.41 111.263 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.33 -41.97 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.814 0.34 . . . . 71.21 111.428 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -58.15 -44.07 87.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.255 -0.43 . . . . 63.44 111.533 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -75.5 -9.9 58.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.282 0.475 . . . . 52.44 112.282 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.28 1.53 11.17 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 115.424 0.93 . . . . 74.34 115.424 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.4 mmt -66.76 139.31 57.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.345 1.073 . . . . 74.24 111.762 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -155.28 111.04 3.1 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.67 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.76 ' SG ' ' HB2' ' A' ' 36' ' ' SER . 17.9 p -164.68 129.73 2.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.435 -0.348 . . . . 75.03 110.357 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 75.63 0.59 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.097 0.475 . . . . 63.45 110.868 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 51.57 44.14 53.6 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.443 -0.408 . . . . 37.9 113.26 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.4 153.02 65.47 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 111.787 0.291 . . . . 74.34 111.787 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.421 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 94.9 Cg_exo -44.36 -35.86 8.83 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.408 2.738 . . . . 71.33 114.403 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -42.62 -50.51 5.4 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.598 0.962 . . . . 72.43 113.598 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.76 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 68.9 m -116.96 -3.23 11.63 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.699 0.285 . . . . 62.11 111.743 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.66 ' HG2' ' SG ' ' A' ' 30' ' ' CYS . 9.7 mmt -100.62 -58.68 1.85 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.979 0.363 . . . . 65.3 111.979 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -77.14 -23.59 68.32 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.035 -0.602 . . . . 63.45 114.462 -172.368 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.421 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 34.4 mm-40 -80.11 154.68 27.91 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 117.241 0.521 . . . . 75.02 112.3 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -64.2 150.86 44.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.339 -0.391 . . . . 71.11 110.89 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mt -51.7 -56.29 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.466 0.543 . . . . 74.42 112.466 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.857 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.3 pt-20 -62.41 -39.75 94.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.813 0.339 . . . . 74.34 111.717 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.481 ' O ' HG22 ' A' ' 47' ' ' VAL . 35.7 t70 -64.64 -54.84 25.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.348 -0.387 . . . . 72.32 110.924 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.35 75.8 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.945 0.402 . . . . 52.33 111.235 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' GLY . 90.3 m -58.76 -52.75 64.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.377 -0.374 . . . . 72.51 111.123 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -42.88 81.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.714 0.264 . . . . 75.53 111.714 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 43' ' ' ASP . 60.6 t -60.58 -44.37 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.175 0.512 . . . . 73.21 111.342 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.459 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.5 t-80 -89.4 -2.7 58.5 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-N 116.257 -0.429 . . . . 62.14 111.505 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 67.77 29.87 74.1 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.65 -0.309 . . . . 54.31 113.519 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.459 HG13 ' HB3' ' A' ' 48' ' ' HIS . 45.5 mt -89.02 151.82 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 122.879 0.471 . . . . 72.2 111.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.03 102.7 9.44 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.81 0.338 . . . . 71.32 110.759 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.3 -23.64 61.21 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.201 0.445 . . . . 75.35 112.201 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.8 -51.07 71.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.959 0.409 . . . . 73.43 110.634 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.467 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 59.9 mtpt -63.66 -50.5 69.03 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.185 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.41 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 36.3 tp -56.19 -54.34 46.35 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.928 -0.578 . . . . 70.21 112.198 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.4 t -59.01 -43.83 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 111.818 0.303 . . . . 72.11 111.818 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.13 -42.82 99.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.679 0.276 . . . . 71.24 111.458 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . 0.467 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 96.4 mt-10 -63.69 -39.93 95.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.832 0.349 . . . . 73.41 111.338 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.41 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 90.8 mt -59.06 -48.26 82.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.776 0.322 . . . . 71.53 111.322 174.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.506 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 29.2 m-80 -54.63 -58.63 6.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.489 -0.323 . . . . 74.41 111.283 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.523 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 44.7 mt-10 -48.7 -41.4 31.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.944 0.402 . . . . 71.24 111.627 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -62.08 -54.85 35.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.213 -0.449 . . . . 74.22 112.158 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -62.18 -38.96 91.07 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.778 0.288 . . . . 73.33 111.778 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.506 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 36.4 mt-10 -61.14 -41.68 97.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.554 0.216 . . . . 70.13 111.034 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.523 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 45.0 mmtm -52.49 -43.26 64.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.988 0.423 . . . . 75.42 110.846 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.401 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 42.7 mtpt -66.76 -46.86 74.04 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.241 -0.436 . . . . 40.43 111.113 177.355 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -57.58 -27.28 62.56 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.024 0.44 . . . . 73.44 111.597 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.423 HG21 ' O ' ' A' ' 64' ' ' GLU . 67.6 t -73.37 -46.8 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.019 0.438 . . . . 71.54 111.41 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . 0.415 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 53.4 mt -71.93 -62.85 1.28 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.621 0.6 . . . . 65.51 112.621 -177.995 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.699 -0.667 . . . . 75.54 112.371 -173.39 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.798 0.332 . . . . 74.12 111.236 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -110.63 121.6 45.72 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.607 -0.516 . . . . 63.34 109.607 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.479 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 44.4 mm -68.13 127.66 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.682 0.277 . . . . 75.4 111.406 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.521 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 18.3 p -115.34 154.05 29.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.707 0.289 . . . . 75.22 110.771 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.778 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 49.9 pttt -68.95 -14.84 63.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.86 0.362 . . . . 73.14 111.844 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.9 -22.75 52.94 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.08 -0.509 . . . . 74.55 111.314 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.521 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 60.7 mtt -62.43 150.57 39.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.604 0.716 . . . . 74.21 112.873 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.65 133.77 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 73.4 111.185 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -51.01 -50.91 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 120.73 0.3 . . . . 74.22 111.806 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.523 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -58.03 -40.94 82.13 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.837 0.31 . . . . 73.32 111.837 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.3 -38.89 88.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.948 0.404 . . . . 64.23 111.026 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.532 ' HA ' ' HE1' ' A' ' 15' ' ' MET . 59.2 t -65.32 -44.92 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.134 0.492 . . . . 75.43 110.953 174.458 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.8 -33.16 71.36 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.041 -0.527 . . . . 72.11 111.987 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.494 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 82.5 mm-40 -61.42 -29.02 69.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.977 0.418 . . . . 73.44 111.618 177.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.532 ' HE1' ' HA ' ' A' ' 12' ' ' VAL . 31.0 mtm -84.15 -41.39 17.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.169 0.509 . . . . 72.11 110.346 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.22 120.96 3.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.002 -0.545 . . . . 74.43 111.325 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -69.83 -16.96 63.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 72.53 112.082 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -66.02 -7.75 38.79 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.236 -0.506 . . . . 53.24 113.144 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.2 p -80.24 -19.49 46.72 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.568 -0.372 . . . . 73.1 111.573 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.463 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.75 -51.78 77.56 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.501 0.556 . . . . 44.11 112.501 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.463 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 17.7 Cg_endo -59.12 -21.68 60.52 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.115 1.877 . . . . 71.4 112.634 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.4 mt -77.07 -41.7 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.974 0.416 . . . . 74.44 110.579 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -60.79 -45.85 92.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.139 0.495 . . . . 72.01 110.229 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.87 -39.11 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.988 -0.551 . . . . 74.14 110.991 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.93 -37.37 63.78 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.046 0.451 . . . . 74.25 111.782 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.483 ' ND2' HD13 ' A' ' 55' ' ' LEU . 33.6 m-80 -89.82 -2.29 58.19 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.31 0.485 . . . . 73.41 112.31 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 37.6 5.44 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.927 -0.654 . . . . 63.31 114.706 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.3 mmt -79.52 166.84 21.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.363 0.582 . . . . 71.4 111.656 173.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -70.72 141.36 51.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.147 -0.479 . . . . 73.55 111.618 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.16 144.52 53.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.775 0.321 . . . . 75.11 110.465 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.444 HD22 ' HE2' ' A' ' 37' ' ' MET . 3.0 tm? -63.79 119.34 9.78 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.472 0.653 . . . . 73.4 111.667 -174.49 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.25 -58.0 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.356 -0.838 . . . . 62.4 111.534 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.7 m -88.86 127.58 55.45 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 122.218 0.207 . . . . 72.52 110.539 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.31 -24.5 34.83 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.829 2.352 . . . . 53.3 113.206 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 m -52.07 -44.01 64.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.614 0.366 . . . . 62.22 111.889 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.4 t -60.42 -21.12 61.89 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.177 0.436 . . . . 72.31 112.177 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.593 ' HE3' ' HA ' ' A' ' 37' ' ' MET . 23.3 mmt -77.61 -37.26 50.66 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.378 -0.201 . . . . 72.14 111.408 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -83.15 -10.69 82.21 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.346 -0.454 . . . . 41.4 114.05 -176.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.34 141.06 45.22 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.156 0.503 . . . . 74.25 111.863 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -75.77 154.98 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.884 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -53.36 -58.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.702 0.63 . . . . 74.23 112.702 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.778 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.4 pt-20 -64.97 -33.55 76.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.863 0.364 . . . . 70.52 111.604 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.43 ' O ' HG22 ' A' ' 47' ' ' VAL . 25.7 t70 -64.49 -54.17 36.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.821 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.084 -0.507 . . . . 73.21 111.038 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.5 m -56.4 -49.21 75.13 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.431 -0.35 . . . . 75.12 110.913 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.0 67.54 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.902 0.334 . . . . 36.86 111.902 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.43 HG22 ' O ' ' A' ' 43' ' ' ASP . 61.8 t -67.41 -39.14 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.872 0.368 . . . . 72.55 111.552 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.01 9.76 24.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.774 0.321 . . . . 75.44 111.839 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.31 31.54 81.19 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.522 -0.371 . . . . 72.31 113.329 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.74 153.28 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.538 0.335 . . . . 60.42 111.646 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.38 107.09 16.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.944 0.402 . . . . 73.44 110.298 175.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -28.74 56.8 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.011 0.374 . . . . 65.14 112.011 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.44 -47.16 84.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.862 0.363 . . . . 62.14 110.776 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.35 -45.93 52.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.586 -0.279 . . . . 74.32 111.594 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.483 HD13 ' ND2' ' A' ' 26' ' ' ASN . 25.0 tp -53.18 -51.4 62.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.996 0.427 . . . . 75.51 111.694 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.511 HG23 ' HB3' ' A' ' 5' ' ' LYS . 88.0 t -59.91 -41.81 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.686 0.279 . . . . 65.53 111.602 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.04 -39.47 90.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.545 0.202 . . . . 74.44 111.545 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.76 -37.03 80.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 73.42 110.723 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.422 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 79.8 mt -65.83 -51.14 61.4 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.454 -0.339 . . . . 73.23 111.764 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.479 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 40.5 m-80 -56.21 -51.66 67.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.926 0.343 . . . . 71.34 111.926 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.429 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.0 mt-10 -57.62 -34.83 69.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.813 0.34 . . . . 64.32 111.632 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.466 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 94.3 t80 -59.35 -48.31 82.11 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.84 0.352 . . . . 63.22 111.181 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.471 ' CZ ' ' HE3' ' A' ' 15' ' ' MET . 57.0 m-85 -61.68 -38.98 89.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.649 -0.251 . . . . 72.42 111.253 177.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -59.86 -37.44 79.31 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.924 0.392 . . . . 62.03 111.264 174.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.429 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 47.1 mmtm -67.76 -26.39 66.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.255 -0.43 . . . . 73.05 111.963 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.69 -43.92 97.93 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.694 0.283 . . . . 62.5 111.57 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.1 -20.81 66.65 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.123 0.487 . . . . 75.32 111.183 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.46 -53.54 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.943 -0.571 . . . . 61.03 111.388 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.61 -57.57 3.78 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.093 -0.503 . . . . 64.31 112.351 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 . . . . . 0 C--O 1.255 1.386 0 CA-C-O 118.724 -0.655 . . . . 61.43 112.469 -177.626 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.82 0.343 . . . . 72.54 111.503 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.479 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 14.0 mmmm -112.98 156.23 23.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.143 0.497 . . . . 73.13 111.322 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.553 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.7 mm -73.98 137.75 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 112.717 0.636 . . . . 61.43 112.717 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -122.28 156.87 32.94 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.274 -0.421 . . . . 73.55 110.725 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.5 ptpt -66.76 -14.07 62.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.796 0.331 . . . . 73.14 111.809 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.7 -19.33 41.77 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.227 -0.442 . . . . 62.1 111.279 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.553 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 53.6 mtt -63.19 151.39 40.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.283 0.563 . . . . 73.24 112.05 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.49 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 42.0 mm -82.62 138.24 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.879 -0.6 . . . . 64.21 110.518 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -53.5 -49.21 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 120.865 0.364 . . . . 64.12 111.825 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.428 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -62.16 -32.01 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.867 0.365 . . . . 71.34 111.718 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.75 -43.7 88.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.039 0.447 . . . . 73.12 110.637 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.67 -36.3 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.211 0.529 . . . . 74.14 110.793 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.403 HD22 ' OG1' ' A' ' 19' ' ' THR . 96.6 mt -65.61 -24.44 67.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.119 -0.491 . . . . 72.2 111.778 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.428 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 73.8 mt-30 -69.48 -32.96 72.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.158 0.504 . . . . 51.33 110.909 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.5 mtt -71.21 -50.46 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.812 -0.631 . . . . 70.44 110.674 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.88 135.96 13.87 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.821 -0.627 . . . . 64.32 110.632 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -72.72 -21.86 60.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.836 0.35 . . . . 75.21 111.909 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.77 3.18 45.16 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.251 -0.432 . . . . 52.23 113.807 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.403 ' OG1' HD22 ' A' ' 13' ' ' LEU . 71.4 p -81.31 -21.29 39.37 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.387 -0.478 . . . . 73.54 111.674 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.499 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.81 -51.41 80.62 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 112.741 0.645 . . . . 72.15 112.741 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.499 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.7 Cg_endo -57.31 -26.01 68.25 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.201 1.934 . . . . 71.2 112.785 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -69.2 -47.07 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.079 0.466 . . . . 71.32 110.7 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.95 -44.55 82.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.157 0.503 . . . . 64.45 110.3 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.8 mt -60.78 -40.62 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.982 -0.554 . . . . 64.21 111.475 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -55.55 -36.02 66.34 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.131 0.491 . . . . 74.1 111.803 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.424 ' ND2' HD13 ' A' ' 55' ' ' LEU . 35.0 m-80 -91.25 1.41 57.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.443 0.534 . . . . 72.41 112.443 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.07 18.54 17.14 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.097 0.799 . . . . 73.23 115.097 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt -68.25 145.38 54.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.109 0.954 . . . . 64.21 111.543 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -121.18 114.29 21.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.242 -0.436 . . . . 75.25 110.582 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.63 113.9 5.81 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.013 0.435 . . . . 45.05 112.095 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.511 HD12 ' N ' ' A' ' 32' ' ' GLY . 2.6 tm? -83.64 139.65 32.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.616 -0.513 . . . . 74.44 109.616 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.511 ' N ' HD12 ' A' ' 31' ' ' LEU . . . -49.57 -69.15 1.1 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.439 -0.41 . . . . 45.24 113.638 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.85 154.19 89.64 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.667 -0.314 . . . . 62.41 110.938 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' SER . 47.4 Cg_exo -36.43 -69.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.495 2.797 . . . . 75.25 114.357 -174.791 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m 39.44 -83.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.821 1.045 . . . . 51.14 113.821 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' PRO . 41.0 t -57.41 -27.48 62.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.076 0.465 . . . . 73.31 112.124 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.5 ' HE2' ' HA ' ' A' ' 37' ' ' MET . 30.0 mmt -73.58 -11.89 60.58 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.004 0.372 . . . . 54.53 112.004 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 2.21 32.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.051 -0.595 . . . . 45.44 113.721 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.0 157.61 26.47 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.347 0.573 . . . . 74.02 111.775 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.49 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.4 p -78.05 162.96 26.32 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.107 0.48 . . . . 72.12 112.201 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.92 -52.74 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.898 -0.592 . . . . 64.44 112.101 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 17.2 pt-20 -62.95 -37.22 86.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.833 0.349 . . . . 73.24 111.752 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -67.53 -49.81 61.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.345 -0.389 . . . . 72.42 110.778 -178.883 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.97 93.96 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.035 0.445 . . . . 73.53 111.72 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -59.28 -51.22 70.9 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.408 -0.36 . . . . 62.45 111.458 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.52 69.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.987 0.366 . . . . 72.32 111.987 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 89.5 t -62.29 -48.59 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.93 0.395 . . . . 53.43 111.477 176.515 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.404 ' HB3' HG13 ' A' ' 50' ' ' ILE . 65.2 t-80 -82.27 -11.88 58.38 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.369 -0.378 . . . . 74.02 111.596 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.28 40.8 15.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.52 -0.371 . . . . 72.43 113.031 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.404 HG13 ' HB3' ' A' ' 48' ' ' HIS . 18.9 mt -103.63 152.16 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.708 0.403 . . . . 63.04 111.177 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -80.48 97.65 7.22 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.073 0.463 . . . . 65.53 109.879 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.495 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -60.74 -37.48 81.93 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.604 0.594 . . . . 73.31 112.604 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.661 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 12.4 t70 -64.1 -39.75 94.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.657 -0.417 . . . . 72.12 110.493 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.02 -41.43 90.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.785 0.326 . . . . 73.53 111.218 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.424 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.0 tp -61.85 -50.05 73.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.958 0.409 . . . . 72.31 111.405 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.495 HG21 ' O ' ' A' ' 52' ' ' ALA . 93.4 t -55.86 -35.23 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.371 -0.377 . . . . 73.25 111.875 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.661 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 58.0 mttm -57.06 -54.96 40.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.664 0.269 . . . . 71.04 110.982 176.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -56.85 -39.6 74.57 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.433 -0.349 . . . . 73.53 111.335 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.439 HD13 ' HA ' ' A' ' 56' ' ' VAL . 89.1 mt -60.19 -51.93 67.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.507 -0.315 . . . . 63.22 111.494 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.479 ' OD1' ' HB3' ' A' ' 2' ' ' LYS . 40.2 m-80 -56.59 -50.03 73.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.508 0.194 . . . . 72.14 111.453 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.579 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.7 mt-10 -54.75 -42.11 71.22 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.46 -0.336 . . . . 75.11 111.143 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -54.45 -44.72 72.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.868 0.366 . . . . 74.32 111.744 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.487 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 85.2 m-85 -66.78 -37.67 85.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.863 0.363 . . . . 73.55 110.975 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.407 ' O ' HG21 ' A' ' 68' ' ' VAL . 35.5 mt-10 -66.11 -27.29 67.94 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.353 -0.385 . . . . 74.33 110.991 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.579 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 30.9 mmmt -73.73 -35.97 65.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.333 -0.394 . . . . 63.31 110.24 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.487 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 27.7 mtpp -56.43 -39.66 73.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.0 0.429 . . . . 74.41 110.791 173.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.54 -11.3 60.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.115 -0.493 . . . . 74.34 111.834 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.407 HG21 ' O ' ' A' ' 64' ' ' GLU . 95.6 t -102.68 -53.98 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.027 0.442 . . . . 62.31 111.93 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -75.6 -57.3 3.97 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.798 0.666 . . . . 75.44 112.798 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CD ' ' HZ3' ' A' ' 66' ' ' LYS . 40.3 mt-10 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.894 -0.574 . . . . 74.41 112.086 -176.248 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.798 0.332 . . . . 74.44 111.573 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.628 ' HB2' ' HZ3' ' A' ' 2' ' ' LYS . 0.1 OUTLIER -72.91 105.41 4.4 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.785 -0.45 . . . . 55.33 109.785 173.906 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 48.4 mm -56.6 137.42 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.814 0.672 . . . . 71.34 112.814 -173.261 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.459 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 43.1 p -117.35 156.2 28.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.745 -0.661 . . . . 74.52 110.403 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.667 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 21.2 pttp -68.94 -13.46 62.45 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.007 0.432 . . . . 60.31 111.557 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.03 -22.51 45.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.27 -0.423 . . . . 62.32 111.284 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.459 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 67.2 mtt -64.73 153.98 38.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.295 0.569 . . . . 54.33 112.102 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -82.25 139.83 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.983 -0.553 . . . . 75.52 111.659 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.3 -55.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.189 0.44 . . . . 62.42 112.189 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.49 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.83 -35.61 73.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.737 0.303 . . . . 72.21 111.517 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.56 -43.8 89.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.047 0.451 . . . . 74.32 111.065 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.19 -43.72 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.235 -0.439 . . . . 73.41 110.775 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.24 -27.91 69.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.094 -0.503 . . . . 71.53 111.912 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.49 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 18.5 mm-40 -63.18 -27.98 69.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.8 0.334 . . . . 75.41 111.397 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.78 -49.15 7.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.029 0.442 . . . . 74.03 110.879 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -148.21 119.84 8.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.226 -0.443 . . . . 62.13 111.396 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.414 HH11 ' HD2' ' A' ' 17' ' ' ARG . 12.6 mmt180 -75.48 -8.34 56.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.382 0.512 . . . . 71.03 112.382 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.02 -8.23 68.64 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.227 -0.511 . . . . 72.24 112.459 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 65.4 p -81.05 -18.04 48.09 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.696 -0.297 . . . . 72.3 111.45 175.73 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.454 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.91 -52.1 75.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 112.178 0.436 . . . . 53.34 112.178 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.454 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -59.52 -28.16 86.78 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.03 1.82 . . . . 74.14 112.318 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 67.9 mt -68.71 -46.63 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.057 0.456 . . . . 71.14 110.894 176.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.488 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 58.5 m-85 -56.75 -48.97 76.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.088 0.47 . . . . 73.34 110.529 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.34 -36.15 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.013 -0.539 . . . . 74.43 111.568 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -57.38 -33.11 67.48 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.081 0.467 . . . . 62.55 111.203 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -92.58 -4.4 53.49 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.197 -0.456 . . . . 74.43 112.068 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.42 -13.34 11.03 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.74 -0.743 . . . . 71.52 114.559 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.488 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.7 mmt -64.0 160.79 17.15 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.559 0.679 . . . . 53.12 111.746 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -132.65 108.24 8.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.991 0.424 . . . . 75.22 111.323 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t -70.09 -30.74 68.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.921 0.391 . . . . 64.04 111.719 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.82 107.23 16.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.325 -0.398 . . . . 74.13 110.233 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.17 -99.88 0.16 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.239 -0.505 . . . . 74.0 112.786 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.401 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 80.5 m -78.79 115.7 54.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 122.543 -0.386 . . . . 75.02 110.964 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.401 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 11.0 Cg_endo -53.44 -41.85 70.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.772 2.315 . . . . 73.0 113.254 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . 0.476 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 23.3 t -60.97 -28.48 69.03 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.839 0.311 . . . . 74.54 111.839 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 m -54.13 -30.61 49.56 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.904 0.383 . . . . 54.44 111.73 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.564 ' HE3' ' HA ' ' A' ' 37' ' ' MET . 6.0 mmt -66.45 -36.63 83.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.795 0.331 . . . . 60.42 111.387 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.86 72.67 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.312 0.485 . . . . 62.45 114.312 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 35' ' ' SER . 40.4 mt-10 -90.29 146.67 24.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.442 0.621 . . . . 63.32 111.911 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.3 m -66.6 147.44 53.27 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.224 -0.444 . . . . 72.13 110.252 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.449 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.7 mt -50.49 -56.95 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.642 0.608 . . . . 73.51 112.642 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.2 pt-20 -62.99 -35.99 82.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.847 0.356 . . . . 73.42 111.791 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.456 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 t70 -65.29 -52.0 57.01 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.064 -0.517 . . . . 73.41 110.767 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.3 79.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.169 -0.469 . . . . 73.21 111.484 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.449 ' SG ' ' O ' ' A' ' 41' ' ' ILE . 85.8 m -58.27 -54.93 41.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.469 -0.332 . . . . 73.43 111.163 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -37.26 64.24 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.838 0.352 . . . . 73.41 111.841 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.456 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -59.72 -52.2 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.392 -0.367 . . . . 73.52 111.839 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -92.12 -0.67 57.44 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.109 0.411 . . . . 73.15 112.109 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.55 46.33 40.65 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.443 -0.408 . . . . 64.43 113.283 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mt -101.91 151.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 122.704 0.401 . . . . 75.34 111.264 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -85.14 98.52 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.035 0.445 . . . . 71.21 110.654 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.35 66.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.429 -0.35 . . . . 73.22 111.78 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.46 -51.82 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.585 -0.279 . . . . 62.33 111.159 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -76.91 -40.16 48.26 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.04 0.385 . . . . 64.23 112.04 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 tp -55.63 -53.69 53.36 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.783 0.325 . . . . 70.11 111.747 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.535 HG23 ' HB3' ' A' ' 5' ' ' LYS . 59.8 t -61.16 -39.93 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.659 0.266 . . . . 72.33 111.595 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.416 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.4 mttt -60.8 -45.78 93.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.802 -0.181 . . . . 71.24 111.315 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.15 -40.0 88.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.751 0.31 . . . . 72.24 111.453 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.479 HD13 ' HA ' ' A' ' 56' ' ' VAL . 87.9 mt -59.24 -52.72 64.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.813 0.339 . . . . 72.2 111.51 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 3' ' ' ILE . 52.9 m-80 -57.74 -49.94 74.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.429 -0.351 . . . . 73.11 111.745 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.568 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.7 mt-10 -52.57 -44.43 65.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.462 -0.336 . . . . 63.14 110.782 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -57.69 -54.15 50.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.336 -0.393 . . . . 72.15 112.054 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.85 -41.41 77.87 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.993 0.368 . . . . 74.4 111.993 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.12 -30.75 65.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.777 0.323 . . . . 64.21 111.268 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.568 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 30.9 mmmt -65.9 -28.11 68.7 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.353 -0.217 . . . . 73.23 111.026 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -56.15 -45.97 79.46 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 72.02 111.765 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.15 -21.42 66.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.077 0.465 . . . . 71.44 111.434 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.3 t -79.65 -45.58 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 121.283 0.563 . . . . 65.3 111.033 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.8 -59.95 3.1 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.937 -0.574 . . . . 71.54 111.744 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.776 -0.63 . . . . 71.25 111.619 179.277 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.488 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.1 mpt? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.02 0.438 . . . . 74.24 111.517 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -124.99 107.78 11.18 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.229 -0.656 . . . . 72.25 109.229 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.47 HG21 HG12 ' A' ' 56' ' ' VAL . 50.9 mm -72.55 137.8 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.944 0.72 . . . . 75.31 112.944 -168.486 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.8 p -125.82 158.58 34.64 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.69 -0.686 . . . . 63.34 109.939 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.736 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.4 pttp -71.92 -15.17 62.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.015 -0.428 . . . . 41.14 111.252 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.84 -23.56 61.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.04 -0.527 . . . . 74.44 111.192 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.42 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.9 mtt -67.64 165.33 17.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.397 0.518 . . . . 74.2 112.397 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.414 ' O ' HG23 ' A' ' 12' ' ' VAL . 47.2 mm -93.75 135.53 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.992 -0.549 . . . . 61.42 111.581 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.7 -51.31 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.821 0.343 . . . . 65.0 111.849 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.407 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.13 -41.52 83.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.805 0.336 . . . . 64.42 111.73 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.4 t70 -58.66 -45.01 90.28 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.407 -0.361 . . . . 74.31 110.95 177.654 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.518 ' HA ' ' HE1' ' A' ' 15' ' ' MET . 88.7 t -57.53 -43.42 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.957 0.408 . . . . 73.43 111.2 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.412 HD21 ' OG1' ' A' ' 19' ' ' THR . 94.9 mt -62.68 -34.4 77.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.321 -0.399 . . . . 71.42 111.395 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.407 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 78.8 mt-30 -67.61 -30.16 69.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.386 -0.37 . . . . 63.51 111.661 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.518 ' HE1' ' HA ' ' A' ' 12' ' ' VAL . 37.2 mtm -74.45 -43.2 57.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.3 0.572 . . . . 65.0 109.949 175.011 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -159.49 124.67 4.11 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.614 -0.721 . . . . 73.52 111.756 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -69.47 -14.7 63.02 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.992 -0.549 . . . . 72.54 111.766 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.502 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -65.51 -9.75 45.54 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.067 -0.587 . . . . 73.32 113.178 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.412 ' OG1' HD21 ' A' ' 13' ' ' LEU . 80.7 p -82.43 -13.85 56.11 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.44 -0.447 . . . . 70.23 111.757 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.496 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.03 -51.07 80.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.604 0.594 . . . . 75.31 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.496 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.5 Cg_endo -58.92 -26.45 81.13 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.169 1.913 . . . . 74.12 112.677 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -71.41 -44.1 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.97 0.414 . . . . 74.33 110.789 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -63.76 -46.03 87.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.972 0.415 . . . . 73.53 110.55 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.56 -39.16 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.205 -0.452 . . . . 64.01 111.259 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.43 -40.7 71.83 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.076 0.465 . . . . 72.5 111.541 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.74 0.42 43.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.14 -0.482 . . . . 75.2 112.041 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 9.51 45.31 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 114.826 0.69 . . . . 71.53 114.826 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt -63.72 142.8 58.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.093 0.946 . . . . 74.15 111.817 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -126.58 112.34 15.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.018 -0.537 . . . . 75.23 110.893 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.3 p -84.12 -18.96 35.1 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.857 0.361 . . . . 75.13 111.567 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.46 103.83 5.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.946 0.403 . . . . 74.21 110.633 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.9 -86.5 0.15 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.204 -0.522 . . . . 72.33 113.07 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.405 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 80.2 m -125.27 145.65 51.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 122.637 -0.331 . . . . 74.33 111.256 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.405 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 37.9 Cg_exo -61.42 -10.43 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.849 2.366 . . . . 74.25 113.478 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -55.83 -39.68 71.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.073 0.463 . . . . 54.0 111.168 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -64.37 -9.76 20.16 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.021 0.378 . . . . 75.25 112.021 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.539 ' HE1' ' HA ' ' A' ' 37' ' ' MET . 3.3 mmt -111.81 -57.94 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.811 0.339 . . . . 73.43 111.767 -179.037 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.22 -20.09 79.82 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.122 0.809 . . . . 43.21 115.122 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -84.09 168.82 15.51 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.564 0.682 . . . . 75.23 112.344 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.7 m -70.29 151.53 45.19 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.041 -0.527 . . . . 72.31 111.899 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.0 mt -52.67 -57.66 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.376 0.509 . . . . 74.22 112.376 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.736 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.6 pt-20 -58.61 -35.56 72.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.912 0.387 . . . . 74.24 111.78 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.412 ' O ' HG22 ' A' ' 47' ' ' VAL . 17.9 t70 -68.85 -53.61 20.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.202 -0.454 . . . . 73.22 111.144 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.41 79.16 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.267 -0.424 . . . . 72.22 111.245 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -60.22 -52.25 66.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 74.11 110.825 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.0 -47.94 64.69 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.411 -0.358 . . . . 38.22 111.871 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.412 HG22 ' O ' ' A' ' 43' ' ' ASP . 59.9 t -51.94 -38.27 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 52.42 111.928 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -103.18 0.51 31.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.294 0.479 . . . . 73.35 112.294 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.57 74.07 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.161 -0.543 . . . . 44.41 113.501 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.6 153.13 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.899 0.38 . . . . 72.32 111.307 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -86.07 105.09 16.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.872 0.368 . . . . 72.15 110.877 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.5 -36.07 68.29 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.045 0.387 . . . . 72.23 112.045 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.74 -44.73 77.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.029 0.442 . . . . 75.34 111.003 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -69.2 -52.02 32.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.343 -0.39 . . . . 75.21 111.469 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -55.09 -49.62 71.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.21 0.448 . . . . 73.33 112.21 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.498 HG23 ' HB3' ' A' ' 5' ' ' LYS . 75.2 t -60.31 -42.1 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 111.978 0.362 . . . . 73.45 111.978 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.71 -35.39 77.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.818 0.342 . . . . 74.45 111.217 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.63 -38.25 86.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.921 0.391 . . . . 73.05 110.999 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.42 -45.0 73.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.204 -0.453 . . . . 73.41 111.971 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.52 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 27.7 m-80 -53.58 -56.4 17.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.794 0.294 . . . . 73.15 111.794 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.59 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 18.4 mt-10 -46.68 -52.53 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 75.52 111.327 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.502 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 80.4 t80 -50.43 -55.36 16.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.54 0.57 . . . . 74.41 112.54 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.512 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 56.2 m-85 -62.45 -37.28 85.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.244 0.461 . . . . 73.44 112.244 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 27.1 mt-10 -71.53 -32.37 68.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.782 0.325 . . . . 72.3 111.07 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.59 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 33.7 mmtp -68.92 -41.12 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.417 -0.356 . . . . 71.51 110.925 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.512 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 26.6 mtpp -46.67 -58.93 3.37 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.439 0.533 . . . . 73.22 112.439 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.05 -11.91 33.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.958 -0.565 . . . . 63.23 112.196 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -95.16 -49.91 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.05 0.453 . . . . 75.04 111.43 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.2 mt -71.58 -56.7 5.36 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.238 0.458 . . . . 62.41 112.238 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 . . . . . 0 C--O 1.255 1.387 0 CA-C-O 118.662 -0.685 . . . . 73.25 112.059 -177.609 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.598 0.237 . . . . 75.41 111.191 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.533 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 3.3 tppp? -94.63 100.86 12.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.216 0.532 . . . . 74.4 110.579 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.512 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm -70.36 137.65 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.582 -0.735 . . . . 75.14 111.435 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 p -121.61 154.69 36.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.841 0.353 . . . . 74.44 111.287 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 18.3 ptpt -53.54 -33.34 54.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.185 0.809 . . . . 75.42 113.185 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.09 -3.39 42.06 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.883 0.697 . . . . 61.45 112.883 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.512 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.2 mtt -73.38 150.79 41.52 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.122 0.487 . . . . 71.15 111.67 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.5 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.6 mm -79.78 131.04 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.237 -0.438 . . . . 72.33 111.444 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 48.8 mt -56.25 -51.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 111.89 0.329 . . . . 72.04 111.89 -178.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.457 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -56.38 -40.11 74.06 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.891 0.377 . . . . 72.3 111.385 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -43.4 96.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.261 -0.427 . . . . 75.13 110.709 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.1 -41.55 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.089 0.471 . . . . 75.2 110.986 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD21 ' OG1' ' A' ' 19' ' ' THR . 94.7 mt -61.42 -35.89 78.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.033 0.444 . . . . 72.35 111.163 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.457 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 99.2 mt-30 -67.66 -22.21 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.257 -0.429 . . . . 64.04 111.598 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -74.2 -58.56 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.254 0.549 . . . . 74.53 109.643 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -146.83 127.51 14.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.612 -0.722 . . . . 74.23 110.825 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . 0.433 HH12 ' HA ' ' A' ' 14' ' ' GLN . 77.8 mmt-85 -69.18 -17.59 63.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.783 0.29 . . . . 73.11 111.783 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.2 -6.75 41.18 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.211 -0.519 . . . . 71.13 113.217 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.431 ' HA ' HD11 ' A' ' 22' ' ' ILE . 80.9 p -81.62 -21.27 38.38 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.557 -0.378 . . . . 70.53 111.251 174.859 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.489 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -57.09 -51.14 83.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 112.181 0.438 . . . . 73.14 112.181 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.489 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.79 -25.44 76.16 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.941 1.761 . . . . 74.22 112.281 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . 0.431 HD11 ' HA ' ' A' ' 19' ' ' THR . 59.9 mt -73.22 -45.43 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.013 0.435 . . . . 72.11 110.72 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -57.01 -52.17 66.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.056 0.455 . . . . 64.04 110.522 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.81 -37.32 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.272 -0.422 . . . . 63.33 111.368 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -55.9 -33.64 64.83 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.137 0.494 . . . . 74.1 111.251 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -91.43 -4.12 55.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.241 0.459 . . . . 72.11 112.241 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.18 19.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.984 -0.627 . . . . 74.31 114.438 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.56 -175.61 2.06 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.593 0.696 . . . . 54.33 111.807 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -95.85 152.64 18.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.033 -0.53 . . . . 73.42 111.396 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 63.8 m -73.12 168.5 18.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.232 0.539 . . . . 70.24 112.21 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.477 HD22 ' SD ' ' A' ' 37' ' ' MET . 1.9 tm? -62.99 100.5 0.21 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.941 -0.572 . . . . 54.43 110.706 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.68 -72.62 0.07 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.794 -0.717 . . . . 53.23 113.331 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -65.28 116.2 28.51 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 111.977 0.362 . . . . 74.35 111.977 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.07 -26.93 77.73 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.882 2.388 . . . . 71.11 113.016 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 87.5 p -54.8 -43.57 73.01 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 75.13 111.903 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -88.22 -9.02 54.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.845 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.559 ' HA ' ' HE3' ' A' ' 37' ' ' MET . 7.7 mmt -94.68 -49.83 5.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.898 0.38 . . . . 72.14 111.794 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.421 ' O ' HD12 ' A' ' 8' ' ' ILE . . . -68.94 -36.28 81.19 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.19 0.436 . . . . 74.53 114.19 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.7 167.57 21.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.685 0.755 . . . . 75.23 112.772 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.5 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 94.1 p -78.84 164.13 24.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.526 -0.761 . . . . 70.4 112.011 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.07 -48.79 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.593 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.489 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 8.0 pt-20 -62.56 -37.18 85.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.982 0.364 . . . . 60.04 111.982 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.513 ' O ' HG22 ' A' ' 47' ' ' VAL . 22.2 t70 -66.01 -58.99 4.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.71 0.29 . . . . 74.14 110.703 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.37 65.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.778 0.323 . . . . 74.15 111.65 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.819 0.342 . . . . 72.4 110.753 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.12 68.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.835 0.309 . . . . 75.4 111.835 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.513 HG22 ' O ' ' A' ' 43' ' ' ASP . 76.7 t -66.45 -54.58 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.939 0.4 . . . . 71.41 111.747 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.75 -18.69 30.52 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.881 0.372 . . . . 64.12 111.748 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.18 53.15 2.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 121.178 0.321 . . . . 72.02 113.066 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.9 mt -110.88 153.15 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.01 0.524 . . . . 60.03 111.107 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . 0.422 ' OD2' ' HG3' ' A' ' 54' ' ' LYS . 14.6 t70 -84.74 103.06 13.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.946 0.403 . . . . 72.02 110.243 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -62.14 -34.15 75.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.377 0.51 . . . . 74.14 112.377 -177.743 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.65 -45.01 90.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.749 0.309 . . . . 73.4 111.181 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . 0.422 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 92.0 mttt -66.42 -49.06 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.955 0.407 . . . . 74.15 111.036 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.17 -52.87 63.75 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.112 -0.495 . . . . 73.13 111.819 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.442 ' HA ' HD13 ' A' ' 59' ' ' LEU . 96.2 t -58.57 -40.02 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.731 0.3 . . . . 65.15 111.639 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.47 -44.92 95.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.538 0.209 . . . . 74.13 111.39 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -62.96 -35.6 80.68 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.847 0.356 . . . . 60.42 111.314 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.442 HD13 ' HA ' ' A' ' 56' ' ' VAL . 90.8 mt -64.09 -51.4 64.18 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.468 -0.333 . . . . 73.44 111.619 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.533 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 52.3 m-80 -58.31 -49.92 75.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.676 0.274 . . . . 72.54 111.571 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.614 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 49.1 mt-10 -50.29 -46.88 55.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.568 -0.287 . . . . 72.51 110.9 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -54.31 -51.77 63.62 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.305 0.483 . . . . 73.14 112.305 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -57.5 -39.37 76.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.547 0.213 . . . . 70.34 111.429 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.432 ' O ' HG21 ' A' ' 68' ' ' VAL . 32.5 mt-10 -68.64 -37.15 79.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.649 0.24 . . . . 70.2 111.649 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.614 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.9 mmtp -60.46 -36.78 79.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.9 0.381 . . . . 73.13 110.82 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.45 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 45.1 mtpt -55.94 -52.75 63.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.962 0.411 . . . . 64.52 110.975 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.76 -11.14 33.24 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.12 -0.491 . . . . 71.3 111.881 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.432 HG21 ' O ' ' A' ' 64' ' ' GLU . 83.4 t -85.66 -48.27 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.083 0.468 . . . . 61.24 111.036 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.15 -55.35 7.43 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.097 -0.501 . . . . 64.51 112.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.441 -0.79 . . . . 73.11 112.179 -178.696 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.498 0.19 . . . . 74.25 111.374 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 98.26 2.3 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.053 0.454 . . . . 74.11 110.71 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 mm -78.46 138.89 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.178 -0.464 . . . . 63.22 111.324 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 p -127.33 154.07 45.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.711 0.291 . . . . 64.33 110.719 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.46 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 10.2 ptpp? -64.46 -15.79 61.32 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.157 0.504 . . . . 71.24 111.237 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.44 -25.2 63.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.591 -0.731 . . . . 63.43 111.287 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.7 mtt -71.71 149.41 45.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.237 0.828 . . . . 64.11 113.237 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mm -78.76 133.37 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.405 -0.816 . . . . 73.22 110.928 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.67 -42.04 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 111.896 0.332 . . . . 63.52 111.896 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.0 94.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.964 0.357 . . . . 61.12 111.964 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.65 -45.99 88.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.093 0.473 . . . . 74.52 110.957 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.511 ' HA ' ' HE2' ' A' ' 15' ' ' MET . 42.7 t -57.51 -37.52 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 74.04 111.249 178.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.36 -37.17 86.23 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.323 -0.399 . . . . 74.44 111.235 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -65.26 -21.83 66.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.365 -0.38 . . . . 72.41 111.428 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.511 ' HE2' ' HA ' ' A' ' 12' ' ' VAL . 29.7 mtm -84.68 -52.15 6.29 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.157 0.503 . . . . 74.13 110.091 175.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -146.55 128.81 15.76 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.919 -0.582 . . . . 73.55 111.042 176.819 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -73.04 -22.75 60.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.299 0.481 . . . . 71.31 112.299 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.55 -2.84 51.96 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.447 -0.406 . . . . 36.26 113.56 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 p -80.26 -24.39 40.13 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.502 -0.411 . . . . 61.24 111.762 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.46 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.7 -52.5 66.81 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.715 0.635 . . . . 74.53 112.715 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.46 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.0 Cg_endo -58.88 -24.57 73.04 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.117 1.878 . . . . 71.25 112.706 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -71.82 -44.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.928 0.394 . . . . 64.51 110.633 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.96 -49.9 76.11 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.185 0.517 . . . . 75.01 110.288 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -61.22 -34.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.111 -0.495 . . . . 55.22 111.265 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -57.76 -34.42 69.53 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.912 0.387 . . . . 64.52 111.326 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -93.73 12.94 23.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.398 0.518 . . . . 73.35 112.398 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.22 38.1 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.707 -0.758 . . . . 40.22 114.846 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.53 178.64 4.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.82 0.81 . . . . 65.51 111.32 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -159.85 109.7 1.85 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.046 0.45 . . . . 73.44 111.28 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.9 m -69.82 -22.91 63.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.199 -0.455 . . . . 71.34 111.681 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.66 124.9 43.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.515 -0.312 . . . . 54.53 110.368 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.14 -49.33 0.92 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.91 -0.662 . . . . 73.33 113.7 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.9 m -149.39 140.01 13.82 Favored Pre-proline 0 N--CA 1.472 0.66 0 O-C-N 122.556 -0.379 . . . . 54.45 111.506 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.47 -15.63 38.29 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.456 2.104 . . . . 72.14 113.055 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.8 p -53.97 -56.61 16.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.976 0.417 . . . . 75.31 111.66 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -57.24 -8.2 0.69 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.456 0.539 . . . . 44.53 112.456 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.528 ' HE1' ' HA ' ' A' ' 37' ' ' MET . 2.9 mmt -103.69 -47.78 4.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.907 0.384 . . . . 75.33 111.393 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.82 68.05 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.831 0.692 . . . . 72.53 114.831 -171.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -93.62 150.75 20.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 117.463 0.632 . . . . 72.44 111.65 179.058 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -68.96 153.45 43.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.411 -0.358 . . . . 62.55 111.063 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.46 ' HB ' ' HA ' ' A' ' 5' ' ' LYS . 22.5 mt -52.16 -52.53 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 72.15 112.583 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.407 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 11.2 pt-20 -61.08 -33.1 72.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.964 0.412 . . . . 62.35 111.886 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.483 ' O ' HG22 ' A' ' 47' ' ' VAL . 39.0 t70 -75.87 -59.19 2.87 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 72.53 110.953 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -57.48 -43.0 83.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.308 -0.405 . . . . 64.51 111.916 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.06 -49.04 77.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.364 -0.21 . . . . 74.44 111.438 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.15 73.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.008 0.432 . . . . 65.23 111.642 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.483 HG22 ' O ' ' A' ' 43' ' ' ASP . 87.0 t -61.05 -45.48 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.197 -0.456 . . . . 61.03 111.815 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -90.03 -10.38 45.09 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.716 0.293 . . . . 72.53 111.787 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.31 35.94 25.24 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.47 -0.395 . . . . 50.11 113.308 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.64 152.89 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.986 0.422 . . . . 72.11 111.721 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -82.24 97.42 8.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.026 0.441 . . . . 72.32 109.865 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.479 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -65.31 -31.55 72.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.524 0.565 . . . . 53.13 112.524 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.539 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 35.6 t70 -60.93 -45.31 95.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.898 0.38 . . . . 73.13 110.716 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.24 -40.42 77.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.784 0.326 . . . . 75.21 111.501 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.453 HD22 HG21 ' A' ' 41' ' ' ILE . 23.2 tp -58.88 -49.89 76.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.056 0.455 . . . . 74.11 111.433 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.479 HG21 ' O ' ' A' ' 52' ' ' ALA . 92.4 t -57.48 -38.78 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.269 -0.423 . . . . 70.04 111.805 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.2 mttm -56.58 -53.68 54.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.769 0.319 . . . . 75.12 111.37 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.05 -36.51 75.16 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.46 -0.336 . . . . 75.43 111.638 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.93 -49.44 74.76 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 111.84 0.311 . . . . 73.31 111.84 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.489 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 33.6 m-80 -59.09 -52.4 65.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.657 0.265 . . . . 62.1 111.397 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.434 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.7 mt-10 -54.2 -41.28 68.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.221 -0.445 . . . . 72.31 111.53 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.16 -51.78 66.75 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.18 0.437 . . . . 74.53 112.18 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.442 ' CZ ' ' HE1' ' A' ' 15' ' ' MET . 55.1 m-85 -62.35 -34.22 76.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.617 0.246 . . . . 71.45 111.455 178.289 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 31.3 mt-10 -65.77 -32.48 74.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.854 0.359 . . . . 71.12 111.375 175.12 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.434 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 72.2 mmtt -61.29 -38.52 87.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.473 -0.331 . . . . 74.31 111.71 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -55.04 -48.37 73.54 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.302 0.482 . . . . 65.54 112.302 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.2 -29.58 67.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.911 0.386 . . . . 74.32 111.577 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.82 -50.44 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.017 0.437 . . . . 63.23 111.285 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.6 -64.4 0.91 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.266 0.469 . . . . 74.2 112.266 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.683 -0.675 . . . . 75.33 112.179 -177.286 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.1 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.688 0.28 . . . . 75.02 111.281 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.58 109.36 21.3 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.36 -0.607 . . . . 71.44 109.36 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.523 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.1 mm -62.28 131.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.738 0.304 . . . . 53.45 111.652 -175.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.408 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 36.4 p -121.69 162.92 19.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.847 0.356 . . . . 75.43 110.902 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.622 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.04 -14.94 62.5 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.892 0.377 . . . . 74.11 111.506 178.193 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.73 -15.93 57.85 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.101 0.476 . . . . 70.23 111.403 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.523 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 65.0 mtt -72.82 154.29 40.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.428 0.632 . . . . 61.33 112.206 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -81.87 133.72 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.65 -0.705 . . . . 75.14 111.485 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.19 -51.45 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.173 0.434 . . . . 52.41 112.173 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -32.97 65.94 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 74.43 111.621 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.02 -45.13 71.25 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.724 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.7 -37.21 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.259 0.552 . . . . 71.23 110.744 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 83.1 mt -63.94 -31.13 72.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.115 -0.493 . . . . 74.43 111.919 175.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -71.6 -29.45 64.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.921 0.391 . . . . 73.15 111.061 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.0 mtt -66.52 -52.12 49.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.344 0.592 . . . . 72.22 110.03 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -154.77 135.3 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.786 -0.643 . . . . 74.1 111.225 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -68.84 -24.92 64.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.339 -0.391 . . . . 74.42 111.69 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.438 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -69.06 -1.37 25.82 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.379 -0.373 . . . . 70.35 113.874 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 78.9 p -82.58 -22.88 34.68 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.607 -0.349 . . . . 72.12 111.518 176.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.96 -51.39 79.83 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 112.59 0.589 . . . . 73.02 112.59 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -59.61 -26.36 81.84 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 121.896 1.731 . . . . 60.45 112.637 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -44.78 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.925 0.393 . . . . 75.32 110.846 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -56.59 -50.4 72.09 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.057 0.456 . . . . 75.24 110.173 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.93 -39.69 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.118 -0.492 . . . . 73.41 111.337 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.86 -39.73 68.93 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.052 -0.522 . . . . 72.41 111.849 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.61 -3.53 58.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.184 0.438 . . . . 64.41 112.184 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.44 0.72 11.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.476 0.95 . . . . 71.33 115.476 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 mmt -73.81 153.24 40.03 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.285 1.042 . . . . 63.5 111.815 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -78.1 144.87 36.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.534 -0.303 . . . . 74.44 110.656 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -66.02 178.05 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.146 0.498 . . . . 72.12 112.323 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -54.09 106.55 0.2 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.127 -0.488 . . . . 61.4 110.937 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.24 -38.85 0.1 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.345 -0.455 . . . . 75.03 112.863 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.6 m -77.91 119.89 79.17 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 122.615 -0.344 . . . . 74.32 111.47 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -64.73 -42.12 16.5 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.887 2.391 . . . . 62.45 112.202 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.5 p -59.15 -61.94 2.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.783 -0.644 . . . . 73.3 111.907 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -49.59 -20.12 0.71 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.275 0.842 . . . . 64.2 113.275 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.577 ' HE1' ' HA ' ' A' ' 37' ' ' MET . 27.4 mmt -76.39 -48.12 20.91 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.252 -0.28 . . . . 62.02 111.666 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.57 6.86 82.07 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.592 0.597 . . . . 61.34 114.592 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.72 158.42 20.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 63.54 112.024 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.7 m -72.26 151.26 42.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.97 -0.559 . . . . 63.4 112.24 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -51.35 -48.88 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.793 0.664 . . . . 61.32 112.793 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.622 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 14.9 pt-20 -63.17 -35.34 79.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.852 0.358 . . . . 55.03 111.642 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.453 ' O ' HG23 ' A' ' 47' ' ' VAL . 36.8 t0 -69.72 -53.56 17.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.189 -0.46 . . . . 75.44 110.751 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.75 71.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.212 0.53 . . . . 75.23 111.297 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.4 ' HA ' ' HB ' ' A' ' 50' ' ' ILE . 84.0 m -59.67 -52.92 63.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.948 -0.569 . . . . 62.35 111.199 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -39.68 69.85 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.252 0.464 . . . . 75.42 112.252 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.453 HG23 ' O ' ' A' ' 43' ' ' ASP . 91.9 t -59.56 -42.31 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.837 0.351 . . . . 75.01 111.446 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -104.23 9.81 35.93 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.306 0.484 . . . . 74.1 112.306 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.21 18.31 71.05 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 114.279 0.472 . . . . 61.34 114.279 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.4 ' HB ' ' HA ' ' A' ' 45' ' ' CYS . 56.7 mt -73.59 154.86 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 122.526 0.33 . . . . 73.24 111.475 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.28 96.48 10.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.14 0.495 . . . . 74.33 110.61 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.442 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -67.48 -34.79 77.89 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.336 -0.393 . . . . 73.01 111.894 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.464 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 30.2 t70 -58.42 -42.5 87.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.613 -0.267 . . . . 72.23 111.494 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.54 -39.28 67.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.943 0.402 . . . . 72.41 111.288 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.3 tp -59.84 -49.47 77.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 73.44 111.636 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.514 ' HA ' HD13 ' A' ' 59' ' ' LEU . 92.3 t -57.38 -36.73 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.371 -0.377 . . . . 73.5 111.816 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.464 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.4 mttm -56.32 -55.24 35.84 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.851 0.357 . . . . 63.33 111.171 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.83 -35.29 74.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.388 -0.369 . . . . 74.24 111.964 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.514 HD13 ' HA ' ' A' ' 56' ' ' VAL . 93.0 mt -60.64 -52.9 63.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.645 0.259 . . . . 64.13 111.449 175.676 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -58.92 -51.81 68.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.82 0.343 . . . . 52.1 111.721 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.06 -30.18 65.98 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.029 0.381 . . . . 62.01 112.029 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.438 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 90.0 t80 -64.02 -44.91 91.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.938 0.399 . . . . 72.0 111.359 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -61.91 -31.96 72.31 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.224 -0.297 . . . . 72.23 111.133 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.06 -40.57 94.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.978 0.418 . . . . 71.44 110.726 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -62.13 -33.79 75.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.172 -0.467 . . . . 62.42 111.172 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -59.73 -43.53 94.14 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.686 0.279 . . . . 74.21 111.277 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.63 -23.93 67.42 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.852 0.358 . . . . 64.05 111.553 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -76.55 -53.11 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.161 0.505 . . . . 64.51 110.844 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.06 -57.51 9.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.027 -0.533 . . . . 75.21 112.166 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.643 -0.694 . . . . 64.3 112.167 -177.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.756 0.312 . . . . 74.52 110.998 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -98.52 115.14 27.93 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.704 0.288 . . . . 71.22 110.328 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.535 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.4 mm -62.14 132.07 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.77 0.655 . . . . 72.11 112.77 -172.319 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -120.76 159.37 25.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.195 -0.457 . . . . 64.03 110.953 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.627 ' HZ2' ' HB3' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -64.26 -15.92 61.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.087 0.47 . . . . 73.51 111.319 176.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.2 -26.37 56.06 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.654 -0.703 . . . . 74.41 111.552 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.535 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -65.57 158.42 27.15 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.423 0.63 . . . . 72.44 112.686 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.442 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 49.8 mm -84.54 134.96 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.926 -0.579 . . . . 70.33 111.329 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -56.66 -49.51 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.42 . . . . 71.45 111.312 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.92 68.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.307 -0.406 . . . . 71.32 111.516 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 13.2 t70 -72.59 -40.78 66.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.487 -0.324 . . . . 72.35 110.807 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.407 HG22 ' O ' ' A' ' 8' ' ' ILE . 57.9 t -57.72 -37.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.148 0.499 . . . . 73.13 110.335 173.525 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.15 -36.04 82.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.139 -0.482 . . . . 63.35 110.983 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.33 -29.3 70.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.727 0.298 . . . . 71.32 111.174 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -71.47 -49.29 42.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.224 0.535 . . . . 73.13 110.035 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -160.43 130.98 5.42 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.496 -0.775 . . . . 74.32 110.893 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -72.04 -20.28 61.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.959 0.355 . . . . 74.11 111.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.65 -1.44 45.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.56 -0.353 . . . . 74.33 113.476 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -19.55 46.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.521 -0.4 . . . . 75.32 111.721 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.502 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.09 -49.91 87.31 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.353 0.501 . . . . 72.01 112.353 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.502 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 76.7 Cg_exo -48.99 -42.08 38.92 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.399 2.066 . . . . 64.35 112.826 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.94 -45.31 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.403 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -58.67 -46.88 86.23 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 71.5 110.508 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.459 HD13 ' SG ' ' A' ' 30' ' ' CYS . 72.7 mt -58.96 -39.07 77.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.019 -0.537 . . . . 73.41 111.387 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.62 -36.29 73.83 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.312 -0.404 . . . . 64.4 111.571 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -86.68 4.46 40.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.637 0.606 . . . . 74.02 112.637 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.54 39.97 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.672 -0.775 . . . . 74.52 114.499 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.53 171.69 9.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.677 0.739 . . . . 73.35 111.419 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.19 131.33 32.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.16 -0.473 . . . . 74.34 111.214 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.459 ' SG ' HD13 ' A' ' 24' ' ' ILE . 80.4 m -73.49 74.49 1.43 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.394 0.616 . . . . 73.53 111.347 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.434 HD13 ' SG ' ' A' ' 33' ' ' CYS . 1.3 tm? -123.24 131.48 53.69 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.979 -0.555 . . . . 72.31 109.967 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.43 ' N ' HD12 ' A' ' 31' ' ' LEU . . . -74.86 64.98 2.24 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.501 -0.38 . . . . 73.43 113.904 -175.63 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . 0.434 ' SG ' HD13 ' A' ' 31' ' ' LEU . 67.4 m -129.6 126.52 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.408 0.283 . . . . 74.01 110.775 175.448 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_exo -44.74 -39.44 13.64 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.174 2.582 . . . . 72.42 113.913 -179.171 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.3 t -55.43 -29.21 58.19 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.629 0.603 . . . . 74.43 112.629 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -107.99 -10.09 15.55 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.036 0.384 . . . . 75.25 112.036 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.2 mmt -121.74 -61.14 1.54 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.217 0.451 . . . . 74.24 112.217 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -71.51 -20.83 78.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.315 0.486 . . . . 65.41 114.315 -176.366 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -82.06 178.1 8.46 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.303 0.573 . . . . 73.31 112.349 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.442 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 92.5 p -78.63 161.54 26.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.391 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.8 mt -56.67 -47.81 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.493 -0.321 . . . . 75.51 111.781 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.07 -43.27 99.19 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.698 0.258 . . . . 74.03 111.698 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.14 -52.05 66.98 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.05 0.389 . . . . 74.54 112.05 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.49 88.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.777 0.322 . . . . 71.31 111.614 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 97.6 m -53.52 -46.46 70.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.68 -0.236 . . . . 73.41 111.166 177.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.04 67.61 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.987 0.365 . . . . 74.31 111.987 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.2 -46.14 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.976 0.417 . . . . 63.11 111.504 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -89.04 -10.02 49.07 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.456 -0.338 . . . . 64.14 111.73 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.26 37.87 30.83 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.106 -0.568 . . . . 72.15 112.795 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.8 mt -93.03 151.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.663 0.385 . . . . 75.24 111.293 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -80.88 102.01 9.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.958 0.409 . . . . 74.33 110.383 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.99 65.14 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.153 0.427 . . . . 74.15 112.153 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.22 -50.91 71.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.88 0.371 . . . . 71.33 110.446 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -70.26 -47.93 59.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.525 . . . . 73.03 112.032 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.5 tp -52.76 -52.64 55.75 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.952 0.406 . . . . 65.44 111.725 -177.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.499 HG12 HG21 ' A' ' 3' ' ' ILE . 88.1 t -61.05 -40.52 85.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 74.35 111.78 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.487 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 98.7 mttt -69.72 -29.45 66.84 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.22 -0.3 . . . . 64.44 111.745 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.61 -39.4 73.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.879 0.371 . . . . 62.32 110.794 171.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD13 ' HA ' ' A' ' 56' ' ' VAL . 87.8 mt -58.12 -46.83 84.9 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.378 -0.374 . . . . 73.14 110.674 172.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.465 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 21.4 m-80 -54.2 -55.97 22.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.251 -0.431 . . . . 73.21 111.595 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.598 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.0 mt-10 -46.05 -48.82 16.85 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.075 0.464 . . . . 75.55 111.201 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -54.21 -52.4 61.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.87 -0.605 . . . . 74.24 112.384 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.79 -39.17 93.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.723 0.297 . . . . 71.1 111.352 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 39.8 mt-10 -63.79 -33.62 76.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.98 0.419 . . . . 64.41 110.979 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.598 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 35.7 mmtp -69.02 -38.69 79.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.345 -0.389 . . . . 52.24 111.24 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.449 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 43.1 mtpt -55.98 -44.84 78.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.825 0.306 . . . . 65.43 111.825 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -62.7 -11.83 19.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.037 0.384 . . . . 65.13 112.037 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.33 -51.32 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.185 0.517 . . . . 52.43 110.699 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.99 -55.59 24.46 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.749 0.648 . . . . 53.33 112.749 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.773 -0.632 . . . . 73.03 112.192 179.565 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.859 0.361 . . . . 71.25 111.847 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.471 ' HZ1' ' HB2' ' A' ' 2' ' ' LYS . 0.0 OUTLIER -73.21 99.97 2.98 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.993 -0.373 . . . . 55.34 109.993 171.528 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.4 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 44.4 mm -68.76 136.68 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.265 -0.425 . . . . 73.55 111.496 -176.861 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 27.3 p -119.27 155.31 32.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.66 0.267 . . . . 74.34 110.862 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.55 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 17.0 ptpt -64.67 -14.66 59.24 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.177 0.513 . . . . 71.01 111.415 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.55 -16.07 55.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.691 -0.686 . . . . 73.2 111.669 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.43 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.4 mtt -75.39 164.87 25.95 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.506 0.67 . . . . 73.1 112.582 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.441 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -88.57 138.06 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.568 -0.742 . . . . 74.52 111.513 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.1 mt -54.5 -53.28 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.994 0.426 . . . . 70.22 111.699 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.84 75.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.833 0.349 . . . . 74.33 111.796 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.77 -39.63 94.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.802 0.334 . . . . 75.44 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.38 -39.73 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.044 0.45 . . . . 60.34 110.844 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.492 HD21 ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -61.43 -34.53 75.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.149 0.5 . . . . 74.43 111.096 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -68.89 -18.77 64.17 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.056 -0.52 . . . . 51.2 111.485 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.4 mtt -81.23 -50.35 9.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.38 0.61 . . . . 73.1 109.791 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.5 132.5 14.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.965 -0.561 . . . . 70.34 111.716 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -74.17 -16.25 60.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.606 0.595 . . . . 72.25 112.606 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.57 -2.21 79.59 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.14 -0.552 . . . . 71.12 113.415 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.492 ' OG1' HD21 ' A' ' 13' ' ' LEU . 74.3 p -80.51 -22.1 41.26 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.114 0.413 . . . . 74.42 112.114 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.539 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.83 -50.64 84.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 112.722 0.638 . . . . 74.45 112.722 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.539 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 75.7 Cg_exo -49.86 -41.24 47.71 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.198 1.932 . . . . 72.3 112.657 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.41 -44.98 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.167 -0.47 . . . . 72.4 111.492 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -58.24 -51.56 69.23 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 63.13 110.936 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.51 -38.98 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.928 0.394 . . . . 75.54 111.107 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -51.86 -41.87 62.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.979 -0.555 . . . . 71.43 111.536 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -85.48 -4.26 59.11 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.277 0.473 . . . . 73.11 112.277 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.5 -5.35 9.31 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.662 -0.78 . . . . 62.55 114.972 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.2 mmt -65.28 143.15 57.98 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.208 1.004 . . . . 74.35 111.833 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -109.36 83.72 1.8 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.496 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . 0.622 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 76.7 m -66.48 100.41 0.66 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.381 0.511 . . . . 51.03 112.381 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -169.95 83.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 111.883 0.327 . . . . 71.25 111.883 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 -63.01 1.79 Allowed Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.733 1.053 . . . . 62.45 115.733 168.616 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.3 m -49.02 147.29 4.9 Favored Pre-proline 0 N--CA 1.476 0.834 0 N-CA-C 113.612 0.967 . . . . 65.23 113.612 -172.581 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.09 -45.62 35.66 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.194 2.596 . . . . 63.2 113.615 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 m -61.98 -10.21 9.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.071 0.462 . . . . 74.24 111.694 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.622 ' OG ' ' HA ' ' A' ' 30' ' ' CYS . 15.4 t -102.18 -25.22 13.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.161 -0.472 . . . . 62.1 111.601 176.447 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.471 ' HE1' ' HA ' ' A' ' 37' ' ' MET . 1.8 mmt -125.69 -69.19 0.79 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.957 0.725 . . . . 64.05 112.957 -172.809 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.97 -22.28 63.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.795 1.078 . . . . 75.54 115.795 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -87.24 160.72 18.35 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 117.876 0.838 . . . . 74.15 111.788 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.441 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.7 p -73.14 158.11 35.94 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.309 0.576 . . . . 73.33 112.503 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mt -54.79 -56.03 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.812 -0.631 . . . . 75.23 112.476 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.55 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.1 pt-20 -60.81 -44.72 96.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.13 0.419 . . . . 63.04 112.13 -176.975 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -65.59 -45.21 84.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.971 0.415 . . . . 73.41 110.987 -178.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.73 81.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.429 . . . . 61.4 111.455 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.35 -49.59 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.413 -0.358 . . . . 75.03 111.26 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.88 -36.21 62.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.121 0.415 . . . . 74.33 112.121 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.19 -37.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.993 0.425 . . . . 74.24 111.854 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.92 18.09 16.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.403 0.519 . . . . 75.11 112.403 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.19 27.83 68.1 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 72.05 113.79 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.33 150.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.895 0.379 . . . . 70.14 111.117 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.66 97.27 10.79 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.821 0.344 . . . . 75.0 110.215 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.402 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -67.29 -36.55 81.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.105 0.409 . . . . 75.01 112.105 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -42.87 83.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.149 0.5 . . . . 64.41 111.072 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.65 -44.11 57.73 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.249 -0.432 . . . . 64.22 111.529 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -55.36 -49.34 72.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.959 0.409 . . . . 72.21 111.951 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.492 HG23 ' HB3' ' A' ' 5' ' ' LYS . 93.0 t -59.32 -38.28 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.395 -0.366 . . . . 64.03 111.837 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.69 -43.84 98.09 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.719 0.295 . . . . 73.24 110.638 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -60.17 -37.9 81.57 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 71.23 111.359 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.448 HD13 ' HA ' ' A' ' 56' ' ' VAL . 84.8 mt -63.36 -53.98 44.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.484 -0.325 . . . . 75.35 111.517 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.452 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.6 m-80 -56.71 -54.22 48.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.918 0.34 . . . . 73.4 111.918 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.525 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.9 mt-10 -52.96 -38.51 62.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.612 -0.267 . . . . 75.52 111.334 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.86 -49.29 78.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.876 0.37 . . . . 72.42 111.762 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -59.69 -34.53 72.99 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.741 0.305 . . . . 72.12 110.897 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.452 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 37.8 mt-10 -64.82 -38.15 90.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.853 0.359 . . . . 72.31 110.806 174.724 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.525 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 31.4 mmmt -57.12 -40.47 77.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.963 0.411 . . . . 72.11 110.236 175.148 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.413 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 51.0 mtpt -59.66 -43.32 94.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 71.1 111.194 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -57.68 -29.41 64.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.968 0.413 . . . . 73.2 111.53 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.1 t -80.3 -53.42 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.05 0.452 . . . . 72.13 111.158 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.17 -52.1 67.15 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.117 0.784 . . . . 65.34 113.117 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 C--O 1.256 1.404 0 CA-C-O 118.837 -0.602 . . . . 74.52 112.3 -177.87 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.6 0.238 . . . . 74.44 111.277 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -96.13 127.33 42.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.822 0.344 . . . . 71.1 110.573 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mm -70.74 139.47 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.066 0.46 . . . . 62.54 111.785 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -122.99 153.13 40.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.417 -0.356 . . . . 70.22 110.748 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.78 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 46.2 pttt -63.36 -15.51 57.67 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.903 0.382 . . . . 74.44 111.98 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.5 -29.83 63.98 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.97 -0.559 . . . . 73.04 111.409 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 65.2 mtt -63.6 150.51 43.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.728 0.64 . . . . 75.53 112.728 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mm -78.37 136.06 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.683 -0.69 . . . . 64.51 111.116 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.44 -48.75 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.762 0.315 . . . . 73.21 111.771 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -59.72 -33.5 71.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.897 0.332 . . . . 75.04 111.897 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.17 -41.73 85.47 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.823 0.344 . . . . 72.22 111.184 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.2 t -60.44 -39.24 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.105 0.479 . . . . 75.13 110.945 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . 0.447 HD21 ' OG1' ' A' ' 19' ' ' THR . 88.1 mt -62.22 -31.01 71.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.26 -0.427 . . . . 73.04 111.519 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 84.3 mm-40 -67.34 -27.01 66.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.941 0.401 . . . . 73.22 111.321 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.2 mtt -75.0 -48.38 24.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.34 0.59 . . . . 73.55 110.064 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -154.99 132.54 11.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.722 -0.672 . . . . 54.13 110.761 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -70.15 -28.41 65.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.093 0.473 . . . . 62.44 111.611 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.04 2.09 14.94 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.078 -0.51 . . . . 74.45 113.807 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . 0.447 ' OG1' HD21 ' A' ' 13' ' ' LEU . 72.6 p -82.72 -19.24 38.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.514 -0.403 . . . . 75.33 111.384 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.475 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.35 -51.41 78.17 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.654 0.613 . . . . 62.14 112.654 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.475 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.5 Cg_endo -57.84 -31.03 91.42 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.953 1.768 . . . . 61.2 112.59 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.97 -46.65 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.98 0.419 . . . . 72.2 110.914 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.7 m-85 -57.52 -46.82 83.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.204 0.525 . . . . 74.33 110.266 171.993 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . 0.411 ' HA ' ' O ' ' A' ' 28' ' ' MET . 73.6 mt -58.05 -36.67 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.958 -0.565 . . . . 75.43 111.668 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -61.73 -32.96 73.23 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.973 0.416 . . . . 65.44 111.574 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.7 1.38 55.51 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.242 0.46 . . . . 74.32 112.242 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.78 10.3 16.81 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.425 -0.893 . . . . 42.44 114.896 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.411 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 22.2 mmt -86.93 156.93 19.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.85 -0.794 . . . . 54.45 111.435 175.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . 0.452 ' HB3' HD23 ' A' ' 31' ' ' LEU . 77.7 m80 -139.75 93.35 2.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.175 0.512 . . . . 62.53 111.209 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 76.3 m -88.6 56.69 3.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.172 0.51 . . . . 71.23 111.958 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.452 HD23 ' HB3' ' A' ' 29' ' ' HIS . 4.0 mm? -85.8 36.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.925 0.393 . . . . 74.51 111.037 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.57 80.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.318 -0.468 . . . . 60.43 112.744 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.7 m -71.03 119.1 71.38 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.479 0.312 . . . . 63.31 111.472 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.68 -54.05 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.252 2.634 . . . . 72.55 114.012 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -60.45 -42.13 95.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.018 0.437 . . . . 73.24 111.758 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -70.98 -8.96 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 75.31 111.938 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.543 ' HA ' ' HE2' ' A' ' 37' ' ' MET . 3.6 mmt -104.93 -67.28 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.626 0.602 . . . . 73.5 112.626 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.42 3.15 87.03 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 114.986 0.754 . . . . 73.32 114.986 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.77 156.38 20.39 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.594 0.697 . . . . 73.53 112.156 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.0 m -67.5 156.22 37.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.915 0.709 . . . . 73.02 112.915 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -55.11 -60.24 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.615 0.598 . . . . 74.43 112.615 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.78 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.5 pt-20 -61.95 -36.01 80.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.873 0.368 . . . . 73.53 111.847 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.44 -48.43 72.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.888 0.375 . . . . 60.24 110.918 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.14 77.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.065 0.459 . . . . 61.52 111.538 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 94.4 m -58.81 -44.59 90.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.442 -0.345 . . . . 74.21 111.22 176.319 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.54 62.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.007 0.373 . . . . 74.23 112.007 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.67 -41.75 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 111.821 0.304 . . . . 73.45 111.821 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -112.31 17.11 19.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 71.14 111.862 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.97 23.11 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.123 -0.561 . . . . 74.41 113.763 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.1 150.27 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.905 0.383 . . . . 71.43 111.639 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.57 108.3 17.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.125 0.488 . . . . 54.33 110.203 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.445 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -75.08 -25.05 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 73.22 111.962 -176.632 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.425 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 13.9 t70 -60.92 -47.86 84.47 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.017 0.436 . . . . 74.35 110.621 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.76 -39.78 66.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.127 -0.488 . . . . 73.41 111.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.87 -50.47 72.38 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.08 0.466 . . . . 75.3 111.077 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.468 ' HA ' HD13 ' A' ' 59' ' ' LEU . 78.6 t -59.27 -38.5 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.442 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.425 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.0 mttm -57.82 -50.38 73.47 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.544 0.201 . . . . 74.31 111.544 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -58.53 -38.44 77.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.826 0.346 . . . . 73.04 111.577 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.468 HD13 ' HA ' ' A' ' 56' ' ' VAL . 85.2 mt -61.64 -50.97 70.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.734 0.302 . . . . 75.14 111.534 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 39.7 m-80 -59.0 -55.78 30.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.932 0.345 . . . . 73.34 111.932 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.474 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.3 mt-10 -52.81 -36.79 58.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.728 0.299 . . . . 73.24 111.577 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -58.27 -51.68 68.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.367 . . . . 74.12 111.495 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.75 -34.76 76.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.729 0.299 . . . . 74.23 111.31 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 32.8 mt-10 -65.97 -36.98 84.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.881 0.372 . . . . 75.14 110.911 175.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.474 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 73.5 mmtt -63.3 -37.5 87.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.235 -0.439 . . . . 73.32 110.928 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . 0.419 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 46.2 mtpt -56.13 -44.05 78.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.666 0.27 . . . . 61.42 111.418 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.74 -28.98 64.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.944 0.402 . . . . 74.33 111.353 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.2 t -85.42 -52.66 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.284 0.564 . . . . 64.22 111.506 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -64.53 -54.72 27.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.071 -0.513 . . . . 63.14 112.35 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.605 -0.712 . . . . 74.03 111.894 -179.041 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.768 0.318 . . . . 73.3 111.284 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . 0.501 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 9.8 mmpt? -74.94 162.82 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.755 0.312 . . . . 64.45 111.111 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 mm -74.44 137.99 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.716 0.293 . . . . 74.53 111.66 -178.206 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 41.8 p -119.84 160.81 21.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.554 -0.294 . . . . 72.15 110.553 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.695 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.3 pttp -73.71 -16.77 61.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.069 -0.394 . . . . 72.33 111.414 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.19 -25.05 62.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.086 -0.506 . . . . 75.53 111.102 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.43 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.0 mtt -62.41 139.86 58.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.438 0.637 . . . . 70.05 111.832 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . 0.467 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 44.9 mm -69.53 137.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.772 -0.649 . . . . 62.33 110.953 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -54.04 -46.21 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.851 0.357 . . . . 62.21 111.273 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.459 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -60.2 -36.37 77.52 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.802 0.335 . . . . 64.34 111.426 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.467 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 12.0 t70 -63.18 -43.98 96.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.041 0.448 . . . . 73.14 110.516 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.44 HG22 HD12 ' A' ' 41' ' ' ILE . 51.6 t -61.19 -40.1 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.141 0.496 . . . . 72.13 110.722 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.23 -33.12 74.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.243 -0.435 . . . . 63.24 111.304 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 74.0 mt-30 -64.21 -30.33 71.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.362 . . . . 54.41 111.242 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.6 mtt -71.89 -51.59 21.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.283 0.563 . . . . 71.15 110.072 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.29 125.66 5.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.55 -0.75 . . . . 73.24 110.693 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -71.72 -15.47 62.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.006 0.373 . . . . 73.51 112.006 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.58 -1.75 39.29 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.212 -0.518 . . . . 44.21 113.157 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.0 p -82.64 -17.87 43.09 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.698 -0.295 . . . . 74.2 111.573 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.488 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.25 -51.06 82.89 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.223 0.453 . . . . 63.1 112.223 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.488 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -58.58 -25.76 75.97 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.957 1.772 . . . . 72.13 112.554 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.74 -44.77 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.995 0.426 . . . . 54.12 110.812 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -58.19 -45.82 86.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 73.12 110.406 173.425 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.96 -40.81 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.192 0.52 . . . . 63.51 110.911 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -56.86 -30.06 63.47 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.622 -0.717 . . . . 72.34 112.001 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -96.82 1.47 50.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.553 0.575 . . . . 74.2 112.553 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -3.0 22.84 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.476 -0.869 . . . . 35.46 115.11 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt -69.03 141.78 54.75 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.251 1.026 . . . . 53.42 112.287 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -133.28 143.01 48.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.763 -0.653 . . . . 74.44 110.882 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.3 m -61.53 136.22 57.94 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.013 0.435 . . . . 75.43 111.679 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 1.2 tm? -135.83 135.78 40.09 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.616 -0.512 . . . . 62.4 109.616 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.463 ' N ' HD11 ' A' ' 31' ' ' LEU . . . -56.87 -46.69 90.22 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.177 0.431 . . . . 65.42 114.177 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -56.63 130.25 77.09 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.915 0.357 . . . . 74.11 111.42 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.99 -23.71 44.85 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.978 2.452 . . . . 65.2 113.59 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -49.56 -36.94 25.38 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.062 0.393 . . . . 75.55 112.062 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' SER . . . . . 0.508 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 73.0 p -51.46 -44.52 62.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.307 0.575 . . . . 74.44 111.72 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.534 ' HE1' ' HA ' ' A' ' 37' ' ' MET . 4.6 mmt -90.35 -28.27 18.82 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.792 -0.64 . . . . 55.42 111.807 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.55 -21.48 60.0 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.891 0.716 . . . . 74.22 114.891 -170.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.1 167.78 11.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.785 0.793 . . . . 72.52 112.504 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' SER . . . . . 0.454 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 90.2 p -75.55 160.12 30.5 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.928 -0.578 . . . . 54.23 112.207 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . 0.44 HD12 HG22 ' A' ' 12' ' ' VAL . 22.3 mt -54.74 -52.57 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.093 -0.503 . . . . 64.14 111.901 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.695 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.0 pt-20 -62.97 -40.33 97.38 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.877 0.325 . . . . 64.22 111.877 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.403 ' O ' HG22 ' A' ' 47' ' ' VAL . 6.7 t70 -62.58 -51.14 68.51 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 54.44 110.499 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.07 94.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.01 -0.541 . . . . 52.34 111.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -58.49 -45.82 87.94 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.561 -0.29 . . . . 72.31 111.307 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -35.8 74.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.753 0.311 . . . . 74.54 111.656 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.403 HG22 ' O ' ' A' ' 43' ' ' ASP . 61.2 t -65.98 -43.24 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.192 0.52 . . . . 63.15 111.364 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.466 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.3 t-80 -86.59 -14.82 41.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.2 -0.454 . . . . 75.03 111.435 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 38.61 23.44 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 116.455 -0.339 . . . . 71.21 113.13 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.466 HG13 ' HB3' ' A' ' 48' ' ' HIS . 27.9 mt -98.02 153.36 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 122.927 0.491 . . . . 73.41 111.284 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.55 101.92 8.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.018 0.437 . . . . 75.25 109.904 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.45 -34.69 77.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.444 0.535 . . . . 63.24 112.444 -176.71 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.01 -45.5 82.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.829 0.347 . . . . 72.22 111.066 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.26 -47.03 75.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.4 -0.363 . . . . 73.2 111.254 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.9 tp -57.51 -50.83 71.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.244 -0.435 . . . . 75.13 111.306 -179.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.476 HG23 ' HB3' ' A' ' 5' ' ' LYS . 85.4 t -60.79 -39.62 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.508 -0.314 . . . . 71.11 111.615 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.65 -41.67 98.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.454 0.168 . . . . 64.22 111.454 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.82 -40.53 95.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.706 0.289 . . . . 62.14 111.043 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . 0.43 HD13 ' HA ' ' A' ' 56' ' ' VAL . 91.1 mt -59.6 -52.24 66.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.617 -0.265 . . . . 55.03 110.971 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.549 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 39.7 m-80 -54.67 -57.97 9.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.622 -0.263 . . . . 44.01 111.537 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 51.3 mt-10 -54.07 -37.78 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.552 -0.295 . . . . 72.31 111.667 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -58.4 -51.3 70.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.842 0.353 . . . . 64.12 111.31 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -61.61 -35.09 76.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.695 0.283 . . . . 73.44 110.971 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 41.8 mt-10 -69.48 -28.18 65.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.657 0.265 . . . . 52.32 111.287 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 75.4 mmtt -64.22 -39.52 94.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.344 0.592 . . . . 72.35 109.61 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.43 -44.76 93.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.667 -0.697 . . . . 63.1 110.474 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -53.73 -28.49 34.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.986 0.422 . . . . 61.34 111.63 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 64' ' ' GLU . 80.1 t -77.37 -50.22 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.087 0.47 . . . . 65.24 111.611 175.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -75.31 -59.26 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.339 0.866 . . . . 72.14 113.339 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.255 1.371 0 N-CA-C 113.304 0.853 . . . . 61.2 113.304 -173.906 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.551 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.621 0.248 . . . . 70.11 111.171 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -69.77 111.78 5.77 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.761 -0.459 . . . . 73.13 109.761 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' ILE . . . . . 0.515 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.8 mm -62.06 130.51 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.426 0.528 . . . . 75.44 112.426 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.6 p -120.21 167.21 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.95 -0.568 . . . . 62.24 110.336 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.412 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.9 ptpt -74.28 -8.79 57.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.134 0.492 . . . . 65.32 110.873 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.91 -24.9 32.92 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.898 -0.592 . . . . 53.24 111.818 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . 0.515 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.3 mtt -66.23 156.92 32.82 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.653 0.612 . . . . 73.12 112.653 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.8 133.78 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.871 -0.604 . . . . 74.13 111.165 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.89 -50.49 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.207 0.447 . . . . 73.22 112.207 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.07 80.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 70.04 111.655 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.38 -44.3 92.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 74.14 110.772 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' VAL . . . . . 0.516 ' HA ' ' HE1' ' A' ' 15' ' ' MET . 60.5 t -60.4 -42.16 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.112 -0.495 . . . . 73.54 111.105 175.103 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.39 -34.14 73.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.214 -0.448 . . . . 70.11 111.91 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -69.23 -22.87 63.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.77 0.319 . . . . 74.41 111.719 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' MET . . . . . 0.516 ' HE1' ' HA ' ' A' ' 12' ' ' VAL . 28.6 mtm -83.3 -45.51 13.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.048 0.451 . . . . 75.02 110.193 177.548 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -152.08 112.93 4.2 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.901 -0.59 . . . . 73.33 110.889 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.3 -11.91 53.42 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.832 0.679 . . . . 74.0 112.832 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.467 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -70.16 -9.53 63.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.175 -0.536 . . . . 74.13 112.916 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -78.67 -16.36 57.39 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.566 -0.373 . . . . 74.14 111.707 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . 0.579 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -56.62 -52.01 76.86 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 112.391 0.515 . . . . 70.41 112.391 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' PRO . . . . . 0.579 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 52.2 Cg_exo -52.63 -38.22 75.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.011 1.807 . . . . 70.12 112.438 175.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.66 -46.49 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.096 -0.502 . . . . 73.13 111.162 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.514 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 54.4 m-85 -59.03 -46.22 88.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.849 0.357 . . . . 74.31 110.836 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.83 -37.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.913 0.387 . . . . 70.33 111.206 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -56.14 -40.31 73.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.059 -0.519 . . . . 74.53 111.337 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.44 ' ND2' HD12 ' A' ' 55' ' ' LEU . 39.9 m-80 -87.79 -2.37 58.57 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.389 0.515 . . . . 71.45 112.389 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.7 11.44 30.66 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 115.011 0.764 . . . . 71.22 115.011 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' MET . . . . . 0.514 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 25.4 mmt -76.3 156.57 33.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.984 0.892 . . . . 62.03 110.975 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -138.54 127.88 24.44 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.686 0.624 . . . . 75.55 112.686 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.4 t -104.55 4.4 32.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.302 0.573 . . . . 64.23 110.79 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.58 106.72 5.47 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.183 -0.462 . . . . 64.35 111.2 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.34 -69.59 3.31 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.279 -0.418 . . . . 71.25 113.78 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.8 m -85.77 117.62 69.07 Favored Pre-proline 0 N--CA 1.472 0.661 0 N-CA-C 112.355 0.502 . . . . 60.15 112.355 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.96 -4.85 16.09 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.708 2.272 . . . . 71.22 113.009 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.5 t -51.24 -60.41 3.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.556 0.217 . . . . 62.31 111.414 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.0 t -53.55 -20.27 4.8 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.489 0.551 . . . . 74.03 112.489 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' MET . . . . . 0.525 ' HE3' ' HA ' ' A' ' 37' ' ' MET . 4.2 mmt -84.48 -46.81 11.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.01 0.433 . . . . 71.54 111.262 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.75 22.56 13.35 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 114.266 0.466 . . . . 73.2 114.266 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.33 170.4 13.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.199 0.524 . . . . 62.34 112.231 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 m -72.41 147.65 45.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.864 -0.607 . . . . 64.2 111.805 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 32.3 mt -51.41 -52.36 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.291 0.478 . . . . 73.44 112.291 178.518 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLU . . . . . 0.412 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.9 pt-20 -62.61 -34.81 77.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.741 0.275 . . . . 65.54 111.741 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . 0.429 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.0 t70 -65.57 -52.39 52.66 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 72.1 110.633 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.91 77.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.23 0.538 . . . . 72.22 111.077 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' CYS . . . . . 0.457 ' SG ' ' HB1' ' A' ' 52' ' ' ALA . 93.0 m -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.129 -0.487 . . . . 63.34 111.392 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.07 52.27 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.264 0.468 . . . . 73.31 112.264 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 43' ' ' ASP . 48.0 t -65.07 -52.1 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.984 0.421 . . . . 65.13 111.716 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' HIS . . . . . 0.43 ' HB2' HG13 ' A' ' 50' ' ' ILE . 85.4 m-70 -98.87 3.19 47.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.021 0.378 . . . . 63.44 112.021 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.01 67.12 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.008 -0.615 . . . . 73.14 112.944 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ILE . . . . . 0.43 HG13 ' HB2' ' A' ' 48' ' ' HIS . 50.5 mt -73.45 150.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.884 0.373 . . . . 65.21 111.291 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.5 97.28 10.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.197 0.522 . . . . 72.33 109.766 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . 0.486 ' O ' HG21 ' A' ' 56' ' ' VAL . . . -64.74 -31.28 72.44 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.407 0.521 . . . . 73.41 112.407 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . 0.502 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 2.9 t70 -63.63 -40.35 96.66 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.663 0.268 . . . . 75.42 110.879 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.32 -47.5 84.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.052 0.453 . . . . 72.32 110.668 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.44 HD12 ' ND2' ' A' ' 26' ' ' ASN . 20.9 tp -58.05 -48.5 79.92 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.804 -0.635 . . . . 72.23 111.262 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' VAL . . . . . 0.486 HG21 ' O ' ' A' ' 52' ' ' ALA . 89.6 t -57.12 -42.58 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.219 -0.446 . . . . 54.42 111.754 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LYS . . . . . 0.502 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.5 mttm -56.5 -52.96 62.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.853 0.359 . . . . 73.21 110.812 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -55.11 -40.32 70.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.081 -0.509 . . . . 54.44 111.622 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 95.4 mt -64.0 -55.41 22.53 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.114 0.413 . . . . 73.45 112.114 178.722 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.448 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 51.6 m-80 -55.47 -51.47 66.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.72 0.295 . . . . 72.23 111.58 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . 0.545 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 37.5 mt-10 -59.56 -27.84 66.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.434 -0.348 . . . . 54.42 111.68 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.467 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 85.8 t80 -69.66 -47.12 64.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.627 -0.261 . . . . 74.45 111.318 175.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.406 ' CZ ' ' HE3' ' A' ' 15' ' ' MET . 45.4 m-85 -58.16 -33.02 68.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.763 0.315 . . . . 72.24 111.23 177.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -61.01 -40.31 93.08 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.765 0.317 . . . . 61.21 111.22 171.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . 0.545 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 44.3 mmtm -63.19 -34.6 77.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.453 -0.339 . . . . 61.43 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -47.61 -62.29 1.52 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.336 0.495 . . . . 73.01 112.336 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.23 -11.76 52.02 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.428 0.529 . . . . 71.51 112.428 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.9 t -86.56 -54.4 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.983 0.421 . . . . 72.43 111.054 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.3 mt -70.56 -53.2 16.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.132 -0.485 . . . . 44.21 111.977 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 119.115 -0.469 . . . . 55.24 111.977 179.563 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 mm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.064 0.459 . . . . 75.319999999999993 112.135 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.8 p -122.81 155.12 37.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.472 -0.331 . . . . 75.530000000000001 110.526 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.548 ' HB3' HG21 ' A' ' 56' ' ' VAL . 10.4 ptpp? -69.62 -17.65 63.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.917 -0.489 . . . . 70.109999999999999 111.969 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.98 -17.61 60.51 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.933 0.397 . . . . 73.219999999999999 111.221 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.466 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 66.0 mtt -66.38 149.82 49.82 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.139 0.495 . . . . 74.530000000000001 111.841 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -79.11 133.19 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.245 -0.434 . . . . 71.409999999999997 111.317 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.7 mt -55.55 -48.88 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.848 0.356 . . . . 72.109999999999999 111.367 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.51 69.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.046 0.387 . . . . 73.439999999999998 112.046 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.18 -38.97 60.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.742 0.306 . . . . 54.039999999999999 111.323 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 8' ' ' ILE . 61.6 t -60.08 -40.04 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.523 . . . . 63.210000000000001 110.24 173.353 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.468 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.8 mt -61.43 -25.44 67.21 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.934 -0.575 . . . . 75.319999999999993 111.63 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -73.7 -32.26 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.814 0.34 . . . . 71.129999999999995 111.098 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mtt -71.24 -39.48 71.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 74.310000000000002 110.129 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 19' ' ' THR . 40.0 t0 -160.05 130.22 5.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.275 -0.875 . . . . 74.409999999999997 111.018 176.252 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.91 -22.68 62.22 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.082 0.467 . . . . 63.240000000000002 110.637 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.69 2.16 49.52 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.284 -0.416 . . . . 63.210000000000001 113.755 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.468 ' OG1' HD23 ' A' ' 13' ' ' LEU . 68.1 p -82.59 -19.01 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.288 -0.537 . . . . 73.109999999999999 111.585 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.96 -51.13 77.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.72 0.637 . . . . 52.450000000000003 112.72 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.6 Cg_endo -59.4 -21.41 60.99 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.039 1.826 . . . . 72.409999999999997 112.897 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.39 -46.32 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 74.340000000000003 110.376 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -59.27 -45.27 91.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.188 0.518 . . . . 72.430000000000007 110.32 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.66 -37.03 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.112 -0.494 . . . . 64.430000000000007 111.13 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -56.43 -42.18 77.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.031 0.443 . . . . 74.349999999999994 111.457 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.54 -1.36 57.02 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.823 0.675 . . . . 63.200000000000003 112.823 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.49 17.52 15.09 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.224 0.85 . . . . 52.409999999999997 115.224 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.472 0.673 0 CA-C-N 118.093 0.947 . . . . 74.400000000000006 111.813 176.182 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.29 0.848 . . . . 74.310000000000002 113.29 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 24.3 m -72.19 159.73 33.62 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.126 -0.943 . . . . 45.420000000000002 111.5 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.7 mt -52.97 -52.55 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.959 0.355 . . . . 73.230000000000004 111.959 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.09 -40.36 85.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.831 0.348 . . . . 64.150000000000006 111.732 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.2 t70 -63.34 -51.13 67.23 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.246 -0.434 . . . . 63.43 110.804 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.05 -0.523 . . . . 61.229999999999997 111.685 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 89.2 m -62.21 -48.53 79.62 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 72.349999999999994 111.433 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.61 -37.44 65.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.962 0.356 . . . . 25.440000000000001 111.962 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.1 t -57.74 -53.98 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.91 0.386 . . . . 65.150000000000006 111.65 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -92.65 6.64 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.226 0.454 . . . . 72.430000000000007 112.226 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.34 83.56 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.285 -0.483 . . . . 61.149999999999999 112.968 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.43 150.04 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.207 0.527 . . . . 71.450000000000003 111.555 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -80.92 84.23 6.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.104 -0.498 . . . . 72.150000000000006 110.433 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -60.84 -30.3 70.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.545 -0.298 . . . . 72.109999999999999 111.771 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 33.2 t70 -58.75 -47.3 85.12 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.715 0.293 . . . . 61.200000000000003 110.864 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -71.83 -44.16 64.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.763 0.316 . . . . 70.120000000000005 111.432 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp -54.73 -51.61 65.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.323 -0.398 . . . . 64.420000000000002 111.703 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.548 HG21 ' HB3' ' A' ' 5' ' ' LYS . 90.1 t -60.56 -42.28 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.608 -0.269 . . . . 71.510000000000005 111.614 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 98.9 mttt -57.16 -48.0 79.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.591 0.234 . . . . 73.420000000000002 111.375 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.57 -39.71 89.02 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.601 0.238 . . . . 70.420000000000002 111.45 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 56' ' ' VAL . 91.0 mt -59.26 -48.54 81.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.618 0.247 . . . . 74.209999999999994 111.185 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -58.62 -61.7 2.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.608 -0.269 . . . . 74.5 111.373 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -46.17 -46.06 17.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.197 -0.456 . . . . 63.539999999999999 111.153 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -52.09 -58.66 5.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.383 0.512 . . . . 73.25 112.383 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.832 0.349 . . . . 64.319999999999993 111.309 178.789 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.661 ' N ' HD22 ' A' ' 60' ' ' ASN . 43.5 mm . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 120.647 0.26 . . . . 61.009999999999998 111.235 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.48 159.32 25.4 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.413 -0.358 . . . . 44.310000000000002 110.851 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.1 pttp -71.01 -11.29 60.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.94 0.4 . . . . 72.219999999999999 111.356 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.87 -25.41 53.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.895 -0.593 . . . . 65.310000000000002 110.96 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.7 mtt -66.75 154.14 41.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.298 0.571 . . . . 61.409999999999997 112.071 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.51 136.52 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.955 -0.566 . . . . 53.130000000000003 111.334 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.4 mt -56.11 -52.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.847 0.356 . . . . 71.049999999999997 111.696 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.34 65.67 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.97 0.414 . . . . 33.119999999999997 111.631 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.0 -41.12 60.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.908 0.385 . . . . 72.219999999999999 110.822 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.37 -37.96 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.204 0.526 . . . . 74.209999999999994 110.524 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.1 -30.08 70.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.05 -0.523 . . . . 62.43 111.59 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.69 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.929 0.395 . . . . 73.450000000000003 111.042 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.8 mtt -72.35 -49.03 37.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.374 0.607 . . . . 74.329999999999998 109.744 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -158.18 138.14 12.28 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.491 -0.777 . . . . 71.340000000000003 111.364 173.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -77.18 -20.59 55.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.257 0.551 . . . . 75.219999999999999 110.771 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.87 -2.42 23.36 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.864 -0.607 . . . . 71.109999999999999 113.525 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.8 p -81.59 -20.69 39.31 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.43 -0.453 . . . . 74.430000000000007 111.67 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.58 -50.65 82.03 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 113.027 0.751 . . . . 74.230000000000004 113.027 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.9 Cg_endo -59.46 -21.35 61.13 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.298 1.999 . . . . 73.030000000000001 113.025 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.98 -45.62 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.147 0.499 . . . . 75.230000000000004 110.474 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.548 ' HB3' ' HG3' ' A' ' 28' ' ' MET . 68.6 m-85 -57.52 -44.73 85.29 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.211 0.529 . . . . 71.010000000000005 110.105 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.74 -38.61 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.314 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -55.37 -29.19 57.96 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.278 0.561 . . . . 72.209999999999994 111.613 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.427 ' ND2' HD13 ' A' ' 55' ' ' LEU . 37.7 m-80 -98.8 4.1 47.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.244 0.461 . . . . 63.130000000000003 112.244 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.85 26.25 11.93 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.752 0.661 . . . . 42.399999999999999 114.752 172.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.548 ' HG3' ' HB3' ' A' ' 23' ' ' PHE . 22.0 mmt . . . . . 0 CA--C 1.537 0.469 0 CA-C-N 117.803 0.801 . . . . 75.200000000000003 112.209 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.013 0.435 . . . . 75.400000000000006 111.704 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.6 m -63.86 145.81 55.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.323 -0.399 . . . . 74.340000000000003 110.588 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.7 mt -47.92 -50.62 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 113.06 0.763 . . . . 73.230000000000004 113.06 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 7.9 pt-20 -63.69 -37.87 88.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.383 . . . . 75.150000000000006 112.033 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.67 -42.13 78.32 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.912 0.387 . . . . 55.539999999999999 110.747 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.04 75.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.235 -0.438 . . . . 72.519999999999996 111.15 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -57.79 -43.66 85.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.868 0.366 . . . . 43.310000000000002 110.789 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.36 62.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.189 -0.459 . . . . 73.239999999999995 112.061 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.03 -42.66 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 111.993 0.368 . . . . 62.119999999999997 111.993 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -105.1 3.07 29.98 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.992 0.425 . . . . 74.439999999999998 111.618 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 30.85 63.16 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.795 -0.716 . . . . 64.219999999999999 112.979 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.6 mt -81.82 155.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.894 0.478 . . . . 74.519999999999996 111.171 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 53' ' ' ASP . 16.8 t70 -93.89 106.69 18.65 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.971 0.415 . . . . 73.129999999999995 110.349 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . . . -64.42 -33.04 74.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.316 0.487 . . . . 72.219999999999999 112.316 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.404 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 24.5 t70 -54.04 -47.86 71.14 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.95 0.405 . . . . 72.140000000000001 111.067 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -70.27 -47.54 60.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.262 -0.426 . . . . 65.219999999999999 111.479 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.427 HD13 ' ND2' ' A' ' 26' ' ' ASN . 27.6 tp -55.53 -51.58 66.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.933 0.397 . . . . 70.239999999999995 111.973 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.475 ' HA ' HD12 ' A' ' 59' ' ' LEU . 92.5 t -58.4 -38.89 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.019 0.438 . . . . 73.239999999999995 111.648 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.08 -43.5 91.99 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.541 -0.3 . . . . 73.219999999999999 111.434 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -56.9 -42.59 80.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.802 0.334 . . . . 75.230000000000004 111.134 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -57.18 -52.81 63.81 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.252 -0.431 . . . . 64.430000000000007 111.751 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.661 HD22 ' N ' ' A' ' 3' ' ' ILE . 16.1 m120 -55.88 -50.22 71.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.652 0.263 . . . . 73.420000000000002 111.689 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.57 -32.69 65.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.95 0.405 . . . . 71.409999999999997 111.845 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -65.81 -52.15 53.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.129 -0.487 . . . . 74.299999999999997 111.458 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.414 -0.357 . . . . 74.030000000000001 111.426 178.15 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.578 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.6 mm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 113.373 0.879 . . . . 72.230000000000004 113.373 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -121.69 160.39 24.57 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.752 -0.658 . . . . 74.310000000000002 110.287 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.5 pttp -66.45 -16.54 64.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.963 0.411 . . . . 72.129999999999995 111.353 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.24 -19.64 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.765 -0.652 . . . . 75.049999999999997 111.663 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.578 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.5 mtt -69.11 153.82 43.1 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.133 0.492 . . . . 65.329999999999998 111.911 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.2 mm -85.22 129.97 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.399 -0.364 . . . . 54.509999999999998 111.24 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.8 -53.56 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.477 0.547 . . . . 74.549999999999997 112.477 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.07 72.13 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.043 0.386 . . . . 64.239999999999995 112.043 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.72 -40.27 76.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.914 0.388 . . . . 71.040000000000006 110.674 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -60.49 -39.96 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.26 0.552 . . . . 55.109999999999999 110.59 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.98 -32.24 70.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.972 -0.558 . . . . 72.310000000000002 111.393 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.622 ' HA ' HH12 ' A' ' 17' ' ' ARG . 15.8 mm-40 -67.21 -31.76 72.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.339 . . . . 71.239999999999995 111.583 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.4 mtt -65.78 -54.83 21.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.556 0.693 . . . . 73.109999999999999 109.816 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -150.73 121.59 7.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.364 -0.834 . . . . 62.340000000000003 110.58 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.622 HH12 ' HA ' ' A' ' 14' ' ' GLN . 81.9 mmt-85 -60.12 -21.56 61.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.999 0.428 . . . . 73.239999999999995 111.673 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.76 -3.38 27.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.502 -0.38 . . . . 73.450000000000003 113.656 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -82.32 -16.24 50.04 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.425 -0.456 . . . . 75.420000000000002 111.671 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.94 -51.41 79.61 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 112.724 0.638 . . . . 72.109999999999999 112.724 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 12.4 Cg_endo -55.62 -29.19 69.23 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.161 1.908 . . . . 74.329999999999998 112.673 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.3 mt -69.12 -45.57 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.047 0.451 . . . . 75.109999999999999 110.888 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 -45.89 91.08 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.909 0.385 . . . . 74.109999999999999 110.679 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.05 -42.69 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 73.099999999999994 111.348 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -50.72 -50.03 56.31 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.1 0.476 . . . . 75.109999999999999 111.508 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -75.27 -4.31 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.492 0.552 . . . . 64.209999999999994 112.492 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.98 16.85 12.63 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.821 0.688 . . . . 41.140000000000001 114.821 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 118.039 0.919 . . . . 54.219999999999999 111.016 175.369 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 55.399999999999999 111.817 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.6 p -75.74 164.63 26.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.126 0.489 . . . . 62.109999999999999 112.254 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 mt -55.04 -50.64 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.889 -0.596 . . . . 70.230000000000004 112.356 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 10.1 pt-20 -66.62 -37.13 84.22 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.247 -0.283 . . . . 65.439999999999998 111.724 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 47' ' ' VAL . 24.1 t0 -64.76 -49.97 68.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.138 0.495 . . . . 63.119999999999997 110.146 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.79 99.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.858 -0.61 . . . . 64.109999999999999 111.896 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -52.1 -52.97 48.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.593 -0.276 . . . . 50.329999999999998 111.467 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.73 68.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.214 0.45 . . . . 45.32 112.214 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 43' ' ' ASP . 66.7 t -59.88 -42.48 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.914 0.388 . . . . 63.219999999999999 111.794 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -97.61 -0.27 46.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.786 0.327 . . . . 71.219999999999999 111.467 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.71 82.31 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.477 -0.392 . . . . 72.0 113.45 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.5 mt -74.42 154.68 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 122.581 -0.364 . . . . 74.340000000000003 111.273 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -97.38 113.79 25.5 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.977 0.417 . . . . 64.109999999999999 110.529 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -68.34 -32.62 72.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.211 0.449 . . . . 64.409999999999997 112.211 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.49 -40.29 82.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.886 0.374 . . . . 71.319999999999993 111.658 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -70.57 -49.46 47.73 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.212 0.53 . . . . 63.130000000000003 111.043 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.41 -47.31 85.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.799 -0.637 . . . . 73.329999999999998 112.406 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 52' ' ' ALA . 98.4 t -61.75 -38.9 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.149 0.426 . . . . 73.420000000000002 112.149 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -61.95 -45.35 94.05 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.176 -0.327 . . . . 73.129999999999995 110.798 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.53 -42.52 74.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.153 0.501 . . . . 63.329999999999998 111.36 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.3 -53.4 55.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.239 -0.437 . . . . 61.009999999999998 111.745 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -55.0 -50.44 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.038 0.384 . . . . 72.319999999999993 112.038 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.06 -42.3 69.11 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.763 -0.199 . . . . 74.329999999999998 111.346 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.58 -49.41 77.55 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 63.030000000000001 112.188 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.771 0.319 . . . . 75.519999999999996 111.618 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.683 ' N ' HD22 ' A' ' 60' ' ' ASN . 45.9 mm . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 120.529 0.204 . . . . 73.409999999999997 110.602 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.501 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 28.5 p -116.66 155.88 28.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 70.310000000000002 111.134 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HB3' HG21 ' A' ' 56' ' ' VAL . 14.0 ptpt -69.27 -10.5 58.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.01 0.374 . . . . 74.010000000000005 112.01 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.28 -14.95 45.04 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.088 0.47 . . . . 71.299999999999997 111.347 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.501 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 65.5 mtt -69.41 157.29 37.36 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.435 0.531 . . . . 73.530000000000001 112.435 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 48.9 mm -85.39 141.55 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.043 -0.526 . . . . 62.130000000000003 111.552 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.6 mt -55.44 -52.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 120.76 0.314 . . . . 71.340000000000003 111.798 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.22 71.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.961 0.41 . . . . 62.439999999999998 111.616 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.75 -42.08 98.5 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.303 -0.408 . . . . 64.150000000000006 111.044 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.97 -40.93 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.037 0.446 . . . . 72.439999999999998 110.933 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD23 ' OG1' ' A' ' 19' ' ' THR . 97.0 mt -61.22 -31.74 71.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.892 0.377 . . . . 73.439999999999998 111.348 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -70.1 -15.17 62.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.455 -0.339 . . . . 63.130000000000003 111.9 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.4 mtt -86.69 -43.44 12.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.208 0.528 . . . . 63.340000000000003 110.044 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.08 133.79 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.568 -0.742 . . . . 71.540000000000006 110.814 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.8 mmt-85 -69.68 -25.0 63.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.874 0.368 . . . . 74.209999999999994 111.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.49 -1.41 10.83 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.608 -0.33 . . . . 73.019999999999996 113.728 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.501 ' OG1' HD23 ' A' ' 13' ' ' LEU . 73.3 p -82.84 -21.43 34.41 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.469 -0.43 . . . . 74.519999999999996 111.704 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.78 -51.08 82.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 112.396 0.517 . . . . 34.539999999999999 112.396 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 22.6 Cg_endo -60.93 -25.15 80.91 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.885 1.724 . . . . 61.539999999999999 112.613 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.2 mt -71.05 -43.18 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.969 0.414 . . . . 71.530000000000001 110.785 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -58.64 -48.72 80.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.131 0.491 . . . . 72.209999999999994 110.249 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 28' ' ' MET . 66.5 mt -60.71 -37.84 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.99 -0.55 . . . . 62.329999999999998 111.221 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -56.06 -32.95 64.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.275 -0.421 . . . . 61.409999999999997 112.089 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.419 ' ND2' HD13 ' A' ' 55' ' ' LEU . 34.0 m-80 -90.93 -7.5 51.93 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.453 0.538 . . . . 71.219999999999999 112.453 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 -7.47 6.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.624 -0.798 . . . . 61.399999999999999 114.605 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 50.0 mtt . . . . . 0 N--CA 1.473 0.687 0 CA-C-N 117.877 0.838 . . . . 74.239999999999995 111.082 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 121.087 0.47 . . . . 63.229999999999997 112.054 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 54.3 m -70.31 149.45 47.37 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.577 -0.283 . . . . 75.120000000000005 110.578 172.851 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 mt -51.51 -55.61 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.655 0.613 . . . . 73.329999999999998 112.655 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.6 pt-20 -62.1 -36.28 81.23 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.038 0.447 . . . . 74.140000000000001 111.684 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.93 -52.68 22.5 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.071 -0.513 . . . . 71.140000000000001 111.117 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.88 91.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.303 -0.408 . . . . 73.099999999999994 111.504 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -57.49 -45.53 84.79 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.53 -0.304 . . . . 60.009999999999998 110.938 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.88 75.05 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.016 0.376 . . . . 61.43 112.016 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.8 t -55.65 -41.27 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.927 0.394 . . . . 73.099999999999994 112.052 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.535 ' HB3' HG13 ' A' ' 50' ' ' ILE . 8.8 t60 -91.33 -22.96 20.26 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 73.25 111.299 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.75 24.53 17.56 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.546 -0.359 . . . . 73.219999999999999 112.439 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 48' ' ' HIS . 63.8 mt -79.69 155.23 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.92 0.488 . . . . 73.109999999999999 112.058 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.76 101.74 12.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 110.166 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -71.44 -21.88 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.454 0.538 . . . . 73.030000000000001 112.454 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -43.1 77.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.361 . . . . 60.340000000000003 110.467 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.61 -46.78 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.312 -0.404 . . . . 63.420000000000002 110.992 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' ND2' ' A' ' 26' ' ' ASN . 30.1 tp -56.29 -54.84 40.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.223 -0.444 . . . . 62.149999999999999 112.046 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 5' ' ' LYS . 87.4 t -56.51 -41.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.965 0.412 . . . . 63.039999999999999 112.011 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -37.21 80.63 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.73 0.27 . . . . 72.450000000000003 111.73 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -59.91 -42.57 94.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 64.019999999999996 110.692 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -58.6 -52.32 66.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.28 -0.418 . . . . 74.439999999999998 111.381 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.683 HD22 ' N ' ' A' ' 3' ' ' ILE . 15.4 m120 -54.19 -57.36 11.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.695 0.283 . . . . 74.219999999999999 111.59 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -52.42 -40.9 62.71 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 111.789 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -56.45 -48.56 76.81 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.894 0.378 . . . . 74.510000000000005 111.663 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.612 0.244 . . . . 64.400000000000006 111.499 179.313 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.828 0.347 . . . . 71.420000000000002 111.412 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.3 p -118.06 170.23 9.02 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.861 0.362 . . . . 70.209999999999994 110.973 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HB3' HG21 ' A' ' 56' ' ' VAL . 16.8 ptpt -80.87 -11.78 59.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.865 0.364 . . . . 71.340000000000003 111.282 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.52 -25.43 38.72 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.012 -0.54 . . . . 60.340000000000003 111.141 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.478 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 64.3 mtt -65.11 161.07 19.75 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.181 0.515 . . . . 73.549999999999997 112.203 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.0 mm -86.91 129.76 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.062 -0.517 . . . . 73.040000000000006 110.716 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.505 HG12 HG13 ' A' ' 41' ' ' ILE . 57.3 mt -54.66 -45.96 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 112.211 0.448 . . . . 72.150000000000006 112.211 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -63.15 -34.68 78.15 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.195 0.521 . . . . 45.109999999999999 111.078 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.4 t70 -65.06 -41.84 94.74 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.913 -0.585 . . . . 54.100000000000001 110.344 177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.88 -37.96 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.219 0.533 . . . . 62.439999999999998 110.997 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.64 -29.87 70.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 73.310000000000002 111.472 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 77.0 mt-30 -68.34 -25.45 65.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.953 0.406 . . . . 71.140000000000001 111.042 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.0 mtt -75.62 -53.91 7.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.208 0.528 . . . . 73.420000000000002 110.02 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -154.3 124.45 6.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.956 -0.566 . . . . 75.439999999999998 111.127 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.41 -18.12 65.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 74.310000000000002 112.556 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.439 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -68.1 -6.44 46.17 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.274 -0.489 . . . . 73.519999999999996 113.2 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.1 p -80.91 -23.14 39.15 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.644 -0.327 . . . . 34.43 111.455 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.47 -51.79 77.11 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.528 0.566 . . . . 73.439999999999998 112.528 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.46 -26.03 76.29 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.901 1.734 . . . . 72.129999999999995 112.335 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 64.1 mt -72.48 -41.76 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.02 0.438 . . . . 72.150000000000006 110.583 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HD1' HD21 ' A' ' 55' ' ' LEU . 62.0 m-85 -61.9 -49.93 74.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.041 0.448 . . . . 75.120000000000005 110.497 173.094 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.0 mt -59.12 -37.55 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 111.099 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 27.4 t30 -52.09 -46.4 65.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.992 0.425 . . . . 64.310000000000002 111.678 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -81.21 1.69 31.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.312 0.486 . . . . 72.430000000000007 112.312 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.33 13.84 14.32 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.203 0.841 . . . . 62.439999999999998 115.203 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.543 0.703 0 CA-C-N 117.952 0.876 . . . . 65.219999999999999 112.147 176.36 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.4 . . . . 73.400000000000006 111.413 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' MET . 49.2 m -68.54 153.06 44.48 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.415 -0.357 . . . . 72.0 111.024 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.0 mp -51.93 -51.24 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 111.791 0.293 . . . . 53.329999999999998 111.791 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.6 pt-20 -69.05 -33.9 74.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.903 0.382 . . . . 75.420000000000002 111.724 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.88 -47.25 75.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.103 0.478 . . . . 70.109999999999999 111.238 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.73 56.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 75.019999999999996 111.788 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.88 -42.08 75.39 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.72 0.295 . . . . 72.219999999999999 111.679 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.67 65.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.272 0.471 . . . . 53.109999999999999 112.272 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.2 -51.18 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.816 0.341 . . . . 50.119999999999997 111.914 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -87.6 -19.82 27.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.873 0.368 . . . . 74.310000000000002 111.386 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.59 27.04 12.07 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.19 -0.528 . . . . 74.310000000000002 112.655 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mt -76.57 148.28 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.751 0.31 . . . . 70.310000000000002 111.298 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.8 93.84 5.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.202 0.525 . . . . 70.239999999999995 110.283 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HB1' HG22 ' A' ' 41' ' ' ILE . . . -65.7 -24.05 66.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.165 -0.47 . . . . 64.319999999999993 112.105 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.15 -45.76 92.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.792 0.329 . . . . 70.030000000000001 110.962 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.85 -46.44 75.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.893 0.377 . . . . 54.340000000000003 111.126 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 41' ' ' ILE . 26.2 tp -53.19 -51.73 61.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.002 -0.545 . . . . 72.209999999999994 111.624 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 5' ' ' LYS . 80.2 t -57.41 -45.28 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 71.329999999999998 111.524 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.63 -45.0 85.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.515 0.198 . . . . 74.129999999999995 111.395 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -58.97 -40.85 86.02 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.937 0.398 . . . . 74.409999999999997 111.281 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 56' ' ' VAL . 80.9 mt -60.13 -50.46 73.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.854 0.359 . . . . 74.239999999999995 111.38 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -57.57 -55.13 38.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.395 -0.366 . . . . 73.400000000000006 111.418 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -50.11 -41.77 49.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.891 0.377 . . . . 74.010000000000005 111.031 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 87.4 t80 -58.74 -53.23 60.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.17 -0.468 . . . . 65.140000000000001 112.084 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.591 0.234 . . . . 75.200000000000003 111.117 178.424 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.467 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.4 mm . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.174 0.435 . . . . 64.319999999999993 112.174 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.484 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.2 p -116.42 158.9 22.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.282 -0.417 . . . . 75.209999999999994 110.307 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -72.98 -15.55 61.54 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.106 -0.371 . . . . 73.129999999999995 111.959 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.06 -14.11 58.14 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.794 0.331 . . . . 74.349999999999994 111.48 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.484 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 62.8 mtt -63.95 134.92 55.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.28 0.562 . . . . 72.010000000000005 111.575 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 46.7 mm -68.49 136.01 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.901 -0.59 . . . . 61.450000000000003 111.405 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.6 mt -52.13 -52.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.838 0.31 . . . . 73.25 111.838 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.11 -36.85 73.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.934 0.397 . . . . 72.310000000000002 111.627 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.12 -37.54 87.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.208 -0.451 . . . . 64.239999999999995 110.902 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.94 -41.31 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.072 0.463 . . . . 73.040000000000006 110.99 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -59.22 -31.24 68.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.341 -0.391 . . . . 71.019999999999996 111.709 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 79.3 mt-30 -62.95 -37.06 85.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.73 0.3 . . . . 70.230000000000004 111.532 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.9 mtt -65.76 -48.25 72.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 60.399999999999999 110.225 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.85 120.25 3.4 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.445 -0.798 . . . . 74.319999999999993 110.7 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -62.24 -20.8 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.459 0.54 . . . . 74.219999999999999 112.459 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -3.49 22.86 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.418 -0.42 . . . . 61.130000000000003 113.65 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.7 p -83.08 -19.79 36.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.916 0.358 . . . . 70.430000000000007 111.833 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.29 -50.99 81.72 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 112.478 0.547 . . . . 74.409999999999997 112.478 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.1 Cg_endo -59.13 -29.1 89.61 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.899 1.733 . . . . 72.0 112.613 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.88 -42.17 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.094 0.474 . . . . 75.140000000000001 110.613 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -62.38 -53.44 55.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.155 0.502 . . . . 72.519999999999996 110.648 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.7 -35.35 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.136 -0.484 . . . . 44.310000000000002 111.322 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -57.6 -48.84 78.28 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.021 -0.536 . . . . 72.349999999999994 111.511 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -73.92 -5.11 39.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.355 0.502 . . . . 62.350000000000001 112.355 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.89 17.47 7.89 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.653 -0.784 . . . . 75.319999999999993 114.831 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 CA--C 1.537 0.469 0 CA-C-N 117.961 0.881 . . . . 65.409999999999997 111.717 175.651 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.351 0.596 . . . . 72.319999999999993 112.042 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 87.7 p -76.76 162.02 28.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.739 -0.664 . . . . 70.230000000000004 112.248 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.15 -44.08 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.140000000000001 111.91 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.14 -40.78 90.87 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.562 0.208 . . . . 71.329999999999998 111.562 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.01 -48.61 65.24 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.008 0.432 . . . . 71.340000000000003 111.132 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.75 94.08 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.881 0.372 . . . . 61.200000000000003 111.632 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -56.27 -39.49 72.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.709 0.29 . . . . 52.020000000000003 111.355 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.69 69.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.067 0.395 . . . . 34.509999999999998 112.067 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -48.08 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.018 0.437 . . . . 63.340000000000003 111.346 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -92.47 -10.27 38.46 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.388 -0.369 . . . . 75.129999999999995 111.989 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.42 35.44 23.1 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.35 -0.452 . . . . 61.219999999999999 113.233 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -91.95 152.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.646 0.378 . . . . 74.150000000000006 111.286 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.32 99.43 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.411 -0.589 . . . . 71.25 109.411 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -65.07 -30.1 71.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 112.154 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.8 t70 -59.7 -44.29 93.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.68 0.276 . . . . 61.020000000000003 110.677 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.63 -49.1 67.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 75.5 111.079 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.87 -45.09 67.29 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 73.239999999999995 111.354 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 52' ' ' ALA . 75.9 t -61.56 -37.47 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 111.453 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.4 mttm -60.37 -48.83 80.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.743 0.306 . . . . 72.209999999999994 110.649 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.69 -38.19 71.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.241 -0.436 . . . . 60.039999999999999 111.484 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.0 mt -65.2 -51.25 62.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.505 -0.316 . . . . 73.010000000000005 111.364 174.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -53.57 -55.02 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.647 -0.251 . . . . 72.120000000000005 111.445 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 45.0 mt-10 -47.51 -50.46 23.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.059 0.457 . . . . 75.439999999999998 110.773 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -55.15 -49.12 72.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.765 -0.652 . . . . 71.420000000000002 112.292 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.875 0.369 . . . . 73.319999999999993 111.722 -179.857 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 mm . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 112.727 0.64 . . . . 71.219999999999999 112.727 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.5 p -122.34 153.7 38.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.941 -0.572 . . . . 64.530000000000001 110.367 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.9 pttp -68.45 -13.46 62.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.959 0.409 . . . . 72.530000000000001 111.606 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.24 -22.67 59.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.205 0.526 . . . . 71.120000000000005 111.048 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.448 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.3 mtt -68.59 159.67 31.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.268 0.556 . . . . 61.32 111.718 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.9 mm -86.27 135.87 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 111.031 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.8 mt -56.81 -50.88 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 111.892 0.33 . . . . 73.239999999999995 111.892 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.02 -37.33 74.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.942 0.401 . . . . 63.020000000000003 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.81 -44.48 96.78 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.162 -0.472 . . . . 75.439999999999998 110.62 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.13 -39.71 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.116 0.484 . . . . 65.400000000000006 110.837 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.48 HD23 ' OG1' ' A' ' 19' ' ' THR . 97.1 mt -62.69 -33.81 75.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 111.62 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 88.1 mt-30 -69.28 -20.83 63.91 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.7 0.286 . . . . 74.099999999999994 111.538 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.5 mtt -75.95 -56.45 4.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.374 0.607 . . . . 74.420000000000002 109.896 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -145.8 125.45 13.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.683 -0.69 . . . . 72.329999999999998 110.571 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 13' ' ' LEU . 41.1 mmt180 -69.57 -19.53 63.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.516 -0.311 . . . . 75.140000000000001 111.591 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.07 -1.8 43.28 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.318 -0.467 . . . . 64.519999999999996 113.304 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.48 ' OG1' HD23 ' A' ' 13' ' ' LEU . 81.5 p -82.28 -17.21 46.7 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.461 -0.435 . . . . 53.149999999999999 111.183 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.21 -51.82 76.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.497 0.554 . . . . 74.420000000000002 112.497 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -56.95 -26.43 67.86 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.108 1.872 . . . . 72.310000000000002 112.612 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.14 -46.98 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.034 0.445 . . . . 63.149999999999999 110.672 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -58.98 -40.97 86.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.022 0.439 . . . . 73.349999999999994 110.504 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.97 -46.57 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 111.097 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -51.68 -48.61 63.41 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.181 0.515 . . . . 73.349999999999994 111.495 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -77.63 -6.8 55.06 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.176 -0.465 . . . . 75.150000000000006 112.16 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.6 39.05 3.75 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.251 0.86 . . . . 64.140000000000001 115.251 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 CA--C 1.541 0.616 0 CA-C-N 117.806 0.803 . . . . 75.140000000000001 111.654 174.278 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 121.123 0.487 . . . . 74.340000000000003 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 63.6 m -67.03 157.78 32.65 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.364 -0.38 . . . . 74.530000000000001 111.437 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.3 mt -54.81 -54.93 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.867 0.321 . . . . 74.150000000000006 111.867 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.3 pt-20 -63.49 -30.68 71.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.707 0.289 . . . . 54.100000000000001 111.689 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.3 t70 -64.32 -61.84 1.98 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.919 0.39 . . . . 73.319999999999993 109.971 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.72 65.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.157 0.503 . . . . 65.150000000000006 111.588 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 81.4 m -57.57 -40.83 79.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.989 -0.55 . . . . 75.310000000000002 111.43 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.5 69.03 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.013 0.435 . . . . 43.32 111.627 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.4 t -69.98 -39.91 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.784 0.326 . . . . 74.519999999999996 111.831 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -105.39 4.57 30.92 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.089 -0.382 . . . . 74.230000000000004 112.007 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.2 27.97 72.15 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.538 -0.363 . . . . 61.299999999999997 113.958 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 53.3 mt -85.53 153.73 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.973 0.416 . . . . 70.540000000000006 111.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.34 102.2 11.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.672 0.389 . . . . 52.439999999999998 111.675 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.42 85.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 71.430000000000007 111.417 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -51.43 -44.93 62.44 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.961 -0.563 . . . . 73.230000000000004 111.41 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.21 -39.1 34.12 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.224 -0.444 . . . . 72.219999999999999 111.969 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 tp -61.82 -52.81 62.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.918 0.39 . . . . 74.420000000000002 111.98 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.535 ' HA ' HD12 ' A' ' 59' ' ' LEU . 90.1 t -57.46 -37.01 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.956 0.354 . . . . 72.040000000000006 111.956 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -64.41 -42.22 96.19 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.625 -0.261 . . . . 71.310000000000002 111.354 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.98 -42.13 97.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.994 0.426 . . . . 70.219999999999999 110.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -58.37 -52.66 64.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.33 -0.396 . . . . 75.430000000000007 111.678 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -56.11 -54.5 44.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.744 0.307 . . . . 74.129999999999995 111.444 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.09 -31.65 52.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.537 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -69.34 -46.66 66.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.896 0.379 . . . . 74.430000000000007 111.696 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 CA--C 1.535 0.383 0 O-C-N 122.171 -0.33 . . . . 72.519999999999996 111.15 177.424 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.453 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 49.6 mm . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.994 0.426 . . . . 75.209999999999994 111.828 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 p -121.18 161.8 21.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.744 0.307 . . . . 73.439999999999998 110.996 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.9 pttp -69.34 -21.23 63.84 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 111.658 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.66 -21.65 59.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.177 -0.465 . . . . 72.010000000000005 111.731 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -63.08 152.02 38.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.388 0.613 . . . . 73.120000000000005 112.125 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.88 130.5 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.97 -0.559 . . . . 73.540000000000006 111.107 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.41 -47.18 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 111.923 0.342 . . . . 74.450000000000003 111.923 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -60.45 -35.78 76.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.97 0.414 . . . . 32.140000000000001 111.338 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.58 -39.95 80.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.349 -0.387 . . . . 43.140000000000001 110.704 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.93 -41.79 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.277 0.56 . . . . 50.329999999999998 110.128 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.0 mt -64.19 -21.24 66.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.974 -0.557 . . . . 72.230000000000004 111.735 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 83.9 mm-40 -77.44 -30.72 53.47 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.719 0.295 . . . . 72.450000000000003 111.149 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.1 mtt -69.88 -45.89 66.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.317 0.58 . . . . 74.129999999999995 109.894 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.33 127.25 4.94 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.202 -0.908 . . . . 71.340000000000003 111.141 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -65.55 -26.34 67.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.285 -0.416 . . . . 73.430000000000007 111.686 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.62 -1.24 5.85 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 114.179 0.431 . . . . 61.32 114.179 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.456 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.4 p -85.86 -13.19 48.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.166 0.483 . . . . 72.340000000000003 111.589 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.68 -51.35 74.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.699 0.629 . . . . 43.439999999999998 112.699 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -56.93 -31.95 91.12 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.112 1.874 . . . . 64.040000000000006 112.628 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.07 -48.67 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.032 0.444 . . . . 65.040000000000006 110.836 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -60.25 -47.55 85.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.715 0.293 . . . . 60.32 111.263 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.33 -41.97 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.814 0.34 . . . . 61.240000000000002 111.428 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -58.15 -44.07 87.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.255 -0.43 . . . . 63.439999999999998 111.533 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -75.5 -9.9 58.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.282 0.475 . . . . 51.439999999999998 112.282 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.28 1.53 11.17 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 115.424 0.93 . . . . 74.340000000000003 115.424 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.471 0.589 0 CA-C-N 118.345 1.073 . . . . 74.239999999999995 111.762 179.316 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 112.3 0.481 . . . . 75.019999999999996 112.3 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -64.2 150.86 44.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.339 -0.391 . . . . 71.109999999999999 110.89 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mt -51.7 -56.29 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.466 0.543 . . . . 74.420000000000002 112.466 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.3 pt-20 -62.41 -39.75 94.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.813 0.339 . . . . 74.340000000000003 111.717 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 47' ' ' VAL . 35.7 t70 -64.64 -54.84 25.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.348 -0.387 . . . . 72.319999999999993 110.924 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.35 75.8 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.945 0.402 . . . . 52.329999999999998 111.235 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' GLY . 90.3 m -58.76 -52.75 64.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.377 -0.374 . . . . 72.510000000000005 111.123 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -42.88 81.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.714 0.264 . . . . 75.530000000000001 111.714 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 43' ' ' ASP . 60.6 t -60.58 -44.37 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.175 0.512 . . . . 73.209999999999994 111.342 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.454 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.5 t-80 -89.4 -2.7 58.5 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-N 116.257 -0.429 . . . . 62.140000000000001 111.505 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 67.77 29.87 74.1 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.65 -0.309 . . . . 54.310000000000002 113.519 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 48' ' ' HIS . 45.5 mt -89.02 151.82 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 122.879 0.471 . . . . 61.030000000000001 111.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.03 102.7 9.44 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.81 0.338 . . . . 71.319999999999993 110.759 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.3 -23.64 61.21 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.201 0.445 . . . . 75.349999999999994 112.201 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.8 -51.07 71.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.959 0.409 . . . . 73.430000000000007 110.634 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 59.9 mtpt -63.66 -50.5 69.03 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 111.185 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 36.3 tp -56.19 -54.34 46.35 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.928 -0.578 . . . . 70.209999999999994 112.198 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.4 t -59.01 -43.83 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 111.818 0.303 . . . . 71.310000000000002 111.818 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.13 -42.82 99.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.679 0.276 . . . . 71.239999999999995 111.458 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 96.4 mt-10 -63.69 -39.93 95.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.832 0.349 . . . . 73.409999999999997 111.338 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 90.8 mt -59.06 -48.26 82.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.776 0.322 . . . . 71.530000000000001 111.322 174.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -54.63 -58.63 6.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.489 -0.323 . . . . 74.409999999999997 111.283 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -48.7 -41.4 31.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.944 0.402 . . . . 71.239999999999995 111.627 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -62.08 -54.85 35.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 112.158 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 111.778 0.288 . . . . 73.329999999999998 111.778 179.682 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.55 ' N ' HD22 ' A' ' 60' ' ' ASN . 44.4 mm . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.682 0.277 . . . . 75.400000000000006 111.406 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 18.3 p -115.34 154.05 29.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.707 0.289 . . . . 75.219999999999999 110.771 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.785 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 49.9 pttt -68.95 -14.84 63.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.86 0.362 . . . . 73.140000000000001 111.844 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.9 -22.75 52.94 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.08 -0.509 . . . . 65.430000000000007 111.314 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.53 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 60.7 mtt -62.43 150.57 39.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.604 0.716 . . . . 74.209999999999994 112.873 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.65 133.77 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 73.400000000000006 111.185 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -51.01 -50.91 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 120.73 0.3 . . . . 73.519999999999996 111.806 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.03 -40.94 82.13 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.837 0.31 . . . . 73.319999999999993 111.837 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.3 -38.89 88.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.948 0.404 . . . . 64.230000000000004 111.026 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.32 -44.92 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.134 0.492 . . . . 75.430000000000007 110.953 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.8 -33.16 71.36 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.041 -0.527 . . . . 72.109999999999999 111.987 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 82.5 mm-40 -61.42 -29.02 69.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.977 0.418 . . . . 63.140000000000001 111.618 177.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -84.15 -41.39 17.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.169 0.509 . . . . 72.109999999999999 110.346 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.22 120.96 3.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.002 -0.545 . . . . 74.430000000000007 111.325 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -69.83 -16.96 63.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 112.082 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -66.02 -7.75 38.79 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.236 -0.506 . . . . 53.240000000000002 113.144 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.2 p -80.24 -19.49 46.72 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.568 -0.372 . . . . 71.439999999999998 111.573 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.75 -51.78 77.56 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.501 0.556 . . . . 44.109999999999999 112.501 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 17.7 Cg_endo -59.12 -21.68 60.52 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.115 1.877 . . . . 71.400000000000006 112.634 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.4 mt -77.07 -41.7 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.974 0.416 . . . . 74.439999999999998 110.579 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -60.79 -45.85 92.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.139 0.495 . . . . 72.010000000000005 110.229 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.87 -39.11 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.988 -0.551 . . . . 74.140000000000001 110.991 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.93 -37.37 63.78 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.046 0.451 . . . . 74.25 111.782 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 55' ' ' LEU . 33.6 m-80 -89.82 -2.29 58.19 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.31 0.485 . . . . 60.520000000000003 112.31 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 37.6 5.44 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.927 -0.654 . . . . 63.310000000000002 114.706 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 117.363 0.582 . . . . 71.400000000000006 111.656 173.439 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.156 0.503 . . . . 74.25 111.863 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -75.77 154.98 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.884 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -53.36 -58.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.702 0.63 . . . . 74.230000000000004 112.702 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.785 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.4 pt-20 -64.97 -33.55 76.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.863 0.364 . . . . 70.519999999999996 111.604 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 47' ' ' VAL . 25.7 t70 -64.49 -54.17 36.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.248 -0.433 . . . . 72.209999999999994 110.821 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.084 -0.507 . . . . 73.209999999999994 111.038 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.5 m -56.4 -49.21 75.13 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.431 -0.35 . . . . 75.120000000000005 110.913 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.0 67.54 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.902 0.334 . . . . 34.329999999999998 111.902 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 43' ' ' ASP . 61.8 t -67.41 -39.14 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.872 0.368 . . . . 72.549999999999997 111.552 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.01 9.76 24.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.774 0.321 . . . . 75.439999999999998 111.839 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.31 31.54 81.19 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.522 -0.371 . . . . 72.310000000000002 113.329 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.74 153.28 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.538 0.335 . . . . 60.420000000000002 111.646 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.38 107.09 16.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.944 0.402 . . . . 73.109999999999999 110.298 175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -28.74 56.8 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.011 0.374 . . . . 65.140000000000001 112.011 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.44 -47.16 84.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.862 0.363 . . . . 61.350000000000001 110.776 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.35 -45.93 52.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.586 -0.279 . . . . 74.319999999999993 111.594 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' ND2' ' A' ' 26' ' ' ASN . 25.0 tp -53.18 -51.4 62.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.996 0.427 . . . . 75.510000000000005 111.694 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 5' ' ' LYS . 88.0 t -59.91 -41.81 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.686 0.279 . . . . 62.399999999999999 111.602 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.04 -39.47 90.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.545 0.202 . . . . 74.439999999999998 111.545 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.76 -37.03 80.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 73.420000000000002 110.723 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 79.8 mt -65.83 -51.14 61.4 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.454 -0.339 . . . . 73.230000000000004 111.764 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.55 HD22 ' N ' ' A' ' 3' ' ' ILE . 13.6 m120 -56.21 -51.66 67.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.926 0.343 . . . . 71.340000000000003 111.926 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.62 -34.83 69.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.813 0.34 . . . . 53.130000000000003 111.632 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.47 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 94.3 t80 -59.35 -48.31 82.11 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.84 0.352 . . . . 54.310000000000002 111.181 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 116.649 -0.251 . . . . 72.420000000000002 111.253 177.032 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.552 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.7 mm . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 112.717 0.636 . . . . 61.43 112.717 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -122.28 156.87 32.94 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.274 -0.421 . . . . 73.549999999999997 110.725 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.5 ptpt -66.76 -14.07 62.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.796 0.331 . . . . 73.140000000000001 111.809 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.7 -19.33 41.77 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.227 -0.442 . . . . 62.100000000000001 111.279 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.552 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 53.6 mtt -63.19 151.39 40.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.283 0.563 . . . . 73.239999999999995 112.05 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 42.0 mm -82.62 138.24 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.879 -0.6 . . . . 64.209999999999994 110.518 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -53.5 -49.21 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 120.865 0.364 . . . . 64.120000000000005 111.825 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -62.16 -32.01 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.867 0.365 . . . . 71.340000000000003 111.718 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.75 -43.7 88.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.039 0.447 . . . . 73.120000000000005 110.637 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.67 -36.3 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.211 0.529 . . . . 74.140000000000001 110.793 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' OG1' ' A' ' 19' ' ' THR . 96.6 mt -65.61 -24.44 67.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.119 -0.491 . . . . 72.200000000000003 111.778 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 73.8 mt-30 -69.48 -32.96 72.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.158 0.504 . . . . 51.329999999999998 110.909 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.5 mtt -71.21 -50.46 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.812 -0.631 . . . . 70.439999999999998 110.674 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.88 135.96 13.87 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.821 -0.627 . . . . 64.319999999999993 110.632 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -72.72 -21.86 60.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.836 0.35 . . . . 75.209999999999994 111.909 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.77 3.18 45.16 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.251 -0.432 . . . . 52.229999999999997 113.807 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.416 ' OG1' HD23 ' A' ' 13' ' ' LEU . 71.4 p -81.31 -21.29 39.37 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.387 -0.478 . . . . 73.540000000000006 111.674 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.81 -51.41 80.62 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 112.741 0.645 . . . . 72.150000000000006 112.741 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.7 Cg_endo -57.31 -26.01 68.25 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.201 1.934 . . . . 71.200000000000003 112.785 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -69.2 -47.07 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.079 0.466 . . . . 71.319999999999993 110.7 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.95 -44.55 82.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.157 0.503 . . . . 62.439999999999998 110.3 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.8 mt -60.78 -40.62 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.982 -0.554 . . . . 64.209999999999994 111.475 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -55.55 -36.02 66.34 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.131 0.491 . . . . 74.099999999999994 111.803 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' ND2' HD13 ' A' ' 55' ' ' LEU . 35.0 m-80 -91.25 1.41 57.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.443 0.534 . . . . 72.409999999999997 112.443 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.07 18.54 17.14 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.097 0.799 . . . . 73.230000000000004 115.097 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 118.109 0.954 . . . . 53.450000000000003 111.543 175.119 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.17 0.509 . . . . 74.019999999999996 111.775 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.4 p -78.05 162.96 26.32 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.107 0.48 . . . . 72.120000000000005 112.201 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.92 -52.74 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.898 -0.592 . . . . 64.439999999999998 112.101 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 17.2 pt-20 -62.95 -37.22 86.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.833 0.349 . . . . 73.239999999999995 111.752 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 47' ' ' VAL . 21.7 t0 -67.53 -49.81 61.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.345 -0.389 . . . . 72.420000000000002 110.778 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.97 93.96 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.035 0.445 . . . . 73.530000000000001 111.72 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -59.28 -51.22 70.9 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.408 -0.36 . . . . 62.450000000000003 111.458 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.52 69.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.987 0.366 . . . . 44.439999999999998 111.987 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -62.29 -48.59 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.93 0.395 . . . . 53.43 111.477 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.403 ' HB3' HG13 ' A' ' 50' ' ' ILE . 65.2 t-80 -82.27 -11.88 58.38 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.369 -0.378 . . . . 74.019999999999996 111.596 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.28 40.8 15.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.52 -0.371 . . . . 72.430000000000007 113.031 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 48' ' ' HIS . 18.9 mt -103.63 152.16 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.708 0.403 . . . . 63.039999999999999 111.177 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -80.48 97.65 7.22 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.073 0.463 . . . . 65.530000000000001 109.879 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -60.74 -37.48 81.93 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.604 0.594 . . . . 73.310000000000002 112.604 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 12.4 t70 -64.1 -39.75 94.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.657 -0.417 . . . . 72.120000000000005 110.493 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.02 -41.43 90.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.785 0.326 . . . . 73.530000000000001 111.218 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.431 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.0 tp -61.85 -50.05 73.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.958 0.409 . . . . 72.310000000000002 111.405 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 52' ' ' ALA . 93.4 t -55.86 -35.23 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.371 -0.377 . . . . 73.25 111.875 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 58.0 mttm -57.06 -54.96 40.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.664 0.269 . . . . 71.040000000000006 110.982 176.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -56.85 -39.6 74.57 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.433 -0.349 . . . . 73.530000000000001 111.335 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 56' ' ' VAL . 89.1 mt -60.19 -51.93 67.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.507 -0.315 . . . . 63.219999999999999 111.494 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -56.59 -50.03 73.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.508 0.194 . . . . 72.140000000000001 111.453 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 63.7 mt-10 -54.75 -42.11 71.22 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.46 -0.336 . . . . 75.109999999999999 111.143 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -54.45 -44.72 72.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.868 0.366 . . . . 74.319999999999993 111.744 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.863 0.363 . . . . 73.549999999999997 110.975 177.359 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.789 ' N ' HD22 ' A' ' 60' ' ' ASN . 48.4 mm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 112.814 0.672 . . . . 71.340000000000003 112.814 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 43.1 p -117.35 156.2 28.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.745 -0.661 . . . . 74.519999999999996 110.403 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.667 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 21.2 pttp -68.94 -13.46 62.45 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.007 0.432 . . . . 60.310000000000002 111.557 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.03 -22.51 45.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.27 -0.423 . . . . 62.32 111.284 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.469 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 67.2 mtt -64.73 153.98 38.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.295 0.569 . . . . 54.329999999999998 112.102 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -82.25 139.83 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.983 -0.553 . . . . 75.519999999999996 111.659 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.3 -55.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.189 0.44 . . . . 62.420000000000002 112.189 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.83 -35.61 73.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.737 0.303 . . . . 72.209999999999994 111.517 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.56 -43.8 89.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.047 0.451 . . . . 53.439999999999998 111.065 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.19 -43.72 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.235 -0.439 . . . . 60.340000000000003 110.775 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.24 -27.91 69.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.094 -0.503 . . . . 52.420000000000002 111.912 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 18.5 mm-40 -63.18 -27.98 69.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.8 0.334 . . . . 75.409999999999997 111.397 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.78 -49.15 7.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.029 0.442 . . . . 72.450000000000003 110.879 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -148.21 119.84 8.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.226 -0.443 . . . . 62.130000000000003 111.396 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 17' ' ' ARG . 12.6 mmt180 -75.48 -8.34 56.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.382 0.512 . . . . 71.030000000000001 112.382 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.02 -8.23 68.64 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.227 -0.511 . . . . 72.239999999999995 112.459 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.417 ' HA ' HD12 ' A' ' 22' ' ' ILE . 65.4 p -81.05 -18.04 48.09 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.696 -0.297 . . . . 70.310000000000002 111.45 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.91 -52.1 75.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 112.178 0.436 . . . . 44.039999999999999 112.178 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -59.52 -28.16 86.78 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.03 1.82 . . . . 74.140000000000001 112.318 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 19' ' ' THR . 67.9 mt -68.71 -46.63 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.057 0.456 . . . . 71.140000000000001 110.894 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 58.5 m-85 -56.75 -48.97 76.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.088 0.47 . . . . 73.340000000000003 110.529 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.34 -36.15 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.013 -0.539 . . . . 71.209999999999994 111.568 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -57.38 -33.11 67.48 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.081 0.467 . . . . 62.549999999999997 111.203 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -92.58 -4.4 53.49 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 112.068 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.42 -13.34 11.03 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.74 -0.743 . . . . 71.519999999999996 114.559 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.512 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.7 mmt . . . . . 0 N--CA 1.476 0.827 0 CA-C-N 117.559 0.679 . . . . 51.420000000000002 111.746 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.065 0.46 . . . . 63.32 111.911 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.3 m -66.6 147.44 53.27 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 110.252 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.447 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.7 mt -50.49 -56.95 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.642 0.608 . . . . 73.510000000000005 112.642 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.2 pt-20 -62.99 -35.99 82.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.847 0.356 . . . . 62.439999999999998 111.791 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 t70 -65.29 -52.0 57.01 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.064 -0.517 . . . . 51.009999999999998 110.767 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.3 79.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.169 -0.469 . . . . 73.209999999999994 111.484 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 41' ' ' ILE . 85.8 m -58.27 -54.93 41.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.469 -0.332 . . . . 73.430000000000007 111.163 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -37.26 64.24 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.838 0.352 . . . . 73.409999999999997 111.841 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -59.72 -52.2 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.392 -0.367 . . . . 73.519999999999996 111.839 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -92.12 -0.67 57.44 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.109 0.411 . . . . 70.430000000000007 112.109 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.55 46.33 40.65 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.443 -0.408 . . . . 64.430000000000007 113.283 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mt -101.91 151.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 122.704 0.401 . . . . 75.340000000000003 111.264 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -85.14 98.52 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.035 0.445 . . . . 71.209999999999994 110.654 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.35 66.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.429 -0.35 . . . . 73.219999999999999 111.78 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.46 -51.82 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.585 -0.279 . . . . 62.329999999999998 111.159 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -76.91 -40.16 48.26 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.04 0.385 . . . . 62.310000000000002 112.04 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 tp -55.63 -53.69 53.36 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.783 0.325 . . . . 70.109999999999999 111.747 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 5' ' ' LYS . 59.8 t -61.16 -39.93 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.659 0.266 . . . . 72.329999999999998 111.595 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.4 mttt -60.8 -45.78 93.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.802 -0.181 . . . . 71.239999999999995 111.315 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.15 -40.0 88.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.751 0.31 . . . . 72.239999999999995 111.453 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.9 mt -59.24 -52.72 64.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.813 0.339 . . . . 72.200000000000003 111.51 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.789 HD22 ' N ' ' A' ' 3' ' ' ILE . 17.9 m120 -57.74 -49.94 74.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.429 -0.351 . . . . 73.109999999999999 111.745 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 46.7 mt-10 -52.57 -44.43 65.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.462 -0.336 . . . . 63.140000000000001 110.782 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -57.69 -54.15 50.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.336 -0.393 . . . . 72.150000000000006 112.054 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.993 0.368 . . . . 74.400000000000006 111.993 -179.665 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' VAL . 50.9 mm . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.944 0.72 . . . . 75.310000000000002 112.944 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.8 p -125.82 158.58 34.64 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.69 -0.686 . . . . 61.439999999999998 109.939 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.739 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.4 pttp -71.92 -15.17 62.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.015 -0.428 . . . . 41.140000000000001 111.252 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.84 -23.56 61.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.04 -0.527 . . . . 74.439999999999998 111.192 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.9 mtt -67.64 165.33 17.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.397 0.518 . . . . 74.200000000000003 112.397 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 12' ' ' VAL . 47.2 mm -93.75 135.53 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.992 -0.549 . . . . 53.32 111.581 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.7 -51.31 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.821 0.343 . . . . 60.399999999999999 111.849 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.13 -41.52 83.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.805 0.336 . . . . 64.420000000000002 111.73 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 15' ' ' MET . 20.4 t70 -58.66 -45.01 90.28 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.407 -0.361 . . . . 74.310000000000002 110.95 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 8' ' ' ILE . 88.7 t -57.53 -43.42 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.957 0.408 . . . . 73.430000000000007 111.2 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.422 HD23 ' OG1' ' A' ' 19' ' ' THR . 94.9 mt -62.68 -34.4 77.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.321 -0.399 . . . . 71.420000000000002 111.395 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 78.8 mt-30 -67.61 -30.16 69.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.386 -0.37 . . . . 63.509999999999998 111.661 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 37.2 mtm -74.45 -43.2 57.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.3 0.572 . . . . 65.0 109.949 175.011 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -159.49 124.67 4.11 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.614 -0.721 . . . . 73.519999999999996 111.756 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -69.47 -14.7 63.02 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.992 -0.549 . . . . 72.540000000000006 111.766 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.506 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -65.51 -9.75 45.54 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.067 -0.587 . . . . 73.319999999999993 113.178 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.422 ' OG1' HD23 ' A' ' 13' ' ' LEU . 80.7 p -82.43 -13.85 56.11 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.44 -0.447 . . . . 62.119999999999997 111.757 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.03 -51.07 80.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.604 0.594 . . . . 75.310000000000002 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.5 Cg_endo -58.92 -26.45 81.13 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.169 1.913 . . . . 74.120000000000005 112.677 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -71.41 -44.1 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.97 0.414 . . . . 74.329999999999998 110.789 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -63.76 -46.03 87.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.972 0.415 . . . . 73.530000000000001 110.55 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.56 -39.16 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.205 -0.452 . . . . 64.010000000000005 111.259 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.43 -40.7 71.83 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.076 0.465 . . . . 72.5 111.541 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.74 0.42 43.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.14 -0.482 . . . . 75.200000000000003 112.041 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 9.51 45.31 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 114.826 0.69 . . . . 71.530000000000001 114.826 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 118.093 0.946 . . . . 70.239999999999995 111.817 179.279 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 121.253 0.549 . . . . 75.230000000000004 112.344 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.7 m -70.29 151.53 45.19 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.041 -0.527 . . . . 72.310000000000002 111.899 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.0 mt -52.67 -57.66 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.376 0.509 . . . . 74.219999999999999 112.376 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.739 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.6 pt-20 -58.61 -35.56 72.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.912 0.387 . . . . 74.239999999999995 111.78 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 47' ' ' VAL . 17.9 t70 -68.85 -53.61 20.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.202 -0.454 . . . . 73.219999999999999 111.144 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.41 79.16 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.267 -0.424 . . . . 72.219999999999999 111.245 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -60.22 -52.25 66.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 74.109999999999999 110.825 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.0 -47.94 64.69 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.411 -0.358 . . . . 32.219999999999999 111.871 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 43' ' ' ASP . 59.9 t -51.94 -38.27 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 52.420000000000002 111.928 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -103.18 0.51 31.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.294 0.479 . . . . 73.349999999999994 112.294 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.57 74.07 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.161 -0.543 . . . . 44.409999999999997 113.501 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.6 153.13 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.899 0.38 . . . . 60.409999999999997 111.307 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -86.07 105.09 16.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.872 0.368 . . . . 72.150000000000006 110.877 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.5 -36.07 68.29 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.045 0.387 . . . . 72.230000000000004 112.045 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.74 -44.73 77.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.029 0.442 . . . . 75.209999999999994 111.003 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -69.2 -52.02 32.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.343 -0.39 . . . . 75.209999999999994 111.469 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -55.09 -49.62 71.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.21 0.448 . . . . 73.329999999999998 112.21 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 3' ' ' ILE . 75.2 t -60.31 -42.1 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 111.978 0.362 . . . . 72.209999999999994 111.978 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.71 -35.39 77.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.818 0.342 . . . . 74.450000000000003 111.217 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.63 -38.25 86.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.921 0.391 . . . . 73.049999999999997 110.999 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.42 -45.0 73.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.971 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -53.58 -56.4 17.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.794 0.294 . . . . 73.150000000000006 111.794 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -46.68 -52.53 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 71.349999999999994 111.327 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.506 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 80.4 t80 -50.43 -55.36 16.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.54 0.57 . . . . 74.409999999999997 112.54 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.244 0.461 . . . . 73.439999999999998 112.244 -178.715 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.513 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 120.71 0.291 . . . . 75.140000000000001 111.435 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 p -121.61 154.69 36.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.841 0.353 . . . . 74.439999999999998 111.287 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 18.3 ptpt -53.54 -33.34 54.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.185 0.809 . . . . 74.409999999999997 113.185 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.09 -3.39 42.06 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.883 0.697 . . . . 61.210000000000001 112.883 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.2 mtt -73.38 150.79 41.52 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.122 0.487 . . . . 71.150000000000006 111.67 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.6 mm -79.78 131.04 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.237 -0.438 . . . . 72.329999999999998 111.444 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.8 mt -56.25 -51.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 111.89 0.329 . . . . 63.539999999999999 111.89 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -56.38 -40.11 74.06 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.891 0.377 . . . . 71.319999999999993 111.385 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -43.4 96.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 110.709 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.1 -41.55 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.089 0.471 . . . . 71.329999999999998 110.986 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD23 ' OG1' ' A' ' 19' ' ' THR . 94.7 mt -61.42 -35.89 78.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.033 0.444 . . . . 72.349999999999994 111.163 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.2 mt-30 -67.66 -22.21 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.257 -0.429 . . . . 64.040000000000006 111.598 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -74.2 -58.56 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.254 0.549 . . . . 74.530000000000001 109.643 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -146.83 127.51 14.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.612 -0.722 . . . . 74.230000000000004 110.825 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.464 HH12 ' HA ' ' A' ' 14' ' ' GLN . 77.8 mmt-85 -69.18 -17.59 63.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.783 0.29 . . . . 73.109999999999999 111.783 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.2 -6.75 41.18 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.211 -0.519 . . . . 71.129999999999995 113.217 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.437 ' HA ' HD12 ' A' ' 22' ' ' ILE . 80.9 p -81.62 -21.27 38.38 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.557 -0.378 . . . . 70.530000000000001 111.251 174.859 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -57.09 -51.14 83.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 112.181 0.438 . . . . 73.140000000000001 112.181 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.79 -25.44 76.16 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.941 1.761 . . . . 74.219999999999999 112.281 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 19' ' ' THR . 59.9 mt -73.22 -45.43 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.013 0.435 . . . . 72.109999999999999 110.72 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -57.01 -52.17 66.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.056 0.455 . . . . 62.539999999999999 110.522 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.81 -37.32 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.272 -0.422 . . . . 63.329999999999998 111.368 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -55.9 -33.64 64.83 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.137 0.494 . . . . 74.099999999999994 111.251 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -91.43 -4.12 55.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.241 0.459 . . . . 72.109999999999999 112.241 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.18 19.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.984 -0.627 . . . . 74.310000000000002 114.438 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.47 0.565 0 CA-C-N 117.593 0.696 . . . . 54.329999999999998 111.807 176.19 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.685 0.755 . . . . 75.230000000000004 112.772 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 94.1 p -78.84 164.13 24.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.526 -0.761 . . . . 70.400000000000006 112.011 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.07 -48.79 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.182 -0.463 . . . . 72.439999999999998 111.593 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 8.0 pt-20 -62.56 -37.18 85.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.982 0.364 . . . . 60.039999999999999 111.982 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.2 t70 -66.01 -58.99 4.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.71 0.29 . . . . 74.140000000000001 110.703 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.37 65.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.778 0.323 . . . . 74.150000000000006 111.65 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.819 0.342 . . . . 72.400000000000006 110.753 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.12 68.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.835 0.309 . . . . 75.400000000000006 111.835 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 43' ' ' ASP . 76.7 t -66.45 -54.58 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.939 0.4 . . . . 71.409999999999997 111.747 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.75 -18.69 30.52 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.881 0.372 . . . . 64.120000000000005 111.748 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.18 53.15 2.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 121.178 0.321 . . . . 72.019999999999996 113.066 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.9 mt -110.88 153.15 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.01 0.524 . . . . 60.030000000000001 111.107 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 54' ' ' LYS . 14.6 t70 -84.74 103.06 13.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.946 0.403 . . . . 72.019999999999996 110.243 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -62.14 -34.15 75.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.377 0.51 . . . . 74.140000000000001 112.377 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.65 -45.01 90.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.749 0.309 . . . . 73.400000000000006 111.181 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 92.0 mttt -66.42 -49.06 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.955 0.407 . . . . 71.340000000000003 111.036 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.17 -52.87 63.75 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.112 -0.495 . . . . 73.129999999999995 111.819 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HA ' HD12 ' A' ' 59' ' ' LEU . 96.2 t -58.57 -40.02 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.731 0.3 . . . . 65.150000000000006 111.639 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.47 -44.92 95.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.538 0.209 . . . . 74.129999999999995 111.39 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -62.96 -35.6 80.68 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.847 0.356 . . . . 60.420000000000002 111.314 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 56' ' ' VAL . 90.8 mt -64.09 -51.4 64.18 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.468 -0.333 . . . . 73.439999999999998 111.619 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -58.31 -49.92 75.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.676 0.274 . . . . 72.540000000000006 111.571 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.29 -46.88 55.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.568 -0.287 . . . . 72.510000000000005 110.9 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -54.31 -51.77 63.62 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.305 0.483 . . . . 73.140000000000001 112.305 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.547 0.213 . . . . 61.439999999999998 111.429 179.379 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 mm . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.828 0.347 . . . . 63.219999999999999 111.324 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 p -127.33 154.07 45.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.711 0.291 . . . . 62.229999999999997 110.719 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 10.2 ptpp? -64.46 -15.79 61.32 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.157 0.504 . . . . 71.239999999999995 111.237 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.44 -25.2 63.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.591 -0.731 . . . . 63.43 111.287 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.7 mtt -71.71 149.41 45.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.237 0.828 . . . . 53.340000000000003 113.237 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mm -78.76 133.37 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.405 -0.816 . . . . 35.200000000000003 110.928 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.67 -42.04 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 111.896 0.332 . . . . 51.420000000000002 111.896 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.0 94.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.964 0.357 . . . . 61.119999999999997 111.964 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.65 -45.99 88.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.093 0.473 . . . . 74.519999999999996 110.957 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.51 -37.52 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 53.409999999999997 111.249 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.36 -37.17 86.23 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.323 -0.399 . . . . 65.319999999999993 111.235 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -65.26 -21.83 66.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.365 -0.38 . . . . 64.109999999999999 111.428 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 29.7 mtm -84.68 -52.15 6.29 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.157 0.503 . . . . 74.129999999999995 110.091 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -146.55 128.81 15.76 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.919 -0.582 . . . . 73.549999999999997 111.042 176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -73.04 -22.75 60.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.299 0.481 . . . . 71.310000000000002 112.299 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.55 -2.84 51.96 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.447 -0.406 . . . . 34.509999999999998 113.56 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 p -80.26 -24.39 40.13 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.502 -0.411 . . . . 61.240000000000002 111.762 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.7 -52.5 66.81 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.715 0.635 . . . . 74.530000000000001 112.715 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.0 Cg_endo -58.88 -24.57 73.04 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.117 1.878 . . . . 71.25 112.706 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -71.82 -44.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.928 0.394 . . . . 64.510000000000005 110.633 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.96 -49.9 76.11 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.185 0.517 . . . . 75.010000000000005 110.288 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -61.22 -34.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.111 -0.495 . . . . 54.299999999999997 111.265 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -57.76 -34.42 69.53 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.912 0.387 . . . . 64.519999999999996 111.326 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -93.73 12.94 23.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.398 0.518 . . . . 73.349999999999994 112.398 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.22 38.1 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.707 -0.758 . . . . 40.219999999999999 114.846 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 117.82 0.81 . . . . 65.510000000000005 111.32 176.608 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 43.3 mt-10 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.079 0.466 . . . . 72.439999999999998 111.65 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -68.96 153.45 43.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.411 -0.358 . . . . 62.549999999999997 111.063 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 5' ' ' LYS . 22.5 mt -52.16 -52.53 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 72.150000000000006 112.583 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 11.2 pt-20 -61.08 -33.1 72.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.964 0.412 . . . . 62.350000000000001 111.886 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 47' ' ' VAL . 39.0 t70 -75.87 -59.19 2.87 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 72.530000000000001 110.953 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . . . -57.48 -43.0 83.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.308 -0.405 . . . . 63.149999999999999 111.916 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.06 -49.04 77.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.364 -0.21 . . . . 74.439999999999998 111.438 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.15 73.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.008 0.432 . . . . 65.230000000000004 111.642 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 43' ' ' ASP . 87.0 t -61.05 -45.48 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.197 -0.456 . . . . 51.520000000000003 111.815 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -90.03 -10.38 45.09 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.716 0.293 . . . . 72.530000000000001 111.787 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.31 35.94 25.24 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.47 -0.395 . . . . 50.109999999999999 113.308 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.64 152.89 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.986 0.422 . . . . 72.109999999999999 111.721 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -82.24 97.42 8.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.026 0.441 . . . . 71.430000000000007 109.865 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -65.31 -31.55 72.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.524 0.565 . . . . 53.130000000000003 112.524 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 35.6 t70 -60.93 -45.31 95.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.898 0.38 . . . . 73.129999999999995 110.716 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.24 -40.42 77.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.784 0.326 . . . . 75.209999999999994 111.501 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 41' ' ' ILE . 23.2 tp -58.88 -49.89 76.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.056 0.455 . . . . 74.109999999999999 111.433 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 52' ' ' ALA . 92.4 t -57.48 -38.78 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.269 -0.423 . . . . 70.040000000000006 111.805 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.2 mttm -56.58 -53.68 54.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.769 0.319 . . . . 75.120000000000005 111.37 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.05 -36.51 75.16 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.46 -0.336 . . . . 75.430000000000007 111.638 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.93 -49.44 74.76 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 111.84 0.311 . . . . 63.329999999999998 111.84 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -59.09 -52.4 65.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.657 0.265 . . . . 50.149999999999999 111.397 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -54.2 -41.28 68.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 111.53 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.16 -51.78 66.75 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.18 0.437 . . . . 72.310000000000002 112.18 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 120.617 0.246 . . . . 71.450000000000003 111.455 178.289 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.595 ' N ' HD22 ' A' ' 60' ' ' ASN . 45.1 mm . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.738 0.304 . . . . 53.450000000000003 111.652 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.42 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 36.4 p -121.69 162.92 19.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.847 0.356 . . . . 75.430000000000007 110.902 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.04 -14.94 62.5 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.892 0.377 . . . . 74.109999999999999 111.506 178.193 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.73 -15.93 57.85 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.101 0.476 . . . . 64.239999999999995 111.403 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 65.0 mtt -72.82 154.29 40.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.428 0.632 . . . . 61.329999999999998 112.206 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -81.87 133.72 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.65 -0.705 . . . . 75.010000000000005 111.485 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.19 -51.45 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.173 0.434 . . . . 52.409999999999997 112.173 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -32.97 65.94 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 111.621 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.02 -45.13 71.25 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.236 -0.438 . . . . 74.239999999999995 110.724 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.7 -37.21 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.259 0.552 . . . . 71.230000000000004 110.744 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.404 HD23 ' OG1' ' A' ' 19' ' ' THR . 83.1 mt -63.94 -31.13 72.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.115 -0.493 . . . . 74.430000000000007 111.919 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -71.6 -29.45 64.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.921 0.391 . . . . 52.109999999999999 111.061 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.0 mtt -66.52 -52.12 49.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.344 0.592 . . . . 72.219999999999999 110.03 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -154.77 135.3 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.786 -0.643 . . . . 74.099999999999994 111.225 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -68.84 -24.92 64.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.339 -0.391 . . . . 74.420000000000002 111.69 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -69.06 -1.37 25.82 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.379 -0.373 . . . . 70.349999999999994 113.874 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.404 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.9 p -82.58 -22.88 34.68 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.607 -0.349 . . . . 41.549999999999997 111.518 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.96 -51.39 79.83 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 112.59 0.589 . . . . 73.019999999999996 112.59 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -59.61 -26.36 81.84 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 121.896 1.731 . . . . 60.450000000000003 112.637 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -44.78 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.925 0.393 . . . . 54.5 110.846 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -56.59 -50.4 72.09 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.057 0.456 . . . . 75.239999999999995 110.173 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.93 -39.69 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.118 -0.492 . . . . 73.099999999999994 111.337 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.86 -39.73 68.93 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.052 -0.522 . . . . 63.420000000000002 111.849 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.61 -3.53 58.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.184 0.438 . . . . 64.409999999999997 112.184 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.44 0.72 11.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.476 0.95 . . . . 71.329999999999998 115.476 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.474 0.737 0 CA-C-N 118.285 1.042 . . . . 63.5 111.815 178.84 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 121.307 0.575 . . . . 63.539999999999999 112.024 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.7 m -72.26 151.26 42.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.97 -0.559 . . . . 63.399999999999999 112.24 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -51.35 -48.88 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.793 0.664 . . . . 61.32 112.793 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 14.9 pt-20 -63.17 -35.34 79.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.852 0.358 . . . . 55.030000000000001 111.642 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 47' ' ' VAL . 36.8 t0 -69.72 -53.56 17.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.189 -0.46 . . . . 75.439999999999998 110.751 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.75 71.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.212 0.53 . . . . 75.230000000000004 111.297 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 84.0 m -59.67 -52.92 63.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.948 -0.569 . . . . 62.350000000000001 111.199 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -39.68 69.85 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.252 0.464 . . . . 75.420000000000002 112.252 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 43' ' ' ASP . 91.9 t -59.56 -42.31 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.837 0.351 . . . . 73.239999999999995 111.446 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -104.23 9.81 35.93 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.306 0.484 . . . . 74.099999999999994 112.306 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.21 18.31 71.05 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 114.279 0.472 . . . . 61.340000000000003 114.279 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 45' ' ' CYS . 56.7 mt -73.59 154.86 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 122.526 0.33 . . . . 73.239999999999995 111.475 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.28 96.48 10.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.14 0.495 . . . . 74.329999999999998 110.61 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.48 -34.79 77.89 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.336 -0.393 . . . . 73.010000000000005 111.894 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 30.2 t70 -58.42 -42.5 87.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.613 -0.267 . . . . 72.230000000000004 111.494 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.54 -39.28 67.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.943 0.402 . . . . 72.409999999999997 111.288 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.3 tp -59.84 -49.47 77.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 73.439999999999998 111.636 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 59' ' ' LEU . 92.3 t -57.38 -36.73 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.371 -0.377 . . . . 73.5 111.816 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.4 mttm -56.32 -55.24 35.84 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.851 0.357 . . . . 54.43 111.171 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.83 -35.29 74.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.388 -0.369 . . . . 74.239999999999995 111.964 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 56' ' ' VAL . 93.0 mt -60.64 -52.9 63.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.645 0.259 . . . . 64.129999999999995 111.449 175.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.595 HD22 ' N ' ' A' ' 3' ' ' ILE . 16.9 m120 -58.92 -51.81 68.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.82 0.343 . . . . 52.100000000000001 111.721 178.504 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.06 -30.18 65.98 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.029 0.381 . . . . 62.009999999999998 112.029 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.443 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 90.0 t80 -64.02 -44.91 91.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.938 0.399 . . . . 72.0 111.359 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 CA--C 1.538 0.496 0 O-C-N 122.224 -0.297 . . . . 72.230000000000004 111.133 177.896 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.538 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.4 mm . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.77 0.655 . . . . 72.109999999999999 112.77 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -120.76 159.37 25.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.195 -0.457 . . . . 64.030000000000001 110.953 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -15.92 61.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.087 0.47 . . . . 73.510000000000005 111.319 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.2 -26.37 56.06 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.654 -0.703 . . . . 74.409999999999997 111.552 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -65.57 158.42 27.15 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.423 0.63 . . . . 72.439999999999998 112.686 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 49.8 mm -84.54 134.96 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.926 -0.579 . . . . 70.329999999999998 111.329 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -56.66 -49.51 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.42 . . . . 71.450000000000003 111.312 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.92 68.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.307 -0.406 . . . . 71.319999999999993 111.516 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 13.2 t70 -72.59 -40.78 66.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.487 -0.324 . . . . 72.349999999999994 110.807 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 8' ' ' ILE . 57.9 t -57.72 -37.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.148 0.499 . . . . 73.129999999999995 110.335 173.525 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.15 -36.04 82.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.139 -0.482 . . . . 63.350000000000001 110.983 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.33 -29.3 70.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.727 0.298 . . . . 71.319999999999993 111.174 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -71.47 -49.29 42.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.224 0.535 . . . . 73.129999999999995 110.035 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -160.43 130.98 5.42 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.496 -0.775 . . . . 74.319999999999993 110.893 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -72.04 -20.28 61.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.959 0.355 . . . . 70.319999999999993 111.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.65 -1.44 45.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.56 -0.353 . . . . 74.329999999999998 113.476 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -19.55 46.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.521 -0.4 . . . . 75.319999999999993 111.721 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.09 -49.91 87.31 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.353 0.501 . . . . 72.010000000000005 112.353 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 76.7 Cg_exo -48.99 -42.08 38.92 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.399 2.066 . . . . 64.349999999999994 112.826 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.94 -45.31 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 111.403 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -58.67 -46.88 86.23 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 71.5 110.508 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -58.96 -39.07 77.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.019 -0.537 . . . . 62.450000000000003 111.387 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.62 -36.29 73.83 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.312 -0.404 . . . . 64.400000000000006 111.571 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -86.68 4.46 40.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.637 0.606 . . . . 74.019999999999996 112.637 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.54 39.97 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.672 -0.775 . . . . 74.519999999999996 114.499 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 117.677 0.739 . . . . 73.349999999999994 111.419 175.347 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.303 0.573 . . . . 73.310000000000002 112.349 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 92.5 p -78.63 161.54 26.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.292 -0.413 . . . . 72.340000000000003 111.391 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.8 mt -56.67 -47.81 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.493 -0.321 . . . . 75.510000000000005 111.781 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.07 -43.27 99.19 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.698 0.258 . . . . 74.030000000000001 111.698 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.14 -52.05 66.98 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.05 0.389 . . . . 74.540000000000006 112.05 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.49 88.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.777 0.322 . . . . 71.310000000000002 111.614 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.406 ' SG ' HD23 ' A' ' 55' ' ' LEU . 97.6 m -53.52 -46.46 70.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.68 -0.236 . . . . 73.409999999999997 111.166 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.04 67.61 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.987 0.365 . . . . 74.310000000000002 111.987 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.2 -46.14 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.976 0.417 . . . . 63.109999999999999 111.504 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -89.04 -10.02 49.07 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.456 -0.338 . . . . 64.140000000000001 111.73 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.26 37.87 30.83 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.106 -0.568 . . . . 72.150000000000006 112.795 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.8 mt -93.03 151.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.663 0.385 . . . . 61.340000000000003 111.293 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -80.88 102.01 9.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.958 0.409 . . . . 74.329999999999998 110.383 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.99 65.14 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.153 0.427 . . . . 74.150000000000006 112.153 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.22 -50.91 71.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.88 0.371 . . . . 71.329999999999998 110.446 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -70.26 -47.93 59.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.525 . . . . 73.030000000000001 112.032 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.406 HD23 ' SG ' ' A' ' 45' ' ' CYS . 29.5 tp -52.76 -52.64 55.75 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.952 0.406 . . . . 65.439999999999998 111.725 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.513 HG13 HG22 ' A' ' 3' ' ' ILE . 88.1 t -61.05 -40.52 85.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 74.349999999999994 111.78 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 98.7 mttt -69.72 -29.45 66.84 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.22 -0.3 . . . . 64.439999999999998 111.745 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.61 -39.4 73.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.879 0.371 . . . . 62.32 110.794 171.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.8 mt -58.12 -46.83 84.9 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.378 -0.374 . . . . 54.32 110.674 172.741 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -54.2 -55.97 22.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.251 -0.431 . . . . 73.209999999999994 111.595 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 46.0 mt-10 -46.05 -48.82 16.85 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.075 0.464 . . . . 75.549999999999997 111.201 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -54.21 -52.4 61.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.87 -0.605 . . . . 72.040000000000006 112.384 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.723 0.297 . . . . 71.099999999999994 111.352 179.406 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 120.69 0.281 . . . . 73.349999999999994 111.496 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 27.3 p -119.27 155.31 32.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.66 0.267 . . . . 74.340000000000003 110.862 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 17.0 ptpt -64.67 -14.66 59.24 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.177 0.513 . . . . 71.010000000000005 111.415 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.55 -16.07 55.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.691 -0.686 . . . . 73.200000000000003 111.669 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.437 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.4 mtt -75.39 164.87 25.95 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.506 0.67 . . . . 73.099999999999994 112.582 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -88.57 138.06 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.568 -0.742 . . . . 74.519999999999996 111.513 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.1 mt -54.5 -53.28 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.994 0.426 . . . . 70.219999999999999 111.699 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.84 75.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.833 0.349 . . . . 74.329999999999998 111.796 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.77 -39.63 94.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.802 0.334 . . . . 75.439999999999998 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.38 -39.73 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.044 0.45 . . . . 60.340000000000003 110.844 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.494 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -61.43 -34.53 75.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.149 0.5 . . . . 74.430000000000007 111.096 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -68.89 -18.77 64.17 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.056 -0.52 . . . . 51.200000000000003 111.485 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.4 mtt -81.23 -50.35 9.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.38 0.61 . . . . 73.099999999999994 109.791 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.5 132.5 14.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.965 -0.561 . . . . 70.340000000000003 111.716 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -74.17 -16.25 60.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.606 0.595 . . . . 72.25 112.606 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.57 -2.21 79.59 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.14 -0.552 . . . . 71.120000000000005 113.415 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.494 ' OG1' HD23 ' A' ' 13' ' ' LEU . 74.3 p -80.51 -22.1 41.26 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.114 0.413 . . . . 74.420000000000002 112.114 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.83 -50.64 84.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 112.722 0.638 . . . . 31.109999999999999 112.722 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 75.7 Cg_exo -49.86 -41.24 47.71 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.198 1.932 . . . . 72.299999999999997 112.657 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.41 -44.98 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.167 -0.47 . . . . 64.340000000000003 111.492 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -58.24 -51.56 69.23 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 54.350000000000001 110.936 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.51 -38.98 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.928 0.394 . . . . 75.219999999999999 111.107 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -51.86 -41.87 62.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.979 -0.555 . . . . 71.430000000000007 111.536 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -85.48 -4.26 59.11 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.277 0.473 . . . . 73.109999999999999 112.277 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.5 -5.35 9.31 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.662 -0.78 . . . . 62.549999999999997 114.972 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 118.208 1.004 . . . . 74.349999999999994 111.833 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 120.977 0.418 . . . . 74.150000000000006 111.788 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.7 p -73.14 158.11 35.94 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.309 0.576 . . . . 54.530000000000001 112.503 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mt -54.79 -56.03 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.812 -0.631 . . . . 75.230000000000004 112.476 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.1 pt-20 -60.81 -44.72 96.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.13 0.419 . . . . 63.039999999999999 112.13 -176.975 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.401 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 t0 -65.59 -45.21 84.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.971 0.415 . . . . 73.409999999999997 110.987 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.73 81.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.429 . . . . 61.399999999999999 111.455 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.35 -49.59 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.413 -0.358 . . . . 75.030000000000001 111.26 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.88 -36.21 62.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.121 0.415 . . . . 74.329999999999998 112.121 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.19 -37.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.993 0.425 . . . . 74.239999999999995 111.854 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.92 18.09 16.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.403 0.519 . . . . 62.299999999999997 112.403 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.19 27.83 68.1 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 72.049999999999997 113.79 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.33 150.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.895 0.379 . . . . 70.140000000000001 111.117 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.66 97.27 10.79 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.821 0.344 . . . . 75.0 110.215 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.29 -36.55 81.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.105 0.409 . . . . 75.010000000000005 112.105 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -42.87 83.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.149 0.5 . . . . 64.409999999999997 111.072 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.65 -44.11 57.73 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.249 -0.432 . . . . 64.219999999999999 111.529 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -55.36 -49.34 72.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.959 0.409 . . . . 72.209999999999994 111.951 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 5' ' ' LYS . 93.0 t -59.32 -38.28 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.395 -0.366 . . . . 64.030000000000001 111.837 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.69 -43.84 98.09 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.719 0.295 . . . . 73.239999999999995 110.638 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -60.17 -37.9 81.57 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 65.310000000000002 111.359 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 56' ' ' VAL . 84.8 mt -63.36 -53.98 44.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.484 -0.325 . . . . 71.200000000000003 111.517 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -56.71 -54.22 48.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.918 0.34 . . . . 73.400000000000006 111.918 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -52.96 -38.51 62.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.612 -0.267 . . . . 75.519999999999996 111.334 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.86 -49.29 78.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.876 0.37 . . . . 64.310000000000002 111.762 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 120.741 0.305 . . . . 72.120000000000005 110.897 177.349 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.066 0.46 . . . . 62.530000000000001 111.785 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -122.99 153.13 40.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.417 -0.356 . . . . 70.219999999999999 110.748 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 46.2 pttt -63.36 -15.51 57.67 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.903 0.382 . . . . 74.439999999999998 111.98 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.5 -29.83 63.98 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.97 -0.559 . . . . 73.040000000000006 111.409 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 65.2 mtt -63.6 150.51 43.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.728 0.64 . . . . 75.530000000000001 112.728 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mm -78.37 136.06 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.683 -0.69 . . . . 64.510000000000005 111.116 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.44 -48.75 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.762 0.315 . . . . 73.209999999999994 111.771 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -59.72 -33.5 71.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.897 0.332 . . . . 75.040000000000006 111.897 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.17 -41.73 85.47 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.823 0.344 . . . . 72.219999999999999 111.184 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.2 t -60.44 -39.24 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.105 0.479 . . . . 75.129999999999995 110.945 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD23 ' OG1' ' A' ' 19' ' ' THR . 88.1 mt -62.22 -31.01 71.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.26 -0.427 . . . . 73.040000000000006 111.519 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 84.3 mm-40 -67.34 -27.01 66.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.941 0.401 . . . . 71.530000000000001 111.321 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.2 mtt -75.0 -48.38 24.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.34 0.59 . . . . 73.549999999999997 110.064 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -154.99 132.54 11.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.722 -0.672 . . . . 54.130000000000003 110.761 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -70.15 -28.41 65.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.093 0.473 . . . . 53.340000000000003 111.611 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.04 2.09 14.94 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.078 -0.51 . . . . 74.450000000000003 113.807 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.456 ' OG1' HD23 ' A' ' 13' ' ' LEU . 72.6 p -82.72 -19.24 38.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.514 -0.403 . . . . 75.329999999999998 111.384 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.35 -51.41 78.17 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.654 0.613 . . . . 50.340000000000003 112.654 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.5 Cg_endo -57.84 -31.03 91.42 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.953 1.768 . . . . 61.200000000000003 112.59 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.97 -46.65 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.98 0.419 . . . . 72.200000000000003 110.914 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 68.7 m-85 -57.52 -46.82 83.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.204 0.525 . . . . 74.329999999999998 110.266 171.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 28' ' ' MET . 73.6 mt -58.05 -36.67 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.958 -0.565 . . . . 75.430000000000007 111.668 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -61.73 -32.96 73.23 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.973 0.416 . . . . 64.239999999999995 111.574 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.7 1.38 55.51 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.242 0.46 . . . . 74.319999999999993 112.242 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.78 10.3 16.81 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.425 -0.893 . . . . 42.439999999999998 114.896 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.416 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.2 mmt . . . . . 0 N--CA 1.469 0.524 0 O-C-N 121.85 -0.794 . . . . 54.450000000000003 111.435 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 121.247 0.546 . . . . 73.530000000000001 112.156 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.0 m -67.5 156.22 37.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.915 0.709 . . . . 73.019999999999996 112.915 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -55.11 -60.24 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.615 0.598 . . . . 72.5 112.615 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.5 pt-20 -61.95 -36.01 80.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.873 0.368 . . . . 73.530000000000001 111.847 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.44 -48.43 72.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.888 0.375 . . . . 53.350000000000001 110.918 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.14 77.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.065 0.459 . . . . 61.520000000000003 111.538 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 94.4 m -58.81 -44.59 90.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.442 -0.345 . . . . 73.310000000000002 111.22 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.54 62.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.007 0.373 . . . . 73.510000000000005 112.007 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.67 -41.75 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 111.821 0.304 . . . . 73.450000000000003 111.821 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -112.31 17.11 19.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 71.140000000000001 111.862 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.97 23.11 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.123 -0.561 . . . . 74.409999999999997 113.763 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.1 150.27 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.905 0.383 . . . . 71.430000000000007 111.639 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.57 108.3 17.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.125 0.488 . . . . 54.329999999999998 110.203 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -75.08 -25.05 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 73.219999999999999 111.962 -176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 13.9 t70 -60.92 -47.86 84.47 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.017 0.436 . . . . 74.349999999999994 110.621 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.76 -39.78 66.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.127 -0.488 . . . . 64.200000000000003 111.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.87 -50.47 72.38 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.08 0.466 . . . . 75.299999999999997 111.077 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' HD12 ' A' ' 59' ' ' LEU . 78.6 t -59.27 -38.5 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 111.442 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.0 mttm -57.82 -50.38 73.47 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.544 0.201 . . . . 63.409999999999997 111.544 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -58.53 -38.44 77.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.826 0.346 . . . . 73.040000000000006 111.577 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 56' ' ' VAL . 85.2 mt -61.64 -50.97 70.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.734 0.302 . . . . 75.140000000000001 111.534 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -59.0 -55.78 30.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.932 0.345 . . . . 73.340000000000003 111.932 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -52.81 -36.79 58.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.728 0.299 . . . . 73.239999999999995 111.577 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -58.27 -51.68 68.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.367 . . . . 74.120000000000005 111.495 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 120.729 0.299 . . . . 74.230000000000004 111.31 178.192 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.64 ' N ' HD22 ' A' ' 60' ' ' ASN . 44.6 mm . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.716 0.293 . . . . 74.239999999999995 111.66 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 41.8 p -119.84 160.81 21.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.554 -0.294 . . . . 72.150000000000006 110.553 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.3 pttp -73.71 -16.77 61.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.069 -0.394 . . . . 62.240000000000002 111.414 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.19 -25.05 62.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.086 -0.506 . . . . 75.530000000000001 111.102 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.433 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.0 mtt -62.41 139.86 58.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.438 0.637 . . . . 70.049999999999997 111.832 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 44.9 mm -69.53 137.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.772 -0.649 . . . . 62.329999999999998 110.953 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -54.04 -46.21 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.851 0.357 . . . . 62.210000000000001 111.273 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -60.2 -36.37 77.52 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.802 0.335 . . . . 64.340000000000003 111.426 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.495 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 12.0 t70 -63.18 -43.98 96.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 110.516 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 41' ' ' ILE . 51.6 t -61.19 -40.1 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.141 0.496 . . . . 72.129999999999995 110.722 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.23 -33.12 74.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.243 -0.435 . . . . 63.240000000000002 111.304 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 74.0 mt-30 -64.21 -30.33 71.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.362 . . . . 54.409999999999997 111.242 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.6 mtt -71.89 -51.59 21.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.283 0.563 . . . . 71.150000000000006 110.072 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.29 125.66 5.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.55 -0.75 . . . . 70.230000000000004 110.693 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -71.72 -15.47 62.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.006 0.373 . . . . 73.510000000000005 112.006 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.58 -1.75 39.29 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.212 -0.518 . . . . 44.210000000000001 113.157 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.0 p -82.64 -17.87 43.09 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.698 -0.295 . . . . 63.030000000000001 111.573 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.25 -51.06 82.89 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.223 0.453 . . . . 63.100000000000001 112.223 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -58.58 -25.76 75.97 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.957 1.772 . . . . 60.009999999999998 112.554 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.74 -44.77 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.995 0.426 . . . . 53.020000000000003 110.812 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -58.19 -45.82 86.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 71.019999999999996 110.406 173.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.96 -40.81 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.192 0.52 . . . . 63.509999999999998 110.911 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -56.86 -30.06 63.47 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.622 -0.717 . . . . 72.340000000000003 112.001 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -96.82 1.47 50.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.553 0.575 . . . . 74.200000000000003 112.553 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -3.0 22.84 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.476 -0.869 . . . . 22.449999999999999 115.11 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 118.251 1.026 . . . . 45.420000000000002 112.287 -178.887 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.434 0.635 . . . . 72.519999999999996 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 40' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 90.2 p -75.55 160.12 30.5 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.928 -0.578 . . . . 54.229999999999997 112.207 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 12' ' ' VAL . 22.3 mt -54.74 -52.57 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.093 -0.503 . . . . 64.140000000000001 111.901 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.0 pt-20 -62.97 -40.33 97.38 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.877 0.325 . . . . 64.219999999999999 111.877 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.7 t70 -62.58 -51.14 68.51 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 54.439999999999998 110.499 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.07 94.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.01 -0.541 . . . . 52.340000000000003 111.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -58.49 -45.82 87.94 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.561 -0.29 . . . . 72.310000000000002 111.307 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -35.8 74.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.753 0.311 . . . . 74.540000000000006 111.656 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 43' ' ' ASP . 61.2 t -65.98 -43.24 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.192 0.52 . . . . 63.149999999999999 111.364 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.46 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.3 t-80 -86.59 -14.82 41.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.2 -0.454 . . . . 75.030000000000001 111.435 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 38.61 23.44 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 116.455 -0.339 . . . . 71.209999999999994 113.13 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 48' ' ' HIS . 27.9 mt -98.02 153.36 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 122.927 0.491 . . . . 72.129999999999995 111.284 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.55 101.92 8.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.018 0.437 . . . . 75.25 109.904 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.45 -34.69 77.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.444 0.535 . . . . 55.210000000000001 112.444 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.01 -45.5 82.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.829 0.347 . . . . 72.219999999999999 111.066 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.26 -47.03 75.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.4 -0.363 . . . . 73.200000000000003 111.254 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 29.9 tp -57.51 -50.83 71.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.244 -0.435 . . . . 75.129999999999995 111.306 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 5' ' ' LYS . 85.4 t -60.79 -39.62 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.508 -0.314 . . . . 71.109999999999999 111.615 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.65 -41.67 98.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.454 0.168 . . . . 64.219999999999999 111.454 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.82 -40.53 95.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.706 0.289 . . . . 62.140000000000001 111.043 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 56' ' ' VAL . 91.1 mt -59.6 -52.24 66.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.617 -0.265 . . . . 55.030000000000001 110.971 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.64 HD22 ' N ' ' A' ' 3' ' ' ILE . 12.7 m120 -54.67 -57.97 9.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.622 -0.263 . . . . 44.009999999999998 111.537 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.07 -37.78 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.552 -0.295 . . . . 72.310000000000002 111.667 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -58.4 -51.3 70.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.842 0.353 . . . . 63.310000000000002 111.31 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.695 0.283 . . . . 73.439999999999998 110.971 176.755 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' ILE . . . . . 0.519 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.8 mm . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 112.426 0.528 . . . . 74.340000000000003 112.426 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.6 p -120.21 167.21 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.95 -0.568 . . . . 60.409999999999997 110.336 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.9 ptpt -74.28 -8.79 57.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.134 0.492 . . . . 65.319999999999993 110.873 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.91 -24.9 32.92 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.898 -0.592 . . . . 53.240000000000002 111.818 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.3 mtt -66.23 156.92 32.82 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.653 0.612 . . . . 73.120000000000005 112.653 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.8 133.78 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.871 -0.604 . . . . 74.129999999999995 111.165 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.89 -50.49 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.207 0.447 . . . . 73.219999999999999 112.207 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.07 80.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 70.040000000000006 111.655 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.38 -44.3 92.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 74.140000000000001 110.772 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.4 -42.16 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.112 -0.495 . . . . 73.540000000000006 111.105 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.39 -34.14 73.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.214 -0.448 . . . . 70.109999999999999 111.91 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -69.23 -22.87 63.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.77 0.319 . . . . 74.409999999999997 111.719 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.6 mtm -83.3 -45.51 13.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.048 0.451 . . . . 75.019999999999996 110.193 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -152.08 112.93 4.2 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.901 -0.59 . . . . 73.329999999999998 110.889 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.3 -11.91 53.42 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.832 0.679 . . . . 74.0 112.832 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.469 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -70.16 -9.53 63.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.175 -0.536 . . . . 74.129999999999995 112.916 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -78.67 -16.36 57.39 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.566 -0.373 . . . . 74.140000000000001 111.707 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -56.62 -52.01 76.86 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 112.391 0.515 . . . . 70.409999999999997 112.391 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 52.2 Cg_exo -52.63 -38.22 75.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.011 1.807 . . . . 70.120000000000005 112.438 175.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.66 -46.49 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.096 -0.502 . . . . 73.129999999999995 111.162 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 54.4 m-85 -59.03 -46.22 88.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.849 0.357 . . . . 74.310000000000002 110.836 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.83 -37.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.913 0.387 . . . . 70.329999999999998 111.206 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -56.14 -40.31 73.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.059 -0.519 . . . . 74.530000000000001 111.337 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 55' ' ' LEU . 39.9 m-80 -87.79 -2.37 58.57 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.389 0.515 . . . . 71.239999999999995 112.389 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.7 11.44 30.66 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 115.011 0.764 . . . . 71.219999999999999 115.011 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' MET . . . . . 0.536 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 25.4 mmt . . . . . 0 N--CA 1.473 0.719 0 CA-C-N 117.984 0.892 . . . . 62.030000000000001 110.975 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.199 0.524 . . . . 62.340000000000003 112.231 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 m -72.41 147.65 45.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.864 -0.607 . . . . 64.200000000000003 111.805 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ILE . . . . . 0.42 HG23 HD23 ' A' ' 55' ' ' LEU . 32.3 mt -51.41 -52.36 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.291 0.478 . . . . 73.439999999999998 112.291 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.9 pt-20 -62.61 -34.81 77.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.741 0.275 . . . . 65.430000000000007 111.741 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.0 t70 -65.57 -52.39 52.66 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 72.099999999999994 110.633 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.91 77.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.23 0.538 . . . . 72.219999999999999 111.077 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 93.0 m -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.129 -0.487 . . . . 63.340000000000003 111.392 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.07 52.27 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.264 0.468 . . . . 73.310000000000002 112.264 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 43' ' ' ASP . 48.0 t -65.07 -52.1 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.984 0.421 . . . . 65.129999999999995 111.716 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' HIS . . . . . 0.448 ' HB2' HG13 ' A' ' 50' ' ' ILE . 85.4 m-70 -98.87 3.19 47.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.021 0.378 . . . . 63.439999999999998 112.021 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.01 67.12 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.008 -0.615 . . . . 73.140000000000001 112.944 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 48' ' ' HIS . 50.5 mt -73.45 150.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.884 0.373 . . . . 65.209999999999994 111.291 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.5 97.28 10.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.197 0.522 . . . . 72.329999999999998 109.766 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -64.74 -31.28 72.44 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.407 0.521 . . . . 73.409999999999997 112.407 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 2.9 t70 -63.63 -40.35 96.66 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.663 0.268 . . . . 75.420000000000002 110.879 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.32 -47.5 84.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.052 0.453 . . . . 72.319999999999993 110.668 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.9 tp -58.05 -48.5 79.92 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.804 -0.635 . . . . 53.030000000000001 111.262 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 52' ' ' ALA . 89.6 t -57.12 -42.58 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.219 -0.446 . . . . 54.420000000000002 111.754 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.5 mttm -56.5 -52.96 62.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.853 0.359 . . . . 73.209999999999994 110.812 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -55.11 -40.32 70.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.081 -0.509 . . . . 54.439999999999998 111.622 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 95.4 mt -64.0 -55.41 22.53 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.114 0.413 . . . . 73.450000000000003 112.114 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 51.6 m-80 -55.47 -51.47 66.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.72 0.295 . . . . 61.420000000000002 111.58 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.56 -27.84 66.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.434 -0.348 . . . . 54.420000000000002 111.68 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.469 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 85.8 t80 -69.66 -47.12 64.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.627 -0.261 . . . . 74.450000000000003 111.318 175.555 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.763 0.315 . . . . 61.329999999999998 111.23 177.156 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.33 -0.248 . . . . 72.209999999999994 110.33 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.639 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.3 tppt? -128.77 104.79 7.83 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.961 0.41 . . . . 72.540000000000006 111.52 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.53 142.08 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.966 0.506 . . . . 75.319999999999993 112.135 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.8 p -122.81 155.12 37.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.472 -0.331 . . . . 75.530000000000001 110.526 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.548 ' HB3' HG21 ' A' ' 56' ' ' VAL . 10.4 ptpp? -69.62 -17.65 63.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.917 -0.489 . . . . 70.109999999999999 111.969 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.98 -17.61 60.51 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.933 0.397 . . . . 73.219999999999999 111.221 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.466 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 66.0 mtt -66.38 149.82 49.82 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.139 0.495 . . . . 74.530000000000001 111.841 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -79.11 133.19 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.245 -0.434 . . . . 71.409999999999997 111.317 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.7 mt -55.55 -48.88 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.848 0.356 . . . . 72.109999999999999 111.367 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.51 69.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.046 0.387 . . . . 73.439999999999998 112.046 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.18 -38.97 60.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.742 0.306 . . . . 54.039999999999999 111.323 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 8' ' ' ILE . 61.6 t -60.08 -40.04 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.523 . . . . 63.210000000000001 110.24 173.353 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.468 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.8 mt -61.43 -25.44 67.21 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.934 -0.575 . . . . 75.319999999999993 111.63 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -73.7 -32.26 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.814 0.34 . . . . 71.129999999999995 111.098 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mtt -71.24 -39.48 71.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 74.310000000000002 110.129 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 19' ' ' THR . 40.0 t0 -160.05 130.22 5.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.275 -0.875 . . . . 74.409999999999997 111.018 176.252 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.91 -22.68 62.22 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.082 0.467 . . . . 63.240000000000002 110.637 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.69 2.16 49.52 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.284 -0.416 . . . . 63.210000000000001 113.755 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.468 ' OG1' HD23 ' A' ' 13' ' ' LEU . 68.1 p -82.59 -19.01 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.288 -0.537 . . . . 73.109999999999999 111.585 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.96 -51.13 77.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.72 0.637 . . . . 52.450000000000003 112.72 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.6 Cg_endo -59.4 -21.41 60.99 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.039 1.826 . . . . 72.409999999999997 112.897 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.39 -46.32 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 74.340000000000003 110.376 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -59.27 -45.27 91.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.188 0.518 . . . . 72.430000000000007 110.32 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.66 -37.03 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.112 -0.494 . . . . 64.430000000000007 111.13 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -56.43 -42.18 77.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.031 0.443 . . . . 74.349999999999994 111.457 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.54 -1.36 57.02 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.823 0.675 . . . . 63.200000000000003 112.823 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.49 17.52 15.09 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.224 0.85 . . . . 52.409999999999997 115.224 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 mmt -72.09 147.18 46.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.093 0.947 . . . . 74.400000000000006 111.813 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -110.02 97.62 7.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.311 -0.404 . . . . 74.439999999999998 110.718 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.2 p -64.27 103.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.247 0.546 . . . . 74.530000000000001 111.561 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 32' ' ' GLY . 1.3 tm? -148.61 153.19 37.99 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.589 -0.523 . . . . 63.130000000000003 109.589 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.69 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -66.38 70.53 0.15 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 121.145 0.303 . . . . 41.539999999999999 113.096 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.673 ' SG ' HD12 ' A' ' 31' ' ' LEU . 62.8 m -145.19 152.3 50.41 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 122.639 0.375 . . . . 74.310000000000002 111.295 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.96 -47.03 22.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.257 1.971 . . . . 72.230000000000004 112.315 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -69.7 20.61 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.52 0.933 . . . . 74.340000000000003 113.52 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.6 p -146.69 -46.42 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.088 0.47 . . . . 74.420000000000002 111.345 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.7 mmt -109.16 -48.08 3.32 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.642 0.608 . . . . 72.099999999999994 112.642 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.82 -40.26 52.96 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.147 0.819 . . . . 73.540000000000006 115.147 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.49 173.97 11.81 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.29 0.848 . . . . 74.310000000000002 113.29 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 24.3 m -72.19 159.73 33.62 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.126 -0.943 . . . . 45.420000000000002 111.5 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.7 mt -52.97 -52.55 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.959 0.355 . . . . 73.230000000000004 111.959 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.09 -40.36 85.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.831 0.348 . . . . 64.150000000000006 111.732 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.2 t70 -63.34 -51.13 67.23 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.246 -0.434 . . . . 63.43 110.804 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.05 -0.523 . . . . 61.229999999999997 111.685 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 89.2 m -62.21 -48.53 79.62 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 72.349999999999994 111.433 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.61 -37.44 65.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.962 0.356 . . . . 25.440000000000001 111.962 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.1 t -57.74 -53.98 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.91 0.386 . . . . 65.150000000000006 111.65 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -92.65 6.64 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.226 0.454 . . . . 72.430000000000007 112.226 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.34 83.56 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.285 -0.483 . . . . 61.149999999999999 112.968 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.43 150.04 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.207 0.527 . . . . 71.450000000000003 111.555 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -80.92 84.23 6.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.104 -0.498 . . . . 72.150000000000006 110.433 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -60.84 -30.3 70.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.545 -0.298 . . . . 72.109999999999999 111.771 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 33.2 t70 -58.75 -47.3 85.12 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.715 0.293 . . . . 61.200000000000003 110.864 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -71.83 -44.16 64.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.763 0.316 . . . . 70.120000000000005 111.432 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp -54.73 -51.61 65.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.323 -0.398 . . . . 64.420000000000002 111.703 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.548 HG21 ' HB3' ' A' ' 5' ' ' LYS . 90.1 t -60.56 -42.28 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.608 -0.269 . . . . 71.510000000000005 111.614 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 98.9 mttt -57.16 -48.0 79.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.591 0.234 . . . . 73.420000000000002 111.375 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.57 -39.71 89.02 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.601 0.238 . . . . 70.420000000000002 111.45 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 56' ' ' VAL . 91.0 mt -59.26 -48.54 81.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.618 0.247 . . . . 74.209999999999994 111.185 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.601 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 53.2 m-80 -58.62 -61.7 2.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.608 -0.269 . . . . 74.5 111.373 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.675 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 51.8 mt-10 -46.17 -46.06 17.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.197 -0.456 . . . . 63.539999999999999 111.153 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -52.09 -58.66 5.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.383 0.512 . . . . 73.25 112.383 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -60.46 -43.23 97.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.832 0.349 . . . . 64.319999999999993 111.309 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 27.6 mt-10 -68.4 -19.82 64.63 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.266 -0.425 . . . . 63.420000000000002 111.622 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 74.9 mmtt -70.12 -45.76 66.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.269 0.557 . . . . 74.140000000000001 110.058 168.533 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 49.4 mtpt -61.05 -39.18 88.86 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.887 -0.597 . . . . 70.209999999999994 111.515 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -62.27 -11.21 13.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.944 0.402 . . . . 73.409999999999997 111.532 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.21 -50.81 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.069 0.462 . . . . 74.299999999999997 111.272 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -59.81 -53.3 59.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.65 0.611 . . . . 72.25 112.65 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.458 -0.782 . . . . 74.219999999999999 112.054 -178.878 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.603 0.24 . . . . 53.539999999999999 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 4.2 tppp? -62.0 104.29 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.995 0.426 . . . . 44.340000000000003 110.983 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.449 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm -66.23 136.62 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.11 -0.495 . . . . 61.009999999999998 111.235 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.48 159.32 25.4 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.413 -0.358 . . . . 44.310000000000002 110.851 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.1 pttp -71.01 -11.29 60.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.94 0.4 . . . . 72.219999999999999 111.356 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.87 -25.41 53.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.895 -0.593 . . . . 65.310000000000002 110.96 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.7 mtt -66.75 154.14 41.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.298 0.571 . . . . 61.409999999999997 112.071 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.51 136.52 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.955 -0.566 . . . . 53.130000000000003 111.334 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.4 mt -56.11 -52.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.847 0.356 . . . . 71.049999999999997 111.696 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.34 65.67 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.97 0.414 . . . . 33.119999999999997 111.631 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.0 -41.12 60.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.908 0.385 . . . . 72.219999999999999 110.822 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.37 -37.96 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.204 0.526 . . . . 74.209999999999994 110.524 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.1 -30.08 70.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.05 -0.523 . . . . 62.43 111.59 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.69 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.929 0.395 . . . . 73.450000000000003 111.042 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.8 mtt -72.35 -49.03 37.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.374 0.607 . . . . 74.329999999999998 109.744 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -158.18 138.14 12.28 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.491 -0.777 . . . . 71.340000000000003 111.364 173.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -77.18 -20.59 55.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.257 0.551 . . . . 75.219999999999999 110.771 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.87 -2.42 23.36 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.864 -0.607 . . . . 71.109999999999999 113.525 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.8 p -81.59 -20.69 39.31 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.43 -0.453 . . . . 74.430000000000007 111.67 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.58 -50.65 82.03 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 113.027 0.751 . . . . 74.230000000000004 113.027 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.9 Cg_endo -59.46 -21.35 61.13 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.298 1.999 . . . . 73.030000000000001 113.025 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.98 -45.62 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.147 0.499 . . . . 75.230000000000004 110.474 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.548 ' HB3' ' HG3' ' A' ' 28' ' ' MET . 68.6 m-85 -57.52 -44.73 85.29 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.211 0.529 . . . . 71.010000000000005 110.105 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.74 -38.61 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.201 -0.454 . . . . 73.239999999999995 111.314 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -55.37 -29.19 57.96 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.278 0.561 . . . . 72.209999999999994 111.613 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.427 ' ND2' HD13 ' A' ' 55' ' ' LEU . 37.7 m-80 -98.8 4.1 47.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.244 0.461 . . . . 63.130000000000003 112.244 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.85 26.25 11.93 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.752 0.661 . . . . 42.399999999999999 114.752 172.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.548 ' HG3' ' HB3' ' A' ' 23' ' ' PHE . 22.0 mmt -74.18 145.66 44.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.803 0.801 . . . . 75.200000000000003 112.209 175.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -127.28 29.08 5.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.744 -0.662 . . . . 74.209999999999994 110.732 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.4 p -62.32 135.1 57.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.947 -0.57 . . . . 75.319999999999993 111.737 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.71 97.74 2.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.638 0.256 . . . . 72.239999999999995 110.984 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.1 -66.49 1.49 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 114.977 0.751 . . . . 43.240000000000002 114.977 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 68.2 m -57.27 137.85 80.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.087 0.773 . . . . 75.310000000000002 113.087 -172.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 48.8 Cg_exo -56.83 -29.56 81.74 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.974 2.45 . . . . 63.420000000000002 112.577 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -64.03 1.58 0.67 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.369 0.507 . . . . 61.420000000000002 112.369 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.6 p -133.5 -50.28 0.85 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.189 0.518 . . . . 74.140000000000001 111.107 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.31 -39.45 47.77 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.555 0.576 . . . . 61.130000000000003 112.555 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.75 2.13 87.16 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.106 -0.569 . . . . 31.34 114.062 -173.604 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -87.93 154.48 20.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.177 0.489 . . . . 75.400000000000006 111.704 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.6 m -63.86 145.81 55.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.323 -0.399 . . . . 74.340000000000003 110.588 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.7 mt -47.92 -50.62 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 113.06 0.763 . . . . 73.230000000000004 113.06 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 7.9 pt-20 -63.69 -37.87 88.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.383 . . . . 75.150000000000006 112.033 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.67 -42.13 78.32 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.912 0.387 . . . . 55.539999999999999 110.747 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.04 75.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.235 -0.438 . . . . 72.519999999999996 111.15 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -57.79 -43.66 85.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.868 0.366 . . . . 43.310000000000002 110.789 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.36 62.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.189 -0.459 . . . . 73.239999999999995 112.061 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.03 -42.66 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 111.993 0.368 . . . . 62.119999999999997 111.993 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -105.1 3.07 29.98 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.992 0.425 . . . . 74.439999999999998 111.618 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 30.85 63.16 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.795 -0.716 . . . . 64.219999999999999 112.979 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.6 mt -81.82 155.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.894 0.478 . . . . 74.519999999999996 111.171 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 53' ' ' ASP . 16.8 t70 -93.89 106.69 18.65 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.971 0.415 . . . . 73.129999999999995 110.349 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . . . -64.42 -33.04 74.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.316 0.487 . . . . 72.219999999999999 112.316 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.404 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 24.5 t70 -54.04 -47.86 71.14 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.95 0.405 . . . . 72.140000000000001 111.067 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -70.27 -47.54 60.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.262 -0.426 . . . . 65.219999999999999 111.479 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.427 HD13 ' ND2' ' A' ' 26' ' ' ASN . 27.6 tp -55.53 -51.58 66.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.933 0.397 . . . . 70.239999999999995 111.973 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.475 ' HA ' HD12 ' A' ' 59' ' ' LEU . 92.5 t -58.4 -38.89 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.019 0.438 . . . . 73.239999999999995 111.648 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.08 -43.5 91.99 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.541 -0.3 . . . . 73.219999999999999 111.434 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -56.9 -42.59 80.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.802 0.334 . . . . 75.230000000000004 111.134 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -57.18 -52.81 63.81 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.252 -0.431 . . . . 64.430000000000007 111.751 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.505 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.0 m-80 -55.88 -50.22 71.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.652 0.263 . . . . 73.420000000000002 111.689 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 40.6 mt-10 -56.57 -32.69 65.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.95 0.405 . . . . 71.409999999999997 111.845 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -65.81 -52.15 53.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.129 -0.487 . . . . 74.299999999999997 111.458 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -57.5 -35.11 69.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.414 -0.357 . . . . 74.030000000000001 111.426 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 37.1 mt-10 -57.72 -43.71 85.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.024 0.44 . . . . 72.5 111.028 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 45.8 mmtm -62.75 -36.71 83.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.095 0.474 . . . . 55.450000000000003 111.363 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -62.36 -36.02 80.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.25 -0.432 . . . . 65.25 111.225 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.9 -28.41 66.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.288 0.565 . . . . 74.530000000000001 111.256 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.7 t -78.67 -52.45 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.947 -0.569 . . . . 73.129999999999995 110.967 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.09 -59.64 4.77 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.587 0.588 . . . . 44.399999999999999 112.587 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.698 -0.667 . . . . 71.450000000000003 112.705 -176.279 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.891 0.377 . . . . 75.349999999999994 111.692 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 17.2 tppt? -98.91 95.61 7.29 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.178 -0.675 . . . . 75.140000000000001 109.178 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.578 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.6 mm -67.01 140.32 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.373 0.879 . . . . 72.230000000000004 113.373 -168.383 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -121.69 160.39 24.57 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.752 -0.658 . . . . 74.310000000000002 110.287 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.5 pttp -66.45 -16.54 64.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.963 0.411 . . . . 72.129999999999995 111.353 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.24 -19.64 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.765 -0.652 . . . . 75.049999999999997 111.663 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.578 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.5 mtt -69.11 153.82 43.1 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.133 0.492 . . . . 65.329999999999998 111.911 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.2 mm -85.22 129.97 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.399 -0.364 . . . . 54.509999999999998 111.24 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.8 -53.56 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.477 0.547 . . . . 74.549999999999997 112.477 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.07 72.13 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.043 0.386 . . . . 64.239999999999995 112.043 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.72 -40.27 76.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.914 0.388 . . . . 71.040000000000006 110.674 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -60.49 -39.96 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.26 0.552 . . . . 55.109999999999999 110.59 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.98 -32.24 70.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.972 -0.558 . . . . 72.310000000000002 111.393 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.622 ' HA ' HH12 ' A' ' 17' ' ' ARG . 15.8 mm-40 -67.21 -31.76 72.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.339 . . . . 71.239999999999995 111.583 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.4 mtt -65.78 -54.83 21.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.556 0.693 . . . . 73.109999999999999 109.816 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -150.73 121.59 7.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.364 -0.834 . . . . 62.340000000000003 110.58 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.622 HH12 ' HA ' ' A' ' 14' ' ' GLN . 81.9 mmt-85 -60.12 -21.56 61.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.999 0.428 . . . . 73.239999999999995 111.673 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.76 -3.38 27.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.502 -0.38 . . . . 73.450000000000003 113.656 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -82.32 -16.24 50.04 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.425 -0.456 . . . . 75.420000000000002 111.671 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.94 -51.41 79.61 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 112.724 0.638 . . . . 72.109999999999999 112.724 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 12.4 Cg_endo -55.62 -29.19 69.23 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.161 1.908 . . . . 74.329999999999998 112.673 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.3 mt -69.12 -45.57 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.047 0.451 . . . . 75.109999999999999 110.888 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 -45.89 91.08 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.909 0.385 . . . . 74.109999999999999 110.679 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.05 -42.69 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 73.099999999999994 111.348 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -50.72 -50.03 56.31 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.1 0.476 . . . . 75.109999999999999 111.508 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 12.0 m120 -75.27 -4.31 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.492 0.552 . . . . 64.209999999999994 112.492 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.98 16.85 12.63 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.821 0.688 . . . . 41.140000000000001 114.821 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.81 142.77 54.78 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.039 0.919 . . . . 54.219999999999999 111.016 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.48 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 22.7 t-80 -134.91 97.5 3.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.969 0.414 . . . . 73.109999999999999 111.632 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.3 t -75.27 73.91 2.38 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.187 0.518 . . . . 72.439999999999998 111.493 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 29' ' ' HIS . 2.8 tm? -177.0 107.78 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.834 -0.621 . . . . 74.340000000000003 109.327 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.17 -72.86 0.36 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.075 -0.583 . . . . 54.0 112.581 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.9 m -122.46 123.87 26.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.92 0.391 . . . . 72.439999999999998 111.577 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 25.5 Cg_exo -63.18 -27.45 72.81 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.072 2.515 . . . . 73.239999999999995 113.676 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.9 t -58.18 -24.49 59.18 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.551 0.575 . . . . 63.299999999999997 112.551 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 m -56.96 -22.77 40.7 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.987 0.366 . . . . 74.450000000000003 111.987 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.5 mmt -89.71 -19.42 24.83 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.809 0.338 . . . . 74.200000000000003 111.678 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.47 -14.34 38.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.382 -0.437 . . . . 73.140000000000001 113.736 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 55.399999999999999 111.817 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.6 p -75.74 164.63 26.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.126 0.489 . . . . 62.109999999999999 112.254 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 mt -55.04 -50.64 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.889 -0.596 . . . . 70.230000000000004 112.356 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 10.1 pt-20 -66.62 -37.13 84.22 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.247 -0.283 . . . . 65.439999999999998 111.724 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 47' ' ' VAL . 24.1 t0 -64.76 -49.97 68.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.138 0.495 . . . . 63.119999999999997 110.146 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.79 99.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.858 -0.61 . . . . 64.109999999999999 111.896 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -52.1 -52.97 48.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.593 -0.276 . . . . 50.329999999999998 111.467 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.73 68.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.214 0.45 . . . . 45.32 112.214 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 43' ' ' ASP . 66.7 t -59.88 -42.48 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.914 0.388 . . . . 63.219999999999999 111.794 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -97.61 -0.27 46.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.786 0.327 . . . . 71.219999999999999 111.467 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.71 82.31 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.477 -0.392 . . . . 72.0 113.45 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.5 mt -74.42 154.68 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 122.581 -0.364 . . . . 74.340000000000003 111.273 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -97.38 113.79 25.5 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.977 0.417 . . . . 64.109999999999999 110.529 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -68.34 -32.62 72.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.211 0.449 . . . . 64.409999999999997 112.211 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.49 -40.29 82.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.886 0.374 . . . . 71.319999999999993 111.658 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -70.57 -49.46 47.73 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.212 0.53 . . . . 63.130000000000003 111.043 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.41 -47.31 85.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.799 -0.637 . . . . 73.329999999999998 112.406 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 52' ' ' ALA . 98.4 t -61.75 -38.9 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.149 0.426 . . . . 73.420000000000002 112.149 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -61.95 -45.35 94.05 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.176 -0.327 . . . . 73.129999999999995 110.798 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.53 -42.52 74.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.153 0.501 . . . . 63.329999999999998 111.36 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.3 -53.4 55.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.239 -0.437 . . . . 61.009999999999998 111.745 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.482 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 47.3 m-80 -55.0 -50.44 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.038 0.384 . . . . 72.319999999999993 112.038 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.06 -42.3 69.11 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.763 -0.199 . . . . 74.329999999999998 111.346 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.58 -49.41 77.55 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 63.030000000000001 112.188 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 71.8 m-85 -59.52 -36.78 76.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.771 0.319 . . . . 75.519999999999996 111.618 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.15 -34.0 70.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.825 0.345 . . . . 74.510000000000005 111.126 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -65.07 -29.11 69.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.712 -0.222 . . . . 71.230000000000004 111.46 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 26.9 mtpp -51.47 -45.27 62.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.964 0.411 . . . . 74.519999999999996 111.331 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.14 -21.58 66.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.148 -0.478 . . . . 75.439999999999998 112.05 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.37 -54.92 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.99 0.424 . . . . 63.399999999999999 111.48 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -67.32 -59.2 3.61 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.625 0.602 . . . . 73.409999999999997 112.625 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.689 -0.672 . . . . 65.219999999999999 112.682 -176.063 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.965 0.412 . . . . 73.340000000000003 111.586 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -131.3 140.78 49.84 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.181 -0.463 . . . . 71.420000000000002 110.509 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.445 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.9 mm -66.44 133.25 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.529 0.204 . . . . 73.409999999999997 110.602 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.501 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 28.5 p -116.66 155.88 28.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 70.310000000000002 111.134 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HB3' HG21 ' A' ' 56' ' ' VAL . 14.0 ptpt -69.27 -10.5 58.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.01 0.374 . . . . 74.010000000000005 112.01 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.28 -14.95 45.04 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.088 0.47 . . . . 71.299999999999997 111.347 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.501 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 65.5 mtt -69.41 157.29 37.36 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.435 0.531 . . . . 73.530000000000001 112.435 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 48.9 mm -85.39 141.55 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.043 -0.526 . . . . 62.130000000000003 111.552 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.6 mt -55.44 -52.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 120.76 0.314 . . . . 71.340000000000003 111.798 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -57.23 -37.22 71.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.961 0.41 . . . . 62.439999999999998 111.616 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.75 -42.08 98.5 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.303 -0.408 . . . . 64.150000000000006 111.044 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.97 -40.93 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.037 0.446 . . . . 72.439999999999998 110.933 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD23 ' OG1' ' A' ' 19' ' ' THR . 97.0 mt -61.22 -31.74 71.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.892 0.377 . . . . 73.439999999999998 111.348 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -70.1 -15.17 62.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.455 -0.339 . . . . 63.130000000000003 111.9 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.4 mtt -86.69 -43.44 12.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.208 0.528 . . . . 63.340000000000003 110.044 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.08 133.79 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.568 -0.742 . . . . 71.540000000000006 110.814 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.8 mmt-85 -69.68 -25.0 63.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.874 0.368 . . . . 74.209999999999994 111.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.49 -1.41 10.83 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.608 -0.33 . . . . 73.019999999999996 113.728 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.501 ' OG1' HD23 ' A' ' 13' ' ' LEU . 73.3 p -82.84 -21.43 34.41 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.469 -0.43 . . . . 74.519999999999996 111.704 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.78 -51.08 82.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 112.396 0.517 . . . . 34.539999999999999 112.396 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 22.6 Cg_endo -60.93 -25.15 80.91 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.885 1.724 . . . . 61.539999999999999 112.613 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.2 mt -71.05 -43.18 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.969 0.414 . . . . 71.530000000000001 110.785 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -58.64 -48.72 80.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.131 0.491 . . . . 72.209999999999994 110.249 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 28' ' ' MET . 66.5 mt -60.71 -37.84 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.99 -0.55 . . . . 62.329999999999998 111.221 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -56.06 -32.95 64.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.275 -0.421 . . . . 61.409999999999997 112.089 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.419 ' ND2' HD13 ' A' ' 55' ' ' LEU . 34.0 m-80 -90.93 -7.5 51.93 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.453 0.538 . . . . 71.219999999999999 112.453 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 -7.47 6.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.624 -0.798 . . . . 61.399999999999999 114.605 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 50.0 mtt -75.81 176.39 7.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.877 0.838 . . . . 74.239999999999995 111.082 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.84 174.23 10.84 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.994 0.426 . . . . 64.329999999999998 111.665 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.4 p -73.2 -164.34 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.017 -0.538 . . . . 73.340000000000003 111.777 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -72.39 74.71 1.02 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.417 0.627 . . . . 55.530000000000001 111.241 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.63 -23.55 28.16 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.216 -0.754 . . . . 42.43 111.216 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -146.4 134.43 10.62 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.112 0.565 . . . . 53.509999999999998 109.862 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.11 -32.27 79.04 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.646 2.231 . . . . 75.140000000000001 113.054 -176.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.552 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 30.6 t -55.73 -36.05 66.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.487 0.551 . . . . 75.299999999999997 112.487 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 t -48.14 -31.52 5.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.467 0.914 . . . . 61.329999999999998 113.467 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.578 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 3.3 mmt -84.9 -32.72 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.321 0.489 . . . . 75.230000000000004 112.321 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.95 -11.9 80.59 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.13 -0.557 . . . . 70.439999999999998 114.136 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 35' ' ' SER . 8.9 mm-40 -75.56 144.65 41.75 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.282 0.541 . . . . 63.229999999999997 112.054 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 54.3 m -70.31 149.45 47.37 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.577 -0.283 . . . . 75.120000000000005 110.578 172.851 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 mt -51.51 -55.61 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.655 0.613 . . . . 73.329999999999998 112.655 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.6 pt-20 -62.1 -36.28 81.23 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.038 0.447 . . . . 74.140000000000001 111.684 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.93 -52.68 22.5 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.071 -0.513 . . . . 71.140000000000001 111.117 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.88 91.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.303 -0.408 . . . . 73.099999999999994 111.504 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -57.49 -45.53 84.79 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.53 -0.304 . . . . 60.009999999999998 110.938 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.88 75.05 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.016 0.376 . . . . 61.43 112.016 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.8 t -55.65 -41.27 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.927 0.394 . . . . 73.099999999999994 112.052 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.535 ' HB3' HG13 ' A' ' 50' ' ' ILE . 8.8 t60 -91.33 -22.96 20.26 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 73.25 111.299 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.75 24.53 17.56 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.546 -0.359 . . . . 73.219999999999999 112.439 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 48' ' ' HIS . 63.8 mt -79.69 155.23 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.92 0.488 . . . . 73.109999999999999 112.058 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.76 101.74 12.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.183 -0.462 . . . . 73.340000000000003 110.166 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -71.44 -21.88 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.454 0.538 . . . . 73.030000000000001 112.454 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -43.1 77.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.361 . . . . 60.340000000000003 110.467 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.61 -46.78 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.312 -0.404 . . . . 63.420000000000002 110.992 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' ND2' ' A' ' 26' ' ' ASN . 30.1 tp -56.29 -54.84 40.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.223 -0.444 . . . . 62.149999999999999 112.046 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 5' ' ' LYS . 87.4 t -56.51 -41.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.965 0.412 . . . . 63.039999999999999 112.011 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -37.21 80.63 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.73 0.27 . . . . 72.450000000000003 111.73 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -59.91 -42.57 94.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 64.019999999999996 110.692 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -58.6 -52.32 66.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.28 -0.418 . . . . 74.439999999999998 111.381 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 43.5 m-80 -54.19 -57.36 11.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.695 0.283 . . . . 74.219999999999999 111.59 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 48.3 mt-10 -52.42 -40.9 62.71 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.217 -0.447 . . . . 71.129999999999995 111.789 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -56.45 -48.56 76.81 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.894 0.378 . . . . 74.510000000000005 111.663 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -64.55 -38.44 91.03 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.612 0.244 . . . . 64.400000000000006 111.499 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 68' ' ' VAL . 33.9 mt-10 -63.47 -40.7 97.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.822 0.344 . . . . 70.019999999999996 111.116 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.0 mmtp -56.5 -41.36 76.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.919 0.39 . . . . 73.239999999999995 111.26 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.8 -50.27 72.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.299 -0.41 . . . . 74.349999999999994 111.241 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.12 -29.15 68.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 111.765 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 64' ' ' GLU . 65.4 t -74.05 -54.37 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.962 0.41 . . . . 61.140000000000001 111.494 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.2 mt -71.12 -56.88 5.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.496 0.554 . . . . 72.439999999999998 112.496 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.847 -0.597 . . . . 73.430000000000007 112.543 -176.262 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.554 0.216 . . . . 74.319999999999993 110.459 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -117.73 140.74 49.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.231 0.539 . . . . 74.209999999999994 112.425 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.48 143.8 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.8 -0.637 . . . . 71.420000000000002 111.412 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.3 p -118.06 170.23 9.02 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.861 0.362 . . . . 70.209999999999994 110.973 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HB3' HG21 ' A' ' 56' ' ' VAL . 16.8 ptpt -80.87 -11.78 59.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.865 0.364 . . . . 71.340000000000003 111.282 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.52 -25.43 38.72 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.012 -0.54 . . . . 60.340000000000003 111.141 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.478 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 64.3 mtt -65.11 161.07 19.75 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.181 0.515 . . . . 73.549999999999997 112.203 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.0 mm -86.91 129.76 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.062 -0.517 . . . . 73.040000000000006 110.716 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.505 HG12 HG13 ' A' ' 41' ' ' ILE . 57.3 mt -54.66 -45.96 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 112.211 0.448 . . . . 72.150000000000006 112.211 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -63.15 -34.68 78.15 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.195 0.521 . . . . 45.109999999999999 111.078 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.4 t70 -65.06 -41.84 94.74 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.913 -0.585 . . . . 54.100000000000001 110.344 177.787 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.88 -37.96 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.219 0.533 . . . . 62.439999999999998 110.997 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.64 -29.87 70.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 73.310000000000002 111.472 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 77.0 mt-30 -68.34 -25.45 65.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.953 0.406 . . . . 71.140000000000001 111.042 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.0 mtt -75.62 -53.91 7.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.208 0.528 . . . . 73.420000000000002 110.02 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -154.3 124.45 6.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.956 -0.566 . . . . 75.439999999999998 111.127 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.41 -18.12 65.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 74.310000000000002 112.556 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.439 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -68.1 -6.44 46.17 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.274 -0.489 . . . . 73.519999999999996 113.2 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.1 p -80.91 -23.14 39.15 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.644 -0.327 . . . . 34.43 111.455 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.47 -51.79 77.11 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.528 0.566 . . . . 73.439999999999998 112.528 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.46 -26.03 76.29 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.901 1.734 . . . . 72.129999999999995 112.335 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 64.1 mt -72.48 -41.76 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.02 0.438 . . . . 72.150000000000006 110.583 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HD1' HD21 ' A' ' 55' ' ' LEU . 62.0 m-85 -61.9 -49.93 74.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.041 0.448 . . . . 75.120000000000005 110.497 173.094 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.0 mt -59.12 -37.55 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 72.430000000000007 111.099 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 27.4 t30 -52.09 -46.4 65.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.992 0.425 . . . . 64.310000000000002 111.678 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -81.21 1.69 31.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.312 0.486 . . . . 72.430000000000007 112.312 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.33 13.84 14.32 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.203 0.841 . . . . 62.439999999999998 115.203 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mmt -73.67 163.32 28.14 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 117.952 0.876 . . . . 65.219999999999999 112.147 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.48 138.52 23.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.073 -0.512 . . . . 61.340000000000003 110.6 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.402 ' SG ' ' SD ' ' A' ' 37' ' ' MET . 39.4 t -166.66 128.74 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.191 0.811 . . . . 52.43 113.191 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.7 34.41 5.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.498 -1.297 . . . . 71.140000000000001 107.498 167.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.02 41.16 5.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.202 -0.908 . . . . 53.43 111.229 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 57.5 m -102.07 132.09 21.94 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 111.843 0.312 . . . . 73.420000000000002 111.843 -172.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 50.3 Cg_exo -55.36 -60.32 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.973 2.449 . . . . 64.349999999999994 113.587 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 36' ' ' SER . 65.5 m -67.23 76.8 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.276 0.473 . . . . 73.25 112.276 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 35' ' ' SER . 41.0 t 156.36 -30.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.54 1.136 . . . . 61.240000000000002 110.135 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.402 ' SD ' ' SG ' ' A' ' 30' ' ' CYS . 3.6 mmt -103.6 -68.33 0.85 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.325 -0.398 . . . . 73.239999999999995 111.809 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.02 3.86 6.44 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.536 0.574 . . . . 75.340000000000003 114.536 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -106.35 161.6 14.42 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.304 0.552 . . . . 73.400000000000006 111.413 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' MET . 49.2 m -68.54 153.06 44.48 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.415 -0.357 . . . . 72.0 111.024 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.0 mp -51.93 -51.24 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 111.791 0.293 . . . . 53.329999999999998 111.791 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.6 pt-20 -69.05 -33.9 74.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.903 0.382 . . . . 75.420000000000002 111.724 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.88 -47.25 75.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.103 0.478 . . . . 70.109999999999999 111.238 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.73 56.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 75.019999999999996 111.788 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.88 -42.08 75.39 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.72 0.295 . . . . 72.219999999999999 111.679 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.67 65.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.272 0.471 . . . . 53.109999999999999 112.272 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.2 -51.18 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.816 0.341 . . . . 50.119999999999997 111.914 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -87.6 -19.82 27.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.873 0.368 . . . . 74.310000000000002 111.386 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.59 27.04 12.07 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.19 -0.528 . . . . 74.310000000000002 112.655 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mt -76.57 148.28 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.751 0.31 . . . . 70.310000000000002 111.298 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.8 93.84 5.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.202 0.525 . . . . 70.239999999999995 110.283 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HB1' HG22 ' A' ' 41' ' ' ILE . . . -65.7 -24.05 66.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.165 -0.47 . . . . 64.319999999999993 112.105 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.15 -45.76 92.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.792 0.329 . . . . 70.030000000000001 110.962 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.85 -46.44 75.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.893 0.377 . . . . 54.340000000000003 111.126 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 41' ' ' ILE . 26.2 tp -53.19 -51.73 61.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.002 -0.545 . . . . 72.209999999999994 111.624 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 5' ' ' LYS . 80.2 t -57.41 -45.28 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 71.329999999999998 111.524 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.63 -45.0 85.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.515 0.198 . . . . 74.129999999999995 111.395 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -58.97 -40.85 86.02 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.937 0.398 . . . . 74.409999999999997 111.281 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 56' ' ' VAL . 80.9 mt -60.13 -50.46 73.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.854 0.359 . . . . 74.239999999999995 111.38 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.2 m-80 -57.57 -55.13 38.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.395 -0.366 . . . . 73.400000000000006 111.418 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.6 mt-10 -50.11 -41.77 49.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.891 0.377 . . . . 74.010000000000005 111.031 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 87.4 t80 -58.74 -53.23 60.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.17 -0.468 . . . . 65.140000000000001 112.084 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.88 -39.01 87.65 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.591 0.234 . . . . 75.200000000000003 111.117 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 68' ' ' VAL . 33.3 mt-10 -58.41 -40.88 83.65 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.56 0.219 . . . . 73.340000000000003 111.055 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 33.1 mmtp -54.62 -42.81 71.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.017 0.437 . . . . 70.25 110.587 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.82 -47.44 83.4 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.048 -0.524 . . . . 75.340000000000003 111.145 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -65.47 -17.3 64.45 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.342 -0.39 . . . . 63.009999999999998 111.758 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 64' ' ' GLU . 92.4 t -90.88 -56.62 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.015 0.436 . . . . 72.319999999999993 111.575 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -54.82 10.66 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.984 0.735 . . . . 53.210000000000001 112.984 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.746 -0.645 . . . . 73.129999999999995 112.502 -175.458 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.531 0.205 . . . . 62.409999999999997 111.402 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.74 125.09 25.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.932 0.396 . . . . 75.129999999999995 110.575 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.467 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.4 mm -74.01 139.97 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 112.174 0.435 . . . . 64.319999999999993 112.174 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.484 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.2 p -116.42 158.9 22.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.282 -0.417 . . . . 75.209999999999994 110.307 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -72.98 -15.55 61.54 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.106 -0.371 . . . . 73.129999999999995 111.959 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.06 -14.11 58.14 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.794 0.331 . . . . 74.349999999999994 111.48 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.484 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 62.8 mtt -63.95 134.92 55.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.28 0.562 . . . . 72.010000000000005 111.575 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 46.7 mm -68.49 136.01 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.901 -0.59 . . . . 61.450000000000003 111.405 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.6 mt -52.13 -52.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.838 0.31 . . . . 73.25 111.838 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.11 -36.85 73.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.934 0.397 . . . . 72.310000000000002 111.627 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.12 -37.54 87.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.208 -0.451 . . . . 64.239999999999995 110.902 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.94 -41.31 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.072 0.463 . . . . 73.040000000000006 110.99 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -59.22 -31.24 68.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.341 -0.391 . . . . 71.019999999999996 111.709 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 79.3 mt-30 -62.95 -37.06 85.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.73 0.3 . . . . 70.230000000000004 111.532 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.9 mtt -65.76 -48.25 72.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 60.399999999999999 110.225 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.85 120.25 3.4 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.445 -0.798 . . . . 74.319999999999993 110.7 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -62.24 -20.8 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.459 0.54 . . . . 74.219999999999999 112.459 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -3.49 22.86 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.418 -0.42 . . . . 61.130000000000003 113.65 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.7 p -83.08 -19.79 36.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.916 0.358 . . . . 70.430000000000007 111.833 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.29 -50.99 81.72 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 112.478 0.547 . . . . 74.409999999999997 112.478 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.1 Cg_endo -59.13 -29.1 89.61 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.899 1.733 . . . . 72.0 112.613 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.88 -42.17 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.094 0.474 . . . . 75.140000000000001 110.613 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -62.38 -53.44 55.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.155 0.502 . . . . 72.519999999999996 110.648 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.7 -35.35 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.136 -0.484 . . . . 44.310000000000002 111.322 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -57.6 -48.84 78.28 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.021 -0.536 . . . . 72.349999999999994 111.511 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 11.3 m120 -73.92 -5.11 39.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.355 0.502 . . . . 62.350000000000001 112.355 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.89 17.47 7.89 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.653 -0.784 . . . . 75.319999999999993 114.831 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.87 143.16 49.49 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.961 0.881 . . . . 65.409999999999997 111.717 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 71.7 m80 -138.36 -179.37 5.76 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.029 -0.532 . . . . 75.549999999999997 110.73 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 44.3 t 59.8 20.42 9.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.143 0.497 . . . . 41.130000000000003 111.362 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.26 110.19 1.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.845 -0.616 . . . . 74.239999999999995 110.704 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.33 -28.45 3.15 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.315 -0.469 . . . . 73.329999999999998 112.748 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 74.3 m -72.88 143.83 84.75 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.638 -0.331 . . . . 74.409999999999997 111.519 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -44.57 -54.97 3.59 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.375 2.717 . . . . 74.209999999999994 114.439 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -58.63 -55.67 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.425 0.155 . . . . 74.430000000000007 111.415 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -55.8 -29.28 59.45 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.184 0.439 . . . . 71.099999999999994 112.184 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.2 mmt -79.77 -35.14 39.13 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.667 0.27 . . . . 71.319999999999993 111.421 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.39 10.98 69.2 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.843 0.697 . . . . 72.200000000000003 114.843 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.22 161.72 16.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.759 0.779 . . . . 72.319999999999993 112.042 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 87.7 p -76.76 162.02 28.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.739 -0.664 . . . . 70.230000000000004 112.248 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.15 -44.08 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.140000000000001 111.91 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.14 -40.78 90.87 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.562 0.208 . . . . 71.329999999999998 111.562 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.01 -48.61 65.24 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.008 0.432 . . . . 71.340000000000003 111.132 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.75 94.08 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.881 0.372 . . . . 61.200000000000003 111.632 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -56.27 -39.49 72.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.709 0.29 . . . . 52.020000000000003 111.355 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.69 69.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.067 0.395 . . . . 34.509999999999998 112.067 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -48.08 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.018 0.437 . . . . 63.340000000000003 111.346 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -92.47 -10.27 38.46 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.388 -0.369 . . . . 75.129999999999995 111.989 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.42 35.44 23.1 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.35 -0.452 . . . . 61.219999999999999 113.233 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -91.95 152.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.646 0.378 . . . . 74.150000000000006 111.286 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.32 99.43 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.411 -0.589 . . . . 71.25 109.411 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -65.07 -30.1 71.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 112.154 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.8 t70 -59.7 -44.29 93.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.68 0.276 . . . . 61.020000000000003 110.677 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.63 -49.1 67.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 75.5 111.079 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.87 -45.09 67.29 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 73.239999999999995 111.354 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 52' ' ' ALA . 75.9 t -61.56 -37.47 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.169 -0.469 . . . . 73.409999999999997 111.453 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.4 mttm -60.37 -48.83 80.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.743 0.306 . . . . 72.209999999999994 110.649 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.69 -38.19 71.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.241 -0.436 . . . . 60.039999999999999 111.484 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.0 mt -65.2 -51.25 62.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.505 -0.316 . . . . 73.010000000000005 111.364 174.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.513 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.4 m-80 -53.57 -55.02 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.647 -0.251 . . . . 72.120000000000005 111.445 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.0 mt-10 -47.51 -50.46 23.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.059 0.457 . . . . 75.439999999999998 110.773 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -55.15 -49.12 72.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.765 -0.652 . . . . 71.420000000000002 112.292 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -65.73 -37.1 85.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.875 0.369 . . . . 73.319999999999993 111.722 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 33.0 mt-10 -70.4 -24.57 62.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.948 0.404 . . . . 71.549999999999997 111.199 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.7 mmtp -75.72 -31.27 59.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.438 -0.346 . . . . 73.109999999999999 111.315 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -52.69 -42.78 65.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.715 0.293 . . . . 60.409999999999997 111.767 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.36 -28.99 65.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.155 0.502 . . . . 74.109999999999999 111.535 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.19 -44.4 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.019 -0.537 . . . . 64.319999999999993 111.465 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.51 -62.24 2.03 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.064 -0.517 . . . . 60.310000000000002 111.689 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.566 -0.73 . . . . 75.409999999999997 112.054 -179.142 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.715 0.293 . . . . 73.109999999999999 111.452 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -88.78 96.04 10.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.431 -0.581 . . . . 73.109999999999999 109.431 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 mm -74.02 144.64 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.727 0.64 . . . . 71.219999999999999 112.727 -171.858 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.5 p -122.34 153.7 38.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.941 -0.572 . . . . 64.530000000000001 110.367 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.9 pttp -68.45 -13.46 62.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.959 0.409 . . . . 72.530000000000001 111.606 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.24 -22.67 59.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.205 0.526 . . . . 71.120000000000005 111.048 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.448 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.3 mtt -68.59 159.67 31.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.268 0.556 . . . . 61.32 111.718 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.9 mm -86.27 135.87 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.164 -0.471 . . . . 74.450000000000003 111.031 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.8 mt -56.81 -50.88 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 111.892 0.33 . . . . 73.239999999999995 111.892 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.02 -37.33 74.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.942 0.401 . . . . 63.020000000000003 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.81 -44.48 96.78 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.162 -0.472 . . . . 75.439999999999998 110.62 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.13 -39.71 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.116 0.484 . . . . 65.400000000000006 110.837 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.48 HD23 ' OG1' ' A' ' 19' ' ' THR . 97.1 mt -62.69 -33.81 75.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.216 -0.447 . . . . 74.400000000000006 111.62 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 88.1 mt-30 -69.28 -20.83 63.91 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.7 0.286 . . . . 74.099999999999994 111.538 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.5 mtt -75.95 -56.45 4.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.374 0.607 . . . . 74.420000000000002 109.896 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -145.8 125.45 13.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.683 -0.69 . . . . 72.329999999999998 110.571 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 13' ' ' LEU . 41.1 mmt180 -69.57 -19.53 63.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.516 -0.311 . . . . 75.140000000000001 111.591 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.07 -1.8 43.28 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.318 -0.467 . . . . 64.519999999999996 113.304 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.48 ' OG1' HD23 ' A' ' 13' ' ' LEU . 81.5 p -82.28 -17.21 46.7 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.461 -0.435 . . . . 53.149999999999999 111.183 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.21 -51.82 76.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.497 0.554 . . . . 74.420000000000002 112.497 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -56.95 -26.43 67.86 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.108 1.872 . . . . 72.310000000000002 112.612 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.14 -46.98 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.034 0.445 . . . . 63.149999999999999 110.672 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -58.98 -40.97 86.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.022 0.439 . . . . 73.349999999999994 110.504 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.97 -46.57 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.131 -0.486 . . . . 74.310000000000002 111.097 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -51.68 -48.61 63.41 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.181 0.515 . . . . 73.349999999999994 111.495 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -77.63 -6.8 55.06 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.176 -0.465 . . . . 75.150000000000006 112.16 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.6 39.05 3.75 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.251 0.86 . . . . 64.140000000000001 115.251 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 mmt -90.23 158.1 17.37 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.806 0.803 . . . . 75.140000000000001 111.654 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.27 92.0 3.76 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.137 0.494 . . . . 74.239999999999995 110.947 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.06 -9.12 59.68 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.912 0.708 . . . . 73.219999999999999 112.912 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.46 79.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.456 0.539 . . . . 73.329999999999998 112.456 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.65 8.48 27.12 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 114.591 0.596 . . . . 63.32 114.591 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 79.6 m -88.59 117.27 68.16 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 117.168 0.484 . . . . 40.140000000000001 111.595 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 12.4 Cg_endo -54.93 -32.36 77.89 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.686 2.258 . . . . 64.209999999999994 112.248 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.0 m -50.64 -54.41 23.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.786 -0.643 . . . . 44.210000000000001 112.228 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -90.98 -5.1 55.87 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.42 0.526 . . . . 72.340000000000003 112.42 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 16.3 mmt -100.15 -71.66 0.69 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.823 0.675 . . . . 73.209999999999994 112.823 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.22 -21.92 59.87 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.019 -0.61 . . . . 71.230000000000004 114.426 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -79.87 160.92 25.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.123 0.487 . . . . 74.340000000000003 111.87 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 63.6 m -67.03 157.78 32.65 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.364 -0.38 . . . . 74.530000000000001 111.437 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.3 mt -54.81 -54.93 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.867 0.321 . . . . 74.150000000000006 111.867 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.3 pt-20 -63.49 -30.68 71.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.707 0.289 . . . . 54.100000000000001 111.689 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.3 t70 -64.32 -61.84 1.98 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.919 0.39 . . . . 73.319999999999993 109.971 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.72 65.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.157 0.503 . . . . 65.150000000000006 111.588 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 81.4 m -57.57 -40.83 79.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.989 -0.55 . . . . 75.310000000000002 111.43 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.5 69.03 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.013 0.435 . . . . 43.32 111.627 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.4 t -69.98 -39.91 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.784 0.326 . . . . 74.519999999999996 111.831 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -105.39 4.57 30.92 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.089 -0.382 . . . . 74.230000000000004 112.007 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.2 27.97 72.15 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.538 -0.363 . . . . 61.299999999999997 113.958 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 53.3 mt -85.53 153.73 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.973 0.416 . . . . 70.540000000000006 111.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.34 102.2 11.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.672 0.389 . . . . 52.439999999999998 111.675 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.42 85.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 71.430000000000007 111.417 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -51.43 -44.93 62.44 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.961 -0.563 . . . . 73.230000000000004 111.41 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.21 -39.1 34.12 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.224 -0.444 . . . . 72.219999999999999 111.969 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 tp -61.82 -52.81 62.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.918 0.39 . . . . 74.420000000000002 111.98 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.535 ' HA ' HD12 ' A' ' 59' ' ' LEU . 90.1 t -57.46 -37.01 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.956 0.354 . . . . 72.040000000000006 111.956 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -64.41 -42.22 96.19 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.625 -0.261 . . . . 71.310000000000002 111.354 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.98 -42.13 97.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.994 0.426 . . . . 70.219999999999999 110.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -58.37 -52.66 64.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.33 -0.396 . . . . 75.430000000000007 111.678 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.6 m-80 -56.11 -54.5 44.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.744 0.307 . . . . 74.129999999999995 111.444 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.4 mt-10 -54.09 -31.65 52.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.456 -0.338 . . . . 73.310000000000002 111.537 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -69.34 -46.66 66.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.896 0.379 . . . . 74.430000000000007 111.696 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -61.54 -32.62 72.69 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.171 -0.33 . . . . 72.519999999999996 111.15 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 69.0 mt-10 -66.57 -32.94 74.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.913 0.387 . . . . 52.340000000000003 111.15 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 44.6 mmtm -63.44 -39.83 95.52 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.195 -0.316 . . . . 73.420000000000002 110.877 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.42 -37.61 70.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.989 0.423 . . . . 65.420000000000002 111.158 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.3 -21.18 66.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.219 -0.446 . . . . 71.329999999999998 111.496 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.63 -50.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.001 0.429 . . . . 74.140000000000001 111.792 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.78 -58.16 6.99 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.384 0.512 . . . . 73.349999999999994 112.384 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.911 -0.566 . . . . 62.130000000000003 111.909 -178.313 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.48 0.181 . . . . 72.450000000000003 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -76.92 102.59 6.44 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.996 0.427 . . . . 74.310000000000002 110.106 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.453 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 49.6 mm -70.94 139.06 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.049 -0.523 . . . . 75.209999999999994 111.828 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 p -121.18 161.8 21.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.744 0.307 . . . . 73.439999999999998 110.996 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.9 pttp -69.34 -21.23 63.84 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.869 0.366 . . . . 74.340000000000003 111.658 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.66 -21.65 59.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.177 -0.465 . . . . 72.010000000000005 111.731 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -63.08 152.02 38.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.388 0.613 . . . . 73.120000000000005 112.125 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.88 130.5 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.97 -0.559 . . . . 73.540000000000006 111.107 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.41 -47.18 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 111.923 0.342 . . . . 74.450000000000003 111.923 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -60.45 -35.78 76.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.97 0.414 . . . . 32.140000000000001 111.338 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.58 -39.95 80.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.349 -0.387 . . . . 43.140000000000001 110.704 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.93 -41.79 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.277 0.56 . . . . 50.329999999999998 110.128 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.0 mt -64.19 -21.24 66.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.974 -0.557 . . . . 72.230000000000004 111.735 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 83.9 mm-40 -77.44 -30.72 53.47 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.719 0.295 . . . . 72.450000000000003 111.149 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.1 mtt -69.88 -45.89 66.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.317 0.58 . . . . 74.129999999999995 109.894 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.33 127.25 4.94 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.202 -0.908 . . . . 71.340000000000003 111.141 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -65.55 -26.34 67.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.285 -0.416 . . . . 73.430000000000007 111.686 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.62 -1.24 5.85 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 114.179 0.431 . . . . 61.32 114.179 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.456 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.4 p -85.86 -13.19 48.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.166 0.483 . . . . 72.340000000000003 111.589 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.68 -51.35 74.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.699 0.629 . . . . 43.439999999999998 112.699 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -56.93 -31.95 91.12 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.112 1.874 . . . . 64.040000000000006 112.628 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.07 -48.67 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.032 0.444 . . . . 65.040000000000006 110.836 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -60.25 -47.55 85.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.715 0.293 . . . . 60.32 111.263 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.33 -41.97 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.814 0.34 . . . . 61.240000000000002 111.428 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -58.15 -44.07 87.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.255 -0.43 . . . . 63.439999999999998 111.533 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -75.5 -9.9 58.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.282 0.475 . . . . 51.439999999999998 112.282 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.28 1.53 11.17 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 115.424 0.93 . . . . 74.340000000000003 115.424 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.4 mmt -66.76 139.31 57.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.345 1.073 . . . . 74.239999999999995 111.762 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -155.28 111.04 3.1 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 111.67 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 36' ' ' SER . 17.9 p -164.68 129.73 2.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.435 -0.348 . . . . 74.230000000000004 110.357 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 75.63 0.59 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.097 0.475 . . . . 63.450000000000003 110.868 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 51.57 44.14 53.6 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.443 -0.408 . . . . 31.23 113.26 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.4 153.02 65.47 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 111.787 0.291 . . . . 74.340000000000003 111.787 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HA ' ' H ' ' A' ' 38' ' ' GLY . 94.9 Cg_exo -44.36 -35.86 8.83 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.408 2.738 . . . . 71.329999999999998 114.403 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -42.62 -50.51 5.4 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.598 0.962 . . . . 72.430000000000007 113.598 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.762 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 68.9 m -116.96 -3.23 11.63 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.699 0.285 . . . . 62.109999999999999 111.743 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.678 ' HG2' ' SG ' ' A' ' 30' ' ' CYS . 9.7 mmt -100.62 -58.68 1.85 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.979 0.363 . . . . 62.43 111.979 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' H ' ' HA ' ' A' ' 34' ' ' PRO . . . -77.14 -23.59 68.32 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.035 -0.602 . . . . 63.450000000000003 114.462 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 34.4 mm-40 -80.11 154.68 27.91 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 117.241 0.521 . . . . 75.019999999999996 112.3 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -64.2 150.86 44.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.339 -0.391 . . . . 71.109999999999999 110.89 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mt -51.7 -56.29 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.466 0.543 . . . . 74.420000000000002 112.466 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.3 pt-20 -62.41 -39.75 94.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.813 0.339 . . . . 74.340000000000003 111.717 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 47' ' ' VAL . 35.7 t70 -64.64 -54.84 25.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.348 -0.387 . . . . 72.319999999999993 110.924 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.35 75.8 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.945 0.402 . . . . 52.329999999999998 111.235 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' GLY . 90.3 m -58.76 -52.75 64.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.377 -0.374 . . . . 72.510000000000005 111.123 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -42.88 81.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.714 0.264 . . . . 75.530000000000001 111.714 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 43' ' ' ASP . 60.6 t -60.58 -44.37 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.175 0.512 . . . . 73.209999999999994 111.342 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.454 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.5 t-80 -89.4 -2.7 58.5 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-N 116.257 -0.429 . . . . 62.140000000000001 111.505 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 67.77 29.87 74.1 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.65 -0.309 . . . . 54.310000000000002 113.519 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 48' ' ' HIS . 45.5 mt -89.02 151.82 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 122.879 0.471 . . . . 61.030000000000001 111.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.03 102.7 9.44 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.81 0.338 . . . . 71.319999999999993 110.759 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.3 -23.64 61.21 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.201 0.445 . . . . 75.349999999999994 112.201 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.8 -51.07 71.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.959 0.409 . . . . 73.430000000000007 110.634 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 59.9 mtpt -63.66 -50.5 69.03 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.194 -0.457 . . . . 62.140000000000001 111.185 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 36.3 tp -56.19 -54.34 46.35 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.928 -0.578 . . . . 70.209999999999994 112.198 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.4 t -59.01 -43.83 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 111.818 0.303 . . . . 71.310000000000002 111.818 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.13 -42.82 99.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.679 0.276 . . . . 71.239999999999995 111.458 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 96.4 mt-10 -63.69 -39.93 95.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.832 0.349 . . . . 73.409999999999997 111.338 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 90.8 mt -59.06 -48.26 82.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.776 0.322 . . . . 71.530000000000001 111.322 174.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 29.2 m-80 -54.63 -58.63 6.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.489 -0.323 . . . . 74.409999999999997 111.283 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 44.7 mt-10 -48.7 -41.4 31.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.944 0.402 . . . . 71.239999999999995 111.627 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -62.08 -54.85 35.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.213 -0.449 . . . . 74.219999999999999 112.158 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -62.18 -38.96 91.07 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.778 0.288 . . . . 73.329999999999998 111.778 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 36.4 mt-10 -61.14 -41.68 97.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.554 0.216 . . . . 70.129999999999995 111.034 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 45.0 mmtm -52.49 -43.26 64.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.988 0.423 . . . . 75.420000000000002 110.846 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -66.76 -46.86 74.04 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.241 -0.436 . . . . 40.43 111.113 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -57.58 -27.28 62.56 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.024 0.44 . . . . 73.439999999999998 111.597 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 64' ' ' GLU . 67.6 t -73.37 -46.8 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.019 0.438 . . . . 71.540000000000006 111.41 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 53.4 mt -71.93 -62.85 1.28 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.621 0.6 . . . . 65.510000000000005 112.621 -177.995 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.699 -0.667 . . . . 64.329999999999998 112.371 -173.39 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.798 0.332 . . . . 74.120000000000005 111.236 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -110.63 121.6 45.72 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.607 -0.516 . . . . 63.340000000000003 109.607 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.487 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 44.4 mm -68.13 127.66 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.682 0.277 . . . . 75.400000000000006 111.406 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 18.3 p -115.34 154.05 29.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.707 0.289 . . . . 75.219999999999999 110.771 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.785 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 49.9 pttt -68.95 -14.84 63.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.86 0.362 . . . . 73.140000000000001 111.844 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.9 -22.75 52.94 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.08 -0.509 . . . . 65.430000000000007 111.314 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.53 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 60.7 mtt -62.43 150.57 39.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.604 0.716 . . . . 74.209999999999994 112.873 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 38' ' ' GLY . 50.8 mm -80.65 133.77 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 73.400000000000006 111.185 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -51.01 -50.91 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 120.73 0.3 . . . . 73.519999999999996 111.806 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.552 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -58.03 -40.94 82.13 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.837 0.31 . . . . 73.319999999999993 111.837 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.3 -38.89 88.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.948 0.404 . . . . 64.230000000000004 111.026 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.32 -44.92 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.134 0.492 . . . . 75.430000000000007 110.953 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.8 -33.16 71.36 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.041 -0.527 . . . . 72.109999999999999 111.987 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 82.5 mm-40 -61.42 -29.02 69.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.977 0.418 . . . . 63.140000000000001 111.618 177.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -84.15 -41.39 17.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.169 0.509 . . . . 72.109999999999999 110.346 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.22 120.96 3.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.002 -0.545 . . . . 74.430000000000007 111.325 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -69.83 -16.96 63.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 112.082 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -66.02 -7.75 38.79 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.236 -0.506 . . . . 53.240000000000002 113.144 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.2 p -80.24 -19.49 46.72 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.568 -0.372 . . . . 71.439999999999998 111.573 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.75 -51.78 77.56 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.501 0.556 . . . . 44.109999999999999 112.501 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 17.7 Cg_endo -59.12 -21.68 60.52 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.115 1.877 . . . . 71.400000000000006 112.634 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.4 mt -77.07 -41.7 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.974 0.416 . . . . 74.439999999999998 110.579 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -60.79 -45.85 92.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.139 0.495 . . . . 72.010000000000005 110.229 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.87 -39.11 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.988 -0.551 . . . . 74.140000000000001 110.991 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.93 -37.37 63.78 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.046 0.451 . . . . 74.25 111.782 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 55' ' ' LEU . 33.6 m-80 -89.82 -2.29 58.19 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.31 0.485 . . . . 60.520000000000003 112.31 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 37.6 5.44 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.927 -0.654 . . . . 63.310000000000002 114.706 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.3 mmt -79.52 166.84 21.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.363 0.582 . . . . 71.400000000000006 111.656 173.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -70.72 141.36 51.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.147 -0.479 . . . . 73.549999999999997 111.618 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.16 144.52 53.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.775 0.321 . . . . 75.109999999999999 110.465 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.79 119.34 9.78 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.472 0.653 . . . . 73.400000000000006 111.667 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.25 -58.0 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.356 -0.838 . . . . 62.399999999999999 111.534 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.7 m -88.86 127.58 55.45 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 122.218 0.207 . . . . 72.519999999999996 110.539 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.31 -24.5 34.83 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.829 2.352 . . . . 53.299999999999997 113.206 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 m -52.07 -44.01 64.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.614 0.366 . . . . 62.219999999999999 111.889 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.4 t -60.42 -21.12 61.89 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.177 0.436 . . . . 35.450000000000003 112.177 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.552 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 23.3 mmt -77.61 -37.26 50.66 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.378 -0.201 . . . . 72.140000000000001 111.408 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' HD12 ' A' ' 8' ' ' ILE . . . -83.15 -10.69 82.21 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.346 -0.454 . . . . 41.399999999999999 114.05 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.34 141.06 45.22 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.156 0.503 . . . . 74.25 111.863 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -75.77 154.98 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 75.120000000000005 110.884 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -53.36 -58.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.702 0.63 . . . . 74.230000000000004 112.702 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.785 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.4 pt-20 -64.97 -33.55 76.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.863 0.364 . . . . 70.519999999999996 111.604 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 47' ' ' VAL . 25.7 t70 -64.49 -54.17 36.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.248 -0.433 . . . . 72.209999999999994 110.821 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.084 -0.507 . . . . 73.209999999999994 111.038 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.5 m -56.4 -49.21 75.13 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.431 -0.35 . . . . 75.120000000000005 110.913 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.0 67.54 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.902 0.334 . . . . 34.329999999999998 111.902 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 43' ' ' ASP . 61.8 t -67.41 -39.14 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.872 0.368 . . . . 72.549999999999997 111.552 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.01 9.76 24.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.774 0.321 . . . . 75.439999999999998 111.839 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.31 31.54 81.19 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.522 -0.371 . . . . 72.310000000000002 113.329 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.74 153.28 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.538 0.335 . . . . 60.420000000000002 111.646 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.38 107.09 16.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.944 0.402 . . . . 73.109999999999999 110.298 175.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -28.74 56.8 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.011 0.374 . . . . 65.140000000000001 112.011 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.44 -47.16 84.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.862 0.363 . . . . 61.350000000000001 110.776 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.35 -45.93 52.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.586 -0.279 . . . . 74.319999999999993 111.594 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' ND2' ' A' ' 26' ' ' ASN . 25.0 tp -53.18 -51.4 62.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.996 0.427 . . . . 75.510000000000005 111.694 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 5' ' ' LYS . 88.0 t -59.91 -41.81 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.686 0.279 . . . . 62.399999999999999 111.602 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.04 -39.47 90.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.545 0.202 . . . . 74.439999999999998 111.545 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.76 -37.03 80.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 73.420000000000002 110.723 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 79.8 mt -65.83 -51.14 61.4 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.454 -0.339 . . . . 73.230000000000004 111.764 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 40.5 m-80 -56.21 -51.66 67.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.926 0.343 . . . . 71.340000000000003 111.926 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.0 mt-10 -57.62 -34.83 69.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.813 0.34 . . . . 53.130000000000003 111.632 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.47 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 94.3 t80 -59.35 -48.31 82.11 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.84 0.352 . . . . 54.310000000000002 111.181 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -61.68 -38.98 89.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.649 -0.251 . . . . 72.420000000000002 111.253 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 34.9 mt-10 -59.86 -37.44 79.31 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.924 0.392 . . . . 62.030000000000001 111.264 174.343 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 47.1 mmtm -67.76 -26.39 66.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.255 -0.43 . . . . 73.049999999999997 111.963 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.69 -43.92 97.93 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.694 0.283 . . . . 62.5 111.57 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.1 -20.81 66.65 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.123 0.487 . . . . 75.319999999999993 111.183 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.46 -53.54 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.943 -0.571 . . . . 54.350000000000001 111.388 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.61 -57.57 3.78 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.093 -0.503 . . . . 64.310000000000002 112.351 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 . . . . . 0 C--O 1.255 1.386 0 CA-C-O 118.724 -0.655 . . . . 61.43 112.469 -177.626 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.82 0.343 . . . . 72.540000000000006 111.503 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 14.0 mmmm -112.98 156.23 23.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.143 0.497 . . . . 73.129999999999995 111.322 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.552 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.7 mm -73.98 137.75 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 112.717 0.636 . . . . 61.43 112.717 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -122.28 156.87 32.94 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.274 -0.421 . . . . 73.549999999999997 110.725 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.5 ptpt -66.76 -14.07 62.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.796 0.331 . . . . 73.140000000000001 111.809 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.7 -19.33 41.77 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.227 -0.442 . . . . 62.100000000000001 111.279 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.552 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 53.6 mtt -63.19 151.39 40.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.283 0.563 . . . . 73.239999999999995 112.05 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 42.0 mm -82.62 138.24 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.879 -0.6 . . . . 64.209999999999994 110.518 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -53.5 -49.21 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 120.865 0.364 . . . . 64.120000000000005 111.825 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -62.16 -32.01 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.867 0.365 . . . . 71.340000000000003 111.718 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.75 -43.7 88.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.039 0.447 . . . . 73.120000000000005 110.637 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.67 -36.3 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.211 0.529 . . . . 74.140000000000001 110.793 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' OG1' ' A' ' 19' ' ' THR . 96.6 mt -65.61 -24.44 67.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.119 -0.491 . . . . 72.200000000000003 111.778 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 73.8 mt-30 -69.48 -32.96 72.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.158 0.504 . . . . 51.329999999999998 110.909 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.5 mtt -71.21 -50.46 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.812 -0.631 . . . . 70.439999999999998 110.674 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.88 135.96 13.87 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.821 -0.627 . . . . 64.319999999999993 110.632 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -72.72 -21.86 60.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.836 0.35 . . . . 75.209999999999994 111.909 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.77 3.18 45.16 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.251 -0.432 . . . . 52.229999999999997 113.807 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.416 ' OG1' HD23 ' A' ' 13' ' ' LEU . 71.4 p -81.31 -21.29 39.37 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.387 -0.478 . . . . 73.540000000000006 111.674 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.81 -51.41 80.62 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 112.741 0.645 . . . . 72.150000000000006 112.741 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.7 Cg_endo -57.31 -26.01 68.25 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.201 1.934 . . . . 71.200000000000003 112.785 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -69.2 -47.07 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.079 0.466 . . . . 71.319999999999993 110.7 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.95 -44.55 82.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.157 0.503 . . . . 62.439999999999998 110.3 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.8 mt -60.78 -40.62 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.982 -0.554 . . . . 64.209999999999994 111.475 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -55.55 -36.02 66.34 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.131 0.491 . . . . 74.099999999999994 111.803 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' ND2' HD13 ' A' ' 55' ' ' LEU . 35.0 m-80 -91.25 1.41 57.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.443 0.534 . . . . 72.409999999999997 112.443 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.07 18.54 17.14 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.097 0.799 . . . . 73.230000000000004 115.097 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt -68.25 145.38 54.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.109 0.954 . . . . 53.450000000000003 111.543 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -121.18 114.29 21.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.242 -0.436 . . . . 62.340000000000003 110.582 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.63 113.9 5.81 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.013 0.435 . . . . 45.049999999999997 112.095 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 32' ' ' GLY . 2.6 tm? -83.64 139.65 32.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.616 -0.513 . . . . 74.439999999999998 109.616 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.525 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -49.57 -69.15 1.1 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.439 -0.41 . . . . 45.240000000000002 113.638 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.85 154.19 89.64 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.667 -0.314 . . . . 62.409999999999997 110.938 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' SER . 47.4 Cg_exo -36.43 -69.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.495 2.797 . . . . 75.25 114.357 -174.791 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m 39.44 -83.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.821 1.045 . . . . 51.140000000000001 113.821 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' PRO . 41.0 t -57.41 -27.48 62.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.076 0.465 . . . . 73.310000000000002 112.124 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 30.0 mmt -73.58 -11.89 60.58 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.004 0.372 . . . . 54.530000000000001 112.004 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 2.21 32.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.051 -0.595 . . . . 45.439999999999998 113.721 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.0 157.61 26.47 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.347 0.573 . . . . 74.019999999999996 111.775 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.4 p -78.05 162.96 26.32 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.107 0.48 . . . . 72.120000000000005 112.201 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.92 -52.74 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.898 -0.592 . . . . 64.439999999999998 112.101 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 17.2 pt-20 -62.95 -37.22 86.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.833 0.349 . . . . 73.239999999999995 111.752 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 47' ' ' VAL . 21.7 t0 -67.53 -49.81 61.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.345 -0.389 . . . . 72.420000000000002 110.778 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.97 93.96 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.035 0.445 . . . . 73.530000000000001 111.72 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -59.28 -51.22 70.9 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.408 -0.36 . . . . 62.450000000000003 111.458 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.52 69.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.987 0.366 . . . . 44.439999999999998 111.987 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -62.29 -48.59 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.93 0.395 . . . . 53.43 111.477 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.403 ' HB3' HG13 ' A' ' 50' ' ' ILE . 65.2 t-80 -82.27 -11.88 58.38 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.369 -0.378 . . . . 74.019999999999996 111.596 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.28 40.8 15.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.52 -0.371 . . . . 72.430000000000007 113.031 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 48' ' ' HIS . 18.9 mt -103.63 152.16 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.708 0.403 . . . . 63.039999999999999 111.177 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -80.48 97.65 7.22 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.073 0.463 . . . . 65.530000000000001 109.879 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -60.74 -37.48 81.93 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.604 0.594 . . . . 73.310000000000002 112.604 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 12.4 t70 -64.1 -39.75 94.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.657 -0.417 . . . . 72.120000000000005 110.493 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.02 -41.43 90.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.785 0.326 . . . . 73.530000000000001 111.218 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.431 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.0 tp -61.85 -50.05 73.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.958 0.409 . . . . 72.310000000000002 111.405 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 52' ' ' ALA . 93.4 t -55.86 -35.23 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.371 -0.377 . . . . 73.25 111.875 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 58.0 mttm -57.06 -54.96 40.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.664 0.269 . . . . 71.040000000000006 110.982 176.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -56.85 -39.6 74.57 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.433 -0.349 . . . . 73.530000000000001 111.335 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 56' ' ' VAL . 89.1 mt -60.19 -51.93 67.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.507 -0.315 . . . . 63.219999999999999 111.494 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 2' ' ' LYS . 40.2 m-80 -56.59 -50.03 73.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.508 0.194 . . . . 72.140000000000001 111.453 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.7 mt-10 -54.75 -42.11 71.22 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.46 -0.336 . . . . 75.109999999999999 111.143 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -54.45 -44.72 72.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.868 0.366 . . . . 74.319999999999993 111.744 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.5 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 85.2 m-85 -66.78 -37.67 85.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.863 0.363 . . . . 73.549999999999997 110.975 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' O ' HG23 ' A' ' 68' ' ' VAL . 35.5 mt-10 -66.11 -27.29 67.94 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.353 -0.385 . . . . 74.329999999999998 110.991 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 30.9 mmmt -73.73 -35.97 65.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.333 -0.394 . . . . 63.310000000000002 110.24 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 27.7 mtpp -56.43 -39.66 73.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.0 0.429 . . . . 72.510000000000005 110.791 173.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.54 -11.3 60.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.115 -0.493 . . . . 74.340000000000003 111.834 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 64' ' ' GLU . 95.6 t -102.68 -53.98 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.027 0.442 . . . . 62.310000000000002 111.93 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -75.6 -57.3 3.97 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.798 0.666 . . . . 75.439999999999998 112.798 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.894 -0.574 . . . . 74.409999999999997 112.086 -176.248 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.798 0.332 . . . . 71.310000000000002 111.573 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -72.91 105.41 4.4 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.785 -0.45 . . . . 55.329999999999998 109.785 173.906 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 48.4 mm -56.6 137.42 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.814 0.672 . . . . 71.340000000000003 112.814 -173.261 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 43.1 p -117.35 156.2 28.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.745 -0.661 . . . . 74.519999999999996 110.403 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.667 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 21.2 pttp -68.94 -13.46 62.45 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.007 0.432 . . . . 60.310000000000002 111.557 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.03 -22.51 45.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.27 -0.423 . . . . 62.32 111.284 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.469 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 67.2 mtt -64.73 153.98 38.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.295 0.569 . . . . 54.329999999999998 112.102 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -82.25 139.83 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.983 -0.553 . . . . 75.519999999999996 111.659 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.3 -55.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.189 0.44 . . . . 62.420000000000002 112.189 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.83 -35.61 73.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.737 0.303 . . . . 72.209999999999994 111.517 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.56 -43.8 89.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.047 0.451 . . . . 53.439999999999998 111.065 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.19 -43.72 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.235 -0.439 . . . . 60.340000000000003 110.775 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.24 -27.91 69.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.094 -0.503 . . . . 52.420000000000002 111.912 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 18.5 mm-40 -63.18 -27.98 69.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.8 0.334 . . . . 75.409999999999997 111.397 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.78 -49.15 7.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.029 0.442 . . . . 72.450000000000003 110.879 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -148.21 119.84 8.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.226 -0.443 . . . . 62.130000000000003 111.396 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 17' ' ' ARG . 12.6 mmt180 -75.48 -8.34 56.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.382 0.512 . . . . 71.030000000000001 112.382 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.02 -8.23 68.64 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.227 -0.511 . . . . 72.239999999999995 112.459 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.417 ' HA ' HD12 ' A' ' 22' ' ' ILE . 65.4 p -81.05 -18.04 48.09 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.696 -0.297 . . . . 70.310000000000002 111.45 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.91 -52.1 75.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 112.178 0.436 . . . . 44.039999999999999 112.178 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -59.52 -28.16 86.78 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.03 1.82 . . . . 74.140000000000001 112.318 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 19' ' ' THR . 67.9 mt -68.71 -46.63 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.057 0.456 . . . . 71.140000000000001 110.894 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 58.5 m-85 -56.75 -48.97 76.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.088 0.47 . . . . 73.340000000000003 110.529 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.34 -36.15 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.013 -0.539 . . . . 71.209999999999994 111.568 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -57.38 -33.11 67.48 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.081 0.467 . . . . 62.549999999999997 111.203 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -92.58 -4.4 53.49 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.197 -0.456 . . . . 74.430000000000007 112.068 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.42 -13.34 11.03 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.74 -0.743 . . . . 71.519999999999996 114.559 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.512 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.7 mmt -64.0 160.79 17.15 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.559 0.679 . . . . 51.420000000000002 111.746 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -132.65 108.24 8.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.991 0.424 . . . . 75.219999999999999 111.323 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t -70.09 -30.74 68.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.921 0.391 . . . . 64.040000000000006 111.719 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.82 107.23 16.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.325 -0.398 . . . . 74.129999999999995 110.233 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.17 -99.88 0.16 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.239 -0.505 . . . . 74.0 112.786 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 80.5 m -78.79 115.7 54.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 122.543 -0.386 . . . . 71.209999999999994 110.964 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 11.0 Cg_endo -53.44 -41.85 70.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.772 2.315 . . . . 73.0 113.254 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 23.3 t -60.97 -28.48 69.03 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.839 0.311 . . . . 62.219999999999999 111.839 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 m -54.13 -30.61 49.56 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.904 0.383 . . . . 54.439999999999998 111.73 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.402 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 6.0 mmt -66.45 -36.63 83.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.795 0.331 . . . . 60.420000000000002 111.387 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.86 72.67 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.312 0.485 . . . . 62.450000000000003 114.312 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 35' ' ' SER . 40.4 mt-10 -90.29 146.67 24.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.442 0.621 . . . . 63.32 111.911 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.3 m -66.6 147.44 53.27 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.224 -0.444 . . . . 72.129999999999995 110.252 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.447 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.7 mt -50.49 -56.95 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.642 0.608 . . . . 73.510000000000005 112.642 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.2 pt-20 -62.99 -35.99 82.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.847 0.356 . . . . 62.439999999999998 111.791 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 t70 -65.29 -52.0 57.01 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.064 -0.517 . . . . 51.009999999999998 110.767 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.3 79.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.169 -0.469 . . . . 73.209999999999994 111.484 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 41' ' ' ILE . 85.8 m -58.27 -54.93 41.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.469 -0.332 . . . . 73.430000000000007 111.163 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -37.26 64.24 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.838 0.352 . . . . 73.409999999999997 111.841 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -59.72 -52.2 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.392 -0.367 . . . . 73.519999999999996 111.839 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 11.1 t-160 -92.12 -0.67 57.44 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.109 0.411 . . . . 70.430000000000007 112.109 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.55 46.33 40.65 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.443 -0.408 . . . . 64.430000000000007 113.283 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mt -101.91 151.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 122.704 0.401 . . . . 75.340000000000003 111.264 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -85.14 98.52 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.035 0.445 . . . . 71.209999999999994 110.654 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.35 66.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.429 -0.35 . . . . 73.219999999999999 111.78 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.46 -51.82 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.585 -0.279 . . . . 62.329999999999998 111.159 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -76.91 -40.16 48.26 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.04 0.385 . . . . 62.310000000000002 112.04 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 tp -55.63 -53.69 53.36 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.783 0.325 . . . . 70.109999999999999 111.747 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 5' ' ' LYS . 59.8 t -61.16 -39.93 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.659 0.266 . . . . 72.329999999999998 111.595 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.4 mttt -60.8 -45.78 93.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.802 -0.181 . . . . 71.239999999999995 111.315 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.15 -40.0 88.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.751 0.31 . . . . 72.239999999999995 111.453 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.9 mt -59.24 -52.72 64.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.813 0.339 . . . . 72.200000000000003 111.51 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 52.9 m-80 -57.74 -49.94 74.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.429 -0.351 . . . . 73.109999999999999 111.745 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.7 mt-10 -52.57 -44.43 65.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.462 -0.336 . . . . 63.140000000000001 110.782 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -57.69 -54.15 50.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.336 -0.393 . . . . 72.150000000000006 112.054 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.85 -41.41 77.87 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.993 0.368 . . . . 74.400000000000006 111.993 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.12 -30.75 65.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.777 0.323 . . . . 64.209999999999994 111.268 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 30.9 mmmt -65.9 -28.11 68.7 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.353 -0.217 . . . . 73.230000000000004 111.026 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -56.15 -45.97 79.46 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 72.019999999999996 111.765 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.15 -21.42 66.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.077 0.465 . . . . 70.409999999999997 111.434 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.3 t -79.65 -45.58 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 121.283 0.563 . . . . 43.340000000000003 111.033 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.8 -59.95 3.1 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.937 -0.574 . . . . 71.540000000000006 111.744 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.776 -0.63 . . . . 71.25 111.619 179.277 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.02 0.438 . . . . 74.239999999999995 111.517 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -124.99 107.78 11.18 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.229 -0.656 . . . . 72.25 109.229 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' VAL . 50.9 mm -72.55 137.8 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.944 0.72 . . . . 75.310000000000002 112.944 -168.486 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.8 p -125.82 158.58 34.64 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.69 -0.686 . . . . 61.439999999999998 109.939 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.739 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.4 pttp -71.92 -15.17 62.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.015 -0.428 . . . . 41.140000000000001 111.252 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.84 -23.56 61.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.04 -0.527 . . . . 74.439999999999998 111.192 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.9 mtt -67.64 165.33 17.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.397 0.518 . . . . 74.200000000000003 112.397 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 12' ' ' VAL . 47.2 mm -93.75 135.53 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.992 -0.549 . . . . 53.32 111.581 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.7 -51.31 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.821 0.343 . . . . 60.399999999999999 111.849 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.13 -41.52 83.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.805 0.336 . . . . 64.420000000000002 111.73 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 15' ' ' MET . 20.4 t70 -58.66 -45.01 90.28 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.407 -0.361 . . . . 74.310000000000002 110.95 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 8' ' ' ILE . 88.7 t -57.53 -43.42 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.957 0.408 . . . . 73.430000000000007 111.2 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.422 HD23 ' OG1' ' A' ' 19' ' ' THR . 94.9 mt -62.68 -34.4 77.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.321 -0.399 . . . . 71.420000000000002 111.395 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 78.8 mt-30 -67.61 -30.16 69.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.386 -0.37 . . . . 63.509999999999998 111.661 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 37.2 mtm -74.45 -43.2 57.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.3 0.572 . . . . 65.0 109.949 175.011 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -159.49 124.67 4.11 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.614 -0.721 . . . . 73.519999999999996 111.756 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -69.47 -14.7 63.02 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.992 -0.549 . . . . 72.540000000000006 111.766 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.506 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -65.51 -9.75 45.54 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.067 -0.587 . . . . 73.319999999999993 113.178 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.422 ' OG1' HD23 ' A' ' 13' ' ' LEU . 80.7 p -82.43 -13.85 56.11 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.44 -0.447 . . . . 62.119999999999997 111.757 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.03 -51.07 80.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.604 0.594 . . . . 75.310000000000002 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.5 Cg_endo -58.92 -26.45 81.13 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.169 1.913 . . . . 74.120000000000005 112.677 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -71.41 -44.1 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.97 0.414 . . . . 74.329999999999998 110.789 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -63.76 -46.03 87.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.972 0.415 . . . . 73.530000000000001 110.55 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.56 -39.16 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.205 -0.452 . . . . 64.010000000000005 111.259 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.43 -40.7 71.83 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.076 0.465 . . . . 72.5 111.541 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.74 0.42 43.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.14 -0.482 . . . . 75.200000000000003 112.041 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 9.51 45.31 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 114.826 0.69 . . . . 71.530000000000001 114.826 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt -63.72 142.8 58.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.093 0.946 . . . . 70.239999999999995 111.817 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -126.58 112.34 15.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.018 -0.537 . . . . 75.230000000000004 110.893 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.3 p -84.12 -18.96 35.1 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.857 0.361 . . . . 75.129999999999995 111.567 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.46 103.83 5.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.946 0.403 . . . . 74.209999999999994 110.633 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.9 -86.5 0.15 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.204 -0.522 . . . . 72.329999999999998 113.07 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 80.2 m -125.27 145.65 51.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 122.637 -0.331 . . . . 72.150000000000006 111.256 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 37.9 Cg_exo -61.42 -10.43 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.849 2.366 . . . . 74.25 113.478 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -55.83 -39.68 71.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.073 0.463 . . . . 54.0 111.168 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -64.37 -9.76 20.16 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.021 0.378 . . . . 75.25 112.021 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.3 mmt -111.81 -57.94 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.811 0.339 . . . . 73.430000000000007 111.767 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.22 -20.09 79.82 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.122 0.809 . . . . 43.210000000000001 115.122 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -84.09 168.82 15.51 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.564 0.682 . . . . 75.230000000000004 112.344 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.7 m -70.29 151.53 45.19 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.041 -0.527 . . . . 72.310000000000002 111.899 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.0 mt -52.67 -57.66 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.376 0.509 . . . . 74.219999999999999 112.376 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.739 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.6 pt-20 -58.61 -35.56 72.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.912 0.387 . . . . 74.239999999999995 111.78 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 47' ' ' VAL . 17.9 t70 -68.85 -53.61 20.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.202 -0.454 . . . . 73.219999999999999 111.144 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.41 79.16 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.267 -0.424 . . . . 72.219999999999999 111.245 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -60.22 -52.25 66.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 74.109999999999999 110.825 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.0 -47.94 64.69 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.411 -0.358 . . . . 32.219999999999999 111.871 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 43' ' ' ASP . 59.9 t -51.94 -38.27 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 52.420000000000002 111.928 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -103.18 0.51 31.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.294 0.479 . . . . 73.349999999999994 112.294 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.57 74.07 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.161 -0.543 . . . . 44.409999999999997 113.501 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.6 153.13 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.899 0.38 . . . . 60.409999999999997 111.307 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -86.07 105.09 16.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.872 0.368 . . . . 72.150000000000006 110.877 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.5 -36.07 68.29 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.045 0.387 . . . . 72.230000000000004 112.045 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.74 -44.73 77.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.029 0.442 . . . . 75.209999999999994 111.003 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -69.2 -52.02 32.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.343 -0.39 . . . . 75.209999999999994 111.469 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -55.09 -49.62 71.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.21 0.448 . . . . 73.329999999999998 112.21 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 3' ' ' ILE . 75.2 t -60.31 -42.1 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 111.978 0.362 . . . . 72.209999999999994 111.978 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.71 -35.39 77.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.818 0.342 . . . . 74.450000000000003 111.217 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.63 -38.25 86.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.921 0.391 . . . . 73.049999999999997 110.999 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.42 -45.0 73.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.204 -0.453 . . . . 72.450000000000003 111.971 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 27.7 m-80 -53.58 -56.4 17.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.794 0.294 . . . . 73.150000000000006 111.794 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 18.4 mt-10 -46.68 -52.53 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 71.349999999999994 111.327 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.506 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 80.4 t80 -50.43 -55.36 16.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.54 0.57 . . . . 74.409999999999997 112.54 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 56.2 m-85 -62.45 -37.28 85.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.244 0.461 . . . . 73.439999999999998 112.244 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 27.1 mt-10 -71.53 -32.37 68.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.782 0.325 . . . . 72.299999999999997 111.07 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 33.7 mmtp -68.92 -41.12 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.417 -0.356 . . . . 71.510000000000005 110.925 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 26.6 mtpp -46.67 -58.93 3.37 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.439 0.533 . . . . 73.219999999999999 112.439 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.05 -11.91 33.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.958 -0.565 . . . . 63.229999999999997 112.196 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -95.16 -49.91 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.05 0.453 . . . . 75.040000000000006 111.43 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.2 mt -71.58 -56.7 5.36 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.238 0.458 . . . . 45.509999999999998 112.238 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 . . . . . 0 C--O 1.255 1.387 0 CA-C-O 118.662 -0.685 . . . . 73.25 112.059 -177.609 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.598 0.237 . . . . 75.409999999999997 111.191 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 3.3 tppp? -94.63 100.86 12.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.216 0.532 . . . . 74.400000000000006 110.579 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.513 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm -70.36 137.65 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.582 -0.735 . . . . 75.140000000000001 111.435 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 p -121.61 154.69 36.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.841 0.353 . . . . 74.439999999999998 111.287 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 18.3 ptpt -53.54 -33.34 54.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.185 0.809 . . . . 74.409999999999997 113.185 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.09 -3.39 42.06 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.883 0.697 . . . . 61.210000000000001 112.883 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.2 mtt -73.38 150.79 41.52 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.122 0.487 . . . . 71.150000000000006 111.67 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.6 mm -79.78 131.04 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.237 -0.438 . . . . 72.329999999999998 111.444 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.8 mt -56.25 -51.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 111.89 0.329 . . . . 63.539999999999999 111.89 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -56.38 -40.11 74.06 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.891 0.377 . . . . 71.319999999999993 111.385 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -43.4 96.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.261 -0.427 . . . . 75.129999999999995 110.709 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.1 -41.55 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.089 0.471 . . . . 71.329999999999998 110.986 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD23 ' OG1' ' A' ' 19' ' ' THR . 94.7 mt -61.42 -35.89 78.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.033 0.444 . . . . 72.349999999999994 111.163 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.2 mt-30 -67.66 -22.21 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.257 -0.429 . . . . 64.040000000000006 111.598 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -74.2 -58.56 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.254 0.549 . . . . 74.530000000000001 109.643 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -146.83 127.51 14.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.612 -0.722 . . . . 74.230000000000004 110.825 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.464 HH12 ' HA ' ' A' ' 14' ' ' GLN . 77.8 mmt-85 -69.18 -17.59 63.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.783 0.29 . . . . 73.109999999999999 111.783 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.2 -6.75 41.18 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.211 -0.519 . . . . 71.129999999999995 113.217 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.437 ' HA ' HD12 ' A' ' 22' ' ' ILE . 80.9 p -81.62 -21.27 38.38 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.557 -0.378 . . . . 70.530000000000001 111.251 174.859 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -57.09 -51.14 83.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 112.181 0.438 . . . . 73.140000000000001 112.181 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.79 -25.44 76.16 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.941 1.761 . . . . 74.219999999999999 112.281 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 19' ' ' THR . 59.9 mt -73.22 -45.43 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.013 0.435 . . . . 72.109999999999999 110.72 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -57.01 -52.17 66.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.056 0.455 . . . . 62.539999999999999 110.522 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.81 -37.32 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.272 -0.422 . . . . 63.329999999999998 111.368 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -55.9 -33.64 64.83 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.137 0.494 . . . . 74.099999999999994 111.251 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -91.43 -4.12 55.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.241 0.459 . . . . 72.109999999999999 112.241 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.18 19.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.984 -0.627 . . . . 74.310000000000002 114.438 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.56 -175.61 2.06 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.593 0.696 . . . . 54.329999999999998 111.807 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -95.85 152.64 18.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.033 -0.53 . . . . 73.420000000000002 111.396 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 63.8 m -73.12 168.5 18.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.232 0.539 . . . . 70.239999999999995 112.21 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.493 HD22 ' SD ' ' A' ' 37' ' ' MET . 1.9 tm? -62.99 100.5 0.21 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.941 -0.572 . . . . 54.43 110.706 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.68 -72.62 0.07 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.794 -0.717 . . . . 53.229999999999997 113.331 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -65.28 116.2 28.51 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 111.977 0.362 . . . . 74.349999999999994 111.977 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.07 -26.93 77.73 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.882 2.388 . . . . 71.109999999999999 113.016 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 87.5 p -54.8 -43.57 73.01 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 75.129999999999995 111.903 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -88.22 -9.02 54.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.228 -0.442 . . . . 74.209999999999994 111.845 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' HD22 ' A' ' 31' ' ' LEU . 7.7 mmt -94.68 -49.83 5.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.898 0.38 . . . . 63.549999999999997 111.794 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HD12 ' A' ' 8' ' ' ILE . . . -68.94 -36.28 81.19 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.19 0.436 . . . . 74.530000000000001 114.19 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.7 167.57 21.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.685 0.755 . . . . 75.230000000000004 112.772 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 94.1 p -78.84 164.13 24.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.526 -0.761 . . . . 70.400000000000006 112.011 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.07 -48.79 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.182 -0.463 . . . . 72.439999999999998 111.593 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 8.0 pt-20 -62.56 -37.18 85.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.982 0.364 . . . . 60.039999999999999 111.982 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.2 t70 -66.01 -58.99 4.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.71 0.29 . . . . 74.140000000000001 110.703 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.37 65.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.778 0.323 . . . . 74.150000000000006 111.65 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.819 0.342 . . . . 72.400000000000006 110.753 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.12 68.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.835 0.309 . . . . 75.400000000000006 111.835 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 43' ' ' ASP . 76.7 t -66.45 -54.58 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.939 0.4 . . . . 71.409999999999997 111.747 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.75 -18.69 30.52 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.881 0.372 . . . . 64.120000000000005 111.748 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.18 53.15 2.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 121.178 0.321 . . . . 72.019999999999996 113.066 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.9 mt -110.88 153.15 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.01 0.524 . . . . 60.030000000000001 111.107 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 54' ' ' LYS . 14.6 t70 -84.74 103.06 13.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.946 0.403 . . . . 72.019999999999996 110.243 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -62.14 -34.15 75.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.377 0.51 . . . . 74.140000000000001 112.377 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.65 -45.01 90.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.749 0.309 . . . . 73.400000000000006 111.181 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 92.0 mttt -66.42 -49.06 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.955 0.407 . . . . 71.340000000000003 111.036 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.17 -52.87 63.75 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.112 -0.495 . . . . 73.129999999999995 111.819 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HA ' HD12 ' A' ' 59' ' ' LEU . 96.2 t -58.57 -40.02 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.731 0.3 . . . . 65.150000000000006 111.639 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.47 -44.92 95.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.538 0.209 . . . . 74.129999999999995 111.39 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -62.96 -35.6 80.68 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.847 0.356 . . . . 60.420000000000002 111.314 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 56' ' ' VAL . 90.8 mt -64.09 -51.4 64.18 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.468 -0.333 . . . . 73.439999999999998 111.619 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.542 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 52.3 m-80 -58.31 -49.92 75.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.676 0.274 . . . . 72.540000000000006 111.571 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 49.1 mt-10 -50.29 -46.88 55.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.568 -0.287 . . . . 72.510000000000005 110.9 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -54.31 -51.77 63.62 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.305 0.483 . . . . 73.140000000000001 112.305 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -57.5 -39.37 76.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.547 0.213 . . . . 61.439999999999998 111.429 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 68' ' ' VAL . 32.5 mt-10 -68.64 -37.15 79.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.649 0.24 . . . . 70.200000000000003 111.649 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.9 mmtp -60.46 -36.78 79.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.9 0.381 . . . . 73.129999999999995 110.82 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.463 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 45.1 mtpt -55.94 -52.75 63.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.962 0.411 . . . . 64.519999999999996 110.975 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.76 -11.14 33.24 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.12 -0.491 . . . . 71.299999999999997 111.881 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 64' ' ' GLU . 83.4 t -85.66 -48.27 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.083 0.468 . . . . 61.240000000000002 111.036 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.15 -55.35 7.43 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.097 -0.501 . . . . 64.510000000000005 112.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.441 -0.79 . . . . 73.109999999999999 112.179 -178.696 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.498 0.19 . . . . 64.519999999999996 111.374 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 98.26 2.3 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.053 0.454 . . . . 74.109999999999999 110.71 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 mm -78.46 138.89 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.178 -0.464 . . . . 63.219999999999999 111.324 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 p -127.33 154.07 45.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.711 0.291 . . . . 62.229999999999997 110.719 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 10.2 ptpp? -64.46 -15.79 61.32 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.157 0.504 . . . . 71.239999999999995 111.237 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.44 -25.2 63.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.591 -0.731 . . . . 63.43 111.287 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.7 mtt -71.71 149.41 45.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.237 0.828 . . . . 53.340000000000003 113.237 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mm -78.76 133.37 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.405 -0.816 . . . . 35.200000000000003 110.928 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.67 -42.04 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 111.896 0.332 . . . . 51.420000000000002 111.896 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.0 94.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.964 0.357 . . . . 61.119999999999997 111.964 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.65 -45.99 88.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.093 0.473 . . . . 74.519999999999996 110.957 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.51 -37.52 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 53.409999999999997 111.249 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.36 -37.17 86.23 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.323 -0.399 . . . . 65.319999999999993 111.235 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -65.26 -21.83 66.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.365 -0.38 . . . . 64.109999999999999 111.428 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 29.7 mtm -84.68 -52.15 6.29 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.157 0.503 . . . . 74.129999999999995 110.091 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -146.55 128.81 15.76 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.919 -0.582 . . . . 73.549999999999997 111.042 176.819 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -73.04 -22.75 60.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.299 0.481 . . . . 71.310000000000002 112.299 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.55 -2.84 51.96 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.447 -0.406 . . . . 34.509999999999998 113.56 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 p -80.26 -24.39 40.13 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.502 -0.411 . . . . 61.240000000000002 111.762 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.7 -52.5 66.81 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.715 0.635 . . . . 74.530000000000001 112.715 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.0 Cg_endo -58.88 -24.57 73.04 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.117 1.878 . . . . 71.25 112.706 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -71.82 -44.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.928 0.394 . . . . 64.510000000000005 110.633 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.96 -49.9 76.11 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.185 0.517 . . . . 75.010000000000005 110.288 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -61.22 -34.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.111 -0.495 . . . . 54.299999999999997 111.265 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -57.76 -34.42 69.53 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.912 0.387 . . . . 64.519999999999996 111.326 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -93.73 12.94 23.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.398 0.518 . . . . 73.349999999999994 112.398 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.22 38.1 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.707 -0.758 . . . . 40.219999999999999 114.846 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.53 178.64 4.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.82 0.81 . . . . 65.510000000000005 111.32 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -159.85 109.7 1.85 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.046 0.45 . . . . 63.450000000000003 111.28 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.9 m -69.82 -22.91 63.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.199 -0.455 . . . . 51.509999999999998 111.681 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.66 124.9 43.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.515 -0.312 . . . . 54.530000000000001 110.368 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.14 -49.33 0.92 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.91 -0.662 . . . . 73.329999999999998 113.7 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.9 m -149.39 140.01 13.82 Favored Pre-proline 0 N--CA 1.472 0.66 0 O-C-N 122.556 -0.379 . . . . 45.549999999999997 111.506 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.47 -15.63 38.29 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.456 2.104 . . . . 72.140000000000001 113.055 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.8 p -53.97 -56.61 16.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.976 0.417 . . . . 75.310000000000002 111.66 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -57.24 -8.2 0.69 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.456 0.539 . . . . 44.530000000000001 112.456 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.577 ' HA ' ' HE2' ' A' ' 37' ' ' MET . 2.9 mmt -103.69 -47.78 4.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.907 0.384 . . . . 75.329999999999998 111.393 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.82 68.05 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.831 0.692 . . . . 72.530000000000001 114.831 -171.796 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 43.3 mt-10 -93.62 150.75 20.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 117.463 0.632 . . . . 72.439999999999998 111.65 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -68.96 153.45 43.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.411 -0.358 . . . . 62.549999999999997 111.063 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 5' ' ' LYS . 22.5 mt -52.16 -52.53 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 72.150000000000006 112.583 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 11.2 pt-20 -61.08 -33.1 72.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.964 0.412 . . . . 62.350000000000001 111.886 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 47' ' ' VAL . 39.0 t70 -75.87 -59.19 2.87 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 72.530000000000001 110.953 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . . . -57.48 -43.0 83.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.308 -0.405 . . . . 63.149999999999999 111.916 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.06 -49.04 77.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.364 -0.21 . . . . 74.439999999999998 111.438 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.15 73.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.008 0.432 . . . . 65.230000000000004 111.642 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 43' ' ' ASP . 87.0 t -61.05 -45.48 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.197 -0.456 . . . . 51.520000000000003 111.815 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -90.03 -10.38 45.09 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.716 0.293 . . . . 72.530000000000001 111.787 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.31 35.94 25.24 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.47 -0.395 . . . . 50.109999999999999 113.308 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.64 152.89 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.986 0.422 . . . . 72.109999999999999 111.721 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -82.24 97.42 8.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.026 0.441 . . . . 71.430000000000007 109.865 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -65.31 -31.55 72.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.524 0.565 . . . . 53.130000000000003 112.524 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 35.6 t70 -60.93 -45.31 95.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.898 0.38 . . . . 73.129999999999995 110.716 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.24 -40.42 77.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.784 0.326 . . . . 75.209999999999994 111.501 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 41' ' ' ILE . 23.2 tp -58.88 -49.89 76.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.056 0.455 . . . . 74.109999999999999 111.433 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 52' ' ' ALA . 92.4 t -57.48 -38.78 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.269 -0.423 . . . . 70.040000000000006 111.805 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.2 mttm -56.58 -53.68 54.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.769 0.319 . . . . 75.120000000000005 111.37 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.05 -36.51 75.16 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.46 -0.336 . . . . 75.430000000000007 111.638 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.93 -49.44 74.76 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 111.84 0.311 . . . . 63.329999999999998 111.84 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 33.6 m-80 -59.09 -52.4 65.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.657 0.265 . . . . 50.149999999999999 111.397 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.7 mt-10 -54.2 -41.28 68.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.221 -0.445 . . . . 72.310000000000002 111.53 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.16 -51.78 66.75 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.18 0.437 . . . . 72.310000000000002 112.18 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -62.35 -34.22 76.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.617 0.246 . . . . 71.450000000000003 111.455 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 31.3 mt-10 -65.77 -32.48 74.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.854 0.359 . . . . 71.120000000000005 111.375 175.12 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 72.2 mmtt -61.29 -38.52 87.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.473 -0.331 . . . . 74.310000000000002 111.71 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -55.04 -48.37 73.54 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.302 0.482 . . . . 65.540000000000006 112.302 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.2 -29.58 67.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.911 0.386 . . . . 74.319999999999993 111.577 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.82 -50.44 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.017 0.437 . . . . 63.229999999999997 111.285 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.6 -64.4 0.91 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.266 0.469 . . . . 74.200000000000003 112.266 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.683 -0.675 . . . . 75.329999999999998 112.179 -177.286 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.1 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.688 0.28 . . . . 75.019999999999996 111.281 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.58 109.36 21.3 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.36 -0.607 . . . . 71.439999999999998 109.36 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.524 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.1 mm -62.28 131.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.738 0.304 . . . . 53.450000000000003 111.652 -175.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.42 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 36.4 p -121.69 162.92 19.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.847 0.356 . . . . 75.430000000000007 110.902 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.04 -14.94 62.5 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.892 0.377 . . . . 74.109999999999999 111.506 178.193 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.73 -15.93 57.85 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.101 0.476 . . . . 64.239999999999995 111.403 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 65.0 mtt -72.82 154.29 40.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.428 0.632 . . . . 61.329999999999998 112.206 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -81.87 133.72 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.65 -0.705 . . . . 75.010000000000005 111.485 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.19 -51.45 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.173 0.434 . . . . 52.409999999999997 112.173 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -56.68 -32.97 65.94 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 74.430000000000007 111.621 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.02 -45.13 71.25 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.236 -0.438 . . . . 74.239999999999995 110.724 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.7 -37.21 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.259 0.552 . . . . 71.230000000000004 110.744 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.404 HD23 ' OG1' ' A' ' 19' ' ' THR . 83.1 mt -63.94 -31.13 72.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.115 -0.493 . . . . 74.430000000000007 111.919 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -71.6 -29.45 64.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.921 0.391 . . . . 52.109999999999999 111.061 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.0 mtt -66.52 -52.12 49.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.344 0.592 . . . . 72.219999999999999 110.03 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -154.77 135.3 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.786 -0.643 . . . . 74.099999999999994 111.225 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -68.84 -24.92 64.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.339 -0.391 . . . . 74.420000000000002 111.69 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -69.06 -1.37 25.82 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.379 -0.373 . . . . 70.349999999999994 113.874 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.404 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.9 p -82.58 -22.88 34.68 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.607 -0.349 . . . . 41.549999999999997 111.518 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.96 -51.39 79.83 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 112.59 0.589 . . . . 73.019999999999996 112.59 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -59.61 -26.36 81.84 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 121.896 1.731 . . . . 60.450000000000003 112.637 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -44.78 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.925 0.393 . . . . 54.5 110.846 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -56.59 -50.4 72.09 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.057 0.456 . . . . 75.239999999999995 110.173 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.93 -39.69 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.118 -0.492 . . . . 73.099999999999994 111.337 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.86 -39.73 68.93 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.052 -0.522 . . . . 63.420000000000002 111.849 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.61 -3.53 58.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.184 0.438 . . . . 64.409999999999997 112.184 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.44 0.72 11.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.476 0.95 . . . . 71.329999999999998 115.476 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 mmt -73.81 153.24 40.03 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.285 1.042 . . . . 63.5 111.815 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 60.4 t-80 -78.1 144.87 36.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.534 -0.303 . . . . 74.439999999999998 110.656 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -66.02 178.05 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.146 0.498 . . . . 62.009999999999998 112.323 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -54.09 106.55 0.2 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.127 -0.488 . . . . 61.399999999999999 110.937 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.24 -38.85 0.1 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.345 -0.455 . . . . 75.030000000000001 112.863 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.6 m -77.91 119.89 79.17 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 122.615 -0.344 . . . . 74.319999999999993 111.47 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -64.73 -42.12 16.5 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.887 2.391 . . . . 62.450000000000003 112.202 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.5 p -59.15 -61.94 2.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.783 -0.644 . . . . 73.299999999999997 111.907 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -49.59 -20.12 0.71 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.275 0.842 . . . . 54.140000000000001 113.275 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 27.4 mmt -76.39 -48.12 20.91 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.252 -0.28 . . . . 62.020000000000003 111.666 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.57 6.86 82.07 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.592 0.597 . . . . 61.340000000000003 114.592 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.72 158.42 20.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 63.539999999999999 112.024 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.7 m -72.26 151.26 42.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.97 -0.559 . . . . 63.399999999999999 112.24 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -51.35 -48.88 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.793 0.664 . . . . 61.32 112.793 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 14.9 pt-20 -63.17 -35.34 79.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.852 0.358 . . . . 55.030000000000001 111.642 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 47' ' ' VAL . 36.8 t0 -69.72 -53.56 17.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.189 -0.46 . . . . 75.439999999999998 110.751 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.75 71.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.212 0.53 . . . . 75.230000000000004 111.297 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 84.0 m -59.67 -52.92 63.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.948 -0.569 . . . . 62.350000000000001 111.199 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -39.68 69.85 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.252 0.464 . . . . 75.420000000000002 112.252 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 43' ' ' ASP . 91.9 t -59.56 -42.31 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.837 0.351 . . . . 73.239999999999995 111.446 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -104.23 9.81 35.93 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.306 0.484 . . . . 74.099999999999994 112.306 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.21 18.31 71.05 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 114.279 0.472 . . . . 61.340000000000003 114.279 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 45' ' ' CYS . 56.7 mt -73.59 154.86 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 122.526 0.33 . . . . 73.239999999999995 111.475 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.28 96.48 10.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.14 0.495 . . . . 74.329999999999998 110.61 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.48 -34.79 77.89 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.336 -0.393 . . . . 73.010000000000005 111.894 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 30.2 t70 -58.42 -42.5 87.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.613 -0.267 . . . . 72.230000000000004 111.494 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.54 -39.28 67.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.943 0.402 . . . . 72.409999999999997 111.288 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.3 tp -59.84 -49.47 77.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 73.439999999999998 111.636 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 59' ' ' LEU . 92.3 t -57.38 -36.73 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.371 -0.377 . . . . 73.5 111.816 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.4 mttm -56.32 -55.24 35.84 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.851 0.357 . . . . 54.43 111.171 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.83 -35.29 74.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.388 -0.369 . . . . 74.239999999999995 111.964 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 56' ' ' VAL . 93.0 mt -60.64 -52.9 63.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.645 0.259 . . . . 64.129999999999995 111.449 175.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -58.92 -51.81 68.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.82 0.343 . . . . 52.100000000000001 111.721 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.06 -30.18 65.98 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.029 0.381 . . . . 62.009999999999998 112.029 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.443 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 90.0 t80 -64.02 -44.91 91.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.938 0.399 . . . . 72.0 111.359 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -61.91 -31.96 72.31 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.224 -0.297 . . . . 72.230000000000004 111.133 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.06 -40.57 94.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.978 0.418 . . . . 71.439999999999998 110.726 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -62.13 -33.79 75.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.172 -0.467 . . . . 62.420000000000002 111.172 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -59.73 -43.53 94.14 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.686 0.279 . . . . 74.209999999999994 111.277 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.63 -23.93 67.42 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.852 0.358 . . . . 64.049999999999997 111.553 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -76.55 -53.11 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.161 0.505 . . . . 52.030000000000001 110.844 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.06 -57.51 9.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.027 -0.533 . . . . 75.209999999999994 112.166 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.643 -0.694 . . . . 64.299999999999997 112.167 -177.945 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.756 0.312 . . . . 74.519999999999996 110.998 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -98.52 115.14 27.93 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.704 0.288 . . . . 71.219999999999999 110.328 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.538 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.4 mm -62.14 132.07 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.77 0.655 . . . . 72.109999999999999 112.77 -172.319 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -120.76 159.37 25.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.195 -0.457 . . . . 64.030000000000001 110.953 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -15.92 61.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.087 0.47 . . . . 73.510000000000005 111.319 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.2 -26.37 56.06 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.654 -0.703 . . . . 74.409999999999997 111.552 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -65.57 158.42 27.15 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.423 0.63 . . . . 72.439999999999998 112.686 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 49.8 mm -84.54 134.96 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.926 -0.579 . . . . 70.329999999999998 111.329 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -56.66 -49.51 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.42 . . . . 71.450000000000003 111.312 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.92 68.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.307 -0.406 . . . . 71.319999999999993 111.516 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 13.2 t70 -72.59 -40.78 66.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.487 -0.324 . . . . 72.349999999999994 110.807 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 8' ' ' ILE . 57.9 t -57.72 -37.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.148 0.499 . . . . 73.129999999999995 110.335 173.525 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.15 -36.04 82.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.139 -0.482 . . . . 63.350000000000001 110.983 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.33 -29.3 70.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.727 0.298 . . . . 71.319999999999993 111.174 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -71.47 -49.29 42.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.224 0.535 . . . . 73.129999999999995 110.035 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -160.43 130.98 5.42 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.496 -0.775 . . . . 74.319999999999993 110.893 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -72.04 -20.28 61.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.959 0.355 . . . . 70.319999999999993 111.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.65 -1.44 45.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.56 -0.353 . . . . 74.329999999999998 113.476 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -19.55 46.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.521 -0.4 . . . . 75.319999999999993 111.721 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.09 -49.91 87.31 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.353 0.501 . . . . 72.010000000000005 112.353 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 76.7 Cg_exo -48.99 -42.08 38.92 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.399 2.066 . . . . 64.349999999999994 112.826 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.94 -45.31 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.169 -0.469 . . . . 74.310000000000002 111.403 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -58.67 -46.88 86.23 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 71.5 110.508 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD11 ' SG ' ' A' ' 30' ' ' CYS . 72.7 mt -58.96 -39.07 77.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.019 -0.537 . . . . 62.450000000000003 111.387 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.62 -36.29 73.83 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.312 -0.404 . . . . 64.400000000000006 111.571 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -86.68 4.46 40.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.637 0.606 . . . . 74.019999999999996 112.637 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.54 39.97 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.672 -0.775 . . . . 74.519999999999996 114.499 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.53 171.69 9.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.677 0.739 . . . . 73.349999999999994 111.419 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.19 131.33 32.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.16 -0.473 . . . . 74.340000000000003 111.214 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 24' ' ' ILE . 80.4 m -73.49 74.49 1.43 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.394 0.616 . . . . 73.530000000000001 111.347 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 32' ' ' GLY . 1.3 tm? -123.24 131.48 53.69 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.979 -0.555 . . . . 72.310000000000002 109.967 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -74.86 64.98 2.24 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.501 -0.38 . . . . 73.430000000000007 113.904 -175.63 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 31' ' ' LEU . 67.4 m -129.6 126.52 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.408 0.283 . . . . 74.010000000000005 110.775 175.448 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HA ' ' H ' ' A' ' 38' ' ' GLY . 97.3 Cg_exo -44.74 -39.44 13.64 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.174 2.582 . . . . 72.420000000000002 113.913 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.3 t -55.43 -29.21 58.19 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.629 0.603 . . . . 74.430000000000007 112.629 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -107.99 -10.09 15.55 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.036 0.384 . . . . 75.25 112.036 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.2 mmt -121.74 -61.14 1.54 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.217 0.451 . . . . 74.239999999999995 112.217 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 34' ' ' PRO . . . -71.51 -20.83 78.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.315 0.486 . . . . 65.409999999999997 114.315 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -82.06 178.1 8.46 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.303 0.573 . . . . 73.310000000000002 112.349 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 92.5 p -78.63 161.54 26.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.292 -0.413 . . . . 72.340000000000003 111.391 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.8 mt -56.67 -47.81 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.493 -0.321 . . . . 75.510000000000005 111.781 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.07 -43.27 99.19 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.698 0.258 . . . . 74.030000000000001 111.698 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.14 -52.05 66.98 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.05 0.389 . . . . 74.540000000000006 112.05 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.49 88.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.777 0.322 . . . . 71.310000000000002 111.614 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.406 ' SG ' HD23 ' A' ' 55' ' ' LEU . 97.6 m -53.52 -46.46 70.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.68 -0.236 . . . . 73.409999999999997 111.166 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.04 67.61 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.987 0.365 . . . . 74.310000000000002 111.987 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.2 -46.14 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.976 0.417 . . . . 63.109999999999999 111.504 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 59.8 t-80 -89.04 -10.02 49.07 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.456 -0.338 . . . . 64.140000000000001 111.73 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.26 37.87 30.83 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.106 -0.568 . . . . 72.150000000000006 112.795 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.8 mt -93.03 151.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.663 0.385 . . . . 61.340000000000003 111.293 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -80.88 102.01 9.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.958 0.409 . . . . 74.329999999999998 110.383 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.99 65.14 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.153 0.427 . . . . 74.150000000000006 112.153 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.22 -50.91 71.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.88 0.371 . . . . 71.329999999999998 110.446 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -70.26 -47.93 59.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.525 . . . . 73.030000000000001 112.032 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.406 HD23 ' SG ' ' A' ' 45' ' ' CYS . 29.5 tp -52.76 -52.64 55.75 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.952 0.406 . . . . 65.439999999999998 111.725 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.513 HG13 HG22 ' A' ' 3' ' ' ILE . 88.1 t -61.05 -40.52 85.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 74.349999999999994 111.78 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 98.7 mttt -69.72 -29.45 66.84 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.22 -0.3 . . . . 64.439999999999998 111.745 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.61 -39.4 73.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.879 0.371 . . . . 62.32 110.794 171.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.8 mt -58.12 -46.83 84.9 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.378 -0.374 . . . . 54.32 110.674 172.741 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 21.4 m-80 -54.2 -55.97 22.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.251 -0.431 . . . . 73.209999999999994 111.595 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.0 mt-10 -46.05 -48.82 16.85 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.075 0.464 . . . . 75.549999999999997 111.201 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -54.21 -52.4 61.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.87 -0.605 . . . . 72.040000000000006 112.384 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.79 -39.17 93.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.723 0.297 . . . . 71.099999999999994 111.352 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 39.8 mt-10 -63.79 -33.62 76.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.98 0.419 . . . . 64.409999999999997 110.979 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 35.7 mmtp -69.02 -38.69 79.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.345 -0.389 . . . . 52.240000000000002 111.24 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 43.1 mtpt -55.98 -44.84 78.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.825 0.306 . . . . 65.430000000000007 111.825 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -62.7 -11.83 19.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.037 0.384 . . . . 65.129999999999995 112.037 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.33 -51.32 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.185 0.517 . . . . 52.43 110.699 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.99 -55.59 24.46 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.749 0.648 . . . . 53.329999999999998 112.749 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.773 -0.632 . . . . 73.030000000000001 112.192 179.565 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.859 0.361 . . . . 71.25 111.847 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 99.97 2.98 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.993 -0.373 . . . . 55.340000000000003 109.993 171.528 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 mm -68.76 136.68 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.265 -0.425 . . . . 73.349999999999994 111.496 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 27.3 p -119.27 155.31 32.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.66 0.267 . . . . 74.340000000000003 110.862 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 17.0 ptpt -64.67 -14.66 59.24 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.177 0.513 . . . . 71.010000000000005 111.415 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.55 -16.07 55.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.691 -0.686 . . . . 73.200000000000003 111.669 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.437 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.4 mtt -75.39 164.87 25.95 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.506 0.67 . . . . 73.099999999999994 112.582 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -88.57 138.06 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.568 -0.742 . . . . 74.519999999999996 111.513 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.1 mt -54.5 -53.28 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.994 0.426 . . . . 70.219999999999999 111.699 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.84 75.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.833 0.349 . . . . 74.329999999999998 111.796 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.77 -39.63 94.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.802 0.334 . . . . 75.439999999999998 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.38 -39.73 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.044 0.45 . . . . 60.340000000000003 110.844 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.494 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -61.43 -34.53 75.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.149 0.5 . . . . 74.430000000000007 111.096 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -68.89 -18.77 64.17 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.056 -0.52 . . . . 51.200000000000003 111.485 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.4 mtt -81.23 -50.35 9.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.38 0.61 . . . . 73.099999999999994 109.791 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.5 132.5 14.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.965 -0.561 . . . . 70.340000000000003 111.716 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -74.17 -16.25 60.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.606 0.595 . . . . 72.25 112.606 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.57 -2.21 79.59 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.14 -0.552 . . . . 71.120000000000005 113.415 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.494 ' OG1' HD23 ' A' ' 13' ' ' LEU . 74.3 p -80.51 -22.1 41.26 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.114 0.413 . . . . 74.420000000000002 112.114 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.83 -50.64 84.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 112.722 0.638 . . . . 31.109999999999999 112.722 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 75.7 Cg_exo -49.86 -41.24 47.71 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.198 1.932 . . . . 72.299999999999997 112.657 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.41 -44.98 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.167 -0.47 . . . . 64.340000000000003 111.492 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -58.24 -51.56 69.23 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 54.350000000000001 110.936 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.51 -38.98 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.928 0.394 . . . . 75.219999999999999 111.107 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -51.86 -41.87 62.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.979 -0.555 . . . . 71.430000000000007 111.536 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -85.48 -4.26 59.11 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.277 0.473 . . . . 73.109999999999999 112.277 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.5 -5.35 9.31 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.662 -0.78 . . . . 62.549999999999997 114.972 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.2 mmt -65.28 143.15 57.98 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.208 1.004 . . . . 74.349999999999994 111.833 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -109.36 83.72 1.8 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.211 -0.45 . . . . 74.450000000000003 110.496 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' CYS . . . . . 0.646 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 76.7 m -66.48 100.41 0.66 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.381 0.511 . . . . 51.030000000000001 112.381 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -169.95 83.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 111.883 0.327 . . . . 71.25 111.883 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 -63.01 1.79 Allowed Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.733 1.053 . . . . 62.450000000000003 115.733 168.616 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.3 m -49.02 147.29 4.9 Favored Pre-proline 0 N--CA 1.476 0.834 0 N-CA-C 113.612 0.967 . . . . 61.240000000000002 113.612 -172.581 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.09 -45.62 35.66 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.194 2.596 . . . . 63.200000000000003 113.615 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 m -61.98 -10.21 9.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.071 0.462 . . . . 73.420000000000002 111.694 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.646 ' OG ' ' HA ' ' A' ' 30' ' ' CYS . 15.4 t -102.18 -25.22 13.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.161 -0.472 . . . . 44.240000000000002 111.601 176.447 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 mmt -125.69 -69.19 0.79 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.957 0.725 . . . . 64.049999999999997 112.957 -172.809 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.97 -22.28 63.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.795 1.078 . . . . 75.540000000000006 115.795 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -87.24 160.72 18.35 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 117.876 0.838 . . . . 74.150000000000006 111.788 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.7 p -73.14 158.11 35.94 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.309 0.576 . . . . 54.530000000000001 112.503 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mt -54.79 -56.03 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.812 -0.631 . . . . 75.230000000000004 112.476 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.1 pt-20 -60.81 -44.72 96.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.13 0.419 . . . . 63.039999999999999 112.13 -176.975 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.401 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 t0 -65.59 -45.21 84.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.971 0.415 . . . . 73.409999999999997 110.987 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.73 81.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.429 . . . . 61.399999999999999 111.455 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.35 -49.59 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.413 -0.358 . . . . 75.030000000000001 111.26 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.88 -36.21 62.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.121 0.415 . . . . 74.329999999999998 112.121 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.19 -37.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.993 0.425 . . . . 74.239999999999995 111.854 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.92 18.09 16.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.403 0.519 . . . . 62.299999999999997 112.403 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.19 27.83 68.1 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 72.049999999999997 113.79 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.33 150.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.895 0.379 . . . . 70.140000000000001 111.117 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.66 97.27 10.79 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.821 0.344 . . . . 75.0 110.215 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.29 -36.55 81.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.105 0.409 . . . . 75.010000000000005 112.105 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -42.87 83.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.149 0.5 . . . . 64.409999999999997 111.072 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.65 -44.11 57.73 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.249 -0.432 . . . . 64.219999999999999 111.529 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -55.36 -49.34 72.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.959 0.409 . . . . 72.209999999999994 111.951 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 5' ' ' LYS . 93.0 t -59.32 -38.28 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.395 -0.366 . . . . 64.030000000000001 111.837 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.69 -43.84 98.09 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.719 0.295 . . . . 73.239999999999995 110.638 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -60.17 -37.9 81.57 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 65.310000000000002 111.359 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 56' ' ' VAL . 84.8 mt -63.36 -53.98 44.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.484 -0.325 . . . . 71.200000000000003 111.517 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.6 m-80 -56.71 -54.22 48.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.918 0.34 . . . . 73.400000000000006 111.918 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.9 mt-10 -52.96 -38.51 62.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.612 -0.267 . . . . 75.519999999999996 111.334 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.86 -49.29 78.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.876 0.37 . . . . 64.310000000000002 111.762 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -59.69 -34.53 72.99 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.741 0.305 . . . . 72.120000000000005 110.897 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 37.8 mt-10 -64.82 -38.15 90.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.853 0.359 . . . . 72.310000000000002 110.806 174.724 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 31.4 mmmt -57.12 -40.47 77.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.963 0.411 . . . . 72.109999999999999 110.236 175.148 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 51.0 mtpt -59.66 -43.32 94.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 71.099999999999994 111.194 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -57.68 -29.41 64.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.968 0.413 . . . . 71.420000000000002 111.53 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.1 t -80.3 -53.42 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.05 0.452 . . . . 72.129999999999995 111.158 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.17 -52.1 67.15 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.117 0.784 . . . . 65.340000000000003 113.117 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 C--O 1.256 1.404 0 CA-C-O 118.837 -0.602 . . . . 74.519999999999996 112.3 -177.87 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.6 0.238 . . . . 74.439999999999998 111.277 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -96.13 127.33 42.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.822 0.344 . . . . 35.409999999999997 110.573 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mm -70.74 139.47 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.066 0.46 . . . . 62.530000000000001 111.785 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -122.99 153.13 40.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.417 -0.356 . . . . 70.219999999999999 110.748 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 46.2 pttt -63.36 -15.51 57.67 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.903 0.382 . . . . 74.439999999999998 111.98 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.5 -29.83 63.98 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.97 -0.559 . . . . 73.040000000000006 111.409 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 65.2 mtt -63.6 150.51 43.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.728 0.64 . . . . 75.530000000000001 112.728 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mm -78.37 136.06 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.683 -0.69 . . . . 64.510000000000005 111.116 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.44 -48.75 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.762 0.315 . . . . 73.209999999999994 111.771 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -59.72 -33.5 71.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.897 0.332 . . . . 75.040000000000006 111.897 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.17 -41.73 85.47 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.823 0.344 . . . . 72.219999999999999 111.184 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.2 t -60.44 -39.24 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.105 0.479 . . . . 75.129999999999995 110.945 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD23 ' OG1' ' A' ' 19' ' ' THR . 88.1 mt -62.22 -31.01 71.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.26 -0.427 . . . . 73.040000000000006 111.519 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 84.3 mm-40 -67.34 -27.01 66.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.941 0.401 . . . . 71.530000000000001 111.321 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.2 mtt -75.0 -48.38 24.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.34 0.59 . . . . 73.549999999999997 110.064 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -154.99 132.54 11.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.722 -0.672 . . . . 54.130000000000003 110.761 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -70.15 -28.41 65.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.093 0.473 . . . . 53.340000000000003 111.611 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.04 2.09 14.94 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.078 -0.51 . . . . 74.450000000000003 113.807 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.456 ' OG1' HD23 ' A' ' 13' ' ' LEU . 72.6 p -82.72 -19.24 38.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.514 -0.403 . . . . 75.329999999999998 111.384 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.35 -51.41 78.17 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.654 0.613 . . . . 50.340000000000003 112.654 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.5 Cg_endo -57.84 -31.03 91.42 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.953 1.768 . . . . 61.200000000000003 112.59 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.97 -46.65 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.98 0.419 . . . . 72.200000000000003 110.914 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 68.7 m-85 -57.52 -46.82 83.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.204 0.525 . . . . 74.329999999999998 110.266 171.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 28' ' ' MET . 73.6 mt -58.05 -36.67 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.958 -0.565 . . . . 75.430000000000007 111.668 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -61.73 -32.96 73.23 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.973 0.416 . . . . 64.239999999999995 111.574 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.7 1.38 55.51 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.242 0.46 . . . . 74.319999999999993 112.242 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.78 10.3 16.81 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.425 -0.893 . . . . 42.439999999999998 114.896 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.416 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.2 mmt -86.93 156.93 19.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.85 -0.794 . . . . 54.450000000000003 111.435 175.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' HIS . . . . . 0.47 ' HB3' HD23 ' A' ' 31' ' ' LEU . 77.7 m80 -139.75 93.35 2.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.175 0.512 . . . . 62.530000000000001 111.209 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 76.3 m -88.6 56.69 3.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.172 0.51 . . . . 52.229999999999997 111.958 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 29' ' ' HIS . 4.0 mm? -85.8 36.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.925 0.393 . . . . 74.510000000000005 111.037 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.57 80.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.318 -0.468 . . . . 60.43 112.744 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.7 m -71.03 119.1 71.38 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.479 0.312 . . . . 63.310000000000002 111.472 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.68 -54.05 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.252 2.634 . . . . 72.549999999999997 114.012 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -60.45 -42.13 95.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.018 0.437 . . . . 73.239999999999995 111.758 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -70.98 -8.96 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 74.150000000000006 111.938 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.6 mmt -104.93 -67.28 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.626 0.602 . . . . 73.5 112.626 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.42 3.15 87.03 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 114.986 0.754 . . . . 73.319999999999993 114.986 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.77 156.38 20.39 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.594 0.697 . . . . 73.530000000000001 112.156 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.0 m -67.5 156.22 37.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.915 0.709 . . . . 73.019999999999996 112.915 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -55.11 -60.24 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.615 0.598 . . . . 72.5 112.615 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.5 pt-20 -61.95 -36.01 80.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.873 0.368 . . . . 73.530000000000001 111.847 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.44 -48.43 72.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.888 0.375 . . . . 53.350000000000001 110.918 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.14 77.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.065 0.459 . . . . 61.520000000000003 111.538 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 94.4 m -58.81 -44.59 90.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.442 -0.345 . . . . 73.310000000000002 111.22 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.54 62.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.007 0.373 . . . . 73.510000000000005 112.007 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.67 -41.75 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 111.821 0.304 . . . . 73.450000000000003 111.821 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -112.31 17.11 19.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 71.140000000000001 111.862 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.97 23.11 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.123 -0.561 . . . . 74.409999999999997 113.763 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.1 150.27 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.905 0.383 . . . . 71.430000000000007 111.639 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.57 108.3 17.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.125 0.488 . . . . 54.329999999999998 110.203 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -75.08 -25.05 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 73.219999999999999 111.962 -176.632 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 13.9 t70 -60.92 -47.86 84.47 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.017 0.436 . . . . 74.349999999999994 110.621 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.76 -39.78 66.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.127 -0.488 . . . . 64.200000000000003 111.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.87 -50.47 72.38 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.08 0.466 . . . . 75.299999999999997 111.077 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' HD12 ' A' ' 59' ' ' LEU . 78.6 t -59.27 -38.5 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.217 -0.447 . . . . 73.239999999999995 111.442 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.0 mttm -57.82 -50.38 73.47 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.544 0.201 . . . . 63.409999999999997 111.544 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -58.53 -38.44 77.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.826 0.346 . . . . 73.040000000000006 111.577 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 56' ' ' VAL . 85.2 mt -61.64 -50.97 70.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.734 0.302 . . . . 75.140000000000001 111.534 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 39.7 m-80 -59.0 -55.78 30.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.932 0.345 . . . . 73.340000000000003 111.932 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.3 mt-10 -52.81 -36.79 58.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.728 0.299 . . . . 73.239999999999995 111.577 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -58.27 -51.68 68.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.367 . . . . 74.120000000000005 111.495 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.75 -34.76 76.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.729 0.299 . . . . 74.230000000000004 111.31 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 32.8 mt-10 -65.97 -36.98 84.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.881 0.372 . . . . 75.140000000000001 110.911 175.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 73.5 mmtt -63.3 -37.5 87.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.235 -0.439 . . . . 73.319999999999993 110.928 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 46.2 mtpt -56.13 -44.05 78.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.666 0.27 . . . . 61.420000000000002 111.418 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.74 -28.98 64.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.944 0.402 . . . . 74.329999999999998 111.353 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.2 t -85.42 -52.66 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.284 0.564 . . . . 55.32 111.506 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -64.53 -54.72 27.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.071 -0.513 . . . . 63.140000000000001 112.35 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.605 -0.712 . . . . 74.030000000000001 111.894 -179.041 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.768 0.318 . . . . 73.299999999999997 111.284 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 9.8 mmpt? -74.94 162.82 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.755 0.312 . . . . 62.520000000000003 111.111 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.402 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 44.6 mm -74.44 137.99 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.716 0.293 . . . . 74.239999999999995 111.66 -178.206 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 41.8 p -119.84 160.81 21.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.554 -0.294 . . . . 72.150000000000006 110.553 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.3 pttp -73.71 -16.77 61.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.069 -0.394 . . . . 62.240000000000002 111.414 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.19 -25.05 62.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.086 -0.506 . . . . 75.530000000000001 111.102 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.433 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.0 mtt -62.41 139.86 58.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.438 0.637 . . . . 70.049999999999997 111.832 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 44.9 mm -69.53 137.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.772 -0.649 . . . . 62.329999999999998 110.953 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -54.04 -46.21 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.851 0.357 . . . . 62.210000000000001 111.273 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -60.2 -36.37 77.52 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.802 0.335 . . . . 64.340000000000003 111.426 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.495 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 12.0 t70 -63.18 -43.98 96.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.041 0.448 . . . . 73.140000000000001 110.516 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 41' ' ' ILE . 51.6 t -61.19 -40.1 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.141 0.496 . . . . 72.129999999999995 110.722 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.23 -33.12 74.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.243 -0.435 . . . . 63.240000000000002 111.304 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 74.0 mt-30 -64.21 -30.33 71.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.362 . . . . 54.409999999999997 111.242 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.6 mtt -71.89 -51.59 21.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.283 0.563 . . . . 71.150000000000006 110.072 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.29 125.66 5.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.55 -0.75 . . . . 70.230000000000004 110.693 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -71.72 -15.47 62.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.006 0.373 . . . . 73.510000000000005 112.006 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.58 -1.75 39.29 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.212 -0.518 . . . . 44.210000000000001 113.157 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.0 p -82.64 -17.87 43.09 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.698 -0.295 . . . . 63.030000000000001 111.573 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.25 -51.06 82.89 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.223 0.453 . . . . 63.100000000000001 112.223 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -58.58 -25.76 75.97 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.957 1.772 . . . . 60.009999999999998 112.554 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.74 -44.77 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.995 0.426 . . . . 53.020000000000003 110.812 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -58.19 -45.82 86.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 71.019999999999996 110.406 173.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.96 -40.81 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.192 0.52 . . . . 63.509999999999998 110.911 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -56.86 -30.06 63.47 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.622 -0.717 . . . . 72.340000000000003 112.001 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -96.82 1.47 50.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.553 0.575 . . . . 74.200000000000003 112.553 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -3.0 22.84 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.476 -0.869 . . . . 22.449999999999999 115.11 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt -69.03 141.78 54.75 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.251 1.026 . . . . 45.420000000000002 112.287 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -133.28 143.01 48.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.763 -0.653 . . . . 74.439999999999998 110.882 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.3 m -61.53 136.22 57.94 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.013 0.435 . . . . 75.430000000000007 111.679 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 1.2 tm? -135.83 135.78 40.09 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.616 -0.512 . . . . 62.399999999999999 109.616 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -56.87 -46.69 90.22 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.177 0.431 . . . . 65.420000000000002 114.177 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -56.63 130.25 77.09 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.915 0.357 . . . . 74.109999999999999 111.42 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.99 -23.71 44.85 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.978 2.452 . . . . 65.200000000000003 113.59 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -49.56 -36.94 25.38 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.062 0.393 . . . . 75.549999999999997 112.062 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 73.0 p -51.46 -44.52 62.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.307 0.575 . . . . 74.439999999999998 111.72 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.482 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 4.6 mmt -90.35 -28.27 18.82 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.792 -0.64 . . . . 55.420000000000002 111.807 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.55 -21.48 60.0 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.891 0.716 . . . . 74.219999999999999 114.891 -170.734 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.1 167.78 11.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.785 0.793 . . . . 72.519999999999996 112.504 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 90.2 p -75.55 160.12 30.5 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.928 -0.578 . . . . 54.229999999999997 112.207 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 12' ' ' VAL . 22.3 mt -54.74 -52.57 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.093 -0.503 . . . . 64.140000000000001 111.901 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.0 pt-20 -62.97 -40.33 97.38 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.877 0.325 . . . . 64.219999999999999 111.877 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.7 t70 -62.58 -51.14 68.51 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 54.439999999999998 110.499 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.07 94.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.01 -0.541 . . . . 52.340000000000003 111.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -58.49 -45.82 87.94 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.561 -0.29 . . . . 72.310000000000002 111.307 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -35.8 74.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.753 0.311 . . . . 74.540000000000006 111.656 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 43' ' ' ASP . 61.2 t -65.98 -43.24 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.192 0.52 . . . . 63.149999999999999 111.364 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.46 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.3 t-80 -86.59 -14.82 41.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.2 -0.454 . . . . 75.030000000000001 111.435 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 38.61 23.44 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 116.455 -0.339 . . . . 71.209999999999994 113.13 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 48' ' ' HIS . 27.9 mt -98.02 153.36 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 122.927 0.491 . . . . 72.129999999999995 111.284 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.55 101.92 8.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.018 0.437 . . . . 75.25 109.904 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.45 -34.69 77.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.444 0.535 . . . . 55.210000000000001 112.444 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.01 -45.5 82.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.829 0.347 . . . . 72.219999999999999 111.066 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.26 -47.03 75.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.4 -0.363 . . . . 73.200000000000003 111.254 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 29.9 tp -57.51 -50.83 71.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.244 -0.435 . . . . 75.129999999999995 111.306 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 5' ' ' LYS . 85.4 t -60.79 -39.62 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.508 -0.314 . . . . 71.109999999999999 111.615 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.65 -41.67 98.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.454 0.168 . . . . 64.219999999999999 111.454 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.82 -40.53 95.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.706 0.289 . . . . 62.140000000000001 111.043 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 56' ' ' VAL . 91.1 mt -59.6 -52.24 66.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.617 -0.265 . . . . 55.030000000000001 110.971 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.56 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 39.7 m-80 -54.67 -57.97 9.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.622 -0.263 . . . . 44.009999999999998 111.537 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 51.3 mt-10 -54.07 -37.78 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.552 -0.295 . . . . 72.310000000000002 111.667 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -58.4 -51.3 70.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.842 0.353 . . . . 63.310000000000002 111.31 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -61.61 -35.09 76.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.695 0.283 . . . . 73.439999999999998 110.971 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 41.8 mt-10 -69.48 -28.18 65.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.657 0.265 . . . . 52.32 111.287 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 75.4 mmtt -64.22 -39.52 94.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.344 0.592 . . . . 72.349999999999994 109.61 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.43 -44.76 93.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.667 -0.697 . . . . 63.100000000000001 110.474 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -53.73 -28.49 34.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.986 0.422 . . . . 61.340000000000003 111.63 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 64' ' ' GLU . 80.1 t -77.37 -50.22 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.087 0.47 . . . . 65.239999999999995 111.611 175.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -75.31 -59.26 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.339 0.866 . . . . 72.140000000000001 113.339 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.255 1.371 0 N-CA-C 113.304 0.853 . . . . 61.200000000000003 113.304 -173.906 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.621 0.248 . . . . 70.109999999999999 111.171 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -69.77 111.78 5.77 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.761 -0.459 . . . . 71.439999999999998 109.761 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' ILE . . . . . 0.519 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.8 mm -62.06 130.51 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.426 0.528 . . . . 74.340000000000003 112.426 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.6 p -120.21 167.21 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.95 -0.568 . . . . 60.409999999999997 110.336 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.9 ptpt -74.28 -8.79 57.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.134 0.492 . . . . 65.319999999999993 110.873 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.91 -24.9 32.92 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.898 -0.592 . . . . 53.240000000000002 111.818 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.3 mtt -66.23 156.92 32.82 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.653 0.612 . . . . 73.120000000000005 112.653 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.8 133.78 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.871 -0.604 . . . . 74.129999999999995 111.165 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.89 -50.49 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.207 0.447 . . . . 73.219999999999999 112.207 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -59.74 -38.07 80.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 70.040000000000006 111.655 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.38 -44.3 92.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 74.140000000000001 110.772 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.4 -42.16 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.112 -0.495 . . . . 73.540000000000006 111.105 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.39 -34.14 73.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.214 -0.448 . . . . 70.109999999999999 111.91 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -69.23 -22.87 63.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.77 0.319 . . . . 74.409999999999997 111.719 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.6 mtm -83.3 -45.51 13.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.048 0.451 . . . . 75.019999999999996 110.193 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -152.08 112.93 4.2 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.901 -0.59 . . . . 73.329999999999998 110.889 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.3 -11.91 53.42 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.832 0.679 . . . . 74.0 112.832 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.469 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -70.16 -9.53 63.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.175 -0.536 . . . . 74.129999999999995 112.916 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -78.67 -16.36 57.39 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.566 -0.373 . . . . 74.140000000000001 111.707 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -56.62 -52.01 76.86 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 112.391 0.515 . . . . 70.409999999999997 112.391 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 52.2 Cg_exo -52.63 -38.22 75.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.011 1.807 . . . . 70.120000000000005 112.438 175.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.66 -46.49 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.096 -0.502 . . . . 73.129999999999995 111.162 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 54.4 m-85 -59.03 -46.22 88.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.849 0.357 . . . . 74.310000000000002 110.836 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.83 -37.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.913 0.387 . . . . 70.329999999999998 111.206 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -56.14 -40.31 73.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.059 -0.519 . . . . 74.530000000000001 111.337 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 55' ' ' LEU . 39.9 m-80 -87.79 -2.37 58.57 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.389 0.515 . . . . 71.239999999999995 112.389 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.7 11.44 30.66 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 115.011 0.764 . . . . 71.219999999999999 115.011 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' MET . . . . . 0.536 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 25.4 mmt -76.3 156.57 33.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.984 0.892 . . . . 62.030000000000001 110.975 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -138.54 127.88 24.44 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.686 0.624 . . . . 75.549999999999997 112.686 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.4 t -104.55 4.4 32.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.302 0.573 . . . . 64.230000000000004 110.79 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.58 106.72 5.47 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.183 -0.462 . . . . 64.349999999999994 111.2 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.34 -69.59 3.31 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.279 -0.418 . . . . 71.25 113.78 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.8 m -85.77 117.62 69.07 Favored Pre-proline 0 N--CA 1.472 0.661 0 N-CA-C 112.355 0.502 . . . . 60.149999999999999 112.355 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.96 -4.85 16.09 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.708 2.272 . . . . 71.219999999999999 113.009 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.5 t -51.24 -60.41 3.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.556 0.217 . . . . 62.310000000000002 111.414 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.0 t -53.55 -20.27 4.8 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.489 0.551 . . . . 74.030000000000001 112.489 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' MET . . . . . 0.434 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 4.2 mmt -84.48 -46.81 11.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.01 0.433 . . . . 62.329999999999998 111.262 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.75 22.56 13.35 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 114.266 0.466 . . . . 73.200000000000003 114.266 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.33 170.4 13.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.199 0.524 . . . . 62.340000000000003 112.231 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 m -72.41 147.65 45.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.864 -0.607 . . . . 64.200000000000003 111.805 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ILE . . . . . 0.42 HG23 HD23 ' A' ' 55' ' ' LEU . 32.3 mt -51.41 -52.36 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.291 0.478 . . . . 73.439999999999998 112.291 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.9 pt-20 -62.61 -34.81 77.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.741 0.275 . . . . 65.430000000000007 111.741 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.0 t70 -65.57 -52.39 52.66 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 72.099999999999994 110.633 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.91 77.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.23 0.538 . . . . 72.219999999999999 111.077 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 93.0 m -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.129 -0.487 . . . . 63.340000000000003 111.392 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.07 52.27 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.264 0.468 . . . . 73.310000000000002 112.264 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 43' ' ' ASP . 48.0 t -65.07 -52.1 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.984 0.421 . . . . 65.129999999999995 111.716 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' HIS . . . . . 0.448 ' HB2' HG13 ' A' ' 50' ' ' ILE . 85.4 m-70 -98.87 3.19 47.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.021 0.378 . . . . 63.439999999999998 112.021 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.01 67.12 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.008 -0.615 . . . . 73.140000000000001 112.944 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 48' ' ' HIS . 50.5 mt -73.45 150.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.884 0.373 . . . . 65.209999999999994 111.291 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.5 97.28 10.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.197 0.522 . . . . 72.329999999999998 109.766 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -64.74 -31.28 72.44 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.407 0.521 . . . . 73.409999999999997 112.407 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 2.9 t70 -63.63 -40.35 96.66 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.663 0.268 . . . . 75.420000000000002 110.879 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.32 -47.5 84.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.052 0.453 . . . . 72.319999999999993 110.668 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.9 tp -58.05 -48.5 79.92 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.804 -0.635 . . . . 53.030000000000001 111.262 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 52' ' ' ALA . 89.6 t -57.12 -42.58 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.219 -0.446 . . . . 54.420000000000002 111.754 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.5 mttm -56.5 -52.96 62.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.853 0.359 . . . . 73.209999999999994 110.812 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -55.11 -40.32 70.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.081 -0.509 . . . . 54.439999999999998 111.622 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 95.4 mt -64.0 -55.41 22.53 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.114 0.413 . . . . 73.450000000000003 112.114 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 51.6 m-80 -55.47 -51.47 66.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.72 0.295 . . . . 61.420000000000002 111.58 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 37.5 mt-10 -59.56 -27.84 66.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.434 -0.348 . . . . 54.420000000000002 111.68 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.469 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 85.8 t80 -69.66 -47.12 64.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.627 -0.261 . . . . 74.450000000000003 111.318 175.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -58.16 -33.02 68.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.763 0.315 . . . . 61.329999999999998 111.23 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -61.01 -40.31 93.08 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.765 0.317 . . . . 61.210000000000001 111.22 171.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 44.3 mmtm -63.19 -34.6 77.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.453 -0.339 . . . . 61.43 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -47.61 -62.29 1.52 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.336 0.495 . . . . 73.010000000000005 112.336 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.23 -11.76 52.02 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.428 0.529 . . . . 71.510000000000005 112.428 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.9 t -86.56 -54.4 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.983 0.421 . . . . 72.430000000000007 111.054 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.3 mt -70.56 -53.2 16.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.132 -0.485 . . . . 44.210000000000001 111.977 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 119.115 -0.469 . . . . 55.240000000000002 111.977 179.563 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 mm . . . . . 0 N--CA 1.472 0.634 0 CA-C-O 121.064 0.459 . . . . 75.32 112.135 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.8 p -122.81 155.12 37.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.472 -0.331 . . . . 75.53 110.526 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.548 ' HB3' HG21 ' A' ' 56' ' ' VAL . 10.4 ptpp? -69.62 -17.65 63.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.917 -0.489 . . . . 70.11 111.969 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.98 -17.61 60.51 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.933 0.397 . . . . 73.22 111.221 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.466 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 66.0 mtt -66.38 149.82 49.82 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.139 0.495 . . . . 74.53 111.841 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -79.11 133.19 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.245 -0.434 . . . . 71.41 111.317 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.7 mt -55.55 -48.88 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.848 0.356 . . . . 72.11 111.367 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.51 69.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.046 0.387 . . . . 73.44 112.046 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.18 -38.97 60.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.742 0.306 . . . . 54.04 111.323 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 8' ' ' ILE . 61.6 t -60.08 -40.04 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.523 . . . . 63.21 110.24 173.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.468 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.8 mt -61.43 -25.44 67.21 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.934 -0.575 . . . . 75.32 111.63 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -73.7 -32.26 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.814 0.34 . . . . 71.13 111.098 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mtt -71.24 -39.48 71.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 74.31 110.129 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 19' ' ' THR . 40.0 t0 -160.05 130.22 5.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.275 -0.875 . . . . 74.41 111.018 176.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.91 -22.68 62.22 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.082 0.467 . . . . 63.24 110.637 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.69 2.16 49.52 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.284 -0.416 . . . . 63.21 113.755 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.468 ' OG1' HD23 ' A' ' 13' ' ' LEU . 68.1 p -82.59 -19.01 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.288 -0.537 . . . . 73.11 111.585 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.96 -51.13 77.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.72 0.637 . . . . 52.45 112.72 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.6 Cg_endo -59.4 -21.41 60.99 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.039 1.826 . . . . 72.41 112.897 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.39 -46.32 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 74.34 110.376 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -59.27 -45.27 91.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.188 0.518 . . . . 72.43 110.32 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.66 -37.03 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.112 -0.494 . . . . 64.43 111.13 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -56.43 -42.18 77.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.031 0.443 . . . . 74.35 111.457 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.54 -1.36 57.02 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.823 0.675 . . . . 63.2 112.823 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.49 17.52 15.09 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.224 0.85 . . . . 52.41 115.224 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.472 0.673 0 CA-C-N 118.093 0.947 . . . . 74.4 111.813 176.182 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 . . . . . 0 CA--C 1.538 0.506 0 N-CA-C 113.29 0.848 . . . . 74.31 113.29 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 24.3 m -72.19 159.73 33.62 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.126 -0.943 . . . . 45.42 111.5 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.7 mt -52.97 -52.55 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.959 0.355 . . . . 73.23 111.959 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.09 -40.36 85.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.831 0.348 . . . . 64.15 111.732 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.2 t70 -63.34 -51.13 67.23 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.246 -0.434 . . . . 63.43 110.804 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.05 -0.523 . . . . 61.23 111.685 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 89.2 m -62.21 -48.53 79.62 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 72.35 111.433 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.61 -37.44 65.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.962 0.356 . . . . 25.44 111.962 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.1 t -57.74 -53.98 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.91 0.386 . . . . 65.15 111.65 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -92.65 6.64 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.226 0.454 . . . . 72.43 112.226 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.34 83.56 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.285 -0.483 . . . . 61.15 112.968 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.43 150.04 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.207 0.527 . . . . 71.45 111.555 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -80.92 84.23 6.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.104 -0.498 . . . . 72.15 110.433 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -60.84 -30.3 70.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.545 -0.298 . . . . 72.11 111.771 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 33.2 t70 -58.75 -47.3 85.12 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.715 0.293 . . . . 61.2 110.864 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -71.83 -44.16 64.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.763 0.316 . . . . 70.12 111.432 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp -54.73 -51.61 65.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.323 -0.398 . . . . 64.42 111.703 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.548 HG21 ' HB3' ' A' ' 5' ' ' LYS . 90.1 t -60.56 -42.28 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.608 -0.269 . . . . 71.51 111.614 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 98.9 mttt -57.16 -48.0 79.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.591 0.234 . . . . 73.42 111.375 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.57 -39.71 89.02 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.601 0.238 . . . . 70.42 111.45 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 56' ' ' VAL . 91.0 mt -59.26 -48.54 81.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.618 0.247 . . . . 74.21 111.185 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.2 m-80 -58.62 -61.7 2.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.608 -0.269 . . . . 74.5 111.373 177.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.8 mt-10 -46.17 -46.06 17.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.197 -0.456 . . . . 63.54 111.153 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -52.09 -58.66 5.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.383 0.512 . . . . 73.25 112.383 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 . . . . . 0 N--CA 1.471 0.619 0 CA-C-O 120.832 0.349 . . . . 64.32 111.309 178.789 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.449 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm . . . . . 0 CA--C 1.536 0.434 0 CA-C-O 120.647 0.26 . . . . 61.01 111.235 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.48 159.32 25.4 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.413 -0.358 . . . . 44.31 110.851 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.1 pttp -71.01 -11.29 60.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.94 0.4 . . . . 72.22 111.356 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.87 -25.41 53.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.895 -0.593 . . . . 65.31 110.96 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.7 mtt -66.75 154.14 41.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.298 0.571 . . . . 61.41 112.071 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.51 136.52 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.955 -0.566 . . . . 53.13 111.334 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.4 mt -56.11 -52.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.847 0.356 . . . . 71.05 111.696 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.34 65.67 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.97 0.414 . . . . 33.12 111.631 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.0 -41.12 60.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.908 0.385 . . . . 72.22 110.822 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.37 -37.96 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.204 0.526 . . . . 74.21 110.524 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.1 -30.08 70.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.05 -0.523 . . . . 62.43 111.59 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.69 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.929 0.395 . . . . 73.45 111.042 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.8 mtt -72.35 -49.03 37.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.374 0.607 . . . . 74.33 109.744 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -158.18 138.14 12.28 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.491 -0.777 . . . . 71.34 111.364 173.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -77.18 -20.59 55.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.257 0.551 . . . . 75.22 110.771 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.87 -2.42 23.36 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.864 -0.607 . . . . 71.11 113.525 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.8 p -81.59 -20.69 39.31 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.43 -0.453 . . . . 74.43 111.67 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.58 -50.65 82.03 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 113.027 0.751 . . . . 74.23 113.027 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.9 Cg_endo -59.46 -21.35 61.13 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.298 1.999 . . . . 73.03 113.025 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.98 -45.62 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.147 0.499 . . . . 75.23 110.474 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.548 ' HB3' ' HG3' ' A' ' 28' ' ' MET . 68.6 m-85 -57.52 -44.73 85.29 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.211 0.529 . . . . 71.01 110.105 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.74 -38.61 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.314 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -55.37 -29.19 57.96 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.278 0.561 . . . . 72.21 111.613 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.427 ' ND2' HD13 ' A' ' 55' ' ' LEU . 37.7 m-80 -98.8 4.1 47.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.244 0.461 . . . . 63.13 112.244 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.85 26.25 11.93 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.752 0.661 . . . . 42.4 114.752 172.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.548 ' HG3' ' HB3' ' A' ' 23' ' ' PHE . 22.0 mmt . . . . . 0 CA--C 1.537 0.469 0 CA-C-N 117.803 0.801 . . . . 75.2 112.209 175.991 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 . . . . . 0 CA--C 1.538 0.483 0 CA-C-O 121.013 0.435 . . . . 75.4 111.704 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.6 m -63.86 145.81 55.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.323 -0.399 . . . . 74.34 110.588 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.7 mt -47.92 -50.62 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 113.06 0.763 . . . . 73.23 113.06 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 7.9 pt-20 -63.69 -37.87 88.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.383 . . . . 75.15 112.033 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.67 -42.13 78.32 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.912 0.387 . . . . 55.54 110.747 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.04 75.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.235 -0.438 . . . . 72.52 111.15 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -57.79 -43.66 85.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.868 0.366 . . . . 43.31 110.789 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.36 62.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.189 -0.459 . . . . 73.24 112.061 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.03 -42.66 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 111.993 0.368 . . . . 62.12 111.993 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -105.1 3.07 29.98 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.992 0.425 . . . . 74.44 111.618 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 30.85 63.16 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.795 -0.716 . . . . 64.22 112.979 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.6 mt -81.82 155.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.894 0.478 . . . . 74.52 111.171 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 53' ' ' ASP . 16.8 t70 -93.89 106.69 18.65 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.971 0.415 . . . . 73.13 110.349 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . . . -64.42 -33.04 74.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.316 0.487 . . . . 72.22 112.316 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.404 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 24.5 t70 -54.04 -47.86 71.14 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.95 0.405 . . . . 72.14 111.067 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -70.27 -47.54 60.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.262 -0.426 . . . . 65.22 111.479 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.427 HD13 ' ND2' ' A' ' 26' ' ' ASN . 27.6 tp -55.53 -51.58 66.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.933 0.397 . . . . 70.24 111.973 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.475 ' HA ' HD12 ' A' ' 59' ' ' LEU . 92.5 t -58.4 -38.89 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.019 0.438 . . . . 73.24 111.648 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.08 -43.5 91.99 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.541 -0.3 . . . . 73.22 111.434 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -56.9 -42.59 80.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.802 0.334 . . . . 75.23 111.134 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -57.18 -52.81 63.81 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.252 -0.431 . . . . 64.43 111.751 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 45.0 m-80 -55.88 -50.22 71.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.652 0.263 . . . . 73.42 111.689 178.315 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 40.6 mt-10 -56.57 -32.69 65.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.95 0.405 . . . . 71.41 111.845 179.578 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -65.81 -52.15 53.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.129 -0.487 . . . . 74.3 111.458 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 . . . . . 0 CA--C 1.54 0.593 0 CA-C-N 116.414 -0.357 . . . . 74.03 111.426 178.15 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.578 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.6 mm . . . . . 0 CA--C 1.539 0.522 0 N-CA-C 113.373 0.879 . . . . 72.23 113.373 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -121.69 160.39 24.57 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.752 -0.658 . . . . 74.31 110.287 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.5 pttp -66.45 -16.54 64.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.963 0.411 . . . . 72.13 111.353 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.24 -19.64 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.765 -0.652 . . . . 75.05 111.663 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.578 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.5 mtt -69.11 153.82 43.1 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.133 0.492 . . . . 65.33 111.911 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.2 mm -85.22 129.97 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.399 -0.364 . . . . 54.51 111.24 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.8 -53.56 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.477 0.547 . . . . 74.55 112.477 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.07 72.13 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.043 0.386 . . . . 64.24 112.043 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.72 -40.27 76.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.914 0.388 . . . . 71.04 110.674 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -60.49 -39.96 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.26 0.552 . . . . 55.11 110.59 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.98 -32.24 70.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.972 -0.558 . . . . 72.31 111.393 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.622 ' HA ' HH12 ' A' ' 17' ' ' ARG . 15.8 mm-40 -67.21 -31.76 72.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.339 . . . . 71.24 111.583 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.4 mtt -65.78 -54.83 21.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.556 0.693 . . . . 73.11 109.816 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -150.73 121.59 7.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.364 -0.834 . . . . 62.34 110.58 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.622 HH12 ' HA ' ' A' ' 14' ' ' GLN . 81.9 mmt-85 -60.12 -21.56 61.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.999 0.428 . . . . 73.24 111.673 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.76 -3.38 27.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.502 -0.38 . . . . 73.45 113.656 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -82.32 -16.24 50.04 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.425 -0.456 . . . . 75.42 111.671 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.94 -51.41 79.61 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 112.724 0.638 . . . . 72.11 112.724 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 12.4 Cg_endo -55.62 -29.19 69.23 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.161 1.908 . . . . 74.33 112.673 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.3 mt -69.12 -45.57 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.047 0.451 . . . . 75.11 110.888 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 -45.89 91.08 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.909 0.385 . . . . 74.11 110.679 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.05 -42.69 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 73.1 111.348 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -50.72 -50.03 56.31 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.1 0.476 . . . . 75.11 111.508 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -75.27 -4.31 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.492 0.552 . . . . 64.21 112.492 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.98 16.85 12.63 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.821 0.688 . . . . 41.14 114.821 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 mmt . . . . . 0 N--CA 1.468 0.428 0 CA-C-N 118.039 0.919 . . . . 54.22 111.016 175.369 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 . . . . . 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 55.4 111.817 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.6 p -75.74 164.63 26.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.126 0.489 . . . . 62.11 112.254 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 mt -55.04 -50.64 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.889 -0.596 . . . . 70.23 112.356 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 10.1 pt-20 -66.62 -37.13 84.22 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.247 -0.283 . . . . 65.44 111.724 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 47' ' ' VAL . 24.1 t0 -64.76 -49.97 68.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.138 0.495 . . . . 63.12 110.146 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.79 99.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.858 -0.61 . . . . 64.11 111.896 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -52.1 -52.97 48.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.593 -0.276 . . . . 50.33 111.467 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.73 68.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.214 0.45 . . . . 45.32 112.214 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 43' ' ' ASP . 66.7 t -59.88 -42.48 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.914 0.388 . . . . 63.22 111.794 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -97.61 -0.27 46.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.786 0.327 . . . . 71.22 111.467 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.71 82.31 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.477 -0.392 . . . . 72.0 113.45 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.5 mt -74.42 154.68 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 122.581 -0.364 . . . . 74.34 111.273 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -97.38 113.79 25.5 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.977 0.417 . . . . 64.11 110.529 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -68.34 -32.62 72.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.211 0.449 . . . . 64.41 112.211 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.49 -40.29 82.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.886 0.374 . . . . 71.32 111.658 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -70.57 -49.46 47.73 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.212 0.53 . . . . 63.13 111.043 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.41 -47.31 85.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.799 -0.637 . . . . 73.33 112.406 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 52' ' ' ALA . 98.4 t -61.75 -38.9 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.149 0.426 . . . . 73.42 112.149 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -61.95 -45.35 94.05 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.176 -0.327 . . . . 73.13 110.798 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.53 -42.52 74.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.153 0.501 . . . . 63.33 111.36 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.3 -53.4 55.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.239 -0.437 . . . . 61.01 111.745 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.3 m-80 -55.0 -50.44 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.038 0.384 . . . . 72.32 112.038 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.06 -42.3 69.11 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.763 -0.199 . . . . 74.33 111.346 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.58 -49.41 77.55 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 63.03 112.188 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 71.8 m-85 . . . . . 0 N--CA 1.468 0.462 0 CA-C-O 120.771 0.319 . . . . 75.52 111.618 179.964 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.445 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.9 mm . . . . . 0 CA--C 1.536 0.424 0 CA-C-O 120.529 0.204 . . . . 73.41 110.602 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.501 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 28.5 p -116.66 155.88 28.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 70.31 111.134 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HB3' HG21 ' A' ' 56' ' ' VAL . 14.0 ptpt -69.27 -10.5 58.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.01 0.374 . . . . 74.01 112.01 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.28 -14.95 45.04 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.088 0.47 . . . . 71.3 111.347 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.501 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 65.5 mtt -69.41 157.29 37.36 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.435 0.531 . . . . 73.53 112.435 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 48.9 mm -85.39 141.55 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.043 -0.526 . . . . 62.13 111.552 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.6 mt -55.44 -52.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 120.76 0.314 . . . . 71.34 111.798 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.23 -37.22 71.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.961 0.41 . . . . 62.44 111.616 178.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.75 -42.08 98.5 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.303 -0.408 . . . . 64.15 111.044 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.97 -40.93 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.037 0.446 . . . . 72.44 110.933 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.501 HD23 ' OG1' ' A' ' 19' ' ' THR . 97.0 mt -61.22 -31.74 71.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.892 0.377 . . . . 73.44 111.348 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -70.1 -15.17 62.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.455 -0.339 . . . . 63.13 111.9 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.4 mtt -86.69 -43.44 12.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.208 0.528 . . . . 63.34 110.044 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.08 133.79 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.568 -0.742 . . . . 71.54 110.814 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.8 mmt-85 -69.68 -25.0 63.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.874 0.368 . . . . 74.21 111.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.49 -1.41 10.83 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.608 -0.33 . . . . 73.02 113.728 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.501 ' OG1' HD23 ' A' ' 13' ' ' LEU . 73.3 p -82.84 -21.43 34.41 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.469 -0.43 . . . . 74.52 111.704 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.78 -51.08 82.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 112.396 0.517 . . . . 34.54 112.396 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 22.6 Cg_endo -60.93 -25.15 80.91 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.885 1.724 . . . . 61.54 112.613 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.2 mt -71.05 -43.18 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.969 0.414 . . . . 71.53 110.785 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -58.64 -48.72 80.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.131 0.491 . . . . 72.21 110.249 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 28' ' ' MET . 66.5 mt -60.71 -37.84 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.99 -0.55 . . . . 62.33 111.221 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -56.06 -32.95 64.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.275 -0.421 . . . . 61.41 112.089 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.419 ' ND2' HD13 ' A' ' 55' ' ' LEU . 34.0 m-80 -90.93 -7.5 51.93 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.453 0.538 . . . . 71.22 112.453 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 -7.47 6.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.624 -0.798 . . . . 61.4 114.605 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 50.0 mtt . . . . . 0 N--CA 1.473 0.687 0 CA-C-N 117.877 0.838 . . . . 74.24 111.082 177.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 8.9 mm-40 . . . . . 0 CA--C 1.542 0.669 0 CA-C-O 121.087 0.47 . . . . 63.23 112.054 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 54.3 m -70.31 149.45 47.37 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.577 -0.283 . . . . 75.12 110.578 172.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 mt -51.51 -55.61 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.655 0.613 . . . . 73.33 112.655 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.6 pt-20 -62.1 -36.28 81.23 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.038 0.447 . . . . 74.14 111.684 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.93 -52.68 22.5 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.071 -0.513 . . . . 71.14 111.117 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.88 91.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.303 -0.408 . . . . 73.1 111.504 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -57.49 -45.53 84.79 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.53 -0.304 . . . . 60.01 110.938 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.88 75.05 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.016 0.376 . . . . 61.43 112.016 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.8 t -55.65 -41.27 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.927 0.394 . . . . 73.1 112.052 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.535 ' HB3' HG13 ' A' ' 50' ' ' ILE . 8.8 t60 -91.33 -22.96 20.26 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 73.25 111.299 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.75 24.53 17.56 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.546 -0.359 . . . . 73.22 112.439 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 48' ' ' HIS . 63.8 mt -79.69 155.23 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.92 0.488 . . . . 73.11 112.058 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.76 101.74 12.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.166 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -71.44 -21.88 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.454 0.538 . . . . 73.03 112.454 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -43.1 77.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.361 . . . . 60.34 110.467 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.61 -46.78 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.312 -0.404 . . . . 63.42 110.992 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' ND2' ' A' ' 26' ' ' ASN . 30.1 tp -56.29 -54.84 40.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.223 -0.444 . . . . 62.15 112.046 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 5' ' ' LYS . 87.4 t -56.51 -41.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.965 0.412 . . . . 63.04 112.011 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -37.21 80.63 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.73 0.27 . . . . 72.45 111.73 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -59.91 -42.57 94.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 64.02 110.692 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -58.6 -52.32 66.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.28 -0.418 . . . . 74.44 111.381 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 43.5 m-80 -54.19 -57.36 11.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.695 0.283 . . . . 74.22 111.59 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 48.3 mt-10 -52.42 -40.9 62.71 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.217 -0.447 . . . . 71.13 111.789 -179.667 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -56.45 -48.56 76.81 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.894 0.378 . . . . 74.51 111.663 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 . . . . . 0 CA--C 1.537 0.456 0 CA-C-O 120.612 0.244 . . . . 64.4 111.499 179.313 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.2 mm . . . . . 0 CA--C 1.54 0.558 0 CA-C-O 120.828 0.347 . . . . 71.42 111.412 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.3 p -118.06 170.23 9.02 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.861 0.362 . . . . 70.21 110.973 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HB3' HG21 ' A' ' 56' ' ' VAL . 16.8 ptpt -80.87 -11.78 59.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.865 0.364 . . . . 71.34 111.282 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.52 -25.43 38.72 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.012 -0.54 . . . . 60.34 111.141 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.478 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 64.3 mtt -65.11 161.07 19.75 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.181 0.515 . . . . 73.55 112.203 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.0 mm -86.91 129.76 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.062 -0.517 . . . . 73.04 110.716 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.505 HG12 HG13 ' A' ' 41' ' ' ILE . 57.3 mt -54.66 -45.96 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 112.211 0.448 . . . . 72.15 112.211 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -63.15 -34.68 78.15 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.195 0.521 . . . . 45.11 111.078 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.4 t70 -65.06 -41.84 94.74 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.913 -0.585 . . . . 54.1 110.344 177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.88 -37.96 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.219 0.533 . . . . 62.44 110.997 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.64 -29.87 70.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.472 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 77.0 mt-30 -68.34 -25.45 65.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.953 0.406 . . . . 71.14 111.042 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.0 mtt -75.62 -53.91 7.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.208 0.528 . . . . 73.42 110.02 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -154.3 124.45 6.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.956 -0.566 . . . . 75.44 111.127 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.41 -18.12 65.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 74.31 112.556 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.439 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -68.1 -6.44 46.17 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.274 -0.489 . . . . 73.52 113.2 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.1 p -80.91 -23.14 39.15 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.644 -0.327 . . . . 34.43 111.455 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.47 -51.79 77.11 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.528 0.566 . . . . 73.44 112.528 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.46 -26.03 76.29 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.901 1.734 . . . . 72.13 112.335 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 64.1 mt -72.48 -41.76 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.02 0.438 . . . . 72.15 110.583 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HD1' HD21 ' A' ' 55' ' ' LEU . 62.0 m-85 -61.9 -49.93 74.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.041 0.448 . . . . 75.12 110.497 173.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.0 mt -59.12 -37.55 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 72.43 111.099 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 27.4 t30 -52.09 -46.4 65.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.992 0.425 . . . . 64.31 111.678 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -81.21 1.69 31.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.312 0.486 . . . . 72.43 112.312 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.33 13.84 14.32 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.203 0.841 . . . . 62.44 115.203 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mmt . . . . . 0 CA--C 1.543 0.703 0 CA-C-N 117.952 0.876 . . . . 65.22 112.147 176.36 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 . . . . . 0 N--CA 1.468 0.46 0 CA-C-O 120.941 0.4 . . . . 73.4 111.413 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' MET . 49.2 m -68.54 153.06 44.48 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.415 -0.357 . . . . 72.0 111.024 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.0 mp -51.93 -51.24 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 111.791 0.293 . . . . 53.33 111.791 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.6 pt-20 -69.05 -33.9 74.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.903 0.382 . . . . 75.42 111.724 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.88 -47.25 75.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.103 0.478 . . . . 70.11 111.238 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.73 56.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 75.02 111.788 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.88 -42.08 75.39 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.72 0.295 . . . . 72.22 111.679 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.67 65.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.272 0.471 . . . . 53.11 112.272 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.2 -51.18 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.816 0.341 . . . . 50.12 111.914 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -87.6 -19.82 27.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.873 0.368 . . . . 74.31 111.386 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.59 27.04 12.07 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.19 -0.528 . . . . 74.31 112.655 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mt -76.57 148.28 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.751 0.31 . . . . 70.31 111.298 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.8 93.84 5.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.202 0.525 . . . . 70.24 110.283 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HB1' HG22 ' A' ' 41' ' ' ILE . . . -65.7 -24.05 66.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.165 -0.47 . . . . 64.32 112.105 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.15 -45.76 92.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.792 0.329 . . . . 70.03 110.962 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.85 -46.44 75.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.893 0.377 . . . . 54.34 111.126 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 41' ' ' ILE . 26.2 tp -53.19 -51.73 61.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.002 -0.545 . . . . 72.21 111.624 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 5' ' ' LYS . 80.2 t -57.41 -45.28 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 71.33 111.524 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.63 -45.0 85.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.515 0.198 . . . . 74.13 111.395 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -58.97 -40.85 86.02 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.937 0.398 . . . . 74.41 111.281 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 56' ' ' VAL . 80.9 mt -60.13 -50.46 73.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.854 0.359 . . . . 74.24 111.38 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.2 m-80 -57.57 -55.13 38.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.395 -0.366 . . . . 73.4 111.418 178.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.6 mt-10 -50.11 -41.77 49.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.891 0.377 . . . . 74.01 111.031 178.269 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.439 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 87.4 t80 -58.74 -53.23 60.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.17 -0.468 . . . . 65.14 112.084 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 . . . . . 0 N--CA 1.468 0.461 0 CA-C-O 120.591 0.234 . . . . 75.2 111.117 178.424 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.467 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.4 mm . . . . . 0 CA--C 1.542 0.655 0 N-CA-C 112.174 0.435 . . . . 64.32 112.174 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.484 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.2 p -116.42 158.9 22.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.282 -0.417 . . . . 75.21 110.307 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -72.98 -15.55 61.54 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.106 -0.371 . . . . 73.13 111.959 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.06 -14.11 58.14 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.794 0.331 . . . . 74.35 111.48 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.484 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 62.8 mtt -63.95 134.92 55.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.28 0.562 . . . . 72.01 111.575 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 46.7 mm -68.49 136.01 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.901 -0.59 . . . . 61.45 111.405 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.6 mt -52.13 -52.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.838 0.31 . . . . 73.25 111.838 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.11 -36.85 73.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.934 0.397 . . . . 72.31 111.627 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.12 -37.54 87.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.208 -0.451 . . . . 64.24 110.902 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.94 -41.31 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.072 0.463 . . . . 73.04 110.99 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -59.22 -31.24 68.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.341 -0.391 . . . . 71.02 111.709 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 79.3 mt-30 -62.95 -37.06 85.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.73 0.3 . . . . 70.23 111.532 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.9 mtt -65.76 -48.25 72.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 60.4 110.225 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.85 120.25 3.4 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.445 -0.798 . . . . 74.32 110.7 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -62.24 -20.8 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.459 0.54 . . . . 74.22 112.459 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -3.49 22.86 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.418 -0.42 . . . . 61.13 113.65 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.7 p -83.08 -19.79 36.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.916 0.358 . . . . 70.43 111.833 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.29 -50.99 81.72 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 112.478 0.547 . . . . 74.41 112.478 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.1 Cg_endo -59.13 -29.1 89.61 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.899 1.733 . . . . 72.0 112.613 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.88 -42.17 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.094 0.474 . . . . 75.14 110.613 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -62.38 -53.44 55.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.155 0.502 . . . . 72.52 110.648 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.7 -35.35 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.136 -0.484 . . . . 44.31 111.322 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -57.6 -48.84 78.28 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.021 -0.536 . . . . 72.35 111.511 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.92 -5.11 39.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.355 0.502 . . . . 62.35 112.355 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.89 17.47 7.89 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.653 -0.784 . . . . 75.32 114.831 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mmt . . . . . 0 CA--C 1.537 0.469 0 CA-C-N 117.961 0.881 . . . . 65.41 111.717 175.651 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 N--CA 1.472 0.673 0 CA-C-O 121.351 0.596 . . . . 72.32 112.042 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 87.7 p -76.76 162.02 28.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.739 -0.664 . . . . 70.23 112.248 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.15 -44.08 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.14 111.91 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.14 -40.78 90.87 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.562 0.208 . . . . 71.33 111.562 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.01 -48.61 65.24 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.008 0.432 . . . . 71.34 111.132 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.75 94.08 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.881 0.372 . . . . 61.2 111.632 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -56.27 -39.49 72.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.709 0.29 . . . . 52.02 111.355 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.69 69.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.067 0.395 . . . . 34.51 112.067 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -48.08 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.018 0.437 . . . . 63.34 111.346 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -92.47 -10.27 38.46 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.388 -0.369 . . . . 75.13 111.989 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.42 35.44 23.1 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.35 -0.452 . . . . 61.22 113.233 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -91.95 152.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.646 0.378 . . . . 74.15 111.286 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.32 99.43 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.411 -0.589 . . . . 71.25 109.411 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -65.07 -30.1 71.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.154 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.8 t70 -59.7 -44.29 93.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.68 0.276 . . . . 61.02 110.677 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.63 -49.1 67.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 75.5 111.079 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.87 -45.09 67.29 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 73.24 111.354 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 52' ' ' ALA . 75.9 t -61.56 -37.47 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.169 -0.469 . . . . 73.41 111.453 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.4 mttm -60.37 -48.83 80.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.743 0.306 . . . . 72.21 110.649 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.69 -38.19 71.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.241 -0.436 . . . . 60.04 111.484 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.0 mt -65.2 -51.25 62.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.505 -0.316 . . . . 73.01 111.364 174.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -53.57 -55.02 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.647 -0.251 . . . . 72.12 111.445 178.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.465 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 45.0 mt-10 -47.51 -50.46 23.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.059 0.457 . . . . 75.44 110.773 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -55.15 -49.12 72.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.765 -0.652 . . . . 71.42 112.292 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 . . . . . 0 CA--C 1.536 0.427 0 CA-C-O 120.875 0.369 . . . . 73.32 111.722 -179.857 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 mm . . . . . 0 CA--C 1.539 0.533 0 N-CA-C 112.727 0.64 . . . . 71.22 112.727 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.5 p -122.34 153.7 38.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.941 -0.572 . . . . 64.53 110.367 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.9 pttp -68.45 -13.46 62.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.959 0.409 . . . . 72.53 111.606 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.24 -22.67 59.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.205 0.526 . . . . 71.12 111.048 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.448 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.3 mtt -68.59 159.67 31.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.268 0.556 . . . . 61.32 111.718 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.9 mm -86.27 135.87 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.031 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.8 mt -56.81 -50.88 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 111.892 0.33 . . . . 73.24 111.892 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.02 -37.33 74.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.942 0.401 . . . . 63.02 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.81 -44.48 96.78 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.162 -0.472 . . . . 75.44 110.62 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.13 -39.71 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.116 0.484 . . . . 65.4 110.837 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.48 HD23 ' OG1' ' A' ' 19' ' ' THR . 97.1 mt -62.69 -33.81 75.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.216 -0.447 . . . . 74.4 111.62 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 88.1 mt-30 -69.28 -20.83 63.91 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.7 0.286 . . . . 74.1 111.538 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.5 mtt -75.95 -56.45 4.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.374 0.607 . . . . 74.42 109.896 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -145.8 125.45 13.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.683 -0.69 . . . . 72.33 110.571 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 13' ' ' LEU . 41.1 mmt180 -69.57 -19.53 63.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.516 -0.311 . . . . 75.14 111.591 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.07 -1.8 43.28 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.318 -0.467 . . . . 64.52 113.304 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.48 ' OG1' HD23 ' A' ' 13' ' ' LEU . 81.5 p -82.28 -17.21 46.7 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.461 -0.435 . . . . 53.15 111.183 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.21 -51.82 76.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.497 0.554 . . . . 74.42 112.497 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -56.95 -26.43 67.86 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.108 1.872 . . . . 72.31 112.612 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.14 -46.98 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.034 0.445 . . . . 63.15 110.672 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -58.98 -40.97 86.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.022 0.439 . . . . 73.35 110.504 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.97 -46.57 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.131 -0.486 . . . . 74.31 111.097 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -51.68 -48.61 63.41 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.181 0.515 . . . . 73.35 111.495 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -77.63 -6.8 55.06 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.176 -0.465 . . . . 75.15 112.16 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.6 39.05 3.75 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.251 0.86 . . . . 64.14 115.251 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 mmt . . . . . 0 CA--C 1.541 0.616 0 CA-C-N 117.806 0.803 . . . . 75.14 111.654 174.278 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 . . . . . 0 CA--C 1.541 0.621 0 CA-C-O 121.123 0.487 . . . . 74.34 111.87 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 63.6 m -67.03 157.78 32.65 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.364 -0.38 . . . . 74.53 111.437 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.3 mt -54.81 -54.93 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.867 0.321 . . . . 74.15 111.867 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.3 pt-20 -63.49 -30.68 71.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.707 0.289 . . . . 54.1 111.689 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.3 t70 -64.32 -61.84 1.98 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.919 0.39 . . . . 73.32 109.971 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.72 65.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.157 0.503 . . . . 65.15 111.588 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 81.4 m -57.57 -40.83 79.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.989 -0.55 . . . . 75.31 111.43 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.5 69.03 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.013 0.435 . . . . 43.32 111.627 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.4 t -69.98 -39.91 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.784 0.326 . . . . 74.52 111.831 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -105.39 4.57 30.92 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.089 -0.382 . . . . 74.23 112.007 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.2 27.97 72.15 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.538 -0.363 . . . . 61.3 113.958 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 53.3 mt -85.53 153.73 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.973 0.416 . . . . 70.54 111.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.34 102.2 11.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.672 0.389 . . . . 52.44 111.675 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.42 85.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 71.43 111.417 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -51.43 -44.93 62.44 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.961 -0.563 . . . . 73.23 111.41 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.21 -39.1 34.12 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.224 -0.444 . . . . 72.22 111.969 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 tp -61.82 -52.81 62.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.918 0.39 . . . . 74.42 111.98 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.535 ' HA ' HD12 ' A' ' 59' ' ' LEU . 90.1 t -57.46 -37.01 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.956 0.354 . . . . 72.04 111.956 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -64.41 -42.22 96.19 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.625 -0.261 . . . . 71.31 111.354 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.98 -42.13 97.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.994 0.426 . . . . 70.22 110.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -58.37 -52.66 64.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.33 -0.396 . . . . 75.43 111.678 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -56.11 -54.5 44.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.744 0.307 . . . . 74.13 111.444 178.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -54.09 -31.65 52.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.537 179.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -69.34 -46.66 66.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.896 0.379 . . . . 74.43 111.696 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 . . . . . 0 CA--C 1.535 0.383 0 O-C-N 122.171 -0.33 . . . . 72.52 111.15 177.424 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.453 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 49.6 mm . . . . . 0 N--CA 1.467 0.412 0 CA-C-O 120.994 0.426 . . . . 75.21 111.828 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 p -121.18 161.8 21.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.744 0.307 . . . . 73.44 110.996 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.9 pttp -69.34 -21.23 63.84 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.869 0.366 . . . . 74.34 111.658 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.66 -21.65 59.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.177 -0.465 . . . . 72.01 111.731 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -63.08 152.02 38.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.388 0.613 . . . . 73.12 112.125 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.88 130.5 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.97 -0.559 . . . . 73.54 111.107 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.41 -47.18 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 111.923 0.342 . . . . 74.45 111.923 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -60.45 -35.78 76.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.97 0.414 . . . . 32.14 111.338 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.58 -39.95 80.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.349 -0.387 . . . . 43.14 110.704 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.93 -41.79 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.277 0.56 . . . . 50.33 110.128 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.0 mt -64.19 -21.24 66.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.974 -0.557 . . . . 72.23 111.735 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 83.9 mm-40 -77.44 -30.72 53.47 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.719 0.295 . . . . 72.45 111.149 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.1 mtt -69.88 -45.89 66.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.317 0.58 . . . . 74.13 109.894 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.33 127.25 4.94 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.202 -0.908 . . . . 71.34 111.141 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -65.55 -26.34 67.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.285 -0.416 . . . . 73.43 111.686 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.62 -1.24 5.85 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 114.179 0.431 . . . . 61.32 114.179 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.456 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.4 p -85.86 -13.19 48.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.166 0.483 . . . . 72.34 111.589 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.68 -51.35 74.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.699 0.629 . . . . 43.44 112.699 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -56.93 -31.95 91.12 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.112 1.874 . . . . 64.04 112.628 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.07 -48.67 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.032 0.444 . . . . 65.04 110.836 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -60.25 -47.55 85.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.715 0.293 . . . . 60.32 111.263 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.33 -41.97 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.814 0.34 . . . . 61.24 111.428 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -58.15 -44.07 87.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.255 -0.43 . . . . 63.44 111.533 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -75.5 -9.9 58.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.282 0.475 . . . . 51.44 112.282 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.28 1.53 11.17 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 115.424 0.93 . . . . 74.34 115.424 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.4 mmt . . . . . 0 N--CA 1.471 0.589 0 CA-C-N 118.345 1.073 . . . . 74.24 111.762 179.316 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 34.4 mm-40 . . . . . 0 CA--C 1.542 0.673 0 N-CA-C 112.3 0.481 . . . . 75.02 112.3 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -64.2 150.86 44.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.339 -0.391 . . . . 71.11 110.89 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mt -51.7 -56.29 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.466 0.543 . . . . 74.42 112.466 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.3 pt-20 -62.41 -39.75 94.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.813 0.339 . . . . 74.34 111.717 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 47' ' ' VAL . 35.7 t70 -64.64 -54.84 25.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.348 -0.387 . . . . 72.32 110.924 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.35 75.8 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.945 0.402 . . . . 52.33 111.235 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' GLY . 90.3 m -58.76 -52.75 64.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.377 -0.374 . . . . 72.51 111.123 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -42.88 81.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.714 0.264 . . . . 75.53 111.714 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 43' ' ' ASP . 60.6 t -60.58 -44.37 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.175 0.512 . . . . 73.21 111.342 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.454 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.5 t-80 -89.4 -2.7 58.5 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-N 116.257 -0.429 . . . . 62.14 111.505 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 67.77 29.87 74.1 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.65 -0.309 . . . . 54.31 113.519 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 48' ' ' HIS . 45.5 mt -89.02 151.82 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 122.879 0.471 . . . . 61.03 111.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.03 102.7 9.44 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.81 0.338 . . . . 71.32 110.759 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.3 -23.64 61.21 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.201 0.445 . . . . 75.35 112.201 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.8 -51.07 71.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.959 0.409 . . . . 73.43 110.634 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 59.9 mtpt -63.66 -50.5 69.03 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.185 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 36.3 tp -56.19 -54.34 46.35 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.928 -0.578 . . . . 70.21 112.198 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.4 t -59.01 -43.83 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 111.818 0.303 . . . . 71.31 111.818 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.13 -42.82 99.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.679 0.276 . . . . 71.24 111.458 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 96.4 mt-10 -63.69 -39.93 95.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.832 0.349 . . . . 73.41 111.338 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 90.8 mt -59.06 -48.26 82.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.776 0.322 . . . . 71.53 111.322 174.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 29.2 m-80 -54.63 -58.63 6.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.489 -0.323 . . . . 74.41 111.283 176.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 44.7 mt-10 -48.7 -41.4 31.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.944 0.402 . . . . 71.24 111.627 -179.742 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -62.08 -54.85 35.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.213 -0.449 . . . . 74.22 112.158 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 . . . . . 0 N--CA 1.468 0.46 0 N-CA-C 111.778 0.288 . . . . 73.33 111.778 179.682 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.487 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 44.4 mm . . . . . 0 N--CA 1.471 0.623 0 CA-C-O 120.682 0.277 . . . . 75.4 111.406 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 18.3 p -115.34 154.05 29.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.707 0.289 . . . . 75.22 110.771 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.785 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 49.9 pttt -68.95 -14.84 63.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.86 0.362 . . . . 73.14 111.844 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.9 -22.75 52.94 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.08 -0.509 . . . . 65.43 111.314 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.53 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 60.7 mtt -62.43 150.57 39.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.604 0.716 . . . . 74.21 112.873 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.8 mm -80.65 133.77 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 73.4 111.185 178.089 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -51.01 -50.91 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 120.73 0.3 . . . . 73.52 111.806 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.499 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.03 -40.94 82.13 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.837 0.31 . . . . 73.32 111.837 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.3 -38.89 88.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.948 0.404 . . . . 64.23 111.026 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.32 -44.92 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.134 0.492 . . . . 75.43 110.953 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.8 -33.16 71.36 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.041 -0.527 . . . . 72.11 111.987 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 82.5 mm-40 -61.42 -29.02 69.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.977 0.418 . . . . 63.14 111.618 177.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -84.15 -41.39 17.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.169 0.509 . . . . 72.11 110.346 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.22 120.96 3.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.002 -0.545 . . . . 74.43 111.325 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -69.83 -16.96 63.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 72.53 112.082 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -66.02 -7.75 38.79 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.236 -0.506 . . . . 53.24 113.144 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.2 p -80.24 -19.49 46.72 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.568 -0.372 . . . . 71.44 111.573 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.75 -51.78 77.56 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.501 0.556 . . . . 44.11 112.501 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 17.7 Cg_endo -59.12 -21.68 60.52 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.115 1.877 . . . . 71.4 112.634 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.4 mt -77.07 -41.7 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.974 0.416 . . . . 74.44 110.579 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -60.79 -45.85 92.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.139 0.495 . . . . 72.01 110.229 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.87 -39.11 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.988 -0.551 . . . . 74.14 110.991 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.93 -37.37 63.78 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.046 0.451 . . . . 74.25 111.782 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 55' ' ' LEU . 33.6 m-80 -89.82 -2.29 58.19 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.31 0.485 . . . . 60.52 112.31 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 37.6 5.44 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.927 -0.654 . . . . 63.31 114.706 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.3 mmt . . . . . 0 N--CA 1.469 0.511 0 CA-C-N 117.363 0.582 . . . . 71.4 111.656 173.439 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 . . . . . 0 CA--C 1.542 0.66 0 CA-C-O 121.156 0.503 . . . . 74.25 111.863 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -75.77 154.98 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.884 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -53.36 -58.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.702 0.63 . . . . 74.23 112.702 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.785 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.4 pt-20 -64.97 -33.55 76.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.863 0.364 . . . . 70.52 111.604 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 47' ' ' VAL . 25.7 t70 -64.49 -54.17 36.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.821 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.084 -0.507 . . . . 73.21 111.038 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.5 m -56.4 -49.21 75.13 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.431 -0.35 . . . . 75.12 110.913 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.0 67.54 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.902 0.334 . . . . 34.33 111.902 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 43' ' ' ASP . 61.8 t -67.41 -39.14 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.872 0.368 . . . . 72.55 111.552 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.01 9.76 24.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.774 0.321 . . . . 75.44 111.839 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.31 31.54 81.19 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.522 -0.371 . . . . 72.31 113.329 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.74 153.28 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.538 0.335 . . . . 60.42 111.646 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.38 107.09 16.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.944 0.402 . . . . 73.11 110.298 175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -28.74 56.8 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.011 0.374 . . . . 65.14 112.011 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.44 -47.16 84.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.862 0.363 . . . . 61.35 110.776 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.35 -45.93 52.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.586 -0.279 . . . . 74.32 111.594 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' ND2' ' A' ' 26' ' ' ASN . 25.0 tp -53.18 -51.4 62.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.996 0.427 . . . . 75.51 111.694 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 5' ' ' LYS . 88.0 t -59.91 -41.81 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.686 0.279 . . . . 62.4 111.602 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.04 -39.47 90.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.545 0.202 . . . . 74.44 111.545 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.76 -37.03 80.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 73.42 110.723 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 79.8 mt -65.83 -51.14 61.4 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.454 -0.339 . . . . 73.23 111.764 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 40.5 m-80 -56.21 -51.66 67.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.926 0.343 . . . . 71.34 111.926 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -57.62 -34.83 69.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.813 0.34 . . . . 53.13 111.632 -179.613 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.47 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 94.3 t80 -59.35 -48.31 82.11 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.84 0.352 . . . . 54.31 111.181 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 . . . . . 0 CA--C 1.538 0.498 0 CA-C-N 116.649 -0.251 . . . . 72.42 111.253 177.032 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.552 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.7 mm . . . . . 0 CA--C 1.54 0.59 0 N-CA-C 112.717 0.636 . . . . 61.43 112.717 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -122.28 156.87 32.94 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.274 -0.421 . . . . 73.55 110.725 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.5 ptpt -66.76 -14.07 62.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.796 0.331 . . . . 73.14 111.809 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.7 -19.33 41.77 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.227 -0.442 . . . . 62.1 111.279 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.552 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 53.6 mtt -63.19 151.39 40.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.283 0.563 . . . . 73.24 112.05 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 42.0 mm -82.62 138.24 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.879 -0.6 . . . . 64.21 110.518 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -53.5 -49.21 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 120.865 0.364 . . . . 64.12 111.825 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -62.16 -32.01 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.867 0.365 . . . . 71.34 111.718 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.75 -43.7 88.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.039 0.447 . . . . 73.12 110.637 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.67 -36.3 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.211 0.529 . . . . 74.14 110.793 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' OG1' ' A' ' 19' ' ' THR . 96.6 mt -65.61 -24.44 67.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.119 -0.491 . . . . 72.2 111.778 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 73.8 mt-30 -69.48 -32.96 72.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.158 0.504 . . . . 51.33 110.909 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.5 mtt -71.21 -50.46 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.812 -0.631 . . . . 70.44 110.674 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.88 135.96 13.87 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.821 -0.627 . . . . 64.32 110.632 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -72.72 -21.86 60.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.836 0.35 . . . . 75.21 111.909 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.77 3.18 45.16 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.251 -0.432 . . . . 52.23 113.807 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.416 ' OG1' HD23 ' A' ' 13' ' ' LEU . 71.4 p -81.31 -21.29 39.37 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.387 -0.478 . . . . 73.54 111.674 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.81 -51.41 80.62 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 112.741 0.645 . . . . 72.15 112.741 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.7 Cg_endo -57.31 -26.01 68.25 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.201 1.934 . . . . 71.2 112.785 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -69.2 -47.07 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.079 0.466 . . . . 71.32 110.7 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.95 -44.55 82.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.157 0.503 . . . . 62.44 110.3 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.8 mt -60.78 -40.62 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.982 -0.554 . . . . 64.21 111.475 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -55.55 -36.02 66.34 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.131 0.491 . . . . 74.1 111.803 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.431 ' ND2' HD13 ' A' ' 55' ' ' LEU . 35.0 m-80 -91.25 1.41 57.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.443 0.534 . . . . 72.41 112.443 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.07 18.54 17.14 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.097 0.799 . . . . 73.23 115.097 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.469 0.495 0 CA-C-N 118.109 0.954 . . . . 53.45 111.543 175.119 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 . . . . . 0 N--CA 1.47 0.528 0 CA-C-O 121.17 0.509 . . . . 74.02 111.775 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.4 p -78.05 162.96 26.32 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.107 0.48 . . . . 72.12 112.201 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.92 -52.74 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.898 -0.592 . . . . 64.44 112.101 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 17.2 pt-20 -62.95 -37.22 86.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.833 0.349 . . . . 73.24 111.752 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 47' ' ' VAL . 21.7 t0 -67.53 -49.81 61.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.345 -0.389 . . . . 72.42 110.778 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.97 93.96 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.035 0.445 . . . . 73.53 111.72 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -59.28 -51.22 70.9 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.408 -0.36 . . . . 62.45 111.458 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.52 69.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.987 0.366 . . . . 44.44 111.987 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -62.29 -48.59 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.93 0.395 . . . . 53.43 111.477 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.403 ' HB3' HG13 ' A' ' 50' ' ' ILE . 65.2 t-80 -82.27 -11.88 58.38 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.369 -0.378 . . . . 74.02 111.596 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.28 40.8 15.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.52 -0.371 . . . . 72.43 113.031 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 48' ' ' HIS . 18.9 mt -103.63 152.16 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.708 0.403 . . . . 63.04 111.177 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -80.48 97.65 7.22 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.073 0.463 . . . . 65.53 109.879 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -60.74 -37.48 81.93 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.604 0.594 . . . . 73.31 112.604 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.677 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 12.4 t70 -64.1 -39.75 94.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.657 -0.417 . . . . 72.12 110.493 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.02 -41.43 90.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.785 0.326 . . . . 73.53 111.218 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.431 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.0 tp -61.85 -50.05 73.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.958 0.409 . . . . 72.31 111.405 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 52' ' ' ALA . 93.4 t -55.86 -35.23 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.371 -0.377 . . . . 73.25 111.875 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 58.0 mttm -57.06 -54.96 40.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.664 0.269 . . . . 71.04 110.982 176.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -56.85 -39.6 74.57 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.433 -0.349 . . . . 73.53 111.335 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 56' ' ' VAL . 89.1 mt -60.19 -51.93 67.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.507 -0.315 . . . . 63.22 111.494 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 40.2 m-80 -56.59 -50.03 73.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.508 0.194 . . . . 72.14 111.453 177.323 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.45 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 63.7 mt-10 -54.75 -42.11 71.22 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.46 -0.336 . . . . 75.11 111.143 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -54.45 -44.72 72.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.868 0.366 . . . . 74.32 111.744 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 . . . . . 0 CA--C 1.534 0.343 0 CA-C-O 120.863 0.363 . . . . 73.55 110.975 177.359 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 48.4 mm . . . . . 0 N--CA 1.472 0.652 0 N-CA-C 112.814 0.672 . . . . 71.34 112.814 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 43.1 p -117.35 156.2 28.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.745 -0.661 . . . . 74.52 110.403 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.667 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 21.2 pttp -68.94 -13.46 62.45 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.007 0.432 . . . . 60.31 111.557 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.03 -22.51 45.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.27 -0.423 . . . . 62.32 111.284 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.469 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 67.2 mtt -64.73 153.98 38.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.295 0.569 . . . . 54.33 112.102 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -82.25 139.83 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.983 -0.553 . . . . 75.52 111.659 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.3 -55.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.189 0.44 . . . . 62.42 112.189 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.83 -35.61 73.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.737 0.303 . . . . 72.21 111.517 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.56 -43.8 89.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.047 0.451 . . . . 53.44 111.065 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.19 -43.72 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.235 -0.439 . . . . 60.34 110.775 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.24 -27.91 69.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.094 -0.503 . . . . 52.42 111.912 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 18.5 mm-40 -63.18 -27.98 69.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.8 0.334 . . . . 75.41 111.397 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.78 -49.15 7.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.029 0.442 . . . . 72.45 110.879 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -148.21 119.84 8.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.226 -0.443 . . . . 62.13 111.396 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 17' ' ' ARG . 12.6 mmt180 -75.48 -8.34 56.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.382 0.512 . . . . 71.03 112.382 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.02 -8.23 68.64 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.227 -0.511 . . . . 72.24 112.459 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.417 ' HA ' HD12 ' A' ' 22' ' ' ILE . 65.4 p -81.05 -18.04 48.09 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.696 -0.297 . . . . 70.31 111.45 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.91 -52.1 75.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 112.178 0.436 . . . . 44.04 112.178 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -59.52 -28.16 86.78 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.03 1.82 . . . . 74.14 112.318 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 19' ' ' THR . 67.9 mt -68.71 -46.63 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.057 0.456 . . . . 71.14 110.894 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 58.5 m-85 -56.75 -48.97 76.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.088 0.47 . . . . 73.34 110.529 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.34 -36.15 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.013 -0.539 . . . . 71.21 111.568 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -57.38 -33.11 67.48 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.081 0.467 . . . . 62.55 111.203 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -92.58 -4.4 53.49 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.197 -0.456 . . . . 74.43 112.068 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.42 -13.34 11.03 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.74 -0.743 . . . . 71.52 114.559 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.512 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.7 mmt . . . . . 0 N--CA 1.476 0.827 0 CA-C-N 117.559 0.679 . . . . 51.42 111.746 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 N--CA 1.47 0.543 0 CA-C-O 121.065 0.46 . . . . 63.32 111.911 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.3 m -66.6 147.44 53.27 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.224 -0.444 . . . . 72.13 110.252 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.447 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.7 mt -50.49 -56.95 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.642 0.608 . . . . 73.51 112.642 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.2 pt-20 -62.99 -35.99 82.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.847 0.356 . . . . 62.44 111.791 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 t70 -65.29 -52.0 57.01 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.064 -0.517 . . . . 51.01 110.767 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.3 79.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.169 -0.469 . . . . 73.21 111.484 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 41' ' ' ILE . 85.8 m -58.27 -54.93 41.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.469 -0.332 . . . . 73.43 111.163 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -37.26 64.24 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.838 0.352 . . . . 73.41 111.841 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -59.72 -52.2 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.392 -0.367 . . . . 73.52 111.839 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -92.12 -0.67 57.44 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.109 0.411 . . . . 70.43 112.109 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.55 46.33 40.65 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.443 -0.408 . . . . 64.43 113.283 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mt -101.91 151.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 122.704 0.401 . . . . 75.34 111.264 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -85.14 98.52 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.035 0.445 . . . . 71.21 110.654 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.35 66.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.429 -0.35 . . . . 73.22 111.78 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.46 -51.82 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.585 -0.279 . . . . 62.33 111.159 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -76.91 -40.16 48.26 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.04 0.385 . . . . 62.31 112.04 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 tp -55.63 -53.69 53.36 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.783 0.325 . . . . 70.11 111.747 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 5' ' ' LYS . 59.8 t -61.16 -39.93 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.659 0.266 . . . . 72.33 111.595 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.4 mttt -60.8 -45.78 93.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.802 -0.181 . . . . 71.24 111.315 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.15 -40.0 88.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.751 0.31 . . . . 72.24 111.453 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.9 mt -59.24 -52.72 64.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.813 0.339 . . . . 72.2 111.51 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.401 ' OD1' ' N ' ' A' ' 3' ' ' ILE . 52.9 m-80 -57.74 -49.94 74.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.429 -0.351 . . . . 73.11 111.745 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.413 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 46.7 mt-10 -52.57 -44.43 65.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.462 -0.336 . . . . 63.14 110.782 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -57.69 -54.15 50.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.336 -0.393 . . . . 72.15 112.054 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 N--CA 1.469 0.486 0 N-CA-C 111.993 0.368 . . . . 74.4 111.993 -179.665 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' VAL . 50.9 mm . . . . . 0 CA--C 1.539 0.536 0 N-CA-C 112.944 0.72 . . . . 75.31 112.944 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.8 p -125.82 158.58 34.64 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.69 -0.686 . . . . 61.44 109.939 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.739 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.4 pttp -71.92 -15.17 62.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.015 -0.428 . . . . 41.14 111.252 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.84 -23.56 61.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.04 -0.527 . . . . 74.44 111.192 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.9 mtt -67.64 165.33 17.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.397 0.518 . . . . 74.2 112.397 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 12' ' ' VAL . 47.2 mm -93.75 135.53 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.992 -0.549 . . . . 53.32 111.581 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.7 -51.31 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.821 0.343 . . . . 60.4 111.849 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.13 -41.52 83.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.805 0.336 . . . . 64.42 111.73 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 15' ' ' MET . 20.4 t70 -58.66 -45.01 90.28 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.407 -0.361 . . . . 74.31 110.95 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 8' ' ' ILE . 88.7 t -57.53 -43.42 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.957 0.408 . . . . 73.43 111.2 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.422 HD23 ' OG1' ' A' ' 19' ' ' THR . 94.9 mt -62.68 -34.4 77.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.321 -0.399 . . . . 71.42 111.395 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 78.8 mt-30 -67.61 -30.16 69.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.386 -0.37 . . . . 63.51 111.661 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 37.2 mtm -74.45 -43.2 57.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.3 0.572 . . . . 65.0 109.949 175.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -159.49 124.67 4.11 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.614 -0.721 . . . . 73.52 111.756 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -69.47 -14.7 63.02 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.992 -0.549 . . . . 72.54 111.766 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.506 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -65.51 -9.75 45.54 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.067 -0.587 . . . . 73.32 113.178 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.422 ' OG1' HD23 ' A' ' 13' ' ' LEU . 80.7 p -82.43 -13.85 56.11 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.44 -0.447 . . . . 62.12 111.757 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.03 -51.07 80.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.604 0.594 . . . . 75.31 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.5 Cg_endo -58.92 -26.45 81.13 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.169 1.913 . . . . 74.12 112.677 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -71.41 -44.1 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.97 0.414 . . . . 74.33 110.789 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -63.76 -46.03 87.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.972 0.415 . . . . 73.53 110.55 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.56 -39.16 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.205 -0.452 . . . . 64.01 111.259 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.43 -40.7 71.83 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.076 0.465 . . . . 72.5 111.541 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.74 0.42 43.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.14 -0.482 . . . . 75.2 112.041 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 9.51 45.31 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 114.826 0.69 . . . . 71.53 114.826 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 118.093 0.946 . . . . 70.24 111.817 179.279 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 . . . . . 0 CA--C 1.541 0.601 0 CA-C-O 121.253 0.549 . . . . 75.23 112.344 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.7 m -70.29 151.53 45.19 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.041 -0.527 . . . . 72.31 111.899 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.0 mt -52.67 -57.66 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.376 0.509 . . . . 74.22 112.376 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.739 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.6 pt-20 -58.61 -35.56 72.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.912 0.387 . . . . 74.24 111.78 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 47' ' ' VAL . 17.9 t70 -68.85 -53.61 20.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.202 -0.454 . . . . 73.22 111.144 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.41 79.16 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.267 -0.424 . . . . 72.22 111.245 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -60.22 -52.25 66.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 74.11 110.825 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.0 -47.94 64.69 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.411 -0.358 . . . . 32.22 111.871 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 43' ' ' ASP . 59.9 t -51.94 -38.27 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 52.42 111.928 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -103.18 0.51 31.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.294 0.479 . . . . 73.35 112.294 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.57 74.07 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.161 -0.543 . . . . 44.41 113.501 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.6 153.13 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.899 0.38 . . . . 60.41 111.307 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -86.07 105.09 16.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.872 0.368 . . . . 72.15 110.877 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.5 -36.07 68.29 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.045 0.387 . . . . 72.23 112.045 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.74 -44.73 77.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.029 0.442 . . . . 75.21 111.003 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -69.2 -52.02 32.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.343 -0.39 . . . . 75.21 111.469 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -55.09 -49.62 71.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.21 0.448 . . . . 73.33 112.21 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 3' ' ' ILE . 75.2 t -60.31 -42.1 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 111.978 0.362 . . . . 72.21 111.978 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.71 -35.39 77.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.818 0.342 . . . . 74.45 111.217 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.63 -38.25 86.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.921 0.391 . . . . 73.05 110.999 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.42 -45.0 73.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.204 -0.453 . . . . 72.45 111.971 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -53.58 -56.4 17.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.794 0.294 . . . . 73.15 111.794 -179.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 18.4 mt-10 -46.68 -52.53 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 71.35 111.327 177.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.506 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 80.4 t80 -50.43 -55.36 16.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.54 0.57 . . . . 74.41 112.54 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 . . . . . 0 N--CA 1.47 0.567 0 N-CA-C 112.244 0.461 . . . . 73.44 112.244 -178.715 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.513 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm . . . . . 0 CA--C 1.537 0.461 0 CA-C-O 120.71 0.291 . . . . 75.14 111.435 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 p -121.61 154.69 36.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.841 0.353 . . . . 74.44 111.287 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 18.3 ptpt -53.54 -33.34 54.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.185 0.809 . . . . 74.41 113.185 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.09 -3.39 42.06 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.883 0.697 . . . . 61.21 112.883 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.2 mtt -73.38 150.79 41.52 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.122 0.487 . . . . 71.15 111.67 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.6 mm -79.78 131.04 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.237 -0.438 . . . . 72.33 111.444 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.8 mt -56.25 -51.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 111.89 0.329 . . . . 63.54 111.89 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -56.38 -40.11 74.06 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.891 0.377 . . . . 71.32 111.385 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -43.4 96.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.261 -0.427 . . . . 75.13 110.709 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.1 -41.55 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.089 0.471 . . . . 71.33 110.986 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.426 HD23 ' OG1' ' A' ' 19' ' ' THR . 94.7 mt -61.42 -35.89 78.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.033 0.444 . . . . 72.35 111.163 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.2 mt-30 -67.66 -22.21 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.257 -0.429 . . . . 64.04 111.598 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -74.2 -58.56 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.254 0.549 . . . . 74.53 109.643 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -146.83 127.51 14.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.612 -0.722 . . . . 74.23 110.825 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.464 HH12 ' HA ' ' A' ' 14' ' ' GLN . 77.8 mmt-85 -69.18 -17.59 63.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.783 0.29 . . . . 73.11 111.783 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.2 -6.75 41.18 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.211 -0.519 . . . . 71.13 113.217 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.437 ' HA ' HD12 ' A' ' 22' ' ' ILE . 80.9 p -81.62 -21.27 38.38 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.557 -0.378 . . . . 70.53 111.251 174.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -57.09 -51.14 83.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 112.181 0.438 . . . . 73.14 112.181 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.79 -25.44 76.16 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.941 1.761 . . . . 74.22 112.281 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 19' ' ' THR . 59.9 mt -73.22 -45.43 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.013 0.435 . . . . 72.11 110.72 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -57.01 -52.17 66.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.056 0.455 . . . . 62.54 110.522 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.81 -37.32 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.272 -0.422 . . . . 63.33 111.368 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -55.9 -33.64 64.83 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.137 0.494 . . . . 74.1 111.251 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -91.43 -4.12 55.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.241 0.459 . . . . 72.11 112.241 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.18 19.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.984 -0.627 . . . . 74.31 114.438 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.47 0.565 0 CA-C-N 117.593 0.696 . . . . 54.33 111.807 176.19 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 . . . . . 0 CA--C 1.541 0.61 0 CA-C-O 121.685 0.755 . . . . 75.23 112.772 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 94.1 p -78.84 164.13 24.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.526 -0.761 . . . . 70.4 112.011 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.07 -48.79 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.593 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 8.0 pt-20 -62.56 -37.18 85.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.982 0.364 . . . . 60.04 111.982 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.2 t70 -66.01 -58.99 4.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.71 0.29 . . . . 74.14 110.703 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.37 65.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.778 0.323 . . . . 74.15 111.65 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.819 0.342 . . . . 72.4 110.753 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.12 68.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.835 0.309 . . . . 75.4 111.835 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 43' ' ' ASP . 76.7 t -66.45 -54.58 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.939 0.4 . . . . 71.41 111.747 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.75 -18.69 30.52 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.881 0.372 . . . . 64.12 111.748 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.18 53.15 2.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 121.178 0.321 . . . . 72.02 113.066 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.9 mt -110.88 153.15 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.01 0.524 . . . . 60.03 111.107 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 54' ' ' LYS . 14.6 t70 -84.74 103.06 13.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.946 0.403 . . . . 72.02 110.243 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -62.14 -34.15 75.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.377 0.51 . . . . 74.14 112.377 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.65 -45.01 90.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.749 0.309 . . . . 73.4 111.181 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 92.0 mttt -66.42 -49.06 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.955 0.407 . . . . 71.34 111.036 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.17 -52.87 63.75 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.112 -0.495 . . . . 73.13 111.819 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HA ' HD12 ' A' ' 59' ' ' LEU . 96.2 t -58.57 -40.02 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.731 0.3 . . . . 65.15 111.639 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.47 -44.92 95.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.538 0.209 . . . . 74.13 111.39 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -62.96 -35.6 80.68 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.847 0.356 . . . . 60.42 111.314 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 56' ' ' VAL . 90.8 mt -64.09 -51.4 64.18 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.468 -0.333 . . . . 73.44 111.619 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 52.3 m-80 -58.31 -49.92 75.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.676 0.274 . . . . 72.54 111.571 177.729 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -50.29 -46.88 55.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.568 -0.287 . . . . 72.51 110.9 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -54.31 -51.77 63.62 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.305 0.483 . . . . 73.14 112.305 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 . . . . . 0 CA--C 1.539 0.525 0 CA-C-O 120.547 0.213 . . . . 61.44 111.429 179.379 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 mm . . . . . 0 CA--C 1.537 0.457 0 CA-C-O 120.828 0.347 . . . . 63.22 111.324 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 p -127.33 154.07 45.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.711 0.291 . . . . 62.23 110.719 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 10.2 ptpp? -64.46 -15.79 61.32 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.157 0.504 . . . . 71.24 111.237 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.44 -25.2 63.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.591 -0.731 . . . . 63.43 111.287 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.7 mtt -71.71 149.41 45.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.237 0.828 . . . . 53.34 113.237 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mm -78.76 133.37 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.405 -0.816 . . . . 35.2 110.928 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.67 -42.04 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 111.896 0.332 . . . . 51.42 111.896 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.0 94.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.964 0.357 . . . . 61.12 111.964 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.65 -45.99 88.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.093 0.473 . . . . 74.52 110.957 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.51 -37.52 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 53.41 111.249 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.36 -37.17 86.23 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.323 -0.399 . . . . 65.32 111.235 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -65.26 -21.83 66.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.365 -0.38 . . . . 64.11 111.428 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 29.7 mtm -84.68 -52.15 6.29 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.157 0.503 . . . . 74.13 110.091 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -146.55 128.81 15.76 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.919 -0.582 . . . . 73.55 111.042 176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -73.04 -22.75 60.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.299 0.481 . . . . 71.31 112.299 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.55 -2.84 51.96 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.447 -0.406 . . . . 34.51 113.56 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 p -80.26 -24.39 40.13 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.502 -0.411 . . . . 61.24 111.762 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.7 -52.5 66.81 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.715 0.635 . . . . 74.53 112.715 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.0 Cg_endo -58.88 -24.57 73.04 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.117 1.878 . . . . 71.25 112.706 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -71.82 -44.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.928 0.394 . . . . 64.51 110.633 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.96 -49.9 76.11 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.185 0.517 . . . . 75.01 110.288 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -61.22 -34.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.111 -0.495 . . . . 54.3 111.265 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -57.76 -34.42 69.53 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.912 0.387 . . . . 64.52 111.326 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -93.73 12.94 23.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.398 0.518 . . . . 73.35 112.398 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.22 38.1 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.707 -0.758 . . . . 40.22 114.846 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt . . . . . 0 N--CA 1.471 0.602 0 CA-C-N 117.82 0.81 . . . . 65.51 111.32 176.608 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 43.3 mt-10 . . . . . 0 CA--C 1.54 0.586 0 CA-C-O 121.079 0.466 . . . . 72.44 111.65 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -68.96 153.45 43.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.411 -0.358 . . . . 62.55 111.063 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 5' ' ' LYS . 22.5 mt -52.16 -52.53 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 72.15 112.583 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 11.2 pt-20 -61.08 -33.1 72.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.964 0.412 . . . . 62.35 111.886 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 47' ' ' VAL . 39.0 t70 -75.87 -59.19 2.87 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 72.53 110.953 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . . . -57.48 -43.0 83.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.308 -0.405 . . . . 63.15 111.916 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.06 -49.04 77.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.364 -0.21 . . . . 74.44 111.438 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.15 73.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.008 0.432 . . . . 65.23 111.642 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 43' ' ' ASP . 87.0 t -61.05 -45.48 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.197 -0.456 . . . . 51.52 111.815 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -90.03 -10.38 45.09 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.716 0.293 . . . . 72.53 111.787 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.31 35.94 25.24 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.47 -0.395 . . . . 50.11 113.308 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.64 152.89 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.986 0.422 . . . . 72.11 111.721 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -82.24 97.42 8.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.026 0.441 . . . . 71.43 109.865 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -65.31 -31.55 72.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.524 0.565 . . . . 53.13 112.524 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 35.6 t70 -60.93 -45.31 95.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.898 0.38 . . . . 73.13 110.716 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.24 -40.42 77.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.784 0.326 . . . . 75.21 111.501 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 41' ' ' ILE . 23.2 tp -58.88 -49.89 76.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.056 0.455 . . . . 74.11 111.433 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 52' ' ' ALA . 92.4 t -57.48 -38.78 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.269 -0.423 . . . . 70.04 111.805 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.2 mttm -56.58 -53.68 54.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.769 0.319 . . . . 75.12 111.37 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.05 -36.51 75.16 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.46 -0.336 . . . . 75.43 111.638 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.93 -49.44 74.76 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 111.84 0.311 . . . . 63.33 111.84 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 33.6 m-80 -59.09 -52.4 65.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.657 0.265 . . . . 50.15 111.397 178.339 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -54.2 -41.28 68.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.221 -0.445 . . . . 72.31 111.53 179.841 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.16 -51.78 66.75 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.18 0.437 . . . . 72.31 112.18 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 . . . . . 0 CA--C 1.541 0.604 0 CA-C-O 120.617 0.246 . . . . 71.45 111.455 178.289 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.524 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.1 mm . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 120.738 0.304 . . . . 53.45 111.652 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.42 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 36.4 p -121.69 162.92 19.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.847 0.356 . . . . 75.43 110.902 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.04 -14.94 62.5 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.892 0.377 . . . . 74.11 111.506 178.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.73 -15.93 57.85 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.101 0.476 . . . . 64.24 111.403 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 65.0 mtt -72.82 154.29 40.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.428 0.632 . . . . 61.33 112.206 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -81.87 133.72 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.65 -0.705 . . . . 75.01 111.485 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.19 -51.45 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.173 0.434 . . . . 52.41 112.173 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.68 -32.97 65.94 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 74.43 111.621 179.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.02 -45.13 71.25 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.724 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.7 -37.21 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.259 0.552 . . . . 71.23 110.744 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.404 HD23 ' OG1' ' A' ' 19' ' ' THR . 83.1 mt -63.94 -31.13 72.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.115 -0.493 . . . . 74.43 111.919 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -71.6 -29.45 64.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.921 0.391 . . . . 52.11 111.061 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.0 mtt -66.52 -52.12 49.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.344 0.592 . . . . 72.22 110.03 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -154.77 135.3 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.786 -0.643 . . . . 74.1 111.225 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -68.84 -24.92 64.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.339 -0.391 . . . . 74.42 111.69 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.443 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -69.06 -1.37 25.82 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.379 -0.373 . . . . 70.35 113.874 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.404 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.9 p -82.58 -22.88 34.68 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.607 -0.349 . . . . 41.55 111.518 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.96 -51.39 79.83 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 112.59 0.589 . . . . 73.02 112.59 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -59.61 -26.36 81.84 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 121.896 1.731 . . . . 60.45 112.637 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -44.78 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.925 0.393 . . . . 54.5 110.846 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -56.59 -50.4 72.09 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.057 0.456 . . . . 75.24 110.173 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.93 -39.69 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.118 -0.492 . . . . 73.1 111.337 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.86 -39.73 68.93 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.052 -0.522 . . . . 63.42 111.849 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.61 -3.53 58.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.184 0.438 . . . . 64.41 112.184 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.44 0.72 11.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.476 0.95 . . . . 71.33 115.476 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 mmt . . . . . 0 N--CA 1.474 0.737 0 CA-C-N 118.285 1.042 . . . . 63.5 111.815 178.84 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 . . . . . 0 N--CA 1.471 0.586 0 CA-C-O 121.307 0.575 . . . . 63.54 112.024 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.7 m -72.26 151.26 42.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.97 -0.559 . . . . 63.4 112.24 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -51.35 -48.88 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.793 0.664 . . . . 61.32 112.793 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 14.9 pt-20 -63.17 -35.34 79.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.852 0.358 . . . . 55.03 111.642 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 47' ' ' VAL . 36.8 t0 -69.72 -53.56 17.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.189 -0.46 . . . . 75.44 110.751 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.75 71.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.212 0.53 . . . . 75.23 111.297 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 84.0 m -59.67 -52.92 63.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.948 -0.569 . . . . 62.35 111.199 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -39.68 69.85 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.252 0.464 . . . . 75.42 112.252 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 43' ' ' ASP . 91.9 t -59.56 -42.31 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.837 0.351 . . . . 73.24 111.446 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -104.23 9.81 35.93 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.306 0.484 . . . . 74.1 112.306 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.21 18.31 71.05 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 114.279 0.472 . . . . 61.34 114.279 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 45' ' ' CYS . 56.7 mt -73.59 154.86 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 122.526 0.33 . . . . 73.24 111.475 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.28 96.48 10.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.14 0.495 . . . . 74.33 110.61 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.48 -34.79 77.89 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.336 -0.393 . . . . 73.01 111.894 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 30.2 t70 -58.42 -42.5 87.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.613 -0.267 . . . . 72.23 111.494 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.54 -39.28 67.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.943 0.402 . . . . 72.41 111.288 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.3 tp -59.84 -49.47 77.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 73.44 111.636 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 59' ' ' LEU . 92.3 t -57.38 -36.73 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.371 -0.377 . . . . 73.5 111.816 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.4 mttm -56.32 -55.24 35.84 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.851 0.357 . . . . 54.43 111.171 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.83 -35.29 74.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.388 -0.369 . . . . 74.24 111.964 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 56' ' ' VAL . 93.0 mt -60.64 -52.9 63.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.645 0.259 . . . . 64.13 111.449 175.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -58.92 -51.81 68.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.82 0.343 . . . . 52.1 111.721 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.06 -30.18 65.98 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.029 0.381 . . . . 62.01 112.029 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.443 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 90.0 t80 -64.02 -44.91 91.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.938 0.399 . . . . 72.0 111.359 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 . . . . . 0 CA--C 1.538 0.496 0 O-C-N 122.224 -0.297 . . . . 72.23 111.133 177.896 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.538 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.4 mm . . . . . 0 N--CA 1.472 0.666 0 N-CA-C 112.77 0.655 . . . . 72.11 112.77 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -120.76 159.37 25.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.195 -0.457 . . . . 64.03 110.953 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -15.92 61.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.087 0.47 . . . . 73.51 111.319 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.2 -26.37 56.06 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.654 -0.703 . . . . 74.41 111.552 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -65.57 158.42 27.15 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.423 0.63 . . . . 72.44 112.686 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 49.8 mm -84.54 134.96 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.926 -0.579 . . . . 70.33 111.329 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -56.66 -49.51 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.42 . . . . 71.45 111.312 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.92 68.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.307 -0.406 . . . . 71.32 111.516 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 13.2 t70 -72.59 -40.78 66.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.487 -0.324 . . . . 72.35 110.807 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 8' ' ' ILE . 57.9 t -57.72 -37.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.148 0.499 . . . . 73.13 110.335 173.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.15 -36.04 82.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.139 -0.482 . . . . 63.35 110.983 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.33 -29.3 70.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.727 0.298 . . . . 71.32 111.174 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -71.47 -49.29 42.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.224 0.535 . . . . 73.13 110.035 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -160.43 130.98 5.42 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.496 -0.775 . . . . 74.32 110.893 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -72.04 -20.28 61.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.959 0.355 . . . . 70.32 111.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.65 -1.44 45.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.56 -0.353 . . . . 74.33 113.476 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -19.55 46.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.521 -0.4 . . . . 75.32 111.721 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.09 -49.91 87.31 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.353 0.501 . . . . 72.01 112.353 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 76.7 Cg_exo -48.99 -42.08 38.92 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.399 2.066 . . . . 64.35 112.826 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.94 -45.31 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.403 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -58.67 -46.88 86.23 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 71.5 110.508 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 72.7 mt -58.96 -39.07 77.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.019 -0.537 . . . . 62.45 111.387 178.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.62 -36.29 73.83 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.312 -0.404 . . . . 64.4 111.571 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -86.68 4.46 40.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.637 0.606 . . . . 74.02 112.637 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.54 39.97 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.672 -0.775 . . . . 74.52 114.499 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.3 mmt . . . . . 0 CA--C 1.539 0.551 0 CA-C-N 117.677 0.739 . . . . 73.35 111.419 175.347 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 . . . . . 0 CA--C 1.539 0.547 0 CA-C-O 121.303 0.573 . . . . 73.31 112.349 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 92.5 p -78.63 161.54 26.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.391 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.8 mt -56.67 -47.81 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.493 -0.321 . . . . 75.51 111.781 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.07 -43.27 99.19 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.698 0.258 . . . . 74.03 111.698 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.14 -52.05 66.98 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.05 0.389 . . . . 74.54 112.05 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.49 88.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.777 0.322 . . . . 71.31 111.614 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.406 ' SG ' HD23 ' A' ' 55' ' ' LEU . 97.6 m -53.52 -46.46 70.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.68 -0.236 . . . . 73.41 111.166 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.04 67.61 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.987 0.365 . . . . 74.31 111.987 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.2 -46.14 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.976 0.417 . . . . 63.11 111.504 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -89.04 -10.02 49.07 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.456 -0.338 . . . . 64.14 111.73 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.26 37.87 30.83 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.106 -0.568 . . . . 72.15 112.795 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.8 mt -93.03 151.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.663 0.385 . . . . 61.34 111.293 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -80.88 102.01 9.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.958 0.409 . . . . 74.33 110.383 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.99 65.14 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.153 0.427 . . . . 74.15 112.153 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.22 -50.91 71.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.88 0.371 . . . . 71.33 110.446 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -70.26 -47.93 59.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.525 . . . . 73.03 112.032 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.406 HD23 ' SG ' ' A' ' 45' ' ' CYS . 29.5 tp -52.76 -52.64 55.75 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.952 0.406 . . . . 65.44 111.725 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.513 HG13 HG22 ' A' ' 3' ' ' ILE . 88.1 t -61.05 -40.52 85.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 74.35 111.78 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 98.7 mttt -69.72 -29.45 66.84 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.22 -0.3 . . . . 64.44 111.745 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.61 -39.4 73.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.879 0.371 . . . . 62.32 110.794 171.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.8 mt -58.12 -46.83 84.9 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.378 -0.374 . . . . 54.32 110.674 172.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -54.2 -55.97 22.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.251 -0.431 . . . . 73.21 111.595 175.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . 0.49 ' HG3' ' O ' ' A' ' 57' ' ' LYS . 46.0 mt-10 -46.05 -48.82 16.85 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.075 0.464 . . . . 75.55 111.201 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -54.21 -52.4 61.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.87 -0.605 . . . . 72.04 112.384 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 . . . . . 0 CA--C 1.538 0.51 0 CA-C-O 120.723 0.297 . . . . 71.1 111.352 179.406 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 mm . . . . . 0 N--CA 1.468 0.473 0 CA-C-O 120.69 0.281 . . . . 73.35 111.496 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 27.3 p -119.27 155.31 32.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.66 0.267 . . . . 74.34 110.862 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 17.0 ptpt -64.67 -14.66 59.24 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.177 0.513 . . . . 71.01 111.415 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.55 -16.07 55.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.691 -0.686 . . . . 73.2 111.669 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.437 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.4 mtt -75.39 164.87 25.95 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.506 0.67 . . . . 73.1 112.582 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -88.57 138.06 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.568 -0.742 . . . . 74.52 111.513 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.1 mt -54.5 -53.28 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.994 0.426 . . . . 70.22 111.699 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.84 75.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.833 0.349 . . . . 74.33 111.796 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.77 -39.63 94.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.802 0.334 . . . . 75.44 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.38 -39.73 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.044 0.45 . . . . 60.34 110.844 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.494 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -61.43 -34.53 75.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.149 0.5 . . . . 74.43 111.096 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -68.89 -18.77 64.17 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.056 -0.52 . . . . 51.2 111.485 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.4 mtt -81.23 -50.35 9.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.38 0.61 . . . . 73.1 109.791 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.5 132.5 14.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.965 -0.561 . . . . 70.34 111.716 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -74.17 -16.25 60.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.606 0.595 . . . . 72.25 112.606 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.57 -2.21 79.59 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.14 -0.552 . . . . 71.12 113.415 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.494 ' OG1' HD23 ' A' ' 13' ' ' LEU . 74.3 p -80.51 -22.1 41.26 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.114 0.413 . . . . 74.42 112.114 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.83 -50.64 84.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 112.722 0.638 . . . . 31.11 112.722 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 75.7 Cg_exo -49.86 -41.24 47.71 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.198 1.932 . . . . 72.3 112.657 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.41 -44.98 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.167 -0.47 . . . . 64.34 111.492 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -58.24 -51.56 69.23 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 54.35 110.936 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.51 -38.98 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.928 0.394 . . . . 75.22 111.107 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -51.86 -41.87 62.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.979 -0.555 . . . . 71.43 111.536 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -85.48 -4.26 59.11 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.277 0.473 . . . . 73.11 112.277 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.5 -5.35 9.31 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.662 -0.78 . . . . 62.55 114.972 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.2 mmt . . . . . 0 N--CA 1.473 0.702 0 CA-C-N 118.208 1.004 . . . . 74.35 111.833 179.983 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 . . . . . 0 CA--C 1.543 0.685 0 CA-C-O 120.977 0.418 . . . . 74.15 111.788 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.7 p -73.14 158.11 35.94 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.309 0.576 . . . . 54.53 112.503 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mt -54.79 -56.03 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.812 -0.631 . . . . 75.23 112.476 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.1 pt-20 -60.81 -44.72 96.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.13 0.419 . . . . 63.04 112.13 -176.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.401 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 t0 -65.59 -45.21 84.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.971 0.415 . . . . 73.41 110.987 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.73 81.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.429 . . . . 61.4 111.455 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.35 -49.59 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.413 -0.358 . . . . 75.03 111.26 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.88 -36.21 62.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.121 0.415 . . . . 74.33 112.121 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.19 -37.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.993 0.425 . . . . 74.24 111.854 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.92 18.09 16.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.403 0.519 . . . . 62.3 112.403 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.19 27.83 68.1 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 72.05 113.79 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.33 150.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.895 0.379 . . . . 70.14 111.117 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.66 97.27 10.79 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.821 0.344 . . . . 75.0 110.215 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.29 -36.55 81.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.105 0.409 . . . . 75.01 112.105 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -42.87 83.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.149 0.5 . . . . 64.41 111.072 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.65 -44.11 57.73 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.249 -0.432 . . . . 64.22 111.529 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -55.36 -49.34 72.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.959 0.409 . . . . 72.21 111.951 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 5' ' ' LYS . 93.0 t -59.32 -38.28 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.395 -0.366 . . . . 64.03 111.837 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.69 -43.84 98.09 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.719 0.295 . . . . 73.24 110.638 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -60.17 -37.9 81.57 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 65.31 111.359 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 56' ' ' VAL . 84.8 mt -63.36 -53.98 44.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.484 -0.325 . . . . 71.2 111.517 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 44.6 m-80 -56.71 -54.22 48.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.918 0.34 . . . . 73.4 111.918 178.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.9 mt-10 -52.96 -38.51 62.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.612 -0.267 . . . . 75.52 111.334 179.112 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.86 -49.29 78.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.876 0.37 . . . . 64.31 111.762 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 . . . . . 0 CA--C 1.538 0.501 0 CA-C-O 120.741 0.305 . . . . 72.12 110.897 177.349 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mm . . . . . 0 CA--C 1.537 0.469 0 CA-C-O 121.066 0.46 . . . . 62.53 111.785 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -122.99 153.13 40.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.417 -0.356 . . . . 70.22 110.748 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 46.2 pttt -63.36 -15.51 57.67 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.903 0.382 . . . . 74.44 111.98 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.5 -29.83 63.98 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.97 -0.559 . . . . 73.04 111.409 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 65.2 mtt -63.6 150.51 43.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.728 0.64 . . . . 75.53 112.728 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mm -78.37 136.06 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.683 -0.69 . . . . 64.51 111.116 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.44 -48.75 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.762 0.315 . . . . 73.21 111.771 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.515 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -59.72 -33.5 71.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.897 0.332 . . . . 75.04 111.897 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.17 -41.73 85.47 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.823 0.344 . . . . 72.22 111.184 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.2 t -60.44 -39.24 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.105 0.479 . . . . 75.13 110.945 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . 0.456 HD23 ' OG1' ' A' ' 19' ' ' THR . 88.1 mt -62.22 -31.01 71.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.26 -0.427 . . . . 73.04 111.519 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 84.3 mm-40 -67.34 -27.01 66.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.941 0.401 . . . . 71.53 111.321 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.2 mtt -75.0 -48.38 24.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.34 0.59 . . . . 73.55 110.064 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -154.99 132.54 11.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.722 -0.672 . . . . 54.13 110.761 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -70.15 -28.41 65.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.093 0.473 . . . . 53.34 111.611 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.04 2.09 14.94 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.078 -0.51 . . . . 74.45 113.807 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.456 ' OG1' HD23 ' A' ' 13' ' ' LEU . 72.6 p -82.72 -19.24 38.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.514 -0.403 . . . . 75.33 111.384 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.35 -51.41 78.17 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.654 0.613 . . . . 50.34 112.654 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.5 Cg_endo -57.84 -31.03 91.42 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.953 1.768 . . . . 61.2 112.59 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.97 -46.65 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.98 0.419 . . . . 72.2 110.914 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 68.7 m-85 -57.52 -46.82 83.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.204 0.525 . . . . 74.33 110.266 171.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 28' ' ' MET . 73.6 mt -58.05 -36.67 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.958 -0.565 . . . . 75.43 111.668 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -61.73 -32.96 73.23 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.973 0.416 . . . . 64.24 111.574 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.7 1.38 55.51 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.242 0.46 . . . . 74.32 112.242 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.78 10.3 16.81 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.425 -0.893 . . . . 42.44 114.896 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.416 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.2 mmt . . . . . 0 N--CA 1.469 0.524 0 O-C-N 121.85 -0.794 . . . . 54.45 111.435 175.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 . . . . . 0 CA--C 1.546 0.813 0 CA-C-O 121.247 0.546 . . . . 73.53 112.156 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.0 m -67.5 156.22 37.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.915 0.709 . . . . 73.02 112.915 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -55.11 -60.24 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.615 0.598 . . . . 72.5 112.615 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.5 pt-20 -61.95 -36.01 80.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.873 0.368 . . . . 73.53 111.847 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.44 -48.43 72.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.888 0.375 . . . . 53.35 110.918 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.14 77.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.065 0.459 . . . . 61.52 111.538 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 94.4 m -58.81 -44.59 90.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.442 -0.345 . . . . 73.31 111.22 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.54 62.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.007 0.373 . . . . 73.51 112.007 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.67 -41.75 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 111.821 0.304 . . . . 73.45 111.821 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -112.31 17.11 19.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 71.14 111.862 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.97 23.11 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.123 -0.561 . . . . 74.41 113.763 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.1 150.27 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.905 0.383 . . . . 71.43 111.639 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.57 108.3 17.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.125 0.488 . . . . 54.33 110.203 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -75.08 -25.05 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 73.22 111.962 -176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 13.9 t70 -60.92 -47.86 84.47 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.017 0.436 . . . . 74.35 110.621 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.76 -39.78 66.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.127 -0.488 . . . . 64.2 111.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.87 -50.47 72.38 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.08 0.466 . . . . 75.3 111.077 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' HD12 ' A' ' 59' ' ' LEU . 78.6 t -59.27 -38.5 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.217 -0.447 . . . . 73.24 111.442 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.0 mttm -57.82 -50.38 73.47 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.544 0.201 . . . . 63.41 111.544 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -58.53 -38.44 77.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.826 0.346 . . . . 73.04 111.577 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 56' ' ' VAL . 85.2 mt -61.64 -50.97 70.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.734 0.302 . . . . 75.14 111.534 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -59.0 -55.78 30.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.932 0.345 . . . . 73.34 111.932 179.684 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -52.81 -36.79 58.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.728 0.299 . . . . 73.24 111.577 -179.2 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -58.27 -51.68 68.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.367 . . . . 74.12 111.495 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 . . . . . 0 CA--C 1.538 0.502 0 CA-C-O 120.729 0.299 . . . . 74.23 111.31 178.192 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.402 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 44.6 mm . . . . . 0 CA--C 1.541 0.607 0 CA-C-O 120.716 0.293 . . . . 74.24 111.66 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 41.8 p -119.84 160.81 21.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.554 -0.294 . . . . 72.15 110.553 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.3 pttp -73.71 -16.77 61.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.069 -0.394 . . . . 62.24 111.414 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.19 -25.05 62.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.086 -0.506 . . . . 75.53 111.102 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.433 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.0 mtt -62.41 139.86 58.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.438 0.637 . . . . 70.05 111.832 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 44.9 mm -69.53 137.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.772 -0.649 . . . . 62.33 110.953 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -54.04 -46.21 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.851 0.357 . . . . 62.21 111.273 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.45 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -60.2 -36.37 77.52 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.802 0.335 . . . . 64.34 111.426 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.495 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 12.0 t70 -63.18 -43.98 96.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.041 0.448 . . . . 73.14 110.516 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 41' ' ' ILE . 51.6 t -61.19 -40.1 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.141 0.496 . . . . 72.13 110.722 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.23 -33.12 74.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.243 -0.435 . . . . 63.24 111.304 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 74.0 mt-30 -64.21 -30.33 71.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.362 . . . . 54.41 111.242 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.6 mtt -71.89 -51.59 21.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.283 0.563 . . . . 71.15 110.072 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.29 125.66 5.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.55 -0.75 . . . . 70.23 110.693 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -71.72 -15.47 62.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.006 0.373 . . . . 73.51 112.006 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.58 -1.75 39.29 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.212 -0.518 . . . . 44.21 113.157 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.0 p -82.64 -17.87 43.09 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.698 -0.295 . . . . 63.03 111.573 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.25 -51.06 82.89 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.223 0.453 . . . . 63.1 112.223 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -58.58 -25.76 75.97 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.957 1.772 . . . . 60.01 112.554 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.74 -44.77 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.995 0.426 . . . . 53.02 110.812 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -58.19 -45.82 86.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 71.02 110.406 173.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.96 -40.81 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.192 0.52 . . . . 63.51 110.911 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -56.86 -30.06 63.47 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.622 -0.717 . . . . 72.34 112.001 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -96.82 1.47 50.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.553 0.575 . . . . 74.2 112.553 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -3.0 22.84 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.476 -0.869 . . . . 22.45 115.11 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt . . . . . 0 N--CA 1.473 0.685 0 CA-C-N 118.251 1.026 . . . . 45.42 112.287 -178.887 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 121.434 0.635 . . . . 72.52 112.504 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 90.2 p -75.55 160.12 30.5 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.928 -0.578 . . . . 54.23 112.207 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 12' ' ' VAL . 22.3 mt -54.74 -52.57 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.093 -0.503 . . . . 64.14 111.901 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.0 pt-20 -62.97 -40.33 97.38 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.877 0.325 . . . . 64.22 111.877 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.7 t70 -62.58 -51.14 68.51 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 54.44 110.499 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.07 94.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.01 -0.541 . . . . 52.34 111.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -58.49 -45.82 87.94 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.561 -0.29 . . . . 72.31 111.307 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -35.8 74.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.753 0.311 . . . . 74.54 111.656 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 43' ' ' ASP . 61.2 t -65.98 -43.24 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.192 0.52 . . . . 63.15 111.364 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.46 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.3 t-80 -86.59 -14.82 41.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.2 -0.454 . . . . 75.03 111.435 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 38.61 23.44 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 116.455 -0.339 . . . . 71.21 113.13 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 48' ' ' HIS . 27.9 mt -98.02 153.36 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 122.927 0.491 . . . . 72.13 111.284 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.55 101.92 8.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.018 0.437 . . . . 75.25 109.904 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.45 -34.69 77.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.444 0.535 . . . . 55.21 112.444 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.01 -45.5 82.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.829 0.347 . . . . 72.22 111.066 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.26 -47.03 75.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.4 -0.363 . . . . 73.2 111.254 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 29.9 tp -57.51 -50.83 71.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.244 -0.435 . . . . 75.13 111.306 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 5' ' ' LYS . 85.4 t -60.79 -39.62 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.508 -0.314 . . . . 71.11 111.615 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.65 -41.67 98.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.454 0.168 . . . . 64.22 111.454 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.82 -40.53 95.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.706 0.289 . . . . 62.14 111.043 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 56' ' ' VAL . 91.1 mt -59.6 -52.24 66.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.617 -0.265 . . . . 55.03 110.971 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.402 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 39.7 m-80 -54.67 -57.97 9.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.622 -0.263 . . . . 44.01 111.537 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -54.07 -37.78 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.552 -0.295 . . . . 72.31 111.667 -179.432 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -58.4 -51.3 70.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.842 0.353 . . . . 63.31 111.31 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 . . . . . 0 CA--C 1.536 0.419 0 CA-C-O 120.695 0.283 . . . . 73.44 110.971 176.755 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' ILE . . . . . 0.519 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.8 mm . . . . . 0 N--CA 1.469 0.508 0 N-CA-C 112.426 0.528 . . . . 74.34 112.426 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.6 p -120.21 167.21 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.95 -0.568 . . . . 60.41 110.336 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.9 ptpt -74.28 -8.79 57.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.134 0.492 . . . . 65.32 110.873 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.91 -24.9 32.92 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.898 -0.592 . . . . 53.24 111.818 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.3 mtt -66.23 156.92 32.82 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.653 0.612 . . . . 73.12 112.653 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.8 133.78 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.871 -0.604 . . . . 74.13 111.165 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.89 -50.49 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.207 0.447 . . . . 73.22 112.207 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.74 -38.07 80.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 70.04 111.655 178.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.38 -44.3 92.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 74.14 110.772 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.4 -42.16 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.112 -0.495 . . . . 73.54 111.105 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.39 -34.14 73.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.214 -0.448 . . . . 70.11 111.91 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -69.23 -22.87 63.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.77 0.319 . . . . 74.41 111.719 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.6 mtm -83.3 -45.51 13.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.048 0.451 . . . . 75.02 110.193 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -152.08 112.93 4.2 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.901 -0.59 . . . . 73.33 110.889 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.3 -11.91 53.42 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.832 0.679 . . . . 74.0 112.832 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.469 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -70.16 -9.53 63.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.175 -0.536 . . . . 74.13 112.916 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -78.67 -16.36 57.39 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.566 -0.373 . . . . 74.14 111.707 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -56.62 -52.01 76.86 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 112.391 0.515 . . . . 70.41 112.391 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 52.2 Cg_exo -52.63 -38.22 75.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.011 1.807 . . . . 70.12 112.438 175.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.66 -46.49 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.096 -0.502 . . . . 73.13 111.162 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 54.4 m-85 -59.03 -46.22 88.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.849 0.357 . . . . 74.31 110.836 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.83 -37.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.913 0.387 . . . . 70.33 111.206 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -56.14 -40.31 73.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.059 -0.519 . . . . 74.53 111.337 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 55' ' ' LEU . 39.9 m-80 -87.79 -2.37 58.57 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.389 0.515 . . . . 71.24 112.389 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.7 11.44 30.66 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 115.011 0.764 . . . . 71.22 115.011 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' MET . . . . . 0.536 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 25.4 mmt . . . . . 0 N--CA 1.473 0.719 0 CA-C-N 117.984 0.892 . . . . 62.03 110.975 175.56 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 . . . . . 0 CA--C 1.539 0.52 0 CA-C-O 121.199 0.524 . . . . 62.34 112.231 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 m -72.41 147.65 45.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.864 -0.607 . . . . 64.2 111.805 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ILE . . . . . 0.42 HG23 HD23 ' A' ' 55' ' ' LEU . 32.3 mt -51.41 -52.36 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.291 0.478 . . . . 73.44 112.291 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.9 pt-20 -62.61 -34.81 77.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.741 0.275 . . . . 65.43 111.741 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.0 t70 -65.57 -52.39 52.66 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 72.1 110.633 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.91 77.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.23 0.538 . . . . 72.22 111.077 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 93.0 m -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.129 -0.487 . . . . 63.34 111.392 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.07 52.27 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.264 0.468 . . . . 73.31 112.264 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 43' ' ' ASP . 48.0 t -65.07 -52.1 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.984 0.421 . . . . 65.13 111.716 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' HIS . . . . . 0.448 ' HB2' HG13 ' A' ' 50' ' ' ILE . 85.4 m-70 -98.87 3.19 47.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.021 0.378 . . . . 63.44 112.021 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.01 67.12 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.008 -0.615 . . . . 73.14 112.944 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 48' ' ' HIS . 50.5 mt -73.45 150.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.884 0.373 . . . . 65.21 111.291 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.5 97.28 10.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.197 0.522 . . . . 72.33 109.766 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -64.74 -31.28 72.44 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.407 0.521 . . . . 73.41 112.407 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 2.9 t70 -63.63 -40.35 96.66 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.663 0.268 . . . . 75.42 110.879 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.32 -47.5 84.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.052 0.453 . . . . 72.32 110.668 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.9 tp -58.05 -48.5 79.92 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.804 -0.635 . . . . 53.03 111.262 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 52' ' ' ALA . 89.6 t -57.12 -42.58 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.219 -0.446 . . . . 54.42 111.754 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.5 mttm -56.5 -52.96 62.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.853 0.359 . . . . 73.21 110.812 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -55.11 -40.32 70.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.081 -0.509 . . . . 54.44 111.622 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 95.4 mt -64.0 -55.41 22.53 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.114 0.413 . . . . 73.45 112.114 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 51.6 m-80 -55.47 -51.47 66.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.72 0.295 . . . . 61.42 111.58 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 37.5 mt-10 -59.56 -27.84 66.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.434 -0.348 . . . . 54.42 111.68 -179.756 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.469 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 85.8 t80 -69.66 -47.12 64.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.627 -0.261 . . . . 74.45 111.318 175.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 . . . . . 0 CA--C 1.536 0.425 0 CA-C-O 120.763 0.315 . . . . 61.33 111.23 177.156 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.639 ' SD ' ' N ' ' A' ' 2' ' ' LYS . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.417 0 N-CA-C 110.33 -0.248 . . . . 72.21 110.33 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.639 ' N ' ' SD ' ' A' ' 1' ' ' MET . 13.3 tppt? -128.77 104.79 7.83 Favored 'General case' 0 CA--C 1.545 0.752 0 CA-C-O 120.961 0.41 . . . . 72.54 111.52 -176.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.3 mm -76.53 142.08 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.634 0 C-N-CA 122.966 0.506 . . . . 75.32 112.135 -179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.466 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.8 p -122.81 155.12 37.23 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 116.472 -0.331 . . . . 75.53 110.526 177.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.548 ' HB3' HG21 ' A' ' 56' ' ' VAL . 10.4 ptpp? -69.62 -17.65 63.54 Favored 'General case' 0 CA--C 1.541 0.609 0 O-C-N 121.917 -0.489 . . . . 70.11 111.969 -177.618 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -74.98 -17.61 60.51 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-O 120.933 0.397 . . . . 73.22 111.221 176.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.466 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 66.0 mtt -66.38 149.82 49.82 Favored 'General case' 0 CA--C 1.54 0.596 0 CA-C-O 121.139 0.495 . . . . 74.53 111.841 178.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.527 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -79.11 133.19 30.48 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.454 0 CA-C-N 116.245 -0.434 . . . . 71.41 111.317 -179.833 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.7 mt -55.55 -48.88 76.84 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.619 0 CA-C-O 120.848 0.356 . . . . 72.11 111.367 179.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.32 -31.51 69.22 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.046 0.387 . . . . 73.44 112.046 177.04 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.2 t70 -75.18 -38.97 60.63 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-O 120.742 0.306 . . . . 54.04 111.323 179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.409 HG23 ' O ' ' A' ' 8' ' ' ILE . 61.6 t -60.08 -40.04 82.15 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-O 121.199 0.523 . . . . 63.21 110.24 173.353 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.468 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.8 mt -61.43 -25.44 67.21 Favored 'General case' 0 N--CA 1.471 0.594 0 CA-C-N 115.934 -0.575 . . . . 75.32 111.63 174.873 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 18.2 mm-40 -73.7 -32.26 63.84 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-O 120.814 0.34 . . . . 71.13 111.098 175.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 26.6 mtt -71.24 -39.48 71.64 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.439 0.638 . . . . 74.31 110.129 177.316 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . 0.433 ' HB3' HG23 ' A' ' 19' ' ' THR . 40.0 t0 -160.05 130.22 5.44 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 115.275 -0.875 . . . . 74.41 111.018 176.252 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.4 mmt180 -70.91 -22.68 62.22 Favored 'General case' 0 CA--C 1.541 0.615 0 CA-C-O 121.082 0.467 . . . . 63.24 110.637 178.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.69 2.16 49.52 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-N 116.284 -0.416 . . . . 63.21 113.755 -178.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.468 ' OG1' HD23 ' A' ' 13' ' ' LEU . 68.1 p -82.59 -19.01 39.28 Favored 'General case' 0 N--CA 1.473 0.696 0 O-C-N 122.288 -0.537 . . . . 73.11 111.585 177.484 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.96 -51.13 77.54 Favored Pre-proline 0 CA--C 1.548 0.895 0 N-CA-C 112.72 0.637 . . . . 52.45 112.72 -179.837 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.6 Cg_endo -59.4 -21.41 60.99 Favored 'Trans proline' 0 C--N 1.361 1.22 0 C-N-CA 122.039 1.826 . . . . 72.41 112.897 179.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -74.39 -46.32 43.91 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.433 0 CA-C-O 120.947 0.403 . . . . 74.34 110.376 176.214 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 74.6 m-85 -59.27 -45.27 91.69 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-O 121.188 0.518 . . . . 72.43 110.32 173.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.2 mt -61.66 -37.03 77.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.658 0 CA-C-N 116.112 -0.494 . . . . 64.43 111.13 176.239 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 56.2 t30 -56.43 -42.18 77.66 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.031 0.443 . . . . 74.35 111.457 178.008 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.4 m-80 -85.54 -1.36 57.02 Favored 'General case' 0 CA--C 1.543 0.693 0 N-CA-C 112.823 0.675 . . . . 63.2 112.823 -177.272 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.49 17.52 15.09 Favored Glycine 0 CA--C 1.531 1.042 0 N-CA-C 115.224 0.85 . . . . 52.41 115.224 173.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.6 mmt -72.09 147.18 46.99 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 118.093 0.947 . . . . 74.4 111.813 176.182 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 48.0 t-80 -110.02 97.62 7.09 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.311 -0.404 . . . . 74.44 110.718 179.371 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 24.2 p -64.27 103.13 0.59 Allowed 'General case' 0 N--CA 1.471 0.591 0 CA-C-O 121.247 0.546 . . . . 74.53 111.561 -178.016 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.69 HD13 ' N ' ' A' ' 32' ' ' GLY . 1.3 tm? -148.61 153.19 37.99 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 109.589 -0.523 . . . . 63.13 109.589 -177.106 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.69 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -66.38 70.53 0.15 Allowed Glycine 0 CA--C 1.526 0.75 0 CA-C-O 121.145 0.303 . . . . 41.54 113.096 178.632 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.673 ' SG ' HD12 ' A' ' 31' ' ' LEU . 62.8 m -145.19 152.3 50.41 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 122.639 0.375 . . . . 74.31 111.295 179.381 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_exo -57.96 -47.03 22.3 Favored 'Trans proline' 0 CA--C 1.539 0.756 0 C-N-CA 122.257 1.971 . . . . 72.23 112.315 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 19.4 m -69.7 20.61 0.03 OUTLIER 'General case' 0 N--CA 1.482 1.142 0 N-CA-C 113.52 0.933 . . . . 74.34 113.52 -176.222 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 80.6 p -146.69 -46.42 0.19 Allowed 'General case' 0 N--CA 1.468 0.473 0 CA-C-O 121.088 0.47 . . . . 74.42 111.345 -179.872 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 2.7 mmt -109.16 -48.08 3.32 Favored 'General case' 0 CA--C 1.542 0.64 0 N-CA-C 112.642 0.608 . . . . 72.1 112.642 -179.301 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -72.82 -40.26 52.96 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 115.147 0.819 . . . . 73.54 115.147 -171.209 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.7 mm-40 -78.49 173.97 11.81 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 113.29 0.848 . . . . 74.31 113.29 -176.162 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.527 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 24.3 m -72.19 159.73 33.62 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 115.126 -0.943 . . . . 45.42 111.5 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.7 mt -52.97 -52.55 27.9 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 N-CA-C 111.959 0.355 . . . . 73.23 111.959 179.693 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -59.09 -40.36 85.04 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.831 0.348 . . . . 64.15 111.732 179.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.411 ' O ' HG23 ' A' ' 47' ' ' VAL . 4.2 t70 -63.34 -51.13 67.23 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.246 -0.434 . . . . 63.43 110.804 -177.601 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.37 -36.9 85.38 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-N 116.05 -0.523 . . . . 61.23 111.685 178.26 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.411 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 89.2 m -62.21 -48.53 79.62 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.553 -0.294 . . . . 72.35 111.433 177.829 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.61 -37.44 65.58 Favored 'General case' 0 CA--C 1.539 0.525 0 N-CA-C 111.962 0.356 . . . . 25.44 111.962 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.411 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.1 t -57.74 -53.98 37.69 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 CA-C-O 120.91 0.386 . . . . 65.15 111.65 178.067 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 17.9 m-70 -92.65 6.64 46.62 Favored 'General case' 0 N--CA 1.473 0.694 0 N-CA-C 112.226 0.454 . . . . 72.43 112.226 -177.79 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 62.89 32.34 83.56 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 121.285 -0.483 . . . . 61.15 112.968 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 58.8 mt -78.43 150.04 5.55 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-O 121.207 0.527 . . . . 71.45 111.555 -179.29 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.3 t0 -80.92 84.23 6.46 Favored 'General case' 0 CA--C 1.542 0.653 0 CA-C-N 116.104 -0.498 . . . . 72.15 110.433 -179.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.414 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -60.84 -30.3 70.02 Favored 'General case' 0 N--CA 1.469 0.483 0 CA-C-N 116.545 -0.298 . . . . 72.11 111.771 -178.7 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.411 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 33.2 t70 -58.75 -47.3 85.12 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-O 120.715 0.293 . . . . 61.2 110.864 177.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.7 mttp -71.83 -44.16 64.35 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.763 0.316 . . . . 70.12 111.432 177.772 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.9 tp -54.73 -51.61 65.1 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.323 -0.398 . . . . 64.42 111.703 179.442 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.548 HG21 ' HB3' ' A' ' 5' ' ' LYS . 90.1 t -60.56 -42.28 90.92 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.402 0 CA-C-N 116.608 -0.269 . . . . 71.51 111.614 179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.411 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 98.9 mttt -57.16 -48.0 79.78 Favored 'General case' 0 N--CA 1.469 0.476 0 CA-C-O 120.591 0.234 . . . . 73.42 111.375 177.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -60.57 -39.71 89.02 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 120.601 0.238 . . . . 70.42 111.45 177.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 56' ' ' VAL . 91.0 mt -59.26 -48.54 81.23 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.618 0.247 . . . . 74.21 111.185 175.122 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.601 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 53.2 m-80 -58.62 -61.7 2.4 Favored 'General case' 0 N--CA 1.471 0.591 0 CA-C-N 116.608 -0.269 . . . . 74.5 111.373 177.187 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.675 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 51.8 mt-10 -46.17 -46.06 17.1 Favored 'General case' 0 N--CA 1.469 0.484 0 CA-C-N 116.197 -0.456 . . . . 63.54 111.153 179.584 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 85.9 t80 -52.09 -58.66 5.9 Favored 'General case' 0 CA--C 1.539 0.55 0 N-CA-C 112.383 0.512 . . . . 73.25 112.383 178.024 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -60.46 -43.23 97.09 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 120.832 0.349 . . . . 64.32 111.309 178.789 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.476 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 27.6 mt-10 -68.4 -19.82 64.63 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 116.266 -0.425 . . . . 63.42 111.622 -176.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.675 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 74.9 mmtt -70.12 -45.76 66.21 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-O 121.269 0.557 . . . . 74.14 110.058 168.533 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.41 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 49.4 mtpt -61.05 -39.18 88.86 Favored 'General case' 0 N--CA 1.469 0.504 0 CA-C-N 115.887 -0.597 . . . . 70.21 111.515 179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.2 mt-10 -62.27 -11.21 13.76 Favored 'General case' 0 CA--C 1.542 0.672 0 CA-C-O 120.944 0.402 . . . . 73.41 111.532 178.598 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.3 t -101.21 -50.81 10.01 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-O 121.069 0.462 . . . . 74.3 111.272 173.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 92.7 mt -59.81 -53.3 59.57 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 112.65 0.611 . . . . 72.25 112.65 -179.099 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.4 mt-10 . . . . . 0 C--O 1.25 1.129 0 CA-C-O 118.458 -0.782 . . . . 74.22 112.054 -178.878 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 49.4 ttm . . . . . 0 N--CA 1.49 1.568 0 CA-C-O 120.603 0.24 . . . . 53.54 111.053 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.4 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 4.2 tppp? -62.0 104.29 0.45 Allowed 'General case' 0 N--CA 1.468 0.474 0 CA-C-O 120.995 0.426 . . . . 44.34 110.983 175.455 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.449 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm -66.23 136.62 26.39 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.434 0 CA-C-N 116.11 -0.495 . . . . 61.01 111.235 179.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 47.6 p -120.48 159.32 25.4 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 116.413 -0.358 . . . . 44.31 110.851 177.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.609 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.1 pttp -71.01 -11.29 60.89 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-O 120.94 0.4 . . . . 72.22 111.356 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.4 t70 -76.87 -25.41 53.06 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.895 -0.593 . . . . 65.31 110.96 176.008 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.449 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.7 mtt -66.75 154.14 41.5 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 121.298 0.571 . . . . 61.41 112.071 -179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.3 mm -84.51 136.52 22.6 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-N 115.955 -0.566 . . . . 53.13 111.334 -178.77 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 45.4 mt -56.11 -52.2 53.36 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 CA-C-O 120.847 0.356 . . . . 71.05 111.696 179.051 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.23 -27.34 65.67 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-O 120.97 0.414 . . . . 33.12 111.631 177.634 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -75.0 -41.12 60.12 Favored 'General case' 0 CA--C 1.538 0.499 0 CA-C-O 120.908 0.385 . . . . 72.22 110.822 177.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 87.7 t -58.37 -37.96 66.69 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.589 0 CA-C-O 121.204 0.526 . . . . 74.21 110.524 173.982 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 94.6 mt -61.1 -30.08 70.15 Favored 'General case' 0 CA--C 1.539 0.523 0 CA-C-N 116.05 -0.523 . . . . 62.43 111.59 175.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -64.69 -30.94 71.97 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.929 0.395 . . . . 73.45 111.042 176.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.8 mtt -72.35 -49.03 37.19 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 121.374 0.607 . . . . 74.33 109.744 175.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.9 t0 -158.18 138.14 12.28 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 115.491 -0.777 . . . . 71.34 111.364 173.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.5 mmt180 -77.18 -20.59 55.2 Favored 'General case' 0 CA--C 1.539 0.519 0 CA-C-O 121.257 0.551 . . . . 75.22 110.771 178.291 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.87 -2.42 23.36 Favored Glycine 0 CA--C 1.529 0.932 0 CA-C-N 115.864 -0.607 . . . . 71.11 113.525 178.135 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 71.8 p -81.59 -20.69 39.31 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 122.43 -0.453 . . . . 74.43 111.67 176.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.58 -50.65 82.03 Favored Pre-proline 0 CA--C 1.55 0.946 0 N-CA-C 113.027 0.751 . . . . 74.23 113.027 -179.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.9 Cg_endo -59.46 -21.35 61.13 Favored 'Trans proline' 0 C--N 1.361 1.209 0 C-N-CA 122.298 1.999 . . . . 73.03 113.025 178.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.2 mt -74.98 -45.62 42.37 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 121.147 0.499 . . . . 75.23 110.474 175.973 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.548 ' HB3' ' HG3' ' A' ' 28' ' ' MET . 68.6 m-85 -57.52 -44.73 85.29 Favored 'General case' 0 CA--C 1.541 0.625 0 CA-C-O 121.211 0.529 . . . . 71.01 110.105 172.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.5 mt -61.74 -38.61 80.84 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.657 0 CA-C-N 116.201 -0.454 . . . . 73.24 111.314 175.243 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.0 t30 -55.37 -29.19 57.96 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.278 0.561 . . . . 72.21 111.613 177.74 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.427 ' ND2' HD13 ' A' ' 55' ' ' LEU . 37.7 m-80 -98.8 4.1 47.56 Favored 'General case' 0 CA--C 1.54 0.585 0 N-CA-C 112.244 0.461 . . . . 63.13 112.244 -179.771 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 95.85 26.25 11.93 Favored Glycine 0 CA--C 1.529 0.915 0 N-CA-C 114.752 0.661 . . . . 42.4 114.752 172.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.548 ' HG3' ' HB3' ' A' ' 23' ' ' PHE . 22.0 mmt -74.18 145.66 44.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.803 0.801 . . . . 75.2 112.209 175.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 52.8 m-70 -127.28 29.08 5.62 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 115.744 -0.662 . . . . 74.21 110.732 178.077 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.4 p -62.32 135.1 57.3 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 115.947 -0.57 . . . . 75.32 111.737 -179.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -153.71 97.74 2.14 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.638 0.256 . . . . 72.24 110.984 -177.502 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.1 -66.49 1.49 Allowed Glycine 0 CA--C 1.531 1.075 0 N-CA-C 114.977 0.751 . . . . 43.24 114.977 172.029 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.432 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 68.2 m -57.27 137.85 80.8 Favored Pre-proline 0 CA--C 1.543 0.708 0 N-CA-C 113.087 0.773 . . . . 75.31 113.087 -172.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.432 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 48.8 Cg_exo -56.83 -29.56 81.74 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.974 2.45 . . . . 63.42 112.577 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 21.9 m -64.03 1.58 0.67 Allowed 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 112.369 0.507 . . . . 61.42 112.369 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 93.6 p -133.5 -50.28 0.85 Allowed 'General case' 0 CA--C 1.538 0.489 0 CA-C-O 121.189 0.518 . . . . 74.14 111.107 176.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 0.6 OUTLIER -77.31 -39.45 47.77 Favored 'General case' 0 CA--C 1.542 0.646 0 N-CA-C 112.555 0.576 . . . . 61.13 112.555 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.75 2.13 87.16 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 121.106 -0.569 . . . . 31.34 114.062 -173.604 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 4.9 mm-40 -87.93 154.48 20.48 Favored 'General case' 0 CA--C 1.538 0.483 0 CA-C-N 117.177 0.489 . . . . 75.4 111.704 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 63.6 m -63.86 145.81 55.13 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.323 -0.399 . . . . 74.34 110.588 173.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 25.7 mt -47.92 -50.62 9.8 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.604 0 N-CA-C 113.06 0.763 . . . . 73.23 113.06 -175.495 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.609 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 7.9 pt-20 -63.69 -37.87 88.99 Favored 'General case' 0 N--CA 1.472 0.648 0 N-CA-C 112.033 0.383 . . . . 75.15 112.033 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -68.67 -42.13 78.32 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-O 120.912 0.387 . . . . 55.54 110.747 -178.018 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -67.87 -34.04 75.9 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-N 116.235 -0.438 . . . . 72.52 111.15 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 84.8 m -57.79 -43.66 85.74 Favored 'General case' 0 N--CA 1.472 0.639 0 CA-C-O 120.868 0.366 . . . . 43.31 110.789 174.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.44 -35.36 62.89 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.189 -0.459 . . . . 73.24 112.061 178.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 63.6 t -55.03 -42.66 65.78 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 N-CA-C 111.993 0.368 . . . . 62.12 111.993 -179.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 83.8 t60 -105.1 3.07 29.98 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 120.992 0.425 . . . . 74.44 111.618 179.899 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 72.78 30.85 63.16 Favored Glycine 0 CA--C 1.527 0.797 0 C-N-CA 120.795 -0.716 . . . . 64.22 112.979 -178.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 31.6 mt -81.82 155.98 4.09 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 C-N-CA 122.894 0.478 . . . . 74.52 111.171 179.946 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.404 ' OD2' ' HB3' ' A' ' 53' ' ' ASP . 16.8 t70 -93.89 106.69 18.65 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-O 120.971 0.415 . . . . 73.13 110.349 175.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.539 ' HB2' ' HA ' ' A' ' 42' ' ' GLU . . . -64.42 -33.04 74.94 Favored 'General case' 0 N--CA 1.466 0.36 0 N-CA-C 112.316 0.487 . . . . 72.22 112.316 -176.389 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.404 ' HB3' ' OD2' ' A' ' 51' ' ' ASP . 24.5 t70 -54.04 -47.86 71.14 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-O 120.95 0.405 . . . . 72.14 111.067 178.806 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 66.7 mttm -70.27 -47.54 60.81 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-N 116.262 -0.426 . . . . 65.22 111.479 178.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.427 HD13 ' ND2' ' A' ' 26' ' ' ASN . 27.6 tp -55.53 -51.58 66.57 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.933 0.397 . . . . 70.24 111.973 -178.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.475 ' HA ' HD12 ' A' ' 59' ' ' LEU . 92.5 t -58.4 -38.89 72.4 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 CA-C-O 121.019 0.438 . . . . 73.24 111.648 179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -65.08 -43.5 91.99 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.541 -0.3 . . . . 73.22 111.434 178.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 67.0 mt-10 -56.9 -42.59 80.19 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.802 0.334 . . . . 75.23 111.134 175.038 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.475 HD12 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -57.18 -52.81 63.81 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-N 116.252 -0.431 . . . . 64.43 111.751 176.863 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.505 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 45.0 m-80 -55.88 -50.22 71.24 Favored 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 120.652 0.263 . . . . 73.42 111.689 178.315 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.498 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 40.6 mt-10 -56.57 -32.69 65.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.95 0.405 . . . . 71.41 111.845 179.578 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.2 t80 -65.81 -52.15 53.08 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.129 -0.487 . . . . 74.3 111.458 177.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -57.5 -35.11 69.8 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.414 -0.357 . . . . 74.03 111.426 178.15 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.505 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 37.1 mt-10 -57.72 -43.71 85.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 121.024 0.44 . . . . 72.5 111.028 174.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.498 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 45.8 mmtm -62.75 -36.71 83.91 Favored 'General case' 0 N--CA 1.467 0.409 0 CA-C-O 121.095 0.474 . . . . 55.45 111.363 -179.414 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 41.9 mtpt -62.36 -36.02 80.93 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 116.25 -0.432 . . . . 65.25 111.225 177.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.3 mt-10 -58.9 -28.41 66.16 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 121.288 0.565 . . . . 74.53 111.256 175.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 69.7 t -78.67 -52.45 15.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-N 115.947 -0.569 . . . . 73.13 110.967 175.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.0 mt -62.09 -59.64 4.77 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.587 0.588 . . . . 44.4 112.587 -179.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 29.5 mt-10 . . . . . 0 C--O 1.251 1.146 0 CA-C-O 118.698 -0.667 . . . . 71.45 112.705 -176.279 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 N--CA 1.487 1.384 0 CA-C-O 120.891 0.377 . . . . 75.35 111.692 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.482 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 17.2 tppt? -98.91 95.61 7.29 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 109.178 -0.675 . . . . 75.14 109.178 172.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.578 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.6 mm -67.01 140.32 19.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.522 0 N-CA-C 113.373 0.879 . . . . 72.23 113.373 -168.383 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 64.6 p -121.69 160.39 24.57 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 115.752 -0.658 . . . . 74.31 110.287 172.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.779 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.5 pttp -66.45 -16.54 64.19 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 120.963 0.411 . . . . 72.13 111.353 176.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -77.24 -19.64 56.31 Favored 'General case' 0 CA--C 1.542 0.635 0 CA-C-N 115.765 -0.652 . . . . 75.05 111.663 179.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.578 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.5 mtt -69.11 153.82 43.1 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.133 0.492 . . . . 65.33 111.911 179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.2 mm -85.22 129.97 36.94 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.399 -0.364 . . . . 54.51 111.24 -178.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.4 mt -50.8 -53.56 13.12 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 112.477 0.547 . . . . 74.55 112.477 -177.842 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.55 -33.07 72.13 Favored 'General case' 0 N--CA 1.469 0.505 0 N-CA-C 112.043 0.386 . . . . 64.24 112.043 -179.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -69.72 -40.27 76.35 Favored 'General case' 0 CA--C 1.542 0.637 0 CA-C-O 120.914 0.388 . . . . 71.04 110.674 178.137 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.5 t -60.49 -39.96 82.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-O 121.26 0.552 . . . . 55.11 110.59 173.845 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.4 mt -59.98 -32.24 70.65 Favored 'General case' 0 CA--C 1.539 0.554 0 CA-C-N 115.972 -0.558 . . . . 72.31 111.393 175.075 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.622 ' HA ' HH12 ' A' ' 17' ' ' ARG . 15.8 mm-40 -67.21 -31.76 72.36 Favored 'General case' 0 N--CA 1.469 0.485 0 CA-C-O 120.811 0.339 . . . . 71.24 111.583 176.648 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 37.4 mtt -65.78 -54.83 21.77 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-O 121.556 0.693 . . . . 73.11 109.816 176.084 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -150.73 121.59 7.59 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 115.364 -0.834 . . . . 62.34 110.58 174.61 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.622 HH12 ' HA ' ' A' ' 14' ' ' GLN . 81.9 mmt-85 -60.12 -21.56 61.73 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 120.999 0.428 . . . . 73.24 111.673 177.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.76 -3.38 27.66 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 121.502 -0.38 . . . . 73.45 113.656 179.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.3 p -82.32 -16.24 50.04 Favored 'General case' 0 N--CA 1.469 0.508 0 O-C-N 122.425 -0.456 . . . . 75.42 111.671 175.532 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.5 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.94 -51.41 79.61 Favored Pre-proline 0 CA--C 1.548 0.904 0 N-CA-C 112.724 0.638 . . . . 72.11 112.724 -179.6 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.5 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 12.4 Cg_endo -55.62 -29.19 69.23 Favored 'Trans proline' 0 C--N 1.362 1.266 0 C-N-CA 122.161 1.908 . . . . 74.33 112.673 177.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.3 mt -69.12 -45.57 79.57 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-O 121.047 0.451 . . . . 75.11 110.888 178.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 67.6 m-85 -62.4 -45.89 91.08 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.909 0.385 . . . . 74.11 110.679 174.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.1 mt -59.05 -42.69 87.15 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-N 116.403 -0.362 . . . . 73.1 111.348 177.603 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.3 t30 -50.72 -50.03 56.31 Favored 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 121.1 0.476 . . . . 75.11 111.508 177.422 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.4 m-80 -75.27 -4.31 38.34 Favored 'General case' 0 CA--C 1.541 0.614 0 N-CA-C 112.492 0.552 . . . . 64.21 112.492 -178.248 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.98 16.85 12.63 Favored Glycine 0 CA--C 1.528 0.872 0 N-CA-C 114.821 0.688 . . . . 41.14 114.821 172.35 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.5 mmt -68.81 142.77 54.78 Favored 'General case' 0 N--CA 1.468 0.428 0 CA-C-N 118.039 0.919 . . . . 54.22 111.016 175.369 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.48 ' CE1' ' HB3' ' A' ' 31' ' ' LEU . 22.7 t-80 -134.91 97.5 3.77 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 120.969 0.414 . . . . 73.11 111.632 -173.452 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 53.3 t -75.27 73.91 2.38 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 121.187 0.518 . . . . 72.44 111.493 179.215 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.48 ' HB3' ' CE1' ' A' ' 29' ' ' HIS . 2.8 tm? -177.0 107.78 0.07 Allowed 'General case' 0 CA--C 1.536 0.441 0 CA-C-N 115.834 -0.621 . . . . 74.34 109.327 179.051 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 143.17 -72.86 0.36 Allowed Glycine 0 CA--C 1.524 0.65 0 C-N-CA 121.075 -0.583 . . . . 54.0 112.581 -177.933 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.444 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 78.9 m -122.46 123.87 26.94 Favored Pre-proline 0 CA--C 1.542 0.647 0 CA-C-O 120.92 0.391 . . . . 72.44 111.577 179.364 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.444 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 25.5 Cg_exo -63.18 -27.45 72.81 Favored 'Trans proline' 0 CA--C 1.541 0.848 0 C-N-CA 123.072 2.515 . . . . 73.24 113.676 -178.654 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.9 t -58.18 -24.49 59.18 Favored 'General case' 0 N--CA 1.476 0.834 0 N-CA-C 112.551 0.575 . . . . 63.3 112.551 -177.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.6 m -56.96 -22.77 40.7 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 111.987 0.366 . . . . 74.45 111.987 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 9.5 mmt -89.71 -19.42 24.83 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.809 0.338 . . . . 74.2 111.678 176.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -98.47 -14.34 38.45 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.382 -0.437 . . . . 73.14 113.736 -178.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -98.46 167.69 10.66 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 121.285 0.564 . . . . 55.4 111.817 179.684 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 98.6 p -75.74 164.63 26.06 Favored 'General case' 0 N--CA 1.471 0.588 0 CA-C-O 121.126 0.489 . . . . 62.11 112.254 -175.341 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.6 mt -55.04 -50.64 61.48 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.889 -0.596 . . . . 70.23 112.356 178.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.779 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 10.1 pt-20 -66.62 -37.13 84.22 Favored 'General case' 0 N--CA 1.47 0.574 0 O-C-N 122.247 -0.283 . . . . 65.44 111.724 -178.234 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.419 ' O ' HG23 ' A' ' 47' ' ' VAL . 24.1 t0 -64.76 -49.97 68.66 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.138 0.495 . . . . 63.12 110.146 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.0 -42.79 99.53 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-N 115.858 -0.61 . . . . 64.11 111.896 178.1 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.4 m -52.1 -52.97 48.05 Favored 'General case' 0 N--CA 1.468 0.472 0 CA-C-N 116.593 -0.276 . . . . 50.33 111.467 176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.71 -37.73 68.8 Favored 'General case' 0 CA--C 1.54 0.59 0 N-CA-C 112.214 0.45 . . . . 45.32 112.214 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.419 HG23 ' O ' ' A' ' 43' ' ' ASP . 66.7 t -59.88 -42.48 89.35 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.61 0 CA-C-O 120.914 0.388 . . . . 63.22 111.794 179.035 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 43.3 t60 -97.61 -0.27 46.02 Favored 'General case' 0 CA--C 1.545 0.776 0 CA-C-O 120.786 0.327 . . . . 71.22 111.467 -178.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.98 12.71 82.31 Favored Glycine 0 CA--C 1.529 0.95 0 C-N-CA 121.477 -0.392 . . . . 72.0 113.45 -179.55 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 53.5 mt -74.42 154.68 6.62 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.495 0 O-C-N 122.581 -0.364 . . . . 74.34 111.273 179.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -97.38 113.79 25.5 Favored 'General case' 0 CA--C 1.539 0.531 0 CA-C-O 120.977 0.417 . . . . 64.11 110.529 175.701 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.47 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -68.34 -32.62 72.85 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.211 0.449 . . . . 64.41 112.211 -178.1 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -58.49 -40.29 82.35 Favored 'General case' 0 CA--C 1.545 0.764 0 CA-C-O 120.886 0.374 . . . . 71.32 111.658 -178.038 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -70.57 -49.46 47.73 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 121.212 0.53 . . . . 63.13 111.043 174.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.5 tp -59.41 -47.31 85.95 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 115.799 -0.637 . . . . 73.33 112.406 -175.121 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.47 HG23 ' O ' ' A' ' 52' ' ' ALA . 98.4 t -61.75 -38.9 81.54 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.149 0.426 . . . . 73.42 112.149 -177.17 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 32.4 mtmm -61.95 -45.35 94.05 Favored 'General case' 0 N--CA 1.471 0.611 0 O-C-N 122.176 -0.327 . . . . 73.13 110.798 176.432 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -55.53 -42.52 74.69 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.153 0.501 . . . . 63.33 111.36 175.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 89.1 mt -62.3 -53.4 55.59 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.239 -0.437 . . . . 61.01 111.745 177.546 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.482 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 47.3 m-80 -55.0 -50.44 69.01 Favored 'General case' 0 N--CA 1.475 0.795 0 N-CA-C 112.038 0.384 . . . . 72.32 112.038 179.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 45.9 mt-10 -54.06 -42.3 69.11 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-N 116.763 -0.199 . . . . 74.33 111.346 178.694 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 82.8 t80 -58.58 -49.41 77.55 Favored 'General case' 0 CA--C 1.538 0.484 0 N-CA-C 112.188 0.44 . . . . 63.03 112.188 -178.844 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.431 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 71.8 m-85 -59.52 -36.78 76.75 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-O 120.771 0.319 . . . . 75.52 111.618 179.964 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 28.3 mt-10 -71.15 -34.0 70.58 Favored 'General case' 0 CA--C 1.544 0.719 0 CA-C-O 120.825 0.345 . . . . 74.51 111.126 173.381 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.3 mmtm -65.07 -29.11 69.97 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.712 -0.222 . . . . 71.23 111.46 175.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.431 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 26.9 mtpp -51.47 -45.27 62.71 Favored 'General case' 0 N--CA 1.474 0.746 0 CA-C-O 120.964 0.411 . . . . 74.52 111.331 176.631 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -66.14 -21.58 66.35 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.148 -0.478 . . . . 75.44 112.05 178.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 70.1 t -86.37 -54.92 7.31 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 120.99 0.424 . . . . 63.4 111.48 178.66 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 61.3 mt -67.32 -59.2 3.61 Favored 'General case' 0 CA--C 1.539 0.546 0 N-CA-C 112.625 0.602 . . . . 73.41 112.625 -176.334 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 . . . . . 0 C--O 1.25 1.117 0 CA-C-O 118.689 -0.672 . . . . 65.22 112.682 -176.063 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 67.2 mtt . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.965 0.412 . . . . 73.34 111.586 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 71.3 mmtt -131.3 140.78 49.84 Favored 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 116.181 -0.463 . . . . 71.42 110.509 175.658 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.445 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.9 mm -66.44 133.25 31.42 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.424 0 CA-C-O 120.529 0.204 . . . . 73.41 110.602 176.988 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.501 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 28.5 p -116.66 155.88 28.05 Favored 'General case' 0 N--CA 1.471 0.597 0 CA-C-O 121.023 0.44 . . . . 70.31 111.134 -179.691 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.522 ' HB3' HG21 ' A' ' 56' ' ' VAL . 14.0 ptpt -69.27 -10.5 58.11 Favored 'General case' 0 CA--C 1.54 0.573 0 N-CA-C 112.01 0.374 . . . . 74.01 112.01 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -85.28 -14.95 45.04 Favored 'General case' 0 CA--C 1.545 0.78 0 CA-C-O 121.088 0.47 . . . . 71.3 111.347 176.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.501 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 65.5 mtt -69.41 157.29 37.36 Favored 'General case' 0 CA--C 1.541 0.601 0 N-CA-C 112.435 0.531 . . . . 73.53 112.435 -179.347 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.453 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 48.9 mm -85.39 141.55 14.4 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 116.043 -0.526 . . . . 62.13 111.552 -179.937 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 58.6 mt -55.44 -52.42 46.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-O 120.76 0.314 . . . . 71.34 111.798 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.578 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -57.23 -37.22 71.94 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.961 0.41 . . . . 62.44 111.616 178.442 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.0 t70 -61.75 -42.08 98.5 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.303 -0.408 . . . . 64.15 111.044 179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.6 t -63.97 -40.93 90.84 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-O 121.037 0.446 . . . . 72.44 110.933 175.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.501 HD23 ' OG1' ' A' ' 19' ' ' THR . 97.0 mt -61.22 -31.74 71.52 Favored 'General case' 0 N--CA 1.47 0.559 0 CA-C-O 120.892 0.377 . . . . 73.44 111.348 176.174 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 85.3 mm-40 -70.1 -15.17 62.94 Favored 'General case' 0 CA--C 1.54 0.583 0 CA-C-N 116.455 -0.339 . . . . 63.13 111.9 177.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 27.4 mtt -86.69 -43.44 12.59 Favored 'General case' 0 N--CA 1.468 0.441 0 CA-C-O 121.208 0.528 . . . . 63.34 110.044 174.064 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.0 t70 -162.08 133.79 5.42 Favored 'General case' 0 CA--C 1.542 0.671 0 CA-C-N 115.568 -0.742 . . . . 71.54 110.814 175.79 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 71.8 mmt-85 -69.68 -25.0 63.68 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 120.874 0.368 . . . . 74.21 111.952 -178.048 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.49 -1.41 10.83 Favored Glycine 0 CA--C 1.531 1.059 0 C-N-CA 121.608 -0.33 . . . . 73.02 113.728 -178.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.501 ' OG1' HD23 ' A' ' 13' ' ' LEU . 73.3 p -82.84 -21.43 34.41 Favored 'General case' 0 N--CA 1.469 0.515 0 O-C-N 122.469 -0.43 . . . . 74.52 111.704 176.895 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.78 -51.08 82.04 Favored Pre-proline 0 CA--C 1.546 0.821 0 N-CA-C 112.396 0.517 . . . . 34.54 112.396 -179.699 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 22.6 Cg_endo -60.93 -25.15 80.91 Favored 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 121.885 1.724 . . . . 61.54 112.613 176.349 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.2 mt -71.05 -43.18 76.36 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.566 0 CA-C-O 120.969 0.414 . . . . 71.53 110.785 177.272 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 72.5 m-85 -58.64 -48.72 80.06 Favored 'General case' 0 CA--C 1.537 0.445 0 CA-C-O 121.131 0.491 . . . . 72.21 110.249 172.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.459 ' HA ' ' O ' ' A' ' 28' ' ' MET . 66.5 mt -60.71 -37.84 76.98 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-N 115.99 -0.55 . . . . 62.33 111.221 176.904 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 10.8 t30 -56.06 -32.95 64.55 Favored 'General case' 0 N--CA 1.472 0.675 0 CA-C-N 116.275 -0.421 . . . . 61.41 112.089 178.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.419 ' ND2' HD13 ' A' ' 55' ' ' LEU . 34.0 m-80 -90.93 -7.5 51.93 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.453 0.538 . . . . 71.22 112.453 -179.267 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 129.22 -7.47 6.33 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 120.624 -0.798 . . . . 61.4 114.605 177.037 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.459 ' O ' ' HA ' ' A' ' 24' ' ' ILE . 50.0 mtt -75.81 176.39 7.82 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-N 117.877 0.838 . . . . 74.24 111.082 177.5 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 37.3 m80 -135.84 174.23 10.84 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 120.994 0.426 . . . . 64.33 111.665 -179.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.4 p -73.2 -164.34 0.18 Allowed 'General case' 0 N--CA 1.473 0.698 0 CA-C-N 116.017 -0.538 . . . . 73.34 111.777 179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -72.39 74.71 1.02 Allowed 'General case' 0 CA--C 1.543 0.681 0 CA-C-O 121.417 0.627 . . . . 55.53 111.241 -178.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -91.63 -23.55 28.16 Favored Glycine 0 CA--C 1.523 0.582 0 N-CA-C 111.216 -0.754 . . . . 42.43 111.216 170.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 79.6 m -146.4 134.43 10.62 Favored Pre-proline 0 CA--C 1.537 0.465 0 C-N-CA 123.112 0.565 . . . . 53.51 109.862 175.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -55.11 -32.27 79.04 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.646 2.231 . . . . 75.14 113.054 -176.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.552 ' O ' ' HG2' ' A' ' 39' ' ' GLU . 30.6 t -55.73 -36.05 66.81 Favored 'General case' 0 N--CA 1.473 0.704 0 N-CA-C 112.487 0.551 . . . . 75.3 112.487 179.488 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 46.8 t -48.14 -31.52 5.76 Favored 'General case' 0 N--CA 1.479 1.0 0 N-CA-C 113.467 0.914 . . . . 61.33 113.467 -173.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.578 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 3.3 mmt -84.9 -32.72 22.99 Favored 'General case' 0 N--CA 1.47 0.535 0 N-CA-C 112.321 0.489 . . . . 75.23 112.321 -175.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.95 -11.9 80.59 Favored Glycine 0 CA--C 1.527 0.842 0 C-N-CA 121.13 -0.557 . . . . 70.44 114.136 -175.872 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.552 ' HG2' ' O ' ' A' ' 35' ' ' SER . 8.9 mm-40 -75.56 144.65 41.75 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 117.282 0.541 . . . . 63.23 112.054 -178.316 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.453 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 54.3 m -70.31 149.45 47.37 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 116.577 -0.283 . . . . 75.12 110.578 172.851 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.7 mt -51.51 -55.61 7.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.655 0.613 . . . . 73.33 112.655 -177.353 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.516 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.6 pt-20 -62.1 -36.28 81.23 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-O 121.038 0.447 . . . . 74.14 111.684 -178.939 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -69.93 -52.68 22.5 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 116.071 -0.513 . . . . 71.14 111.117 -177.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.56 -41.88 91.16 Favored 'General case' 0 CA--C 1.537 0.473 0 CA-C-N 116.303 -0.408 . . . . 73.1 111.504 176.637 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -57.49 -45.53 84.79 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 116.53 -0.304 . . . . 60.01 110.938 175.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.84 -39.88 75.05 Favored 'General case' 0 CA--C 1.539 0.52 0 N-CA-C 112.016 0.376 . . . . 61.43 112.016 179.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 61.8 t -55.65 -41.27 64.08 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.676 0 CA-C-O 120.927 0.394 . . . . 73.1 112.052 179.113 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.535 ' HB3' HG13 ' A' ' 50' ' ' ILE . 8.8 t60 -91.33 -22.96 20.26 Favored 'General case' 0 CA--C 1.544 0.73 0 CA-C-O 120.846 0.355 . . . . 73.25 111.299 -179.75 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.75 24.53 17.56 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.546 -0.359 . . . . 73.22 112.439 -175.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.535 HG13 ' HB3' ' A' ' 48' ' ' HIS . 63.8 mt -79.69 155.23 4.63 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 122.92 0.488 . . . . 73.11 112.058 -177.289 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -84.76 101.74 12.47 Favored 'General case' 0 CA--C 1.54 0.592 0 CA-C-N 116.183 -0.462 . . . . 73.34 110.166 173.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.433 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -71.44 -21.88 61.91 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 112.454 0.538 . . . . 73.03 112.454 -175.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -68.41 -43.1 77.93 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 120.857 0.361 . . . . 60.34 110.467 -178.325 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 95.0 mttt -66.61 -46.78 74.76 Favored 'General case' 0 CA--C 1.537 0.479 0 CA-C-N 116.312 -0.404 . . . . 63.42 110.992 176.233 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.419 HD13 ' ND2' ' A' ' 26' ' ' ASN . 30.1 tp -56.29 -54.84 40.68 Favored 'General case' 0 N--CA 1.47 0.532 0 CA-C-N 116.223 -0.444 . . . . 62.15 112.046 -178.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.522 HG21 ' HB3' ' A' ' 5' ' ' LYS . 87.4 t -56.51 -41.83 73.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.965 0.412 . . . . 63.04 112.011 -179.068 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -68.21 -37.21 80.63 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 111.73 0.27 . . . . 72.45 111.73 -179.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -59.91 -42.57 94.15 Favored 'General case' 0 N--CA 1.472 0.638 0 CA-C-O 120.948 0.404 . . . . 64.02 110.692 172.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.9 mt -58.6 -52.32 66.18 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 116.28 -0.418 . . . . 74.44 111.381 176.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 43.5 m-80 -54.19 -57.36 11.46 Favored 'General case' 0 N--CA 1.473 0.721 0 CA-C-O 120.695 0.283 . . . . 74.22 111.59 177.543 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.491 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 48.3 mt-10 -52.42 -40.9 62.71 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 116.217 -0.447 . . . . 71.13 111.789 -179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.0 t80 -56.45 -48.56 76.81 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 120.894 0.378 . . . . 74.51 111.663 176.538 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 64.0 m-85 -64.55 -38.44 91.03 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-O 120.612 0.244 . . . . 64.4 111.499 179.313 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.495 ' O ' HG23 ' A' ' 68' ' ' VAL . 33.9 mt-10 -63.47 -40.7 97.8 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 120.822 0.344 . . . . 70.02 111.116 176.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.491 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.0 mmtp -56.5 -41.36 76.55 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.919 0.39 . . . . 73.24 111.26 175.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 54.5 mtpt -56.8 -50.27 72.84 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 116.299 -0.41 . . . . 74.35 111.241 175.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -60.12 -29.15 68.42 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.765 -178.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.495 HG23 ' O ' ' A' ' 64' ' ' GLU . 65.4 t -74.05 -54.37 15.15 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.463 0 CA-C-O 120.962 0.41 . . . . 61.14 111.494 177.808 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.2 mt -71.12 -56.88 5.19 Favored 'General case' 0 CA--C 1.542 0.637 0 N-CA-C 112.496 0.554 . . . . 72.44 112.496 -177.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 25.2 mt-10 . . . . . 0 C--O 1.253 1.27 0 CA-C-O 118.847 -0.597 . . . . 73.43 112.543 -176.262 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.496 0 CA-C-O 120.554 0.216 . . . . 74.32 110.459 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 34.5 mmtp -117.73 140.74 49.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 121.231 0.539 . . . . 74.21 112.425 -175.74 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 49.2 mm -91.48 143.8 10.52 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.558 0 CA-C-N 115.8 -0.637 . . . . 71.42 111.412 -179.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.478 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.3 p -118.06 170.23 9.02 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-O 120.861 0.362 . . . . 70.21 110.973 177.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.525 ' HB3' HG21 ' A' ' 56' ' ' VAL . 16.8 ptpt -80.87 -11.78 59.53 Favored 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 120.865 0.364 . . . . 71.34 111.282 177.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.6 t70 -80.52 -25.43 38.72 Favored 'General case' 0 CA--C 1.54 0.577 0 CA-C-N 116.012 -0.54 . . . . 60.34 111.141 178.702 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.478 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 64.3 mtt -65.11 161.07 19.75 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.181 0.515 . . . . 73.55 112.203 -178.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.444 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.0 mm -86.91 129.76 37.96 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.587 0 CA-C-N 116.062 -0.517 . . . . 73.04 110.716 178.526 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.505 HG12 HG13 ' A' ' 41' ' ' ILE . 57.3 mt -54.66 -45.96 72.87 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.705 0 N-CA-C 112.211 0.448 . . . . 72.15 112.211 -178.622 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.411 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -63.15 -34.68 78.15 Favored 'General case' 0 N--CA 1.469 0.492 0 CA-C-O 121.195 0.521 . . . . 45.11 111.078 177.366 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.427 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 15.4 t70 -65.06 -41.84 94.74 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.913 -0.585 . . . . 54.1 110.344 177.787 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 62.3 t -61.88 -37.96 79.46 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.545 0 CA-C-O 121.219 0.533 . . . . 62.44 110.997 175.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 91.7 mt -61.64 -29.87 70.34 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.472 175.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.411 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 77.0 mt-30 -68.34 -25.45 65.1 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.953 0.406 . . . . 71.14 111.042 177.096 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 32.0 mtt -75.62 -53.91 7.83 Favored 'General case' 0 N--CA 1.466 0.344 0 CA-C-O 121.208 0.528 . . . . 73.42 110.02 175.682 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -154.3 124.45 6.85 Favored 'General case' 0 CA--C 1.543 0.696 0 CA-C-N 115.956 -0.566 . . . . 75.44 111.127 178.099 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.1 mmt-85 -65.41 -18.12 65.07 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 112.556 0.576 . . . . 74.31 112.556 179.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.439 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -68.1 -6.44 46.17 Favored Glycine 0 CA--C 1.527 0.826 0 C-N-CA 121.274 -0.489 . . . . 73.52 113.2 179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.1 p -80.91 -23.14 39.15 Favored 'General case' 0 N--CA 1.468 0.426 0 O-C-N 122.644 -0.327 . . . . 34.43 111.455 174.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.471 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.47 -51.79 77.11 Favored Pre-proline 0 CA--C 1.549 0.904 0 N-CA-C 112.528 0.566 . . . . 73.44 112.528 -178.607 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.471 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.46 -26.03 76.29 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 121.901 1.734 . . . . 72.13 112.335 176.873 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.415 ' O ' ' HB3' ' A' ' 25' ' ' ASN . 64.1 mt -72.48 -41.76 64.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.506 0 CA-C-O 121.02 0.438 . . . . 72.15 110.583 176.496 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.414 ' HD1' HD21 ' A' ' 55' ' ' LEU . 62.0 m-85 -61.9 -49.93 74.23 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 121.041 0.448 . . . . 75.12 110.497 173.094 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.0 mt -59.12 -37.55 68.93 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.571 0 CA-C-N 116.19 -0.459 . . . . 72.43 111.099 177.152 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.415 ' HB3' ' O ' ' A' ' 22' ' ' ILE . 27.4 t30 -52.09 -46.4 65.2 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.992 0.425 . . . . 64.31 111.678 176.198 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 37.3 m-80 -81.21 1.69 31.06 Favored 'General case' 0 CA--C 1.545 0.772 0 N-CA-C 112.312 0.486 . . . . 72.43 112.312 -177.222 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 110.33 13.84 14.32 Favored Glycine 0 CA--C 1.53 1.03 0 N-CA-C 115.203 0.841 . . . . 62.44 115.203 172.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.3 mmt -73.67 163.32 28.14 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-N 117.952 0.876 . . . . 65.22 112.147 176.36 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 8.9 p-80 -147.48 138.52 23.61 Favored 'General case' 0 N--CA 1.468 0.446 0 CA-C-N 116.073 -0.512 . . . . 61.34 110.6 -179.912 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.402 ' SG ' ' SD ' ' A' ' 37' ' ' MET . 39.4 t -166.66 128.74 1.78 Allowed 'General case' 0 CA--C 1.534 0.348 0 N-CA-C 113.191 0.811 . . . . 52.43 113.191 -175.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -116.7 34.41 5.08 Favored 'General case' 0 CA--C 1.542 0.669 0 N-CA-C 107.498 -1.297 . . . . 71.14 107.498 167.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 91.02 41.16 5.35 Favored Glycine 0 CA--C 1.524 0.631 0 CA-C-N 115.202 -0.908 . . . . 53.43 111.229 -165.426 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.412 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 57.5 m -102.07 132.09 21.94 Favored Pre-proline 0 N--CA 1.469 0.504 0 N-CA-C 111.843 0.312 . . . . 73.42 111.843 -172.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.412 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 50.3 Cg_exo -55.36 -60.32 0.57 Allowed 'Trans proline' 0 CA--C 1.542 0.913 0 C-N-CA 122.973 2.449 . . . . 64.35 113.587 179.863 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.489 ' O ' ' HB2' ' A' ' 36' ' ' SER . 65.5 m -67.23 76.8 0.15 Allowed 'General case' 0 N--CA 1.475 0.798 0 N-CA-C 112.276 0.473 . . . . 73.25 112.276 -178.073 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.489 ' HB2' ' O ' ' A' ' 35' ' ' SER . 41.0 t 156.36 -30.54 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.06 0 C-N-CA 124.54 1.136 . . . . 61.24 110.135 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.402 ' SD ' ' SG ' ' A' ' 30' ' ' CYS . 3.6 mmt -103.6 -68.33 0.85 Allowed 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 116.325 -0.398 . . . . 73.24 111.809 -178.675 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -69.02 3.86 6.44 Favored Glycine 0 CA--C 1.53 0.992 0 N-CA-C 114.536 0.574 . . . . 75.34 114.536 -174.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -106.35 161.6 14.42 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 117.304 0.552 . . . . 73.4 111.413 -179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.475 ' HA ' ' O ' ' A' ' 7' ' ' MET . 49.2 m -68.54 153.06 44.48 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-N 116.415 -0.357 . . . . 72.0 111.024 178.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.517 ' H ' HD12 ' A' ' 41' ' ' ILE . 4.0 mp -51.93 -51.24 30.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.611 0 N-CA-C 111.791 0.293 . . . . 53.33 111.791 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.501 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.6 pt-20 -69.05 -33.9 74.32 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.903 0.382 . . . . 75.42 111.724 -179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -65.88 -47.25 75.48 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.103 0.478 . . . . 70.11 111.238 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.16 -48.73 56.09 Favored 'General case' 0 CA--C 1.54 0.561 0 CA-C-N 116.03 -0.532 . . . . 75.02 111.788 178.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 92.4 m -55.88 -42.08 75.39 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 120.72 0.295 . . . . 72.22 111.679 179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.36 -33.67 65.92 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.272 0.471 . . . . 53.11 112.272 -180.0 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.8 t -56.2 -51.18 65.82 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.68 0 CA-C-O 120.816 0.341 . . . . 50.12 111.914 -178.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 60.0 t-80 -87.6 -19.82 27.25 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.873 0.368 . . . . 74.31 111.386 178.307 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 94.59 27.04 12.07 Favored Glycine 0 CA--C 1.527 0.833 0 C-N-CA 121.19 -0.528 . . . . 74.31 112.655 -176.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 25.5 mt -76.57 148.28 7.08 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.475 0 CA-C-O 120.751 0.31 . . . . 70.31 111.298 179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -78.8 93.84 5.04 Favored 'General case' 0 CA--C 1.537 0.447 0 CA-C-O 121.202 0.525 . . . . 70.24 110.283 175.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.483 ' HB1' HG22 ' A' ' 41' ' ' ILE . . . -65.7 -24.05 66.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 116.165 -0.47 . . . . 64.32 112.105 -179.031 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -62.15 -45.76 92.01 Favored 'General case' 0 CA--C 1.542 0.643 0 CA-C-O 120.792 0.329 . . . . 70.03 110.962 -178.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 98.3 mttt -66.85 -46.44 75.05 Favored 'General case' 0 N--CA 1.468 0.468 0 CA-C-O 120.893 0.377 . . . . 54.34 111.126 175.853 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.495 HD23 HG23 ' A' ' 41' ' ' ILE . 26.2 tp -53.19 -51.73 61.13 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-N 116.002 -0.545 . . . . 72.21 111.624 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.525 HG21 ' HB3' ' A' ' 5' ' ' LYS . 80.2 t -57.41 -45.28 85.53 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.354 0 CA-C-N 116.417 -0.356 . . . . 71.33 111.524 178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -57.63 -45.0 85.96 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.515 0.198 . . . . 74.13 111.395 178.057 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -58.97 -40.85 86.02 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 120.937 0.398 . . . . 74.41 111.281 176.232 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.434 HD12 ' HA ' ' A' ' 56' ' ' VAL . 80.9 mt -60.13 -50.46 73.59 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 120.854 0.359 . . . . 74.24 111.38 175.64 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.484 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.2 m-80 -57.57 -55.13 38.77 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-N 116.395 -0.366 . . . . 73.4 111.418 178.619 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.645 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.6 mt-10 -50.11 -41.77 49.14 Favored 'General case' 0 CA--C 1.536 0.418 0 CA-C-O 120.891 0.377 . . . . 74.01 111.031 178.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.439 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 87.4 t80 -58.74 -53.23 60.67 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 116.17 -0.468 . . . . 65.14 112.084 178.788 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 61.7 m-85 -60.88 -39.01 87.65 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-O 120.591 0.234 . . . . 75.2 111.117 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.535 ' O ' HG23 ' A' ' 68' ' ' VAL . 33.3 mt-10 -58.41 -40.88 83.65 Favored 'General case' 0 CA--C 1.536 0.42 0 CA-C-O 120.56 0.219 . . . . 73.34 111.055 175.148 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.645 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 33.1 mmtp -54.62 -42.81 71.62 Favored 'General case' 0 N--CA 1.471 0.59 0 CA-C-O 121.017 0.437 . . . . 70.25 110.587 176.072 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.6 mtpt -62.82 -47.44 83.4 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 116.048 -0.524 . . . . 75.34 111.145 176.218 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 86.9 mt-10 -65.47 -17.3 64.45 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-N 116.342 -0.39 . . . . 63.01 111.758 -179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.535 HG23 ' O ' ' A' ' 64' ' ' GLU . 92.4 t -90.88 -56.62 4.99 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.636 0 CA-C-O 121.015 0.436 . . . . 72.32 111.575 176.193 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.6 mt -70.52 -54.82 10.66 Favored 'General case' 0 CA--C 1.537 0.444 0 N-CA-C 112.984 0.735 . . . . 53.21 112.984 -173.876 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 53.2 mt-10 . . . . . 0 C--O 1.253 1.253 0 CA-C-O 118.746 -0.645 . . . . 73.13 112.502 -175.458 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 50.5 ttm . . . . . 0 N--CA 1.489 1.489 0 CA-C-O 120.531 0.205 . . . . 62.41 111.402 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 32.5 mmmt -69.74 125.09 25.69 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-O 120.932 0.396 . . . . 75.13 110.575 176.221 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.467 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.4 mm -74.01 139.97 18.45 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 N-CA-C 112.174 0.435 . . . . 64.32 112.174 -175.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.484 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 30.2 p -116.42 158.9 22.79 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-N 116.282 -0.417 . . . . 75.21 110.307 176.137 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 18.2 ptpt -72.98 -15.55 61.54 Favored 'General case' 0 N--CA 1.471 0.595 0 O-C-N 122.106 -0.371 . . . . 73.13 111.959 -177.638 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 36.4 t70 -81.06 -14.11 58.14 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-O 120.794 0.331 . . . . 74.35 111.48 176.228 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.484 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 62.8 mtt -63.95 134.92 55.98 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-O 121.28 0.562 . . . . 72.01 111.575 178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.427 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 46.7 mm -68.49 136.01 27.28 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 115.901 -0.59 . . . . 61.45 111.405 -179.301 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 55.6 mt -52.13 -52.38 24.49 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.709 0 N-CA-C 111.838 0.31 . . . . 73.25 111.838 -178.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.46 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.11 -36.85 73.5 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.934 0.397 . . . . 72.31 111.627 178.725 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -64.12 -37.54 87.81 Favored 'General case' 0 CA--C 1.542 0.669 0 CA-C-N 116.208 -0.451 . . . . 64.24 110.902 179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 61.0 t -69.94 -41.31 79.44 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.072 0.463 . . . . 73.04 110.99 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 92.9 mt -59.22 -31.24 68.87 Favored 'General case' 0 N--CA 1.472 0.632 0 CA-C-N 116.341 -0.391 . . . . 71.02 111.709 178.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.46 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 79.3 mt-30 -62.95 -37.06 85.54 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-O 120.73 0.3 . . . . 70.23 111.532 176.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.9 mtt -65.76 -48.25 72.47 Favored 'General case' 0 N--CA 1.468 0.436 0 CA-C-O 121.448 0.642 . . . . 60.4 110.225 179.702 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.1 t70 -158.85 120.25 3.4 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 115.445 -0.798 . . . . 74.32 110.7 177.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 19.6 mmt180 -62.24 -20.8 64.61 Favored 'General case' 0 N--CA 1.471 0.605 0 N-CA-C 112.459 0.54 . . . . 74.22 112.459 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -66.96 -3.49 22.86 Favored Glycine 0 CA--C 1.53 1.022 0 C-N-CA 121.418 -0.42 . . . . 61.13 113.65 179.365 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 70.7 p -83.08 -19.79 36.12 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.916 0.358 . . . . 70.43 111.833 176.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.473 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.29 -50.99 81.72 Favored Pre-proline 0 CA--C 1.547 0.831 0 N-CA-C 112.478 0.547 . . . . 74.41 112.478 -179.508 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.473 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.1 Cg_endo -59.13 -29.1 89.61 Favored 'Trans proline' 0 C--N 1.36 1.146 0 C-N-CA 121.899 1.733 . . . . 72.0 112.613 176.742 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.7 mt -66.88 -42.17 88.64 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 CA-C-O 121.094 0.474 . . . . 75.14 110.613 177.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -62.38 -53.44 55.0 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 121.155 0.502 . . . . 72.52 110.648 173.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 67.8 mt -57.7 -35.35 50.46 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-N 116.136 -0.484 . . . . 44.31 111.322 178.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.1 t30 -57.6 -48.84 78.28 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-N 116.021 -0.536 . . . . 72.35 111.511 178.852 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.3 m-80 -73.92 -5.11 39.2 Favored 'General case' 0 CA--C 1.541 0.629 0 N-CA-C 112.355 0.502 . . . . 62.35 112.355 -179.721 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.89 17.47 7.89 Favored Glycine 0 CA--C 1.526 0.758 0 C-N-CA 120.653 -0.784 . . . . 75.32 114.831 173.441 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.4 mmt -71.87 143.16 49.49 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 117.961 0.881 . . . . 65.41 111.717 175.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 76.5 m-70 -138.36 -179.37 5.76 Favored 'General case' 0 N--CA 1.468 0.458 0 CA-C-N 116.029 -0.532 . . . . 75.55 110.73 179.691 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 33' ' ' CYS . 44.3 t 59.8 20.42 9.26 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-O 121.143 0.497 . . . . 41.13 111.362 -178.987 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -60.26 110.19 1.17 Allowed 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 115.845 -0.616 . . . . 74.24 110.704 -176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 134.33 -28.45 3.15 Favored Glycine 0 CA--C 1.525 0.711 0 C-N-CA 121.315 -0.469 . . . . 73.33 112.748 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.523 ' SG ' ' SG ' ' A' ' 30' ' ' CYS . 74.3 m -72.88 143.83 84.75 Favored Pre-proline 0 CA--C 1.542 0.662 0 O-C-N 122.638 -0.331 . . . . 74.41 111.519 179.484 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 93.3 Cg_exo -44.57 -54.97 3.59 Favored 'Trans proline' 0 CA--C 1.542 0.898 0 C-N-CA 123.375 2.717 . . . . 74.21 114.439 -175.318 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.8 t -58.63 -55.67 32.04 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-O 120.425 0.155 . . . . 74.43 111.415 -177.449 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.8 t -55.8 -29.28 59.45 Favored 'General case' 0 N--CA 1.477 0.899 0 N-CA-C 112.184 0.439 . . . . 71.1 112.184 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 6.2 mmt -79.77 -35.14 39.13 Favored 'General case' 0 CA--C 1.536 0.434 0 CA-C-O 120.667 0.27 . . . . 71.32 111.421 177.432 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -95.39 10.98 69.2 Favored Glycine 0 CA--C 1.529 0.909 0 N-CA-C 114.843 0.697 . . . . 72.2 114.843 -173.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -113.22 161.72 16.85 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-N 117.759 0.779 . . . . 72.32 112.042 178.077 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 87.7 p -76.76 162.02 28.01 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.739 -0.664 . . . . 70.23 112.248 -175.162 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 20.6 mt -57.15 -44.08 82.68 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-N 115.907 -0.588 . . . . 74.14 111.91 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -66.14 -40.78 90.87 Favored 'General case' 0 CA--C 1.537 0.481 0 N-CA-C 111.562 0.208 . . . . 71.33 111.562 179.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 26.2 t0 -68.01 -48.61 65.24 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.008 0.432 . . . . 71.34 111.132 -179.895 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.9 -44.75 94.08 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 120.881 0.372 . . . . 61.2 111.632 177.436 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 67.5 m -56.27 -39.49 72.73 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.709 0.29 . . . . 52.02 111.355 176.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -62.01 -27.69 69.04 Favored 'General case' 0 CA--C 1.541 0.603 0 N-CA-C 112.067 0.395 . . . . 34.51 112.067 179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.8 t -66.24 -48.08 82.34 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.498 0 CA-C-O 121.018 0.437 . . . . 63.34 111.346 176.912 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 64.3 t60 -92.47 -10.27 38.46 Favored 'General case' 0 CA--C 1.544 0.739 0 CA-C-N 116.388 -0.369 . . . . 75.13 111.989 -177.906 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 81.42 35.44 23.1 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.35 -0.452 . . . . 61.22 113.233 -179.249 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 23.0 mt -91.95 152.94 3.32 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.469 0 C-N-CA 122.646 0.378 . . . . 74.15 111.286 -178.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.5 t70 -82.32 99.43 9.35 Favored 'General case' 0 CA--C 1.539 0.552 0 N-CA-C 109.411 -0.589 . . . . 71.25 109.411 170.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.493 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -65.07 -30.1 71.03 Favored 'General case' 0 N--CA 1.464 0.265 0 CA-C-N 116.151 -0.477 . . . . 71.32 112.154 -177.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 6.8 t70 -59.7 -44.29 93.74 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 120.68 0.276 . . . . 61.02 110.677 -178.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 54.4 mtpt -66.63 -49.1 67.35 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 120.885 0.374 . . . . 75.5 111.079 176.331 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 23.4 tp -52.87 -45.09 67.29 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-O 121.078 0.466 . . . . 73.24 111.354 178.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.493 HG23 ' O ' ' A' ' 52' ' ' ALA . 75.9 t -61.56 -37.47 77.93 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.509 0 CA-C-N 116.169 -0.469 . . . . 73.41 111.453 178.079 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.4 mttm -60.37 -48.83 80.07 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-O 120.743 0.306 . . . . 72.21 110.649 175.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -56.69 -38.19 71.91 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.241 -0.436 . . . . 60.04 111.484 176.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.424 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.0 mt -65.2 -51.25 62.2 Favored 'General case' 0 CA--C 1.542 0.64 0 CA-C-N 116.505 -0.316 . . . . 73.01 111.364 174.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.513 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 30.4 m-80 -53.57 -55.02 29.23 Favored 'General case' 0 N--CA 1.473 0.682 0 CA-C-N 116.647 -0.251 . . . . 72.12 111.445 178.24 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.58 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.0 mt-10 -47.51 -50.46 23.4 Favored 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 121.059 0.457 . . . . 75.44 110.773 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 86.1 t80 -55.15 -49.12 72.62 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-N 115.765 -0.652 . . . . 71.42 112.292 -178.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 66.5 m-85 -65.73 -37.1 85.47 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.875 0.369 . . . . 73.32 111.722 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.513 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 33.0 mt-10 -70.4 -24.57 62.96 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.948 0.404 . . . . 71.55 111.199 176.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.58 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.7 mmtp -75.72 -31.27 59.58 Favored 'General case' 0 CA--C 1.538 0.494 0 CA-C-N 116.438 -0.346 . . . . 73.11 111.315 174.389 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.9 mtpt -52.69 -42.78 65.12 Favored 'General case' 0 N--CA 1.473 0.694 0 CA-C-O 120.715 0.293 . . . . 60.41 111.767 179.361 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -58.36 -28.99 65.64 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-O 121.155 0.502 . . . . 74.11 111.535 178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 94.6 t -85.19 -44.4 17.23 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.019 -0.537 . . . . 64.32 111.465 177.723 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.7 mt -59.51 -62.24 2.03 Favored 'General case' 0 CA--C 1.539 0.534 0 CA-C-N 116.064 -0.517 . . . . 60.31 111.689 177.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 C--O 1.252 1.221 0 CA-C-O 118.566 -0.73 . . . . 75.41 112.054 -179.142 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 23.6 mmt . . . . . 0 N--CA 1.488 1.427 0 CA-C-O 120.715 0.293 . . . . 73.11 111.452 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 6.9 tmtt? -88.78 96.04 10.52 Favored 'General case' 0 CA--C 1.542 0.639 0 N-CA-C 109.431 -0.581 . . . . 73.11 109.431 175.476 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 47.1 mm -74.02 144.64 12.28 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 N-CA-C 112.727 0.64 . . . . 71.22 112.727 -171.858 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.448 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 44.5 p -122.34 153.7 38.63 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 115.941 -0.572 . . . . 64.53 110.367 174.872 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.558 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 20.9 pttp -68.45 -13.46 62.32 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 120.959 0.409 . . . . 72.53 111.606 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -74.24 -22.67 59.23 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 121.205 0.526 . . . . 71.12 111.048 175.562 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.448 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.3 mtt -68.59 159.67 31.5 Favored 'General case' 0 CA--C 1.541 0.619 0 CA-C-O 121.268 0.556 . . . . 61.32 111.718 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.401 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 47.9 mm -86.27 135.87 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.507 0 CA-C-N 116.164 -0.471 . . . . 74.45 111.031 -179.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 64.8 mt -56.81 -50.88 73.41 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 N-CA-C 111.892 0.33 . . . . 73.24 111.892 -179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.531 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.02 -37.33 74.14 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.942 0.401 . . . . 63.02 111.637 176.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -61.81 -44.48 96.78 Favored 'General case' 0 CA--C 1.541 0.627 0 CA-C-N 116.162 -0.472 . . . . 75.44 110.62 178.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 74.4 t -61.13 -39.71 83.32 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.636 0 CA-C-O 121.116 0.484 . . . . 65.4 110.837 174.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.48 HD23 ' OG1' ' A' ' 19' ' ' THR . 97.1 mt -62.69 -33.81 75.85 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 116.216 -0.447 . . . . 74.4 111.62 176.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.531 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 88.1 mt-30 -69.28 -20.83 63.91 Favored 'General case' 0 CA--C 1.541 0.603 0 CA-C-O 120.7 0.286 . . . . 74.1 111.538 178.367 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.5 mtt -75.95 -56.45 4.66 Favored 'General case' 0 N--CA 1.468 0.448 0 CA-C-O 121.374 0.607 . . . . 74.42 109.896 172.074 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -145.8 125.45 13.34 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.683 -0.69 . . . . 72.33 110.571 176.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.454 HH11 ' HB3' ' A' ' 13' ' ' LEU . 41.1 mmt180 -69.57 -19.53 63.67 Favored 'General case' 0 N--CA 1.47 0.533 0 CA-C-N 116.516 -0.311 . . . . 75.14 111.591 -179.213 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.07 -1.8 43.28 Favored Glycine 0 CA--C 1.529 0.963 0 C-N-CA 121.318 -0.467 . . . . 64.52 113.304 -179.722 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.48 ' OG1' HD23 ' A' ' 13' ' ' LEU . 81.5 p -82.28 -17.21 46.7 Favored 'General case' 0 N--CA 1.467 0.393 0 O-C-N 122.461 -0.435 . . . . 53.15 111.183 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.497 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.21 -51.82 76.49 Favored Pre-proline 0 CA--C 1.545 0.776 0 N-CA-C 112.497 0.554 . . . . 74.42 112.497 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.497 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.4 Cg_endo -56.95 -26.43 67.86 Favored 'Trans proline' 0 C--N 1.361 1.196 0 C-N-CA 122.108 1.872 . . . . 72.31 112.612 178.273 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.5 mt -71.14 -46.98 63.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 121.034 0.445 . . . . 63.15 110.672 176.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.7 m-85 -58.98 -40.97 86.43 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 121.022 0.439 . . . . 73.35 110.504 173.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 81.7 mt -58.97 -46.57 91.46 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 116.131 -0.486 . . . . 74.31 111.097 175.188 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 35.0 t30 -51.68 -48.61 63.41 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-O 121.181 0.515 . . . . 73.35 111.495 177.279 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.6 m-80 -77.63 -6.8 55.06 Favored 'General case' 0 CA--C 1.544 0.74 0 CA-C-N 116.176 -0.465 . . . . 75.15 112.16 -178.776 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 98.6 39.05 3.75 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.251 0.86 . . . . 64.14 115.251 171.914 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.9 mmt -90.23 158.1 17.37 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 117.806 0.803 . . . . 75.14 111.654 174.278 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 15.4 m-70 -116.27 92.0 3.76 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 121.137 0.494 . . . . 74.24 110.947 178.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 63.0 m -80.06 -9.12 59.68 Favored 'General case' 0 N--CA 1.474 0.737 0 N-CA-C 112.912 0.708 . . . . 73.22 112.912 -174.768 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -70.46 79.55 0.56 Allowed 'General case' 0 CA--C 1.541 0.607 0 N-CA-C 112.456 0.539 . . . . 73.33 112.456 -175.493 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 63.65 8.48 27.12 Favored Glycine 0 CA--C 1.53 0.995 0 N-CA-C 114.591 0.596 . . . . 63.32 114.591 175.42 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.449 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 79.6 m -88.59 117.27 68.16 Favored Pre-proline 0 N--CA 1.471 0.586 0 CA-C-N 117.168 0.484 . . . . 40.14 111.595 -178.698 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.449 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 12.4 Cg_endo -54.93 -32.36 77.89 Favored 'Trans proline' 0 CA--C 1.538 0.691 0 C-N-CA 122.686 2.258 . . . . 64.21 112.248 179.686 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 16.0 m -50.64 -54.41 23.16 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-N 115.786 -0.643 . . . . 44.21 112.228 -179.947 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 66.5 m -90.98 -5.1 55.87 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 112.42 0.526 . . . . 72.34 112.42 -176.816 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 16.3 mmt -100.15 -71.66 0.69 Allowed 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.823 0.675 . . . . 73.21 112.823 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.22 -21.92 59.87 Favored Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.019 -0.61 . . . . 71.23 114.426 -170.727 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 14.9 mm-40 -79.87 160.92 25.88 Favored 'General case' 0 CA--C 1.541 0.621 0 CA-C-O 121.123 0.487 . . . . 74.34 111.87 -178.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.401 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 63.6 m -67.03 157.78 32.65 Favored 'General case' 0 N--CA 1.474 0.753 0 CA-C-N 116.364 -0.38 . . . . 74.53 111.437 176.791 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.3 mt -54.81 -54.93 18.59 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 N-CA-C 111.867 0.321 . . . . 74.15 111.867 178.414 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.558 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.3 pt-20 -63.49 -30.68 71.77 Favored 'General case' 0 N--CA 1.472 0.655 0 CA-C-O 120.707 0.289 . . . . 54.1 111.689 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.455 ' O ' HG23 ' A' ' 47' ' ' VAL . 9.3 t70 -64.32 -61.84 1.98 Allowed 'General case' 0 CA--C 1.54 0.57 0 CA-C-O 120.919 0.39 . . . . 73.32 109.971 177.629 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.51 -40.72 65.65 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-O 121.157 0.503 . . . . 65.15 111.588 176.228 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.419 ' HB3' ' O ' ' A' ' 50' ' ' ILE . 81.4 m -57.57 -40.83 79.83 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 115.989 -0.55 . . . . 75.31 111.43 175.626 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -70.15 -31.5 69.03 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.013 0.435 . . . . 43.32 111.627 177.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.455 HG23 ' O ' ' A' ' 43' ' ' ASP . 56.4 t -69.98 -39.91 77.98 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-O 120.784 0.326 . . . . 74.52 111.831 178.909 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 8.7 t-160 -105.39 4.57 30.92 Favored 'General case' 0 N--CA 1.477 0.917 0 O-C-N 122.089 -0.382 . . . . 74.23 112.007 -179.94 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.2 27.97 72.15 Favored Glycine 0 CA--C 1.533 1.202 0 C-N-CA 121.538 -0.363 . . . . 61.3 113.958 177.525 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.419 ' O ' ' HB3' ' A' ' 45' ' ' CYS . 53.3 mt -85.53 153.73 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.544 0 CA-C-O 120.973 0.416 . . . . 70.54 111.558 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 5.4 m-20 -82.34 102.2 11.07 Favored 'General case' 0 CA--C 1.542 0.641 0 C-N-CA 122.672 0.389 . . . . 52.44 111.675 177.055 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.08 -38.42 85.7 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 120.967 0.413 . . . . 71.43 111.417 179.585 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -51.43 -44.93 62.44 Favored 'General case' 0 CA--C 1.542 0.638 0 CA-C-N 115.961 -0.563 . . . . 73.23 111.41 177.06 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.0 mttt -79.21 -39.1 34.12 Favored 'General case' 0 CA--C 1.539 0.533 0 CA-C-N 116.224 -0.444 . . . . 72.22 111.969 -177.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.4 tp -61.82 -52.81 62.64 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.918 0.39 . . . . 74.42 111.98 179.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.535 ' HA ' HD12 ' A' ' 59' ' ' LEU . 90.1 t -57.46 -37.01 55.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.513 0 N-CA-C 111.956 0.354 . . . . 72.04 111.956 -178.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -64.41 -42.22 96.19 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.625 -0.261 . . . . 71.31 111.354 178.46 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.98 -42.13 97.76 Favored 'General case' 0 N--CA 1.472 0.656 0 CA-C-O 120.994 0.426 . . . . 70.22 110.739 174.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.535 HD12 ' HA ' ' A' ' 56' ' ' VAL . 86.1 mt -58.37 -52.66 64.68 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.33 -0.396 . . . . 75.43 111.678 177.016 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.44 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 32.6 m-80 -56.11 -54.5 44.27 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-O 120.744 0.307 . . . . 74.13 111.444 178.432 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.615 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 45.4 mt-10 -54.09 -31.65 52.52 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.456 -0.338 . . . . 73.31 111.537 179.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.0 t80 -69.34 -46.66 66.5 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-O 120.896 0.379 . . . . 74.43 111.696 176.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -61.54 -32.62 72.69 Favored 'General case' 0 CA--C 1.535 0.383 0 O-C-N 122.171 -0.33 . . . . 72.52 111.15 177.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.44 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 69.0 mt-10 -66.57 -32.94 74.6 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-O 120.913 0.387 . . . . 52.34 111.15 171.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.615 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 44.6 mmtm -63.44 -39.83 95.52 Favored 'General case' 0 N--CA 1.473 0.676 0 O-C-N 122.195 -0.316 . . . . 73.42 110.877 174.744 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -56.42 -37.61 70.45 Favored 'General case' 0 N--CA 1.47 0.575 0 CA-C-O 120.989 0.423 . . . . 65.42 111.158 175.745 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.0 mt-10 -66.3 -21.18 66.26 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 116.219 -0.446 . . . . 71.33 111.496 178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 95.4 t -93.63 -50.99 11.73 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.66 0 CA-C-O 121.001 0.429 . . . . 74.14 111.792 178.531 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.5 mt -64.78 -58.16 6.99 Favored 'General case' 0 CA--C 1.539 0.533 0 N-CA-C 112.384 0.512 . . . . 73.35 112.384 -178.14 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.1 mt-10 . . . . . 0 C--O 1.251 1.184 0 CA-C-O 118.911 -0.566 . . . . 62.13 111.909 -178.313 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 58.0 mtt . . . . . 0 N--CA 1.489 1.503 0 CA-C-O 120.48 0.181 . . . . 72.45 110.564 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 2.3 tmtp? -76.92 102.59 6.44 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-O 120.996 0.427 . . . . 74.31 110.106 178.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.453 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 49.6 mm -70.94 139.06 20.58 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.412 0 CA-C-N 116.049 -0.523 . . . . 75.21 111.828 -176.999 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.6 p -121.18 161.8 21.23 Favored 'General case' 0 N--CA 1.47 0.55 0 CA-C-O 120.744 0.307 . . . . 73.44 110.996 178.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.863 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.9 pttp -69.34 -21.23 63.84 Favored 'General case' 0 CA--C 1.543 0.694 0 CA-C-O 120.869 0.366 . . . . 74.34 111.658 -177.291 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 30.4 t70 -74.66 -21.65 59.3 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-N 116.177 -0.465 . . . . 72.01 111.731 179.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.453 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -63.08 152.02 38.32 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.388 0.613 . . . . 73.12 112.125 -179.632 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.4 mm -83.88 130.5 35.77 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 CA-C-N 115.97 -0.559 . . . . 73.54 111.107 -179.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.6 mt -54.41 -47.18 70.38 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 N-CA-C 111.923 0.342 . . . . 74.45 111.923 -179.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -60.45 -35.78 76.66 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-O 120.97 0.414 . . . . 32.14 111.338 176.992 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.9 t70 -68.58 -39.95 80.76 Favored 'General case' 0 CA--C 1.539 0.529 0 CA-C-N 116.349 -0.387 . . . . 43.14 110.704 179.219 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.9 t -58.93 -41.79 84.07 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.541 0 CA-C-O 121.277 0.56 . . . . 50.33 110.128 172.743 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.0 mt -64.19 -21.24 66.49 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-N 115.974 -0.557 . . . . 72.23 111.735 174.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 83.9 mm-40 -77.44 -30.72 53.47 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-O 120.719 0.295 . . . . 72.45 111.149 175.219 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.1 mtt -69.88 -45.89 66.68 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 121.317 0.58 . . . . 74.13 109.894 173.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 61.7 t0 -159.33 127.25 4.94 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-N 115.202 -0.908 . . . . 71.34 111.141 177.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 17.0 mmt180 -65.55 -26.34 67.83 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 116.285 -0.416 . . . . 73.43 111.686 177.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -64.62 -1.24 5.85 Favored Glycine 0 CA--C 1.528 0.897 0 N-CA-C 114.179 0.431 . . . . 61.32 114.179 -177.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.456 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.4 p -85.86 -13.19 48.71 Favored 'General case' 0 N--CA 1.469 0.513 0 CA-C-N 117.166 0.483 . . . . 72.34 111.589 176.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -52.68 -51.35 74.4 Favored Pre-proline 0 CA--C 1.546 0.826 0 N-CA-C 112.699 0.629 . . . . 43.44 112.699 -179.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -56.93 -31.95 91.12 Favored 'Trans proline' 0 C--N 1.363 1.299 0 C-N-CA 122.112 1.874 . . . . 64.04 112.628 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -66.07 -48.67 80.79 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.459 0 CA-C-O 121.032 0.444 . . . . 65.04 110.836 178.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.9 m-85 -60.25 -47.55 85.5 Favored 'General case' 0 CA--C 1.541 0.608 0 CA-C-O 120.715 0.293 . . . . 60.32 111.263 176.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.4 mt -59.33 -41.97 85.88 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-O 120.814 0.34 . . . . 61.24 111.428 178.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.4 t30 -58.15 -44.07 87.69 Favored 'General case' 0 N--CA 1.472 0.635 0 CA-C-N 116.255 -0.43 . . . . 63.44 111.533 179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 47.0 m-80 -75.5 -9.9 58.98 Favored 'General case' 0 CA--C 1.544 0.75 0 N-CA-C 112.282 0.475 . . . . 51.44 112.282 179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.28 1.53 11.17 Favored Glycine 0 CA--C 1.531 1.052 0 N-CA-C 115.424 0.93 . . . . 74.34 115.424 172.095 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 26.4 mmt -66.76 139.31 57.8 Favored 'General case' 0 N--CA 1.471 0.589 0 CA-C-N 118.345 1.073 . . . . 74.24 111.762 179.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.5 m80 -155.28 111.04 3.1 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-N 116.088 -0.505 . . . . 74.34 111.67 -175.125 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.762 ' SG ' ' HB2' ' A' ' 36' ' ' SER . 17.9 p -164.68 129.73 2.68 Favored 'General case' 0 N--CA 1.471 0.62 0 CA-C-N 116.435 -0.348 . . . . 74.23 110.357 174.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -70.64 75.63 0.59 Allowed 'General case' 0 CA--C 1.543 0.709 0 CA-C-O 121.097 0.475 . . . . 63.45 110.868 -179.032 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 51.57 44.14 53.6 Favored Glycine 0 CA--C 1.528 0.851 0 C-N-CA 121.443 -0.408 . . . . 31.23 113.26 -177.386 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 63.8 m -123.4 153.02 65.47 Favored Pre-proline 0 N--CA 1.47 0.572 0 N-CA-C 111.787 0.291 . . . . 74.34 111.787 -175.288 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.471 ' HA ' ' H ' ' A' ' 38' ' ' GLY . 94.9 Cg_exo -44.36 -35.86 8.83 Favored 'Trans proline' 0 CA--C 1.542 0.902 0 C-N-CA 123.408 2.738 . . . . 71.33 114.403 -178.42 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 22.4 m -42.62 -50.51 5.4 Favored 'General case' 0 N--CA 1.481 1.088 0 N-CA-C 113.598 0.962 . . . . 72.43 113.598 -174.679 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.762 ' HB2' ' SG ' ' A' ' 30' ' ' CYS . 68.9 m -116.96 -3.23 11.63 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 120.699 0.285 . . . . 62.11 111.743 178.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.678 ' HG2' ' SG ' ' A' ' 30' ' ' CYS . 9.7 mmt -100.62 -58.68 1.85 Allowed 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 111.979 0.363 . . . . 62.43 111.979 179.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.471 ' H ' ' HA ' ' A' ' 34' ' ' PRO . . . -77.14 -23.59 68.32 Favored Glycine 0 CA--C 1.526 0.756 0 C-N-CA 121.035 -0.602 . . . . 63.45 114.462 -172.368 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' A' ' 34' ' ' PRO . 34.4 mm-40 -80.11 154.68 27.91 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 117.241 0.521 . . . . 75.02 112.3 -178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.9 m -64.2 150.86 44.93 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 116.339 -0.391 . . . . 71.11 110.89 176.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.5 mt -51.7 -56.29 6.23 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.647 0 N-CA-C 112.466 0.543 . . . . 74.42 112.466 -178.336 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.863 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.3 pt-20 -62.41 -39.75 94.3 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-O 120.813 0.339 . . . . 74.34 111.717 -179.017 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.496 ' O ' HG23 ' A' ' 47' ' ' VAL . 35.7 t70 -64.64 -54.84 25.52 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-N 116.348 -0.387 . . . . 72.32 110.924 -178.687 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.8 -40.35 75.8 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-O 120.945 0.402 . . . . 52.33 111.235 176.322 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.412 ' O ' ' N ' ' A' ' 49' ' ' GLY . 90.3 m -58.76 -52.75 64.36 Favored 'General case' 0 N--CA 1.467 0.416 0 CA-C-N 116.377 -0.374 . . . . 72.51 111.123 174.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.99 -42.88 81.04 Favored 'General case' 0 N--CA 1.471 0.621 0 N-CA-C 111.714 0.264 . . . . 75.53 111.714 -179.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.496 HG23 ' O ' ' A' ' 43' ' ' ASP . 60.6 t -60.58 -44.37 96.61 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.563 0 CA-C-O 121.175 0.512 . . . . 73.21 111.342 176.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.454 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.5 t-80 -89.4 -2.7 58.5 Favored 'General case' 0 CA--C 1.548 0.865 0 CA-C-N 116.257 -0.429 . . . . 62.14 111.505 -178.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 45' ' ' CYS . . . 67.77 29.87 74.1 Favored Glycine 0 CA--C 1.532 1.143 0 C-N-CA 121.65 -0.309 . . . . 54.31 113.519 -178.756 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.454 HG13 ' HB3' ' A' ' 48' ' ' HIS . 45.5 mt -89.02 151.82 3.42 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 C-N-CA 122.879 0.471 . . . . 61.03 111.43 179.445 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -80.03 102.7 9.44 Favored 'General case' 0 CA--C 1.544 0.748 0 CA-C-O 120.81 0.338 . . . . 71.32 110.759 176.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.3 -23.64 61.21 Favored 'General case' 0 N--CA 1.471 0.615 0 N-CA-C 112.201 0.445 . . . . 75.35 112.201 -178.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -57.8 -51.07 71.09 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-O 120.959 0.409 . . . . 73.43 110.634 178.093 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.468 ' O ' ' HG3' ' A' ' 58' ' ' GLU . 59.9 mtpt -63.66 -50.5 69.03 Favored 'General case' 0 N--CA 1.465 0.306 0 CA-C-N 116.194 -0.457 . . . . 62.14 111.185 178.854 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.418 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 36.3 tp -56.19 -54.34 46.35 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-N 115.928 -0.578 . . . . 70.21 112.198 -175.516 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . . . . . . . . . 90.4 t -59.01 -43.83 89.84 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 N-CA-C 111.818 0.303 . . . . 71.31 111.818 -178.205 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 93.2 mttt -61.13 -42.82 99.24 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.679 0.276 . . . . 71.24 111.458 178.441 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . 0.468 ' HG3' ' O ' ' A' ' 54' ' ' LYS . 96.4 mt-10 -63.69 -39.93 95.54 Favored 'General case' 0 CA--C 1.538 0.512 0 CA-C-O 120.832 0.349 . . . . 73.41 111.338 177.866 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.418 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 90.8 mt -59.06 -48.26 82.24 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-O 120.776 0.322 . . . . 71.53 111.322 174.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 29.2 m-80 -54.63 -58.63 6.77 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.489 -0.323 . . . . 74.41 111.283 176.262 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 44.7 mt-10 -48.7 -41.4 31.6 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.944 0.402 . . . . 71.24 111.627 -179.742 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 92.3 t80 -62.08 -54.85 35.5 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-N 116.213 -0.449 . . . . 74.22 112.158 -179.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 63.5 m-85 -62.18 -38.96 91.07 Favored 'General case' 0 N--CA 1.468 0.46 0 N-CA-C 111.778 0.288 . . . . 73.33 111.778 179.682 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.507 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 36.4 mt-10 -61.14 -41.68 97.18 Favored 'General case' 0 CA--C 1.538 0.492 0 CA-C-O 120.554 0.216 . . . . 70.13 111.034 177.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 45.0 mmtm -52.49 -43.26 64.92 Favored 'General case' 0 N--CA 1.472 0.649 0 CA-C-O 120.988 0.423 . . . . 75.42 110.846 173.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 42.7 mtpt -66.76 -46.86 74.04 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-N 116.241 -0.436 . . . . 40.43 111.113 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -57.58 -27.28 62.56 Favored 'General case' 0 CA--C 1.541 0.602 0 CA-C-O 121.024 0.44 . . . . 73.44 111.597 177.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.433 HG23 ' O ' ' A' ' 64' ' ' GLU . 67.6 t -73.37 -46.8 48.42 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 CA-C-O 121.019 0.438 . . . . 71.54 111.41 173.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . 0.42 ' HG ' ' O ' ' A' ' 65' ' ' LYS . 53.4 mt -71.93 -62.85 1.28 Allowed 'General case' 0 N--CA 1.472 0.638 0 N-CA-C 112.621 0.6 . . . . 65.51 112.621 -177.995 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 31.6 mt-10 . . . . . 0 C--O 1.253 1.267 0 CA-C-O 118.699 -0.667 . . . . 64.33 112.371 -173.39 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.0 mtt . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.798 0.332 . . . . 74.12 111.236 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.3 tmtp? -110.63 121.6 45.72 Favored 'General case' 0 CA--C 1.537 0.474 0 N-CA-C 109.607 -0.516 . . . . 63.34 109.607 177.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.487 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 44.4 mm -68.13 127.66 30.22 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.623 0 CA-C-O 120.682 0.277 . . . . 75.4 111.406 -178.204 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.53 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 18.3 p -115.34 154.05 29.86 Favored 'General case' 0 N--CA 1.47 0.564 0 CA-C-O 120.707 0.289 . . . . 75.22 110.771 179.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.785 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 49.9 pttt -68.95 -14.84 63.28 Favored 'General case' 0 CA--C 1.54 0.591 0 CA-C-O 120.86 0.362 . . . . 73.14 111.844 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.9 -22.75 52.94 Favored 'General case' 0 CA--C 1.541 0.632 0 CA-C-N 116.08 -0.509 . . . . 65.43 111.314 176.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.53 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 60.7 mtt -62.43 150.57 39.54 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 121.604 0.716 . . . . 74.21 112.873 -176.733 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.403 HD12 ' O ' ' A' ' 38' ' ' GLY . 50.8 mm -80.65 133.77 28.73 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 CA-C-N 115.169 -0.923 . . . . 73.4 111.185 178.089 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.9 mt -51.01 -50.91 22.84 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.629 0 CA-C-O 120.73 0.3 . . . . 73.52 111.806 -179.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.552 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -58.03 -40.94 82.13 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 111.837 0.31 . . . . 73.32 111.837 178.757 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 26.6 t70 -61.3 -38.89 88.46 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.948 0.404 . . . . 64.23 111.026 -178.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -65.32 -44.92 94.69 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.596 0 CA-C-O 121.134 0.492 . . . . 75.43 110.953 174.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 98.9 mt -59.8 -33.16 71.36 Favored 'General case' 0 N--CA 1.471 0.582 0 CA-C-N 116.041 -0.527 . . . . 72.11 111.987 178.459 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.499 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 82.5 mm-40 -61.42 -29.02 69.68 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.977 0.418 . . . . 63.14 111.618 177.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.0 mtm -84.15 -41.39 17.1 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-O 121.169 0.509 . . . . 72.11 110.346 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.1 t70 -159.22 120.96 3.38 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.002 -0.545 . . . . 74.43 111.325 175.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 32.4 mmt180 -69.83 -16.96 63.36 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-N 116.194 -0.457 . . . . 72.53 112.082 -179.462 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.47 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -66.02 -7.75 38.79 Favored Glycine 0 CA--C 1.527 0.787 0 C-N-CA 121.236 -0.506 . . . . 53.24 113.144 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 77.2 p -80.24 -19.49 46.72 Favored 'General case' 0 CA--C 1.537 0.462 0 O-C-N 122.568 -0.372 . . . . 71.44 111.573 175.81 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.75 -51.78 77.56 Favored Pre-proline 0 CA--C 1.547 0.84 0 N-CA-C 112.501 0.556 . . . . 44.11 112.501 -179.823 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 17.7 Cg_endo -59.12 -21.68 60.52 Favored 'Trans proline' 0 C--N 1.36 1.133 0 C-N-CA 122.115 1.877 . . . . 71.4 112.634 176.235 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 61.4 mt -77.07 -41.7 31.3 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.55 0 CA-C-O 120.974 0.416 . . . . 74.44 110.579 176.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 68.2 m-85 -60.79 -45.85 92.78 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 121.139 0.495 . . . . 72.01 110.229 171.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.2 mt -60.87 -39.11 80.85 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.544 0 CA-C-N 115.988 -0.551 . . . . 74.14 110.991 175.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 43.7 t30 -53.93 -37.37 63.78 Favored 'General case' 0 N--CA 1.471 0.607 0 CA-C-O 121.046 0.451 . . . . 74.25 111.782 177.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 55' ' ' LEU . 33.6 m-80 -89.82 -2.29 58.19 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 112.31 0.485 . . . . 60.52 112.31 -179.528 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.82 37.6 5.44 Favored Glycine 0 CA--C 1.529 0.921 0 C-N-CA 120.927 -0.654 . . . . 63.31 114.706 174.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.3 mmt -79.52 166.84 21.52 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 117.363 0.582 . . . . 71.4 111.656 173.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 51.2 m80 -70.72 141.36 51.54 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 116.147 -0.479 . . . . 73.55 111.618 179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 86.8 m -69.16 144.52 53.79 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 120.775 0.321 . . . . 75.11 110.465 173.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -63.79 119.34 9.78 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.472 0.653 . . . . 73.4 111.667 -174.49 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -156.25 -58.0 0.01 OUTLIER Glycine 0 CA--C 1.522 0.531 0 CA-C-N 115.356 -0.838 . . . . 62.4 111.534 176.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 64.7 m -88.86 127.58 55.45 Favored Pre-proline 0 CA--C 1.538 0.503 0 C-N-CA 122.218 0.207 . . . . 72.52 110.539 174.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -54.31 -24.5 34.83 Favored 'Trans proline' 0 CA--C 1.54 0.793 0 C-N-CA 122.829 2.352 . . . . 53.3 113.206 -177.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.0 m -52.07 -44.01 64.1 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 122.614 0.366 . . . . 62.22 111.889 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 44.4 t -60.42 -21.12 61.89 Favored 'General case' 0 N--CA 1.477 0.896 0 N-CA-C 112.177 0.436 . . . . 35.45 112.177 -177.151 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.552 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 23.3 mmt -77.61 -37.26 50.66 Favored 'General case' 0 N--CA 1.467 0.386 0 O-C-N 122.378 -0.201 . . . . 72.14 111.408 177.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.403 ' O ' HD12 ' A' ' 8' ' ' ILE . . . -83.15 -10.69 82.21 Favored Glycine 0 CA--C 1.528 0.906 0 C-N-CA 121.346 -0.454 . . . . 41.4 114.05 -176.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mt-10 -74.34 141.06 45.22 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.156 0.503 . . . . 74.25 111.863 179.225 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 49.4 m -75.77 154.98 35.95 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.21 -0.45 . . . . 75.12 110.884 177.063 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -53.36 -58.59 2.83 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.648 0 N-CA-C 112.702 0.63 . . . . 74.23 112.702 -177.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.785 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 16.4 pt-20 -64.97 -33.55 76.31 Favored 'General case' 0 N--CA 1.472 0.664 0 CA-C-O 120.863 0.364 . . . . 70.52 111.604 -178.438 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.44 ' O ' HG23 ' A' ' 47' ' ' VAL . 25.7 t70 -64.49 -54.17 36.65 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.248 -0.433 . . . . 72.21 110.821 178.677 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.32 -38.94 78.11 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 116.084 -0.507 . . . . 73.21 111.038 175.782 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 85.5 m -56.4 -49.21 75.13 Favored 'General case' 0 N--CA 1.467 0.417 0 CA-C-N 116.431 -0.35 . . . . 75.12 110.913 173.596 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.5 -29.0 67.54 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 111.902 0.334 . . . . 34.33 111.902 -179.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.44 HG23 ' O ' ' A' ' 43' ' ' ASP . 61.8 t -67.41 -39.14 82.04 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.612 0 CA-C-O 120.872 0.368 . . . . 72.55 111.552 177.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 12.7 t-80 -110.01 9.76 24.24 Favored 'General case' 0 CA--C 1.544 0.718 0 CA-C-O 120.774 0.321 . . . . 75.44 111.839 -177.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 64.31 31.54 81.19 Favored Glycine 0 CA--C 1.531 1.034 0 C-N-CA 121.522 -0.371 . . . . 72.31 113.329 179.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.6 mt -81.74 153.28 4.11 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.483 0 C-N-CA 122.538 0.335 . . . . 60.42 111.646 -178.529 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -84.38 107.09 16.46 Favored 'General case' 0 CA--C 1.54 0.558 0 CA-C-O 120.944 0.402 . . . . 73.11 110.298 175.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -76.4 -28.74 56.8 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 112.011 0.374 . . . . 65.14 112.011 -178.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.4 t70 -58.44 -47.16 84.88 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.862 0.363 . . . . 61.35 110.776 -179.948 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 99.5 mttt -73.35 -45.93 52.22 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 116.586 -0.279 . . . . 74.32 111.594 177.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' ND2' ' A' ' 26' ' ' ASN . 25.0 tp -53.18 -51.4 62.19 Favored 'General case' 0 N--CA 1.472 0.626 0 CA-C-O 120.996 0.427 . . . . 75.51 111.694 -179.781 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.5 HG21 ' HB3' ' A' ' 5' ' ' LYS . 88.0 t -59.91 -41.81 87.18 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-O 120.686 0.279 . . . . 62.4 111.602 -179.852 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -66.04 -39.47 90.17 Favored 'General case' 0 N--CA 1.469 0.51 0 N-CA-C 111.545 0.202 . . . . 74.44 111.545 178.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 27.8 mt-10 -60.76 -37.03 80.45 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.924 0.392 . . . . 73.42 110.723 174.725 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.431 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 79.8 mt -65.83 -51.14 61.4 Favored 'General case' 0 CA--C 1.542 0.667 0 CA-C-N 116.454 -0.339 . . . . 73.23 111.764 174.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.487 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 40.5 m-80 -56.21 -51.66 67.27 Favored 'General case' 0 N--CA 1.475 0.817 0 N-CA-C 111.926 0.343 . . . . 71.34 111.926 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.435 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.0 mt-10 -57.62 -34.83 69.72 Favored 'General case' 0 N--CA 1.468 0.454 0 CA-C-O 120.813 0.34 . . . . 53.13 111.632 -179.613 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.47 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 94.3 t80 -59.35 -48.31 82.11 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 120.84 0.352 . . . . 54.31 111.181 177.152 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -61.68 -38.98 89.8 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-N 116.649 -0.251 . . . . 72.42 111.253 177.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.406 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 34.9 mt-10 -59.86 -37.44 79.31 Favored 'General case' 0 CA--C 1.541 0.596 0 CA-C-O 120.924 0.392 . . . . 62.03 111.264 174.343 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.435 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 47.1 mmtm -67.76 -26.39 66.1 Favored 'General case' 0 N--CA 1.469 0.525 0 CA-C-N 116.255 -0.43 . . . . 73.05 111.963 177.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.0 mtpt -61.69 -43.92 97.93 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 120.694 0.283 . . . . 62.5 111.57 178.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -65.1 -20.81 66.65 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 121.123 0.487 . . . . 75.32 111.183 176.404 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 97.6 t -79.46 -53.54 13.08 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.566 0 CA-C-N 115.943 -0.571 . . . . 54.35 111.388 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 57.4 mt -76.61 -57.57 3.78 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.093 -0.503 . . . . 64.31 112.351 -176.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 22.5 mt-10 . . . . . 0 C--O 1.255 1.386 0 CA-C-O 118.724 -0.655 . . . . 61.43 112.469 -177.626 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 83.7 mtp . . . . . 0 N--CA 1.487 1.419 0 CA-C-O 120.82 0.343 . . . . 72.54 111.503 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.488 ' HB3' ' OD1' ' A' ' 60' ' ' ASN . 14.0 mmmm -112.98 156.23 23.41 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.143 0.497 . . . . 73.13 111.322 177.656 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.552 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.7 mm -73.98 137.75 22.59 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.59 0 N-CA-C 112.717 0.636 . . . . 61.43 112.717 -173.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 58.8 p -122.28 156.87 32.94 Favored 'General case' 0 N--CA 1.472 0.652 0 CA-C-N 116.274 -0.421 . . . . 73.55 110.725 175.915 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.565 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.5 ptpt -66.76 -14.07 62.17 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.796 0.331 . . . . 73.14 111.809 179.903 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -81.7 -19.33 41.77 Favored 'General case' 0 CA--C 1.543 0.708 0 CA-C-N 116.227 -0.442 . . . . 62.1 111.279 178.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.552 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 53.6 mtt -63.19 151.39 40.47 Favored 'General case' 0 CA--C 1.536 0.424 0 CA-C-O 121.283 0.563 . . . . 73.24 112.05 179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.518 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 42.0 mm -82.62 138.24 19.72 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 115.879 -0.6 . . . . 64.21 110.518 177.452 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 53.5 mt -53.5 -49.21 56.09 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.826 0 CA-C-O 120.865 0.364 . . . . 64.12 111.825 -178.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.439 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -62.16 -32.01 72.57 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.867 0.365 . . . . 71.34 111.718 178.601 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 28.1 t70 -65.75 -43.7 88.13 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-O 121.039 0.447 . . . . 73.12 110.637 178.786 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 59.2 t -60.67 -36.3 69.74 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.665 0 CA-C-O 121.211 0.529 . . . . 74.14 110.793 175.188 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.416 HD23 ' OG1' ' A' ' 19' ' ' THR . 96.6 mt -65.61 -24.44 67.06 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.119 -0.491 . . . . 72.2 111.778 176.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.439 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 73.8 mt-30 -69.48 -32.96 72.17 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 121.158 0.504 . . . . 51.33 110.909 176.487 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.5 mtt -71.21 -50.46 32.84 Favored 'General case' 0 N--CA 1.467 0.421 0 CA-C-N 115.812 -0.631 . . . . 70.44 110.674 -179.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -154.88 135.96 13.87 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-N 115.821 -0.627 . . . . 64.32 110.632 177.076 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 -72.72 -21.86 60.98 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-O 120.836 0.35 . . . . 75.21 111.909 -176.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -74.77 3.18 45.16 Favored Glycine 0 CA--C 1.528 0.86 0 CA-C-N 116.251 -0.432 . . . . 52.23 113.807 -178.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.416 ' OG1' HD23 ' A' ' 13' ' ' LEU . 71.4 p -81.31 -21.29 39.37 Favored 'General case' 0 N--CA 1.469 0.513 0 O-C-N 122.387 -0.478 . . . . 73.54 111.674 176.219 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.504 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.81 -51.41 80.62 Favored Pre-proline 0 CA--C 1.55 0.952 0 N-CA-C 112.741 0.645 . . . . 72.15 112.741 -179.823 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.504 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.7 Cg_endo -57.31 -26.01 68.25 Favored 'Trans proline' 0 C--N 1.361 1.222 0 C-N-CA 122.201 1.934 . . . . 71.2 112.785 178.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.1 mt -69.2 -47.07 76.3 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-O 121.079 0.466 . . . . 71.32 110.7 177.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -56.95 -44.55 82.66 Favored 'General case' 0 CA--C 1.538 0.503 0 CA-C-O 121.157 0.503 . . . . 62.44 110.3 173.658 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 69.8 mt -60.78 -40.62 85.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.718 0 CA-C-N 115.982 -0.554 . . . . 64.21 111.475 176.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.2 t30 -55.55 -36.02 66.34 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-O 121.131 0.491 . . . . 74.1 111.803 179.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.431 ' ND2' HD13 ' A' ' 55' ' ' LEU . 35.0 m-80 -91.25 1.41 57.12 Favored 'General case' 0 CA--C 1.542 0.648 0 N-CA-C 112.443 0.534 . . . . 72.41 112.443 -177.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 102.07 18.54 17.14 Favored Glycine 0 CA--C 1.531 1.058 0 N-CA-C 115.097 0.799 . . . . 73.23 115.097 172.295 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt -68.25 145.38 54.32 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 118.109 0.954 . . . . 53.45 111.543 175.119 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 47.3 t-80 -121.18 114.29 21.21 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.242 -0.436 . . . . 62.34 110.582 -178.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 74.4 m -67.63 113.9 5.81 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.013 0.435 . . . . 45.05 112.095 -175.919 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.525 HD13 ' N ' ' A' ' 32' ' ' GLY . 2.6 tm? -83.64 139.65 32.67 Favored 'General case' 0 CA--C 1.54 0.563 0 N-CA-C 109.616 -0.513 . . . . 74.44 109.616 176.39 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.525 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -49.57 -69.15 1.1 Allowed Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.439 -0.41 . . . . 45.24 113.638 -178.272 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 71.9 m -65.85 154.19 89.64 Favored Pre-proline 0 CA--C 1.539 0.542 0 O-C-N 122.667 -0.314 . . . . 62.41 110.938 175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.441 ' O ' ' N ' ' A' ' 36' ' ' SER . 47.4 Cg_exo -36.43 -69.48 0.07 OUTLIER 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 123.495 2.797 . . . . 75.25 114.357 -174.791 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.7 m 39.44 -83.44 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 113.821 1.045 . . . . 51.14 113.821 176.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.441 ' N ' ' O ' ' A' ' 34' ' ' PRO . 41.0 t -57.41 -27.48 62.41 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-O 121.076 0.465 . . . . 73.31 112.124 -178.36 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 30.0 mmt -73.58 -11.89 60.58 Favored 'General case' 0 CA--C 1.54 0.56 0 N-CA-C 112.004 0.372 . . . . 54.53 112.004 -179.923 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -108.7 2.21 32.17 Favored Glycine 0 CA--C 1.53 1.012 0 C-N-CA 121.051 -0.595 . . . . 45.44 113.721 -178.483 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.9 pt-20 -118.0 157.61 26.47 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 117.347 0.573 . . . . 74.02 111.775 -179.034 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.518 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.4 p -78.05 162.96 26.32 Favored 'General case' 0 N--CA 1.468 0.475 0 CA-C-O 121.107 0.48 . . . . 72.12 112.201 -175.631 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.1 mt -55.92 -52.74 46.1 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-N 115.898 -0.592 . . . . 64.44 112.101 179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.565 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 17.2 pt-20 -62.95 -37.22 86.22 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-O 120.833 0.349 . . . . 73.24 111.752 -178.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.402 ' O ' HG23 ' A' ' 47' ' ' VAL . 21.7 t0 -67.53 -49.81 61.6 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-N 116.345 -0.389 . . . . 72.42 110.778 -178.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -39.97 93.96 Favored 'General case' 0 CA--C 1.54 0.569 0 CA-C-O 121.035 0.445 . . . . 73.53 111.72 176.882 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 87.0 m -59.28 -51.22 70.9 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-N 116.408 -0.36 . . . . 62.45 111.458 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.47 -36.52 69.18 Favored 'General case' 0 N--CA 1.47 0.568 0 N-CA-C 111.987 0.366 . . . . 44.44 111.987 -179.489 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -62.29 -48.59 87.65 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 120.93 0.395 . . . . 53.43 111.477 176.515 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.403 ' HB3' HG13 ' A' ' 50' ' ' ILE . 65.2 t-80 -82.27 -11.88 58.38 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 116.369 -0.378 . . . . 74.02 111.596 -179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 79.28 40.8 15.0 Favored Glycine 0 CA--C 1.529 0.936 0 C-N-CA 121.52 -0.371 . . . . 72.43 113.031 -177.889 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.403 HG13 ' HB3' ' A' ' 48' ' ' HIS . 18.9 mt -103.63 152.16 6.3 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.497 0 C-N-CA 122.708 0.403 . . . . 63.04 111.177 179.986 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.5 t0 -80.48 97.65 7.22 Favored 'General case' 0 CA--C 1.541 0.628 0 CA-C-O 121.073 0.463 . . . . 65.53 109.879 173.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.542 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -60.74 -37.48 81.93 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 112.604 0.594 . . . . 73.31 112.604 -176.45 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.677 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 12.4 t70 -64.1 -39.75 94.73 Favored 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 120.657 -0.417 . . . . 72.12 110.493 -177.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 62.7 mttp -66.02 -41.43 90.98 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-O 120.785 0.326 . . . . 73.53 111.218 176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.431 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.0 tp -61.85 -50.05 73.81 Favored 'General case' 0 N--CA 1.47 0.535 0 CA-C-O 120.958 0.409 . . . . 72.31 111.405 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.542 HG23 ' O ' ' A' ' 52' ' ' ALA . 93.4 t -55.86 -35.23 39.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 CA-C-N 116.371 -0.377 . . . . 73.25 111.875 179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.677 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 58.0 mttm -57.06 -54.96 40.89 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-O 120.664 0.269 . . . . 71.04 110.982 176.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -56.85 -39.6 74.57 Favored 'General case' 0 CA--C 1.539 0.521 0 CA-C-N 116.433 -0.349 . . . . 73.53 111.335 179.642 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.454 HD12 ' HA ' ' A' ' 56' ' ' VAL . 89.1 mt -60.19 -51.93 67.48 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-N 116.507 -0.315 . . . . 63.22 111.494 175.922 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.488 ' OD1' ' HB3' ' A' ' 2' ' ' LYS . 40.2 m-80 -56.59 -50.03 73.16 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.508 0.194 . . . . 72.14 111.453 177.323 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.595 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 63.7 mt-10 -54.75 -42.11 71.22 Favored 'General case' 0 C--O 1.222 -0.365 0 CA-C-N 116.46 -0.336 . . . . 75.11 111.143 179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 84.7 t80 -54.45 -44.72 72.75 Favored 'General case' 0 N--CA 1.471 0.577 0 CA-C-O 120.868 0.366 . . . . 74.32 111.744 -179.178 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.5 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 85.2 m-85 -66.78 -37.67 85.04 Favored 'General case' 0 CA--C 1.534 0.343 0 CA-C-O 120.863 0.363 . . . . 73.55 110.975 177.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.428 ' O ' HG23 ' A' ' 68' ' ' VAL . 35.5 mt-10 -66.11 -27.29 67.94 Favored 'General case' 0 CA--C 1.54 0.594 0 CA-C-N 116.353 -0.385 . . . . 74.33 110.991 172.871 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.595 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 30.9 mmmt -73.73 -35.97 65.14 Favored 'General case' 0 N--CA 1.467 0.386 0 CA-C-N 116.333 -0.394 . . . . 63.31 110.24 173.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.5 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 27.7 mtpp -56.43 -39.66 73.47 Favored 'General case' 0 CA--C 1.538 0.496 0 CA-C-O 121.0 0.429 . . . . 72.51 110.791 173.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.3 mt-10 -69.54 -11.3 60.72 Favored 'General case' 0 CA--C 1.545 0.755 0 CA-C-N 116.115 -0.493 . . . . 74.34 111.834 177.577 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 64' ' ' GLU . 95.6 t -102.68 -53.98 6.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.662 0 CA-C-O 121.027 0.442 . . . . 62.31 111.93 179.182 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.1 mt -75.6 -57.3 3.97 Favored 'General case' 0 CA--C 1.541 0.608 0 N-CA-C 112.798 0.666 . . . . 75.44 112.798 -176.325 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 . . . . . 0 C--O 1.248 0.99 0 CA-C-O 118.894 -0.574 . . . . 74.41 112.086 -176.248 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 71.2 mtm . . . . . 0 N--CA 1.488 1.46 0 CA-C-O 120.798 0.332 . . . . 71.31 111.573 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.411 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 0.1 OUTLIER -72.91 105.41 4.4 Favored 'General case' 0 CA--C 1.545 0.755 0 N-CA-C 109.785 -0.45 . . . . 55.33 109.785 173.906 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.401 ' N ' ' OD1' ' A' ' 60' ' ' ASN . 48.4 mm -56.6 137.42 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.652 0 N-CA-C 112.814 0.672 . . . . 71.34 112.814 -173.261 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 43.1 p -117.35 156.2 28.26 Favored 'General case' 0 N--CA 1.468 0.442 0 CA-C-N 115.745 -0.661 . . . . 74.52 110.403 178.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.667 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 21.2 pttp -68.94 -13.46 62.45 Favored 'General case' 0 CA--C 1.537 0.466 0 CA-C-O 121.007 0.432 . . . . 60.31 111.557 -178.52 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 25.8 t70 -79.03 -22.51 45.31 Favored 'General case' 0 CA--C 1.54 0.564 0 CA-C-N 116.27 -0.423 . . . . 62.32 111.284 178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.469 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 67.2 mtt -64.73 153.98 38.12 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-O 121.295 0.569 . . . . 54.33 112.102 -178.604 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -82.25 139.83 17.32 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.693 0 CA-C-N 115.983 -0.553 . . . . 75.52 111.659 -178.015 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 51.5 mt -55.3 -55.47 16.57 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 N-CA-C 112.189 0.44 . . . . 62.42 112.189 -179.85 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.503 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -58.83 -35.61 73.19 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.737 0.303 . . . . 72.21 111.517 179.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -58.56 -43.8 89.5 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-O 121.047 0.451 . . . . 53.44 111.065 177.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 65.8 t -64.19 -43.72 97.37 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.628 0 CA-C-N 116.235 -0.439 . . . . 60.34 110.775 174.155 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 97.7 mt -62.24 -27.91 69.33 Favored 'General case' 0 N--CA 1.472 0.642 0 CA-C-N 116.094 -0.503 . . . . 52.42 111.912 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.503 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 18.5 mm-40 -63.18 -27.98 69.74 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-O 120.8 0.334 . . . . 75.41 111.397 176.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 25.4 mtm -87.78 -49.15 7.3 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 121.029 0.442 . . . . 72.45 110.879 -179.427 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 6.6 t70 -148.21 119.84 8.02 Favored 'General case' 0 CA--C 1.541 0.616 0 CA-C-N 116.226 -0.443 . . . . 62.13 111.396 178.724 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.432 HH11 ' HD2' ' A' ' 17' ' ' ARG . 12.6 mmt180 -75.48 -8.34 56.48 Favored 'General case' 0 N--CA 1.469 0.501 0 N-CA-C 112.382 0.512 . . . . 71.03 112.382 -179.618 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -72.02 -8.23 68.64 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 121.227 -0.511 . . . . 72.24 112.459 175.848 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.417 ' HA ' HD12 ' A' ' 22' ' ' ILE . 65.4 p -81.05 -18.04 48.09 Favored 'General case' 0 CA--C 1.537 0.443 0 O-C-N 122.696 -0.297 . . . . 70.31 111.45 175.73 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.458 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.91 -52.1 75.14 Favored Pre-proline 0 CA--C 1.548 0.87 0 N-CA-C 112.178 0.436 . . . . 44.04 112.178 -179.108 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.458 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.6 Cg_endo -59.52 -28.16 86.78 Favored 'Trans proline' 0 C--N 1.36 1.165 0 C-N-CA 122.03 1.82 . . . . 74.14 112.318 176.414 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.417 HD12 ' HA ' ' A' ' 19' ' ' THR . 67.9 mt -68.71 -46.63 79.38 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 CA-C-O 121.057 0.456 . . . . 71.14 110.894 176.647 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.512 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 58.5 m-85 -56.75 -48.97 76.62 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 121.088 0.47 . . . . 73.34 110.529 172.687 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 70.8 mt -61.34 -36.15 70.99 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 116.013 -0.539 . . . . 71.21 111.568 179.0 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.3 t30 -57.38 -33.11 67.48 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-O 121.081 0.467 . . . . 62.55 111.203 178.272 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 33.1 m-80 -92.58 -4.4 53.49 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-N 116.197 -0.456 . . . . 74.43 112.068 -179.46 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 119.42 -13.34 11.03 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.74 -0.743 . . . . 71.52 114.559 176.54 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.512 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.7 mmt -64.0 160.79 17.15 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 117.559 0.679 . . . . 51.42 111.746 179.819 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 96.0 m-70 -132.65 108.24 8.92 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-O 120.991 0.424 . . . . 75.22 111.323 178.01 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 43.6 t -70.09 -30.74 68.03 Favored 'General case' 0 N--CA 1.473 0.705 0 CA-C-O 120.921 0.391 . . . . 64.04 111.719 -178.746 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -111.82 107.23 16.21 Favored 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 116.325 -0.398 . . . . 74.13 110.233 178.583 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 167.17 -99.88 0.16 Allowed Glycine 0 CA--C 1.526 0.725 0 C-N-CA 121.239 -0.505 . . . . 74.0 112.786 179.953 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.424 ' HA ' ' HD2' ' A' ' 34' ' ' PRO . 80.5 m -78.79 115.7 54.04 Favored Pre-proline 0 CA--C 1.538 0.491 0 O-C-N 122.543 -0.386 . . . . 71.21 110.964 177.697 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HD2' ' HA ' ' A' ' 33' ' ' CYS . 11.0 Cg_endo -53.44 -41.85 70.06 Favored 'Trans proline' 0 CA--C 1.538 0.72 0 C-N-CA 122.772 2.315 . . . . 73.0 113.254 -177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . 0.489 ' O ' ' HG3' ' A' ' 39' ' ' GLU . 23.3 t -60.97 -28.48 69.03 Favored 'General case' 0 N--CA 1.472 0.651 0 N-CA-C 111.839 0.311 . . . . 62.22 111.839 -177.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 65.1 m -54.13 -30.61 49.56 Favored 'General case' 0 N--CA 1.479 0.996 0 CA-C-O 120.904 0.383 . . . . 54.44 111.73 -179.412 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.402 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 6.0 mmt -66.45 -36.63 83.26 Favored 'General case' 0 CA--C 1.538 0.515 0 CA-C-O 120.795 0.331 . . . . 60.42 111.387 178.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.96 5.86 72.67 Favored Glycine 0 CA--C 1.53 1.006 0 N-CA-C 114.312 0.485 . . . . 62.45 114.312 -175.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.489 ' HG3' ' O ' ' A' ' 35' ' ' SER . 40.4 mt-10 -90.29 146.67 24.04 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 117.442 0.621 . . . . 63.32 111.911 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 62.3 m -66.6 147.44 53.27 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.224 -0.444 . . . . 72.13 110.252 172.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.447 ' O ' ' SG ' ' A' ' 45' ' ' CYS . 19.7 mt -50.49 -56.95 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.643 0 N-CA-C 112.642 0.608 . . . . 73.51 112.642 -177.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.667 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.2 pt-20 -62.99 -35.99 82.03 Favored 'General case' 0 N--CA 1.473 0.681 0 CA-C-O 120.847 0.356 . . . . 62.44 111.791 -179.519 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.464 ' O ' HG23 ' A' ' 47' ' ' VAL . 26.9 t70 -65.29 -52.0 57.01 Favored 'General case' 0 CA--C 1.541 0.634 0 CA-C-N 116.064 -0.517 . . . . 51.01 110.767 -179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.76 -35.3 79.37 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.169 -0.469 . . . . 73.21 111.484 176.24 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.447 ' SG ' ' O ' ' A' ' 41' ' ' ILE . 85.8 m -58.27 -54.93 41.43 Favored 'General case' 0 N--CA 1.469 0.491 0 CA-C-N 116.469 -0.332 . . . . 73.43 111.163 176.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.16 -37.26 64.24 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 120.838 0.352 . . . . 73.41 111.841 179.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.464 HG23 ' O ' ' A' ' 43' ' ' ASP . 89.5 t -59.72 -52.2 63.88 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.578 0 CA-C-N 116.392 -0.367 . . . . 73.52 111.839 177.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 15.0 t60 -92.12 -0.67 57.44 Favored 'General case' 0 CA--C 1.544 0.744 0 N-CA-C 112.109 0.411 . . . . 70.43 112.109 -177.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 71.55 46.33 40.65 Favored Glycine 0 CA--C 1.528 0.877 0 C-N-CA 121.443 -0.408 . . . . 64.43 113.283 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 30.1 mt -101.91 151.06 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 C-N-CA 122.704 0.401 . . . . 75.34 111.264 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 19.7 t70 -85.14 98.52 10.5 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-O 121.035 0.445 . . . . 71.21 110.654 176.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.53 -27.35 66.9 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 116.429 -0.35 . . . . 73.22 111.78 -178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 24.6 t70 -53.46 -51.82 61.45 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-N 116.585 -0.279 . . . . 62.33 111.159 178.136 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 37.6 mtmm -76.91 -40.16 48.26 Favored 'General case' 0 CA--C 1.538 0.509 0 N-CA-C 112.04 0.385 . . . . 62.31 112.04 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 24.1 tp -55.63 -53.69 53.36 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.783 0.325 . . . . 70.11 111.747 -179.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.537 HG21 ' HB3' ' A' ' 5' ' ' LYS . 59.8 t -61.16 -39.93 84.11 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 CA-C-O 120.659 0.266 . . . . 72.33 111.595 -179.411 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.413 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 93.4 mttt -60.8 -45.78 93.1 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-N 116.802 -0.181 . . . . 71.24 111.315 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -60.15 -40.0 88.36 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.751 0.31 . . . . 72.24 111.453 176.485 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.492 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.9 mt -59.24 -52.72 64.48 Favored 'General case' 0 N--CA 1.471 0.593 0 CA-C-O 120.813 0.339 . . . . 72.2 111.51 175.099 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 52.9 m-80 -57.74 -49.94 74.9 Favored 'General case' 0 N--CA 1.468 0.425 0 CA-C-N 116.429 -0.351 . . . . 73.11 111.745 178.947 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.583 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.7 mt-10 -52.57 -44.43 65.89 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 116.462 -0.336 . . . . 63.14 110.782 177.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -57.69 -54.15 50.18 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-N 116.336 -0.393 . . . . 72.15 112.054 178.877 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 -56.85 -41.41 77.87 Favored 'General case' 0 N--CA 1.469 0.486 0 N-CA-C 111.993 0.368 . . . . 74.4 111.993 -179.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 34.9 mt-10 -72.12 -30.75 65.36 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.777 0.323 . . . . 64.21 111.268 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.583 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 30.9 mmmt -65.9 -28.11 68.7 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 122.353 -0.217 . . . . 73.23 111.026 174.288 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 51.3 mtpt -56.15 -45.97 79.46 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-O 120.725 0.298 . . . . 72.02 111.765 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -64.15 -21.42 66.54 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 121.077 0.465 . . . . 70.41 111.434 178.651 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 87.3 t -79.65 -45.58 23.17 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.669 0 CA-C-O 121.283 0.563 . . . . 43.34 111.033 174.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 67.0 mt -66.8 -59.95 3.1 Favored 'General case' 0 CA--C 1.54 0.581 0 CA-C-N 115.937 -0.574 . . . . 71.54 111.744 177.76 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 . . . . . 0 C--O 1.253 1.247 0 CA-C-O 118.776 -0.63 . . . . 71.25 111.619 179.277 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.1 mpt? . . . . . 0 N--CA 1.49 1.558 0 CA-C-O 121.02 0.438 . . . . 74.24 111.517 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 39.1 tptt -124.99 107.78 11.18 Favored 'General case' 0 CA--C 1.539 0.548 0 N-CA-C 109.229 -0.656 . . . . 72.25 109.229 174.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.494 HG22 HG13 ' A' ' 56' ' ' VAL . 50.9 mm -72.55 137.8 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.536 0 N-CA-C 112.944 0.72 . . . . 75.31 112.944 -168.486 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 50.8 p -125.82 158.58 34.64 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 115.69 -0.686 . . . . 61.44 109.939 174.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.739 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.4 pttp -71.92 -15.17 62.09 Favored 'General case' 0 N--CA 1.47 0.561 0 O-C-N 122.015 -0.428 . . . . 41.14 111.252 -178.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -71.84 -23.56 61.55 Favored 'General case' 0 CA--C 1.544 0.729 0 CA-C-N 116.04 -0.527 . . . . 74.44 111.192 176.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.421 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 63.9 mtt -67.64 165.33 17.31 Favored 'General case' 0 CA--C 1.541 0.616 0 N-CA-C 112.397 0.518 . . . . 74.2 112.397 -177.841 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.434 ' O ' HG23 ' A' ' 12' ' ' VAL . 47.2 mm -93.75 135.53 28.0 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.546 0 CA-C-N 115.992 -0.549 . . . . 53.32 111.581 -178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.4 mt -58.7 -51.31 73.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.605 0 CA-C-O 120.821 0.343 . . . . 60.4 111.849 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.406 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -58.13 -41.52 83.83 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-O 120.805 0.336 . . . . 64.42 111.73 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.42 ' O ' ' HG3' ' A' ' 15' ' ' MET . 20.4 t70 -58.66 -45.01 90.28 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.407 -0.361 . . . . 74.31 110.95 177.654 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.434 HG23 ' O ' ' A' ' 8' ' ' ILE . 88.7 t -57.53 -43.42 83.02 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-O 120.957 0.408 . . . . 73.43 111.2 175.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.422 HD23 ' OG1' ' A' ' 19' ' ' THR . 94.9 mt -62.68 -34.4 77.05 Favored 'General case' 0 CA--C 1.539 0.53 0 CA-C-N 116.321 -0.399 . . . . 71.42 111.395 175.837 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.406 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 78.8 mt-30 -67.61 -30.16 69.68 Favored 'General case' 0 N--CA 1.469 0.517 0 CA-C-N 116.386 -0.37 . . . . 63.51 111.661 178.28 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . 0.42 ' HG3' ' O ' ' A' ' 11' ' ' ASP . 37.2 mtm -74.45 -43.2 57.21 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 121.3 0.572 . . . . 65.0 109.949 175.011 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 54.8 t0 -159.49 124.67 4.11 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 115.614 -0.721 . . . . 73.52 111.756 172.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 18.9 mmt180 -69.47 -14.7 63.02 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-N 115.992 -0.549 . . . . 72.54 111.766 178.828 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.506 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -65.51 -9.75 45.54 Favored Glycine 0 CA--C 1.53 0.979 0 C-N-CA 121.067 -0.587 . . . . 73.32 113.178 177.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.422 ' OG1' HD23 ' A' ' 13' ' ' LEU . 80.7 p -82.43 -13.85 56.11 Favored 'General case' 0 N--CA 1.471 0.581 0 O-C-N 122.44 -0.447 . . . . 62.12 111.757 177.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.505 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.03 -51.07 80.44 Favored Pre-proline 0 CA--C 1.545 0.766 0 N-CA-C 112.604 0.594 . . . . 75.31 112.604 -179.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.505 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 21.5 Cg_endo -58.92 -26.45 81.13 Favored 'Trans proline' 0 C--N 1.36 1.143 0 C-N-CA 122.169 1.913 . . . . 74.12 112.677 178.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 60.8 mt -71.41 -44.1 72.16 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.491 0 CA-C-O 120.97 0.414 . . . . 74.33 110.789 178.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 69.9 m-85 -63.76 -46.03 87.12 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.972 0.415 . . . . 73.53 110.55 173.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 74.0 mt -59.56 -39.16 78.65 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.593 0 CA-C-N 116.205 -0.452 . . . . 64.01 111.259 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.43 -40.7 71.83 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 121.076 0.465 . . . . 72.5 111.541 178.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 32.0 m-80 -82.74 0.42 43.65 Favored 'General case' 0 CA--C 1.542 0.662 0 CA-C-N 116.14 -0.482 . . . . 75.2 112.041 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 100.97 9.51 45.31 Favored Glycine 0 CA--C 1.528 0.856 0 N-CA-C 114.826 0.69 . . . . 71.53 114.826 173.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.9 mmt -63.72 142.8 58.27 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 118.093 0.946 . . . . 70.24 111.817 179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 87.0 m-70 -126.58 112.34 15.41 Favored 'General case' 0 N--CA 1.467 0.38 0 CA-C-N 116.018 -0.537 . . . . 75.23 110.893 -179.357 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 26.3 p -84.12 -18.96 35.1 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.857 0.361 . . . . 75.13 111.567 178.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -75.46 103.83 5.76 Favored 'General case' 0 CA--C 1.539 0.532 0 CA-C-O 120.946 0.403 . . . . 74.21 110.633 179.27 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 149.9 -86.5 0.15 Allowed Glycine 0 CA--C 1.526 0.779 0 C-N-CA 121.204 -0.522 . . . . 72.33 113.07 178.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.418 ' HA ' ' HD3' ' A' ' 34' ' ' PRO . 80.2 m -125.27 145.65 51.45 Favored Pre-proline 0 N--CA 1.47 0.565 0 O-C-N 122.637 -0.331 . . . . 72.15 111.256 -178.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 33' ' ' CYS . 37.9 Cg_exo -61.42 -10.43 16.06 Favored 'Trans proline' 0 CA--C 1.54 0.815 0 C-N-CA 122.849 2.366 . . . . 74.25 113.478 -179.91 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.8 m -55.83 -39.68 71.73 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 121.073 0.463 . . . . 54.0 111.168 178.331 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.7 m -64.37 -9.76 20.16 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 112.021 0.378 . . . . 75.25 112.021 179.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.3 mmt -111.81 -57.94 2.19 Favored 'General case' 0 CA--C 1.541 0.623 0 CA-C-O 120.811 0.339 . . . . 73.43 111.767 -179.037 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -73.22 -20.09 79.82 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 115.122 0.809 . . . . 43.21 115.122 -172.239 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 11.6 mm-40 -84.09 168.82 15.51 Favored 'General case' 0 CA--C 1.541 0.601 0 CA-C-N 117.564 0.682 . . . . 75.23 112.344 -178.747 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 69.7 m -70.29 151.53 45.19 Favored 'General case' 0 N--CA 1.473 0.69 0 CA-C-N 116.041 -0.527 . . . . 72.31 111.899 -179.495 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 23.0 mt -52.67 -57.66 3.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 N-CA-C 112.376 0.509 . . . . 74.22 112.376 -179.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.739 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.6 pt-20 -58.61 -35.56 72.64 Favored 'General case' 0 N--CA 1.47 0.538 0 CA-C-O 120.912 0.387 . . . . 74.24 111.78 -179.253 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.426 ' O ' HG23 ' A' ' 47' ' ' VAL . 17.9 t70 -68.85 -53.61 20.38 Favored 'General case' 0 CA--C 1.54 0.584 0 CA-C-N 116.202 -0.454 . . . . 73.22 111.144 -178.105 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.84 -37.41 79.16 Favored 'General case' 0 C--O 1.241 0.625 0 CA-C-N 116.267 -0.424 . . . . 72.22 111.245 176.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 89.3 m -60.22 -52.25 66.12 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-N 116.11 -0.495 . . . . 74.11 110.825 173.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -52.0 -47.94 64.69 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 116.411 -0.358 . . . . 32.22 111.871 -179.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 43' ' ' ASP . 59.9 t -51.94 -38.27 22.91 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.992 0.425 . . . . 52.42 111.928 178.682 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 71.6 m80 -103.18 0.51 31.84 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.294 0.479 . . . . 73.35 112.294 -178.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 70.18 26.57 74.07 Favored Glycine 0 CA--C 1.531 1.047 0 C-N-CA 121.161 -0.543 . . . . 44.41 113.501 -178.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 55.2 mt -81.6 153.13 4.14 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 CA-C-O 120.899 0.38 . . . . 60.41 111.307 179.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -86.07 105.09 16.26 Favored 'General case' 0 CA--C 1.544 0.714 0 CA-C-O 120.872 0.368 . . . . 72.15 110.877 -178.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -72.5 -36.07 68.29 Favored 'General case' 0 CA--C 1.536 0.409 0 N-CA-C 112.045 0.387 . . . . 72.23 112.045 -178.332 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -55.74 -44.73 77.85 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.029 0.442 . . . . 75.21 111.003 178.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 60.1 mttp -69.2 -52.02 32.06 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-N 116.343 -0.39 . . . . 75.21 111.469 176.804 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 30.4 tp -55.09 -49.62 71.23 Favored 'General case' 0 N--CA 1.471 0.584 0 N-CA-C 112.21 0.448 . . . . 73.33 112.21 -177.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.494 HG13 HG22 ' A' ' 3' ' ' ILE . 75.2 t -60.31 -42.1 89.49 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 N-CA-C 111.978 0.362 . . . . 72.21 111.978 -178.127 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.3 mttt -68.71 -35.39 77.1 Favored 'General case' 0 N--CA 1.471 0.604 0 CA-C-O 120.818 0.342 . . . . 74.45 111.217 179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 45.5 mt-10 -61.63 -38.25 86.99 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-O 120.921 0.391 . . . . 73.05 110.999 172.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 84.7 mt -68.42 -45.0 73.78 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-N 116.204 -0.453 . . . . 72.45 111.971 175.701 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.525 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 27.7 m-80 -53.58 -56.4 17.47 Favored 'General case' 0 N--CA 1.472 0.635 0 N-CA-C 111.794 0.294 . . . . 73.15 111.794 -179.911 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.607 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 18.4 mt-10 -46.68 -52.53 13.61 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.763 0.316 . . . . 71.35 111.327 177.141 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.506 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 80.4 t80 -50.43 -55.36 16.18 Favored 'General case' 0 CA--C 1.54 0.584 0 N-CA-C 112.54 0.57 . . . . 74.41 112.54 -173.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.533 ' HA ' ' HD3' ' A' ' 66' ' ' LYS . 56.2 m-85 -62.45 -37.28 85.28 Favored 'General case' 0 N--CA 1.47 0.567 0 N-CA-C 112.244 0.461 . . . . 73.44 112.244 -178.715 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 27.1 mt-10 -71.53 -32.37 68.09 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-O 120.782 0.325 . . . . 72.3 111.07 178.979 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.607 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 33.7 mmtp -68.92 -41.12 78.58 Favored 'General case' 0 N--CA 1.471 0.621 0 CA-C-N 116.417 -0.356 . . . . 71.51 110.925 175.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.533 ' HD3' ' HA ' ' A' ' 63' ' ' PHE . 26.6 mtpp -46.67 -58.93 3.37 Favored 'General case' 0 N--CA 1.475 0.792 0 N-CA-C 112.439 0.533 . . . . 73.22 112.439 -179.779 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.2 mt-10 -64.05 -11.91 33.84 Favored 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 115.958 -0.565 . . . . 63.23 112.196 -175.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 88.2 t -95.16 -49.91 12.09 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.671 0 CA-C-O 121.05 0.453 . . . . 75.04 111.43 177.293 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 64.2 mt -71.58 -56.7 5.36 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 112.238 0.458 . . . . 45.51 112.238 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 . . . . . 0 C--O 1.255 1.387 0 CA-C-O 118.662 -0.685 . . . . 73.25 112.059 -177.609 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 84.2 mtp . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.598 0.237 . . . . 75.41 111.191 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.542 ' HD3' ' OD1' ' A' ' 60' ' ' ASN . 3.3 tppp? -94.63 100.86 12.73 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 121.216 0.532 . . . . 74.4 110.579 176.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.513 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.5 mm -70.36 137.65 23.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.461 0 CA-C-N 115.582 -0.735 . . . . 75.14 111.435 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 76.6 p -121.61 154.69 36.44 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 120.841 0.353 . . . . 74.44 111.287 178.811 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.491 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 18.3 ptpt -53.54 -33.34 54.24 Favored 'General case' 0 N--CA 1.473 0.679 0 N-CA-C 113.185 0.809 . . . . 74.41 113.185 -176.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -78.09 -3.39 42.06 Favored 'General case' 0 CA--C 1.542 0.661 0 N-CA-C 112.883 0.697 . . . . 61.21 112.883 -176.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.513 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.2 mtt -73.38 150.79 41.52 Favored 'General case' 0 CA--C 1.54 0.562 0 CA-C-O 121.122 0.487 . . . . 71.15 111.67 178.668 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.529 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.6 mm -79.78 131.04 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 CA-C-N 116.237 -0.438 . . . . 72.33 111.444 -176.447 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . 0.402 ' O ' ' HG ' ' A' ' 13' ' ' LEU . 48.8 mt -56.25 -51.57 61.62 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.653 0 N-CA-C 111.89 0.329 . . . . 63.54 111.89 -178.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.455 ' O ' ' HG3' ' A' ' 14' ' ' GLN . . . -56.38 -40.11 74.06 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 120.891 0.377 . . . . 71.32 111.385 178.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -63.79 -43.4 96.42 Favored 'General case' 0 CA--C 1.542 0.636 0 CA-C-N 116.261 -0.427 . . . . 75.13 110.709 179.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 64.7 t -61.1 -41.55 89.79 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.697 0 CA-C-O 121.089 0.471 . . . . 71.33 110.986 174.823 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.426 HD23 ' OG1' ' A' ' 19' ' ' THR . 94.7 mt -61.42 -35.89 78.8 Favored 'General case' 0 N--CA 1.468 0.447 0 CA-C-O 121.033 0.444 . . . . 72.35 111.163 175.246 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.464 ' HA ' HH12 ' A' ' 17' ' ' ARG . 99.2 mt-30 -67.66 -22.21 65.32 Favored 'General case' 0 CA--C 1.537 0.456 0 CA-C-N 116.257 -0.429 . . . . 64.04 111.598 177.301 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -74.2 -58.56 3.21 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-O 121.254 0.549 . . . . 74.53 109.643 171.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -146.83 127.51 14.26 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.612 -0.722 . . . . 74.23 110.825 175.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.464 HH12 ' HA ' ' A' ' 14' ' ' GLN . 77.8 mmt-85 -69.18 -17.59 63.82 Favored 'General case' 0 N--CA 1.469 0.523 0 N-CA-C 111.783 0.29 . . . . 73.11 111.783 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -67.2 -6.75 41.18 Favored Glycine 0 CA--C 1.527 0.835 0 C-N-CA 121.211 -0.519 . . . . 71.13 113.217 179.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.437 ' HA ' HD12 ' A' ' 22' ' ' ILE . 80.9 p -81.62 -21.27 38.38 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 122.557 -0.378 . . . . 70.53 111.251 174.859 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.495 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -57.09 -51.14 83.92 Favored Pre-proline 0 CA--C 1.544 0.725 0 N-CA-C 112.181 0.438 . . . . 73.14 112.181 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.495 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.9 Cg_endo -58.79 -25.44 76.16 Favored 'Trans proline' 0 C--N 1.359 1.126 0 C-N-CA 121.941 1.761 . . . . 74.22 112.281 176.32 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . 0.437 HD12 ' HA ' ' A' ' 19' ' ' THR . 59.9 mt -73.22 -45.43 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.475 0 CA-C-O 121.013 0.435 . . . . 72.11 110.72 176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.7 m-85 -57.01 -52.17 66.35 Favored 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 121.056 0.455 . . . . 62.54 110.522 173.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -59.81 -37.32 71.02 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.272 -0.422 . . . . 63.33 111.368 177.384 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 57.8 t30 -55.9 -33.64 64.83 Favored 'General case' 0 CA--C 1.542 0.641 0 CA-C-O 121.137 0.494 . . . . 74.1 111.251 176.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 31.1 m-80 -91.43 -4.12 55.95 Favored 'General case' 0 CA--C 1.542 0.666 0 N-CA-C 112.241 0.459 . . . . 72.11 112.241 178.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.26 16.18 19.25 Favored Glycine 0 CA--C 1.529 0.92 0 C-N-CA 120.984 -0.627 . . . . 74.31 114.438 176.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.56 -175.61 2.06 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-N 117.593 0.696 . . . . 54.33 111.807 176.19 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 57.4 m80 -95.85 152.64 18.3 Favored 'General case' 0 CA--C 1.537 0.45 0 CA-C-N 116.033 -0.53 . . . . 73.42 111.396 179.806 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 63.8 m -73.12 168.5 18.96 Favored 'General case' 0 N--CA 1.469 0.519 0 CA-C-O 121.232 0.539 . . . . 70.24 112.21 179.654 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.493 HD22 ' SD ' ' A' ' 37' ' ' MET . 1.9 tm? -62.99 100.5 0.21 Allowed 'General case' 0 N--CA 1.471 0.625 0 CA-C-N 115.941 -0.572 . . . . 54.43 110.706 180.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 179.68 -72.62 0.07 OUTLIER Glycine 0 CA--C 1.527 0.788 0 C-N-CA 120.794 -0.717 . . . . 53.23 113.331 179.316 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 83.8 m -65.28 116.2 28.51 Favored Pre-proline 0 N--CA 1.472 0.657 0 N-CA-C 111.977 0.362 . . . . 74.35 111.977 -177.135 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -58.07 -26.93 77.73 Favored 'Trans proline' 0 C--N 1.355 0.87 0 C-N-CA 122.882 2.388 . . . . 71.11 113.016 -178.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 87.5 p -54.8 -43.57 73.01 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-O 121.105 0.479 . . . . 75.13 111.903 178.266 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 23.3 t -88.22 -9.02 54.35 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.845 -177.709 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.493 ' SD ' HD22 ' A' ' 31' ' ' LEU . 7.7 mmt -94.68 -49.83 5.44 Favored 'General case' 0 N--CA 1.47 0.554 0 CA-C-O 120.898 0.38 . . . . 63.55 111.794 -178.021 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.434 ' O ' HD12 ' A' ' 8' ' ' ILE . . . -68.94 -36.28 81.19 Favored Glycine 0 CA--C 1.527 0.786 0 N-CA-C 114.19 0.436 . . . . 74.53 114.19 -175.177 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 46.2 mm-40 -73.7 167.57 21.12 Favored 'General case' 0 CA--C 1.541 0.61 0 CA-C-O 121.685 0.755 . . . . 75.23 112.772 -178.834 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.529 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 94.1 p -78.84 164.13 24.75 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-N 115.526 -0.761 . . . . 70.4 112.011 -178.133 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 22.2 mt -56.07 -48.79 78.45 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 CA-C-N 116.182 -0.463 . . . . 72.44 111.593 176.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.491 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 8.0 pt-20 -62.56 -37.18 85.16 Favored 'General case' 0 N--CA 1.468 0.453 0 N-CA-C 111.982 0.364 . . . . 60.04 111.982 -179.976 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.533 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.2 t70 -66.01 -58.99 4.27 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-O 120.71 0.29 . . . . 74.14 110.703 178.63 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.79 -37.37 65.96 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-O 120.778 0.323 . . . . 74.15 111.65 178.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -57.01 -49.63 75.21 Favored 'General case' 0 N--CA 1.467 0.377 0 CA-C-O 120.819 0.342 . . . . 72.4 110.753 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -65.77 -28.12 68.79 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 111.835 0.309 . . . . 75.4 111.835 179.333 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.533 HG23 ' O ' ' A' ' 43' ' ' ASP . 76.7 t -66.45 -54.58 24.63 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.672 0 CA-C-O 120.939 0.4 . . . . 71.41 111.747 177.581 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 66.9 t60 -86.75 -18.69 30.52 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 120.881 0.372 . . . . 64.12 111.748 -178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 88.18 53.15 2.72 Favored Glycine 0 CA--C 1.531 1.077 0 CA-C-O 121.178 0.321 . . . . 72.02 113.066 -177.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 19.9 mt -110.88 153.15 12.71 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.468 0 C-N-CA 123.01 0.524 . . . . 60.03 111.107 -179.623 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . 0.424 ' OD2' ' HG3' ' A' ' 54' ' ' LYS . 14.6 t70 -84.74 103.06 13.5 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 120.946 0.403 . . . . 72.02 110.243 176.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.407 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -62.14 -34.15 75.82 Favored 'General case' 0 CA--C 1.532 0.285 0 N-CA-C 112.377 0.51 . . . . 74.14 112.377 -177.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -58.65 -45.01 90.23 Favored 'General case' 0 CA--C 1.54 0.589 0 CA-C-O 120.749 0.309 . . . . 73.4 111.181 179.016 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . 0.424 ' HG3' ' OD2' ' A' ' 51' ' ' ASP . 92.0 mttt -66.42 -49.06 68.04 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.955 0.407 . . . . 71.34 111.036 177.204 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 35.2 tp -58.17 -52.87 63.75 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 116.112 -0.495 . . . . 73.13 111.819 -177.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.461 ' HA ' HD12 ' A' ' 59' ' ' LEU . 96.2 t -58.57 -40.02 77.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.504 0 CA-C-O 120.731 0.3 . . . . 65.15 111.639 -178.83 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 92.4 mttt -60.47 -44.92 95.4 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 120.538 0.209 . . . . 74.13 111.39 175.104 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 23.3 mt-10 -62.96 -35.6 80.68 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-O 120.847 0.356 . . . . 60.42 111.314 177.472 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.461 HD12 ' HA ' ' A' ' 56' ' ' VAL . 90.8 mt -64.09 -51.4 64.18 Favored 'General case' 0 CA--C 1.54 0.57 0 CA-C-N 116.468 -0.333 . . . . 73.44 111.619 175.556 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.542 ' OD1' ' HD3' ' A' ' 2' ' ' LYS . 52.3 m-80 -58.31 -49.92 75.46 Favored 'General case' 0 N--CA 1.472 0.669 0 CA-C-O 120.676 0.274 . . . . 72.54 111.571 177.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.627 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 49.1 mt-10 -50.29 -46.88 55.55 Favored 'General case' 0 CA--C 1.533 0.291 0 CA-C-N 116.568 -0.287 . . . . 72.51 110.9 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.0 t80 -54.31 -51.77 63.62 Favored 'General case' 0 CA--C 1.538 0.499 0 N-CA-C 112.305 0.483 . . . . 73.14 112.305 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 52.4 m-85 -57.5 -39.37 76.35 Favored 'General case' 0 CA--C 1.539 0.525 0 CA-C-O 120.547 0.213 . . . . 61.44 111.429 179.379 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.441 ' O ' HG23 ' A' ' 68' ' ' VAL . 32.5 mt-10 -68.64 -37.15 79.48 Favored 'General case' 0 CA--C 1.541 0.618 0 N-CA-C 111.649 0.24 . . . . 70.2 111.649 174.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.627 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 34.9 mmtp -60.46 -36.78 79.06 Favored 'General case' 0 N--CA 1.474 0.771 0 CA-C-O 120.9 0.381 . . . . 73.13 110.82 178.145 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.463 ' HB3' ' HE2' ' A' ' 66' ' ' LYS . 45.1 mtpt -55.94 -52.75 63.02 Favored 'General case' 0 CA--C 1.535 0.37 0 CA-C-O 120.962 0.411 . . . . 64.52 110.975 175.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 39.5 mt-10 -64.76 -11.14 33.24 Favored 'General case' 0 CA--C 1.544 0.712 0 CA-C-N 116.12 -0.491 . . . . 71.3 111.881 -179.803 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.441 HG23 ' O ' ' A' ' 64' ' ' GLU . 83.4 t -85.66 -48.27 16.22 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.58 0 CA-C-O 121.083 0.468 . . . . 61.24 111.036 173.311 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 76.0 mt -72.15 -55.35 7.43 Favored 'General case' 0 CA--C 1.54 0.571 0 CA-C-N 116.097 -0.501 . . . . 64.51 112.061 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.8 mt-10 . . . . . 0 C--O 1.253 1.242 0 CA-C-O 118.441 -0.79 . . . . 73.11 112.179 -178.696 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.5 mtt . . . . . 0 N--CA 1.487 1.421 0 CA-C-O 120.498 0.19 . . . . 64.52 111.374 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 23.2 tptm -72.6 98.26 2.3 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 121.053 0.454 . . . . 74.11 110.71 175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.6 mm -78.46 138.89 19.37 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.457 0 CA-C-N 116.178 -0.464 . . . . 63.22 111.324 -179.931 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 49.4 p -127.33 154.07 45.41 Favored 'General case' 0 N--CA 1.469 0.507 0 CA-C-O 120.711 0.291 . . . . 62.23 110.719 179.738 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.489 ' HA ' ' HB ' ' A' ' 41' ' ' ILE . 10.2 ptpp? -64.46 -15.79 61.32 Favored 'General case' 0 N--CA 1.471 0.601 0 CA-C-O 121.157 0.504 . . . . 71.24 111.237 179.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -70.44 -25.2 63.08 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 115.591 -0.731 . . . . 63.43 111.287 177.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 64.7 mtt -71.71 149.41 45.48 Favored 'General case' 0 CA--C 1.541 0.613 0 N-CA-C 113.237 0.828 . . . . 53.34 113.237 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 44.7 mm -78.76 133.37 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 CA-C-N 115.405 -0.816 . . . . 35.2 110.928 176.293 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 65.4 mt -56.67 -42.04 75.78 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.75 0 N-CA-C 111.896 0.332 . . . . 51.42 111.896 -179.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.38 -42.0 94.96 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 111.964 0.357 . . . . 61.12 111.964 178.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 21.9 t70 -58.65 -45.99 88.13 Favored 'General case' 0 CA--C 1.538 0.498 0 CA-C-O 121.093 0.473 . . . . 74.52 110.957 178.702 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 42.7 t -57.51 -37.52 58.54 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 CA-C-N 116.097 -0.501 . . . . 53.41 111.249 178.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 77.7 mt -65.36 -37.17 86.23 Favored 'General case' 0 N--CA 1.469 0.515 0 CA-C-N 116.323 -0.399 . . . . 65.32 111.235 175.834 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 95.3 mt-30 -65.26 -21.83 66.78 Favored 'General case' 0 CA--C 1.54 0.593 0 CA-C-N 116.365 -0.38 . . . . 64.11 111.428 177.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 29.7 mtm -84.68 -52.15 6.29 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-O 121.157 0.503 . . . . 74.13 110.091 175.486 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -146.55 128.81 15.76 Favored 'General case' 0 CA--C 1.539 0.553 0 CA-C-N 115.919 -0.582 . . . . 73.55 111.042 176.819 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.7 mmt180 -73.04 -22.75 60.57 Favored 'General case' 0 N--CA 1.471 0.617 0 N-CA-C 112.299 0.481 . . . . 71.31 112.299 -177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.55 -2.84 51.96 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 121.447 -0.406 . . . . 34.51 113.56 -179.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 82.3 p -80.26 -24.39 40.13 Favored 'General case' 0 N--CA 1.47 0.539 0 O-C-N 122.502 -0.411 . . . . 61.24 111.762 177.439 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.466 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -53.7 -52.5 66.81 Favored Pre-proline 0 CA--C 1.546 0.795 0 N-CA-C 112.715 0.635 . . . . 74.53 112.715 -179.135 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.466 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.0 Cg_endo -58.88 -24.57 73.04 Favored 'Trans proline' 0 C--N 1.359 1.11 0 C-N-CA 122.117 1.878 . . . . 71.25 112.706 177.821 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 66.5 mt -71.82 -44.48 67.98 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.451 0 CA-C-O 120.928 0.394 . . . . 64.51 110.633 177.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 84.8 m-85 -58.96 -49.9 76.11 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.185 0.517 . . . . 75.01 110.288 173.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 60.2 mt -61.22 -34.79 62.08 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.623 0 CA-C-N 116.111 -0.495 . . . . 54.3 111.265 178.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 13.0 t30 -57.76 -34.42 69.53 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 120.912 0.387 . . . . 64.52 111.326 174.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 43.9 m-80 -93.73 12.94 23.86 Favored 'General case' 0 CA--C 1.542 0.66 0 N-CA-C 112.398 0.518 . . . . 73.35 112.398 -179.382 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 106.07 -3.22 38.1 Favored Glycine 0 CA--C 1.529 0.929 0 C-N-CA 120.707 -0.758 . . . . 40.22 114.846 173.457 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 22.8 mmt -73.53 178.64 4.53 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 117.82 0.81 . . . . 65.51 111.32 176.608 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 7.8 p80 -159.85 109.7 1.85 Allowed 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 121.046 0.45 . . . . 63.45 111.28 176.226 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 64.9 m -69.82 -22.91 63.25 Favored 'General case' 0 N--CA 1.469 0.501 0 CA-C-N 116.199 -0.455 . . . . 51.51 111.681 -178.16 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -98.66 124.9 43.76 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-N 116.515 -0.312 . . . . 54.53 110.368 178.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 133.14 -49.33 0.92 Allowed Glycine 0 CA--C 1.525 0.697 0 C-N-CA 120.91 -0.662 . . . . 73.33 113.7 176.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 74.9 m -149.39 140.01 13.82 Favored Pre-proline 0 N--CA 1.472 0.66 0 O-C-N 122.556 -0.379 . . . . 45.55 111.506 -176.655 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -69.47 -15.63 38.29 Favored 'Trans proline' 0 CA--C 1.541 0.871 0 C-N-CA 122.456 2.104 . . . . 72.14 113.055 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 89.8 p -53.97 -56.61 16.28 Favored 'General case' 0 N--CA 1.474 0.745 0 CA-C-O 120.976 0.417 . . . . 75.31 111.66 177.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 38.9 t -57.24 -8.2 0.69 Allowed 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 112.456 0.539 . . . . 44.53 112.456 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.577 ' HA ' ' HE2' ' A' ' 37' ' ' MET . 2.9 mmt -103.69 -47.78 4.14 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-O 120.907 0.384 . . . . 75.33 111.393 176.774 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -89.85 -7.82 68.05 Favored Glycine 0 CA--C 1.53 1.025 0 N-CA-C 114.831 0.692 . . . . 72.53 114.831 -171.796 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.423 ' HB2' ' HB2' ' A' ' 44' ' ' ALA . 43.3 mt-10 -93.62 150.75 20.17 Favored 'General case' 0 CA--C 1.54 0.586 0 CA-C-N 117.463 0.632 . . . . 72.44 111.65 179.058 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 75.3 m -68.96 153.45 43.77 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 116.411 -0.358 . . . . 62.55 111.063 177.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.489 ' HB ' ' HA ' ' A' ' 5' ' ' LYS . 22.5 mt -52.16 -52.53 23.73 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.703 0 N-CA-C 112.583 0.586 . . . . 72.15 112.583 -177.664 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.425 ' HB3' ' HD3' ' A' ' 5' ' ' LYS . 11.2 pt-20 -61.08 -33.1 72.81 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-O 120.964 0.412 . . . . 62.35 111.886 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.502 ' O ' HG23 ' A' ' 47' ' ' VAL . 39.0 t70 -75.87 -59.19 2.87 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 116.239 -0.437 . . . . 72.53 110.953 -178.025 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.423 ' HB2' ' HB2' ' A' ' 39' ' ' GLU . . . -57.48 -43.0 83.77 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 116.308 -0.405 . . . . 63.15 111.916 178.588 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 98.4 m -57.06 -49.04 77.06 Favored 'General case' 0 N--CA 1.47 0.565 0 O-C-N 122.364 -0.21 . . . . 74.44 111.438 177.667 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -57.12 -38.15 73.02 Favored 'General case' 0 N--CA 1.47 0.53 0 CA-C-O 121.008 0.432 . . . . 65.23 111.642 178.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 43' ' ' ASP . 87.0 t -61.05 -45.48 98.48 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 CA-C-N 116.197 -0.456 . . . . 51.52 111.815 178.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 77.0 t60 -90.03 -10.38 45.09 Favored 'General case' 0 CA--C 1.543 0.71 0 CA-C-O 120.716 0.293 . . . . 72.53 111.787 -179.755 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 80.31 35.94 25.24 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 121.47 -0.395 . . . . 50.11 113.308 -178.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 47.1 mt -92.64 152.89 3.36 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.445 0 CA-C-O 120.986 0.422 . . . . 72.11 111.721 -179.944 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.7 t0 -82.24 97.42 8.25 Favored 'General case' 0 CA--C 1.541 0.605 0 CA-C-O 121.026 0.441 . . . . 71.43 109.865 174.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.511 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -65.31 -31.55 72.75 Favored 'General case' 0 N--CA 1.468 0.462 0 N-CA-C 112.524 0.565 . . . . 53.13 112.524 -176.792 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.547 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 35.6 t70 -60.93 -45.31 95.18 Favored 'General case' 0 CA--C 1.538 0.485 0 CA-C-O 120.898 0.38 . . . . 73.13 110.716 -179.735 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -69.24 -40.42 77.89 Favored 'General case' 0 CA--C 1.539 0.535 0 CA-C-O 120.784 0.326 . . . . 75.21 111.501 178.91 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.479 HD23 HG23 ' A' ' 41' ' ' ILE . 23.2 tp -58.88 -49.89 76.07 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 121.056 0.455 . . . . 74.11 111.433 177.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.511 HG23 ' O ' ' A' ' 52' ' ' ALA . 92.4 t -57.48 -38.78 65.27 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.542 0 CA-C-N 116.269 -0.423 . . . . 70.04 111.805 -179.942 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.547 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.2 mttm -56.58 -53.68 54.73 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-O 120.769 0.319 . . . . 75.12 111.37 177.248 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 30.4 mt-10 -59.05 -36.51 75.16 Favored 'General case' 0 CA--C 1.539 0.55 0 CA-C-N 116.46 -0.336 . . . . 75.43 111.638 -179.046 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . . . . . . . . . 90.8 mt -62.93 -49.44 74.76 Favored 'General case' 0 CA--C 1.543 0.707 0 N-CA-C 111.84 0.311 . . . . 63.33 111.84 176.179 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.498 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 33.6 m-80 -59.09 -52.4 65.91 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-O 120.657 0.265 . . . . 50.15 111.397 178.339 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.445 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.7 mt-10 -54.2 -41.28 68.44 Favored 'General case' 0 N--CA 1.469 0.498 0 CA-C-N 116.221 -0.445 . . . . 72.31 111.53 179.841 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 88.2 t80 -56.16 -51.78 66.75 Favored 'General case' 0 CA--C 1.539 0.554 0 N-CA-C 112.18 0.437 . . . . 72.31 112.18 179.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 55.1 m-85 -62.35 -34.22 76.25 Favored 'General case' 0 CA--C 1.541 0.604 0 CA-C-O 120.617 0.246 . . . . 71.45 111.455 178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.498 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 31.3 mt-10 -65.77 -32.48 74.04 Favored 'General case' 0 CA--C 1.542 0.649 0 CA-C-O 120.854 0.359 . . . . 71.12 111.375 175.12 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.445 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 72.2 mmtt -61.29 -38.52 87.07 Favored 'General case' 0 N--CA 1.471 0.602 0 CA-C-N 116.473 -0.331 . . . . 74.31 111.71 177.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 45.4 mtpt -55.04 -48.37 73.54 Favored 'General case' 0 N--CA 1.473 0.697 0 N-CA-C 112.302 0.482 . . . . 65.54 112.302 -176.397 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 43.3 mt-10 -59.2 -29.58 67.58 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 120.911 0.386 . . . . 74.32 111.577 178.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 92.7 t -76.82 -50.44 21.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.581 0 CA-C-O 121.017 0.437 . . . . 63.23 111.285 177.34 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 73.1 mt -63.6 -64.4 0.91 Allowed 'General case' 0 CA--C 1.542 0.638 0 N-CA-C 112.266 0.469 . . . . 74.2 112.266 -179.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 26.7 mt-10 . . . . . 0 C--O 1.252 1.216 0 CA-C-O 118.683 -0.675 . . . . 75.33 112.179 -177.286 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 85.1 mtp . . . . . 0 N--CA 1.49 1.535 0 CA-C-O 120.688 0.28 . . . . 75.02 111.281 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -105.58 109.36 21.3 Favored 'General case' 0 CA--C 1.536 0.419 0 N-CA-C 109.36 -0.607 . . . . 71.44 109.36 175.587 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.524 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 45.1 mm -62.28 131.66 27.66 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-O 120.738 0.304 . . . . 53.45 111.652 -175.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.42 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 36.4 p -121.69 162.92 19.9 Favored 'General case' 0 N--CA 1.475 0.799 0 CA-C-O 120.847 0.356 . . . . 75.43 110.902 178.568 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.621 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 0.0 OUTLIER -71.04 -14.94 62.5 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.892 0.377 . . . . 74.11 111.506 178.193 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 35.3 t70 -78.73 -15.93 57.85 Favored 'General case' 0 CA--C 1.541 0.611 0 CA-C-O 121.101 0.476 . . . . 64.24 111.403 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.524 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 65.0 mtt -72.82 154.29 40.69 Favored 'General case' 0 N--CA 1.468 0.453 0 CA-C-O 121.428 0.632 . . . . 61.33 112.206 -178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.8 mm -81.87 133.72 28.61 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.553 0 CA-C-N 115.65 -0.705 . . . . 75.01 111.485 -178.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 44.7 mt -57.19 -51.45 69.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.686 0 N-CA-C 112.173 0.434 . . . . 52.41 112.173 -178.276 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.41 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -56.68 -32.97 65.94 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-O 120.867 0.365 . . . . 74.43 111.621 179.063 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 30.2 t70 -69.02 -45.13 71.25 Favored 'General case' 0 CA--C 1.535 0.402 0 CA-C-N 116.236 -0.438 . . . . 74.24 110.724 179.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 53.4 t -58.7 -37.21 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.586 0 CA-C-O 121.259 0.552 . . . . 71.23 110.744 174.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.404 HD23 ' OG1' ' A' ' 19' ' ' THR . 83.1 mt -63.94 -31.13 72.2 Favored 'General case' 0 N--CA 1.469 0.486 0 CA-C-N 116.115 -0.493 . . . . 74.43 111.919 175.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -71.6 -29.45 64.7 Favored 'General case' 0 N--CA 1.47 0.548 0 CA-C-O 120.921 0.391 . . . . 52.11 111.061 177.368 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 33.0 mtt -66.52 -52.12 49.23 Favored 'General case' 0 N--CA 1.468 0.44 0 CA-C-O 121.344 0.592 . . . . 72.22 110.03 175.233 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -154.77 135.3 13.42 Favored 'General case' 0 CA--C 1.537 0.444 0 CA-C-N 115.786 -0.643 . . . . 74.1 111.225 173.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 30.6 mmt180 -68.84 -24.92 64.42 Favored 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 116.339 -0.391 . . . . 74.42 111.69 -178.47 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.443 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -69.06 -1.37 25.82 Favored Glycine 0 CA--C 1.526 0.745 0 CA-C-N 116.379 -0.373 . . . . 70.35 113.874 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.404 ' OG1' HD23 ' A' ' 13' ' ' LEU . 78.9 p -82.58 -22.88 34.68 Favored 'General case' 0 CA--C 1.537 0.45 0 O-C-N 122.607 -0.349 . . . . 41.55 111.518 176.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.47 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.96 -51.39 79.83 Favored Pre-proline 0 CA--C 1.548 0.871 0 N-CA-C 112.59 0.589 . . . . 73.02 112.59 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.47 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -59.61 -26.36 81.84 Favored 'Trans proline' 0 C--N 1.36 1.163 0 C-N-CA 121.896 1.731 . . . . 60.45 112.637 177.014 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.3 mt -71.12 -44.78 74.18 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 CA-C-O 120.925 0.393 . . . . 54.5 110.846 177.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 64.1 m-85 -56.59 -50.4 72.09 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-O 121.057 0.456 . . . . 75.24 110.173 172.764 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 68.8 mt -56.93 -39.69 67.06 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.616 0 CA-C-N 116.118 -0.492 . . . . 73.1 111.337 176.264 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 50.0 t30 -54.86 -39.73 68.93 Favored 'General case' 0 N--CA 1.472 0.672 0 CA-C-N 116.052 -0.522 . . . . 63.42 111.849 179.998 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 29.0 m-80 -89.61 -3.53 58.23 Favored 'General case' 0 CA--C 1.544 0.714 0 N-CA-C 112.184 0.438 . . . . 64.41 112.184 -177.966 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 121.44 0.72 11.21 Favored Glycine 0 CA--C 1.532 1.099 0 N-CA-C 115.476 0.95 . . . . 71.33 115.476 174.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 25.4 mmt -73.81 153.24 40.03 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 118.285 1.042 . . . . 63.5 111.815 178.84 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 42.2 t60 -78.1 144.87 36.13 Favored 'General case' 0 CA--C 1.54 0.563 0 CA-C-N 116.534 -0.303 . . . . 74.44 110.656 177.321 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 28.6 p -66.02 178.05 1.22 Allowed 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.146 0.498 . . . . 62.01 112.323 -179.103 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.9 tm? -54.09 106.55 0.2 Allowed 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 116.127 -0.488 . . . . 61.4 110.937 -179.049 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 176.24 -38.85 0.1 Allowed Glycine 0 CA--C 1.526 0.771 0 C-N-CA 121.345 -0.455 . . . . 75.03 112.863 -179.052 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.6 m -77.91 119.89 79.17 Favored Pre-proline 0 N--CA 1.469 0.512 0 O-C-N 122.615 -0.344 . . . . 74.32 111.47 179.31 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_exo -64.73 -42.12 16.5 Favored 'Trans proline' 0 CA--C 1.539 0.732 0 C-N-CA 122.887 2.391 . . . . 62.45 112.202 178.601 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 79.5 p -59.15 -61.94 2.26 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 115.783 -0.644 . . . . 73.3 111.907 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 50.8 m -49.59 -20.12 0.71 Allowed 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 113.275 0.842 . . . . 54.14 113.275 -175.848 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.41 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 27.4 mmt -76.39 -48.12 20.91 Favored 'General case' 0 CA--C 1.539 0.538 0 O-C-N 122.252 -0.28 . . . . 62.02 111.666 177.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -90.57 6.86 82.07 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.592 0.597 . . . . 61.34 114.592 -172.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -112.72 158.42 20.08 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-N 117.369 0.584 . . . . 63.54 112.024 179.241 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 68.7 m -72.26 151.26 42.95 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 115.97 -0.559 . . . . 63.4 112.24 -177.724 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 27.6 mt -51.35 -48.88 32.99 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.646 0 N-CA-C 112.793 0.664 . . . . 61.32 112.793 -179.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.621 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 14.9 pt-20 -63.17 -35.34 79.98 Favored 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 120.852 0.358 . . . . 55.03 111.642 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.469 ' O ' HG23 ' A' ' 47' ' ' VAL . 36.8 t0 -69.72 -53.56 17.91 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-N 116.189 -0.46 . . . . 75.44 110.751 -178.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -54.65 -42.75 71.65 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.212 0.53 . . . . 75.23 111.297 175.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.448 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 84.0 m -59.67 -52.92 63.45 Favored 'General case' 0 CA--C 1.534 0.332 0 CA-C-N 115.948 -0.569 . . . . 62.35 111.199 175.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -55.18 -39.68 69.85 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.252 0.464 . . . . 75.42 112.252 -178.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.469 HG23 ' O ' ' A' ' 43' ' ' ASP . 91.9 t -59.56 -42.31 87.72 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.521 0 CA-C-O 120.837 0.351 . . . . 73.24 111.446 177.526 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 47.9 m80 -104.23 9.81 35.93 Favored 'General case' 0 CA--C 1.543 0.706 0 N-CA-C 112.306 0.484 . . . . 74.1 112.306 -178.274 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 68.21 18.31 71.05 Favored Glycine 0 CA--C 1.531 1.09 0 N-CA-C 114.279 0.472 . . . . 61.34 114.279 177.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.409 ' HB ' ' HA ' ' A' ' 45' ' ' CYS . 56.7 mt -73.59 154.86 6.92 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.777 0 C-N-CA 122.526 0.33 . . . . 73.24 111.475 -179.073 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.9 t70 -90.28 96.48 10.68 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-O 121.14 0.495 . . . . 74.33 110.61 178.699 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.467 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.48 -34.79 77.89 Favored 'General case' 0 N--CA 1.466 0.374 0 CA-C-N 116.336 -0.393 . . . . 73.01 111.894 -177.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.469 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 30.2 t70 -58.42 -42.5 87.38 Favored 'General case' 0 CA--C 1.544 0.724 0 CA-C-N 116.613 -0.267 . . . . 72.23 111.494 -178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.6 mttp -72.54 -39.28 67.62 Favored 'General case' 0 N--CA 1.471 0.586 0 CA-C-O 120.943 0.402 . . . . 72.41 111.288 177.095 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 25.3 tp -59.84 -49.47 77.59 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 73.44 111.636 179.143 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.525 ' HA ' HD12 ' A' ' 59' ' ' LEU . 92.3 t -57.38 -36.73 53.9 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.641 0 CA-C-N 116.371 -0.377 . . . . 73.5 111.816 -179.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.469 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.4 mttm -56.32 -55.24 35.84 Favored 'General case' 0 N--CA 1.472 0.625 0 CA-C-O 120.851 0.357 . . . . 54.43 111.171 176.589 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.83 -35.29 74.44 Favored 'General case' 0 N--CA 1.471 0.585 0 CA-C-N 116.388 -0.369 . . . . 74.24 111.964 179.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.525 HD12 ' HA ' ' A' ' 56' ' ' VAL . 93.0 mt -60.64 -52.9 63.18 Favored 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 120.645 0.259 . . . . 64.13 111.449 175.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 47.4 m-80 -58.92 -51.81 68.43 Favored 'General case' 0 N--CA 1.472 0.63 0 CA-C-O 120.82 0.343 . . . . 52.1 111.721 178.504 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -58.06 -30.18 65.98 Favored 'General case' 0 CA--C 1.538 0.513 0 N-CA-C 112.029 0.381 . . . . 62.01 112.029 -179.237 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.443 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 90.0 t80 -64.02 -44.91 91.12 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 120.938 0.399 . . . . 72.0 111.359 177.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -61.91 -31.96 72.31 Favored 'General case' 0 CA--C 1.538 0.496 0 O-C-N 122.224 -0.297 . . . . 72.23 111.133 177.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -65.06 -40.57 94.9 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 120.978 0.418 . . . . 71.44 110.726 171.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -62.13 -33.79 75.14 Favored 'General case' 0 N--CA 1.47 0.553 0 CA-C-N 116.172 -0.467 . . . . 62.42 111.172 177.028 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 48.0 mtpt -59.73 -43.53 94.14 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 120.686 0.279 . . . . 74.21 111.277 176.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.9 mt-10 -64.63 -23.93 67.42 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.852 0.358 . . . . 64.05 111.553 177.18 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 82.7 t -76.55 -53.11 15.83 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.49 0 CA-C-O 121.161 0.505 . . . . 52.03 110.844 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 69.9 mt -64.06 -57.51 9.42 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 116.027 -0.533 . . . . 75.21 112.166 -179.725 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 23.8 mt-10 . . . . . 0 C--O 1.249 1.079 0 CA-C-O 118.643 -0.694 . . . . 64.3 112.167 -177.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.6 mtt . . . . . 0 N--CA 1.491 1.579 0 CA-C-O 120.756 0.312 . . . . 74.52 110.998 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 14.9 tptp -98.52 115.14 27.93 Favored 'General case' 0 CA--C 1.538 0.491 0 CA-C-O 120.704 0.288 . . . . 71.22 110.328 179.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.538 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 43.4 mm -62.14 132.07 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 N-CA-C 112.77 0.655 . . . . 72.11 112.77 -172.319 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 40.0 p -120.76 159.37 25.54 Favored 'General case' 0 N--CA 1.471 0.587 0 CA-C-N 116.195 -0.457 . . . . 64.03 110.953 177.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -64.26 -15.92 61.08 Favored 'General case' 0 CA--C 1.541 0.614 0 CA-C-O 121.087 0.47 . . . . 73.51 111.319 176.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 18.8 t70 -76.2 -26.37 56.06 Favored 'General case' 0 CA--C 1.544 0.744 0 CA-C-N 115.654 -0.703 . . . . 74.41 111.552 -179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.538 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 64.5 mtt -65.57 158.42 27.15 Favored 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 121.423 0.63 . . . . 72.44 112.686 -176.689 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.472 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 49.8 mm -84.54 134.96 25.83 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.48 0 CA-C-N 115.926 -0.579 . . . . 70.33 111.329 179.449 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 38.5 mt -56.66 -49.51 77.72 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.71 0 CA-C-O 120.983 0.42 . . . . 71.45 111.312 177.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.82 -32.92 68.07 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-N 116.307 -0.406 . . . . 71.32 111.516 177.188 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.453 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 13.2 t70 -72.59 -40.78 66.3 Favored 'General case' 0 CA--C 1.538 0.495 0 CA-C-N 116.487 -0.324 . . . . 72.35 110.807 179.736 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.421 HG23 ' O ' ' A' ' 8' ' ' ILE . 57.9 t -57.72 -37.55 60.04 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-O 121.148 0.499 . . . . 73.13 110.335 173.525 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 96.4 mt -64.15 -36.04 82.75 Favored 'General case' 0 CA--C 1.539 0.538 0 CA-C-N 116.139 -0.482 . . . . 63.35 110.983 173.268 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 20.3 mm-40 -64.33 -29.3 70.38 Favored 'General case' 0 N--CA 1.47 0.552 0 CA-C-O 120.727 0.298 . . . . 71.32 111.174 175.717 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.2 mtt -71.47 -49.29 42.73 Favored 'General case' 0 N--CA 1.468 0.456 0 CA-C-O 121.224 0.535 . . . . 73.13 110.035 173.265 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -160.43 130.98 5.42 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 115.496 -0.775 . . . . 74.32 110.893 176.61 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 33.7 mmt180 -72.04 -20.28 61.71 Favored 'General case' 0 N--CA 1.472 0.666 0 N-CA-C 111.959 0.355 . . . . 70.32 111.959 -177.4 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -71.65 -1.44 45.52 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.56 -0.353 . . . . 74.33 113.476 -179.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.5 p -80.27 -19.55 46.5 Favored 'General case' 0 N--CA 1.469 0.48 0 O-C-N 122.521 -0.4 . . . . 75.32 111.721 177.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.521 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.09 -49.91 87.31 Favored Pre-proline 0 CA--C 1.547 0.863 0 N-CA-C 112.353 0.501 . . . . 72.01 112.353 179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.521 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 76.7 Cg_exo -48.99 -42.08 38.92 Favored 'Trans proline' 0 C--N 1.362 1.275 0 C-N-CA 122.399 2.066 . . . . 64.35 112.826 174.533 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 63.0 mt -60.94 -45.31 98.59 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.573 0 CA-C-N 116.169 -0.469 . . . . 74.31 111.403 179.141 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 71.9 m-85 -58.67 -46.88 86.23 Favored 'General case' 0 CA--C 1.538 0.488 0 CA-C-O 121.156 0.503 . . . . 71.5 110.508 174.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.462 HD11 ' SG ' ' A' ' 30' ' ' CYS . 72.7 mt -58.96 -39.07 77.19 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.594 0 CA-C-N 116.019 -0.537 . . . . 62.45 111.387 178.306 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -58.62 -36.29 73.83 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-N 116.312 -0.404 . . . . 64.4 111.571 178.785 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.2 m-80 -86.68 4.46 40.5 Favored 'General case' 0 N--CA 1.472 0.652 0 N-CA-C 112.637 0.606 . . . . 74.02 112.637 -179.249 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.35 7.54 39.97 Favored Glycine 0 CA--C 1.53 0.978 0 C-N-CA 120.672 -0.775 . . . . 74.52 114.499 174.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.3 mmt -70.53 171.69 9.78 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 117.677 0.739 . . . . 73.35 111.419 175.347 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -137.19 131.33 32.33 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 116.16 -0.473 . . . . 74.34 111.214 -176.991 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.462 ' SG ' HD11 ' A' ' 24' ' ' ILE . 80.4 m -73.49 74.49 1.43 Allowed 'General case' 0 N--CA 1.47 0.555 0 CA-C-O 121.394 0.616 . . . . 73.53 111.347 -179.798 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.457 HD13 ' N ' ' A' ' 32' ' ' GLY . 1.3 tm? -123.24 131.48 53.69 Favored 'General case' 0 CA--C 1.539 0.528 0 CA-C-N 115.979 -0.555 . . . . 72.31 109.967 -178.596 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.457 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -74.86 64.98 2.24 Favored Glycine 0 CA--C 1.527 0.8 0 C-N-CA 121.501 -0.38 . . . . 73.43 113.904 -175.63 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . 0.451 ' SG ' HD12 ' A' ' 31' ' ' LEU . 67.4 m -129.6 126.52 22.75 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 122.408 0.283 . . . . 74.01 110.775 175.448 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.424 ' HA ' ' H ' ' A' ' 38' ' ' GLY . 97.3 Cg_exo -44.74 -39.44 13.64 Favored 'Trans proline' 0 CA--C 1.54 0.808 0 C-N-CA 123.174 2.582 . . . . 72.42 113.913 -179.171 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.3 t -55.43 -29.21 58.19 Favored 'General case' 0 N--CA 1.479 1.023 0 N-CA-C 112.629 0.603 . . . . 74.43 112.629 -178.143 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 49.0 m -107.99 -10.09 15.55 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 112.036 0.384 . . . . 75.25 112.036 -179.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.2 mmt -121.74 -61.14 1.54 Allowed 'General case' 0 N--CA 1.472 0.668 0 N-CA-C 112.217 0.451 . . . . 74.24 112.217 -176.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.424 ' H ' ' HA ' ' A' ' 34' ' ' PRO . . . -71.51 -20.83 78.64 Favored Glycine 0 CA--C 1.53 1.002 0 N-CA-C 114.315 0.486 . . . . 65.41 114.315 -176.366 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 33.3 mm-40 -82.06 178.1 8.46 Favored 'General case' 0 CA--C 1.539 0.547 0 CA-C-O 121.303 0.573 . . . . 73.31 112.349 177.335 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.472 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 92.5 p -78.63 161.54 26.88 Favored 'General case' 0 N--CA 1.468 0.459 0 CA-C-N 116.292 -0.413 . . . . 72.34 111.391 -177.207 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 21.8 mt -56.67 -47.81 81.77 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.532 0 CA-C-N 116.493 -0.321 . . . . 75.51 111.781 178.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -62.07 -43.27 99.19 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 111.698 0.258 . . . . 74.03 111.698 178.698 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -60.14 -52.05 66.98 Favored 'General case' 0 CA--C 1.536 0.421 0 N-CA-C 112.05 0.389 . . . . 74.54 112.05 178.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.54 -46.49 88.12 Favored 'General case' 0 CA--C 1.54 0.568 0 CA-C-O 120.777 0.322 . . . . 71.31 111.614 179.292 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.406 ' SG ' HD23 ' A' ' 55' ' ' LEU . 97.6 m -53.52 -46.46 70.12 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 116.68 -0.236 . . . . 73.41 111.166 177.1 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.52 -35.04 67.61 Favored 'General case' 0 CA--C 1.54 0.594 0 N-CA-C 111.987 0.365 . . . . 74.31 111.987 179.617 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.2 t -63.2 -46.14 96.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-O 120.976 0.417 . . . . 63.11 111.504 178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 41.9 t60 -89.04 -10.02 49.07 Favored 'General case' 0 CA--C 1.543 0.701 0 CA-C-N 116.456 -0.338 . . . . 64.14 111.73 -179.638 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 77.26 37.87 30.83 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 121.106 -0.568 . . . . 72.15 112.795 -177.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 35.8 mt -93.03 151.44 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.494 0 C-N-CA 122.663 0.385 . . . . 61.34 111.293 179.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -80.88 102.01 9.79 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 120.958 0.409 . . . . 74.33 110.383 174.035 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -67.93 -23.99 65.14 Favored 'General case' 0 CA--C 1.536 0.428 0 N-CA-C 112.153 0.427 . . . . 74.15 112.153 -177.666 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -57.22 -50.91 71.38 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-O 120.88 0.371 . . . . 71.33 110.446 178.669 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 56.2 mtpt -70.26 -47.93 59.1 Favored 'General case' 0 CA--C 1.537 0.457 0 CA-C-N 116.044 -0.525 . . . . 73.03 112.032 179.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.406 HD23 ' SG ' ' A' ' 45' ' ' CYS . 29.5 tp -52.76 -52.64 55.75 Favored 'General case' 0 N--CA 1.471 0.58 0 CA-C-O 120.952 0.406 . . . . 65.44 111.725 -177.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.513 HG13 HG22 ' A' ' 3' ' ' ILE . 88.1 t -61.05 -40.52 85.92 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 CA-C-O 120.954 0.407 . . . . 74.35 111.78 -179.597 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.49 ' O ' ' HG3' ' A' ' 61' ' ' GLU . 98.7 mttt -69.72 -29.45 66.84 Favored 'General case' 0 CA--C 1.539 0.52 0 O-C-N 122.22 -0.3 . . . . 64.44 111.745 -179.566 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 32.9 mt-10 -70.61 -39.4 73.8 Favored 'General case' 0 N--CA 1.47 0.573 0 CA-C-O 120.879 0.371 . . . . 62.32 110.794 171.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.497 HD12 ' HA ' ' A' ' 56' ' ' VAL . 87.8 mt -58.12 -46.83 84.9 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-N 116.378 -0.374 . . . . 54.32 110.674 172.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.466 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 21.4 m-80 -54.2 -55.97 22.85 Favored 'General case' 0 N--CA 1.469 0.521 0 CA-C-N 116.251 -0.431 . . . . 73.21 111.595 175.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.612 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.0 mt-10 -46.05 -48.82 16.85 Favored 'General case' 0 N--CA 1.473 0.679 0 CA-C-O 121.075 0.464 . . . . 75.55 111.201 177.936 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 89.7 t80 -54.21 -52.4 61.4 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 115.87 -0.605 . . . . 72.04 112.384 -178.437 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -63.79 -39.17 93.6 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-O 120.723 0.297 . . . . 71.1 111.352 179.406 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.466 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 39.8 mt-10 -63.79 -33.62 76.07 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-O 120.98 0.419 . . . . 64.41 110.979 175.658 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.612 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 35.7 mmtp -69.02 -38.69 79.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-N 116.345 -0.389 . . . . 52.24 111.24 175.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.445 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 43.1 mtpt -55.98 -44.84 78.92 Favored 'General case' 0 N--CA 1.471 0.582 0 N-CA-C 111.825 0.306 . . . . 65.43 111.825 -179.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.5 mt-10 -62.7 -11.83 19.86 Favored 'General case' 0 CA--C 1.542 0.659 0 N-CA-C 112.037 0.384 . . . . 65.13 112.037 -179.768 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 91.9 t -95.33 -51.32 10.95 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.638 0 CA-C-O 121.185 0.517 . . . . 52.43 110.699 172.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 71.5 mt -62.99 -55.59 24.46 Favored 'General case' 0 CA--C 1.543 0.676 0 N-CA-C 112.749 0.648 . . . . 53.33 112.749 -179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 32.2 mt-10 . . . . . 0 C--O 1.253 1.243 0 CA-C-O 118.773 -0.632 . . . . 73.03 112.192 179.565 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 24.5 mmt . . . . . 0 N--CA 1.493 1.676 0 CA-C-O 120.859 0.361 . . . . 71.25 111.847 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -73.21 99.97 2.98 Favored 'General case' 0 CA--C 1.538 0.495 0 N-CA-C 109.993 -0.373 . . . . 55.34 109.993 171.528 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 44.4 mm -68.76 136.68 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.473 0 CA-C-N 116.265 -0.425 . . . . 73.35 111.496 -176.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.437 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 27.3 p -119.27 155.31 32.01 Favored 'General case' 0 N--CA 1.47 0.571 0 CA-C-O 120.66 0.267 . . . . 74.34 110.862 177.016 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.557 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 17.0 ptpt -64.67 -14.66 59.24 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 121.177 0.513 . . . . 71.01 111.415 176.623 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 34.9 t70 -80.55 -16.07 55.11 Favored 'General case' 0 CA--C 1.546 0.793 0 CA-C-N 115.691 -0.686 . . . . 73.2 111.669 179.44 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.437 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.4 mtt -75.39 164.87 25.95 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-O 121.506 0.67 . . . . 73.1 112.582 -178.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.465 ' HA ' ' HA ' ' A' ' 40' ' ' SER . 50.8 mm -88.57 138.06 19.92 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.664 0 CA-C-N 115.568 -0.742 . . . . 74.52 111.513 -179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 61.1 mt -54.5 -53.28 32.28 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.682 0 CA-C-O 120.994 0.426 . . . . 70.22 111.699 179.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -58.2 -37.84 75.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-O 120.833 0.349 . . . . 74.33 111.796 179.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 9.4 t70 -63.77 -39.63 94.74 Favored 'General case' 0 CA--C 1.544 0.715 0 CA-C-O 120.802 0.334 . . . . 75.44 110.856 -179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 67.0 t -64.38 -39.73 86.56 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.588 0 CA-C-O 121.044 0.45 . . . . 60.34 110.844 175.455 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.494 HD23 ' OG1' ' A' ' 19' ' ' THR . 95.5 mt -61.43 -34.53 75.54 Favored 'General case' 0 N--CA 1.472 0.644 0 CA-C-O 121.149 0.5 . . . . 74.43 111.096 174.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 78.7 mt-30 -68.89 -18.77 64.17 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 116.056 -0.52 . . . . 51.2 111.485 177.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 31.4 mtt -81.23 -50.35 9.66 Favored 'General case' 0 N--CA 1.47 0.527 0 CA-C-O 121.38 0.61 . . . . 73.1 109.791 170.627 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 12.3 t70 -151.5 132.5 14.28 Favored 'General case' 0 CA--C 1.542 0.644 0 CA-C-N 115.965 -0.561 . . . . 70.34 111.716 175.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -74.17 -16.25 60.99 Favored 'General case' 0 N--CA 1.472 0.632 0 N-CA-C 112.606 0.595 . . . . 72.25 112.606 -178.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -77.57 -2.21 79.59 Favored Glycine 0 CA--C 1.527 0.789 0 C-N-CA 121.14 -0.552 . . . . 71.12 113.415 -179.565 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.494 ' OG1' HD23 ' A' ' 13' ' ' LEU . 74.3 p -80.51 -22.1 41.26 Favored 'General case' 0 N--CA 1.468 0.465 0 N-CA-C 112.114 0.413 . . . . 74.42 112.114 179.013 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.554 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -54.83 -50.64 84.88 Favored Pre-proline 0 CA--C 1.547 0.853 0 N-CA-C 112.722 0.638 . . . . 31.11 112.722 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.554 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 75.7 Cg_exo -49.86 -41.24 47.71 Favored 'Trans proline' 0 C--N 1.36 1.17 0 C-N-CA 122.198 1.932 . . . . 72.3 112.657 174.286 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 59.4 mt -61.41 -44.98 99.47 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.547 0 CA-C-N 116.167 -0.47 . . . . 64.34 111.492 179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 66.4 m-85 -58.24 -51.56 69.23 Favored 'General case' 0 CA--C 1.539 0.558 0 CA-C-O 121.02 0.438 . . . . 54.35 110.936 175.562 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 63.8 mt -60.51 -38.98 79.82 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.582 0 CA-C-O 120.928 0.394 . . . . 75.22 111.107 179.452 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 48.1 t30 -51.86 -41.87 62.18 Favored 'General case' 0 CA--C 1.538 0.497 0 CA-C-N 115.979 -0.555 . . . . 71.43 111.536 177.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 35.3 m-80 -85.48 -4.26 59.11 Favored 'General case' 0 CA--C 1.541 0.625 0 N-CA-C 112.277 0.473 . . . . 73.11 112.277 -178.894 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 123.5 -5.35 9.31 Favored Glycine 0 CA--C 1.53 1.02 0 C-N-CA 120.662 -0.78 . . . . 62.55 114.972 174.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 24.2 mmt -65.28 143.15 57.98 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 118.208 1.004 . . . . 74.35 111.833 179.983 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 33.9 m-70 -109.36 83.72 1.8 Allowed 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.211 -0.45 . . . . 74.45 110.496 -179.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . 0.646 ' HA ' ' OG ' ' A' ' 36' ' ' SER . 76.7 m -66.48 100.41 0.66 Allowed 'General case' 0 N--CA 1.472 0.672 0 N-CA-C 112.381 0.511 . . . . 51.03 112.381 -175.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 1.4 tm? -169.95 83.3 0.11 Allowed 'General case' 0 CA--C 1.544 0.747 0 N-CA-C 111.883 0.327 . . . . 71.25 111.883 179.356 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 73.33 -63.01 1.79 Allowed Glycine 0 CA--C 1.533 1.193 0 N-CA-C 115.733 1.053 . . . . 62.45 115.733 168.616 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 84.3 m -49.02 147.29 4.9 Favored Pre-proline 0 N--CA 1.476 0.834 0 N-CA-C 113.612 0.967 . . . . 61.24 113.612 -172.581 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_exo -51.09 -45.62 35.66 Favored 'Trans proline' 0 CA--C 1.542 0.891 0 C-N-CA 123.194 2.596 . . . . 63.2 113.615 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 38.5 m -61.98 -10.21 9.14 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-O 121.071 0.462 . . . . 73.42 111.694 179.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.646 ' OG ' ' HA ' ' A' ' 30' ' ' CYS . 15.4 t -102.18 -25.22 13.78 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 116.161 -0.472 . . . . 44.24 111.601 176.447 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 1.8 mmt -125.69 -69.19 0.79 Allowed 'General case' 0 CA--C 1.544 0.735 0 N-CA-C 112.957 0.725 . . . . 64.05 112.957 -172.809 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -79.97 -22.28 63.94 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 115.795 1.078 . . . . 75.54 115.795 -167.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 39.4 mt-10 -87.24 160.72 18.35 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-N 117.876 0.838 . . . . 74.15 111.788 -178.209 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.465 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 91.7 p -73.14 158.11 35.94 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-O 121.309 0.576 . . . . 54.53 112.503 -172.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 26.2 mt -54.79 -56.03 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.539 0 CA-C-N 115.812 -0.631 . . . . 75.23 112.476 -178.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.557 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 11.1 pt-20 -60.81 -44.72 96.52 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.13 0.419 . . . . 63.04 112.13 -176.975 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.401 ' N ' ' HG3' ' A' ' 42' ' ' GLU . 25.3 t0 -65.59 -45.21 84.12 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-O 120.971 0.415 . . . . 73.41 110.987 -178.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -64.07 -35.73 81.69 Favored 'General case' 0 CA--C 1.54 0.567 0 CA-C-O 121.0 0.429 . . . . 61.4 111.455 176.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 78.8 m -60.35 -49.59 76.98 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 116.413 -0.358 . . . . 75.03 111.26 176.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -53.88 -36.21 62.41 Favored 'General case' 0 CA--C 1.538 0.516 0 N-CA-C 112.121 0.415 . . . . 74.33 112.121 179.204 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 57.3 t -57.19 -37.63 57.04 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.576 0 CA-C-O 120.993 0.425 . . . . 74.24 111.854 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 97.7 m-70 -114.92 18.09 16.61 Favored 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.403 0.519 . . . . 62.3 112.403 -178.577 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.19 27.83 68.1 Favored Glycine 0 CA--C 1.529 0.959 0 C-N-CA 121.265 -0.493 . . . . 72.05 113.79 178.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 61.0 mt -80.33 150.36 4.87 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.489 0 CA-C-O 120.895 0.379 . . . . 70.14 111.117 179.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 8.1 t0 -87.66 97.27 10.79 Favored 'General case' 0 CA--C 1.54 0.576 0 CA-C-O 120.821 0.344 . . . . 75.0 110.215 177.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.432 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.29 -36.55 81.77 Favored 'General case' 0 N--CA 1.467 0.416 0 N-CA-C 112.105 0.409 . . . . 75.01 112.105 -176.92 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 21.5 t70 -57.42 -42.87 83.19 Favored 'General case' 0 CA--C 1.539 0.539 0 CA-C-O 121.149 0.5 . . . . 64.41 111.072 -178.781 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 61.8 mttp -73.65 -44.11 57.73 Favored 'General case' 0 CA--C 1.542 0.673 0 CA-C-N 116.249 -0.432 . . . . 64.22 111.529 176.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 29.0 tp -55.36 -49.34 72.53 Favored 'General case' 0 N--CA 1.473 0.713 0 CA-C-O 120.959 0.409 . . . . 72.21 111.951 -179.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.478 HG21 ' HB3' ' A' ' 5' ' ' LYS . 93.0 t -59.32 -38.28 73.87 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.478 0 CA-C-N 116.395 -0.366 . . . . 64.03 111.837 -179.593 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 94.2 mttt -61.69 -43.84 98.09 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-O 120.719 0.295 . . . . 73.24 110.638 176.003 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 63.6 mt-10 -60.17 -37.9 81.57 Favored 'General case' 0 N--CA 1.47 0.563 0 CA-C-N 116.439 -0.346 . . . . 65.31 111.359 176.07 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 56' ' ' VAL . 84.8 mt -63.36 -53.98 44.11 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 116.484 -0.325 . . . . 71.2 111.517 176.157 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.462 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 44.6 m-80 -56.71 -54.22 48.73 Favored 'General case' 0 N--CA 1.473 0.676 0 N-CA-C 111.918 0.34 . . . . 73.4 111.918 178.792 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.539 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.9 mt-10 -52.96 -38.51 62.13 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 116.612 -0.267 . . . . 75.52 111.334 179.112 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.86 -49.29 78.28 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 120.876 0.37 . . . . 64.31 111.762 176.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 60.2 m-85 -59.69 -34.53 72.99 Favored 'General case' 0 CA--C 1.538 0.501 0 CA-C-O 120.741 0.305 . . . . 72.12 110.897 177.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.462 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 37.8 mt-10 -64.82 -38.15 90.02 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 120.853 0.359 . . . . 72.31 110.806 174.724 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.539 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 31.4 mmmt -57.12 -40.47 77.17 Favored 'General case' 0 CA--C 1.536 0.405 0 CA-C-O 120.963 0.411 . . . . 72.11 110.236 175.148 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.423 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 51.0 mtpt -59.66 -43.32 94.0 Favored 'General case' 0 N--CA 1.468 0.473 0 CA-C-N 116.153 -0.476 . . . . 71.1 111.194 175.125 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 41.5 mt-10 -57.68 -29.41 64.64 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-O 120.968 0.413 . . . . 71.42 111.53 178.255 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 78.1 t -80.3 -53.42 12.83 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.569 0 CA-C-O 121.05 0.452 . . . . 72.13 111.158 176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 91.1 mt -59.17 -52.1 67.15 Favored 'General case' 0 CA--C 1.543 0.674 0 N-CA-C 113.117 0.784 . . . . 65.34 113.117 -177.981 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 C--O 1.256 1.404 0 CA-C-O 118.837 -0.602 . . . . 74.52 112.3 -177.87 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 66.8 mtt . . . . . 0 N--CA 1.486 1.327 0 CA-C-O 120.6 0.238 . . . . 74.44 111.277 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 43.8 mmtm -96.13 127.33 42.04 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 120.822 0.344 . . . . 35.41 110.573 172.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . . . . . . . . . 46.8 mm -70.74 139.47 19.95 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.469 0 CA-C-O 121.066 0.46 . . . . 62.53 111.785 -176.51 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 70.0 p -122.99 153.13 40.18 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 116.417 -0.356 . . . . 70.22 110.748 177.191 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.784 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 46.2 pttt -63.36 -15.51 57.67 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 120.903 0.382 . . . . 74.44 111.98 -179.62 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 19.1 t70 -72.5 -29.83 63.98 Favored 'General case' 0 CA--C 1.54 0.56 0 CA-C-N 115.97 -0.559 . . . . 73.04 111.409 176.944 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 65.2 mtt -63.6 150.51 43.95 Favored 'General case' 0 CA--C 1.54 0.572 0 N-CA-C 112.728 0.64 . . . . 75.53 112.728 -174.439 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 50.2 mm -78.37 136.06 24.76 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.52 0 CA-C-N 115.683 -0.69 . . . . 64.51 111.116 178.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 59.1 mt -54.44 -48.75 68.82 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.656 0 CA-C-O 120.762 0.315 . . . . 73.21 111.771 -178.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.515 ' O ' ' HG2' ' A' ' 14' ' ' GLN . . . -59.72 -33.5 71.71 Favored 'General case' 0 CA--C 1.539 0.543 0 N-CA-C 111.897 0.332 . . . . 75.04 111.897 178.112 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -67.17 -41.73 85.47 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-O 120.823 0.344 . . . . 72.22 111.184 179.46 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 55.2 t -60.44 -39.24 80.49 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.551 0 CA-C-O 121.105 0.479 . . . . 75.13 110.945 175.83 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . 0.456 HD23 ' OG1' ' A' ' 19' ' ' THR . 88.1 mt -62.22 -31.01 71.49 Favored 'General case' 0 CA--C 1.54 0.575 0 CA-C-N 116.26 -0.427 . . . . 73.04 111.519 176.298 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.515 ' HG2' ' O ' ' A' ' 10' ' ' ALA . 84.3 mm-40 -67.34 -27.01 66.79 Favored 'General case' 0 N--CA 1.47 0.544 0 CA-C-O 120.941 0.401 . . . . 71.53 111.321 177.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 30.2 mtt -75.0 -48.38 24.4 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-O 121.34 0.59 . . . . 73.55 110.064 175.921 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 11.1 t70 -154.99 132.54 11.25 Favored 'General case' 0 CA--C 1.542 0.652 0 CA-C-N 115.722 -0.672 . . . . 54.13 110.761 175.6 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 23.9 mmt180 -70.15 -28.41 65.33 Favored 'General case' 0 N--CA 1.471 0.612 0 CA-C-O 121.093 0.473 . . . . 53.34 111.611 -177.421 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.04 2.09 14.94 Favored Glycine 0 CA--C 1.53 0.998 0 CA-C-N 116.078 -0.51 . . . . 74.45 113.807 -177.628 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.456 ' OG1' HD23 ' A' ' 13' ' ' LEU . 72.6 p -82.72 -19.24 38.38 Favored 'General case' 0 N--CA 1.469 0.498 0 O-C-N 122.514 -0.403 . . . . 75.33 111.384 175.545 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.479 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -54.35 -51.41 78.17 Favored Pre-proline 0 CA--C 1.547 0.828 0 N-CA-C 112.654 0.613 . . . . 50.34 112.654 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.479 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 19.5 Cg_endo -57.84 -31.03 91.42 Favored 'Trans proline' 0 C--N 1.361 1.197 0 C-N-CA 121.953 1.768 . . . . 61.2 112.59 177.274 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 71.7 mt -65.97 -46.65 87.69 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 CA-C-O 120.98 0.419 . . . . 72.2 110.914 177.613 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 68.7 m-85 -57.52 -46.82 83.37 Favored 'General case' 0 N--CA 1.468 0.457 0 CA-C-O 121.204 0.525 . . . . 74.33 110.266 171.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . 0.416 ' HA ' ' O ' ' A' ' 28' ' ' MET . 73.6 mt -58.05 -36.67 57.68 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.533 0 CA-C-N 115.958 -0.565 . . . . 75.43 111.668 177.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 60.2 t30 -61.73 -32.96 73.23 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 120.973 0.416 . . . . 64.24 111.574 -179.285 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 38.3 m-80 -94.7 1.38 55.51 Favored 'General case' 0 CA--C 1.54 0.586 0 N-CA-C 112.242 0.46 . . . . 74.32 112.242 -178.216 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 112.78 10.3 16.81 Favored Glycine 0 CA--C 1.53 1.011 0 C-N-CA 120.425 -0.893 . . . . 42.44 114.896 174.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.416 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 22.2 mmt -86.93 156.93 19.61 Favored 'General case' 0 N--CA 1.469 0.524 0 O-C-N 121.85 -0.794 . . . . 54.45 111.435 175.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . 0.47 ' HB3' HD23 ' A' ' 31' ' ' LEU . 77.7 m80 -139.75 93.35 2.65 Favored 'General case' 0 CA--C 1.537 0.461 0 CA-C-O 121.175 0.512 . . . . 62.53 111.209 177.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 76.3 m -88.6 56.69 3.87 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 121.172 0.51 . . . . 52.23 111.958 -176.102 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.47 HD23 ' HB3' ' A' ' 29' ' ' HIS . 4.0 mm? -85.8 36.79 0.68 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 120.925 0.393 . . . . 74.51 111.037 178.361 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 83.44 11.57 80.0 Favored Glycine 0 CA--C 1.527 0.809 0 C-N-CA 121.318 -0.468 . . . . 60.43 112.744 -174.978 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 56.7 m -71.03 119.1 71.38 Favored Pre-proline 0 CA--C 1.542 0.644 0 C-N-CA 122.479 0.312 . . . . 63.31 111.472 179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -47.68 -54.05 5.69 Favored 'Trans proline' 0 CA--C 1.541 0.846 0 C-N-CA 123.252 2.634 . . . . 72.55 114.012 -175.563 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.9 m -60.45 -42.13 95.51 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 121.018 0.437 . . . . 73.24 111.758 -178.78 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 42.6 t -70.98 -8.96 56.91 Favored 'General case' 0 N--CA 1.47 0.536 0 CA-C-N 116.422 -0.354 . . . . 74.15 111.938 -179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . . . . . . . . . 3.6 mmt -104.93 -67.28 0.92 Allowed 'General case' 0 CA--C 1.54 0.581 0 N-CA-C 112.626 0.602 . . . . 73.5 112.626 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -84.42 3.15 87.03 Favored Glycine 0 CA--C 1.53 0.98 0 N-CA-C 114.986 0.754 . . . . 73.32 114.986 -170.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 28.4 mt-10 -109.77 156.38 20.39 Favored 'General case' 0 CA--C 1.546 0.813 0 CA-C-N 117.594 0.697 . . . . 73.53 112.156 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 36.0 m -67.5 156.22 37.19 Favored 'General case' 0 N--CA 1.477 0.9 0 N-CA-C 112.915 0.709 . . . . 73.02 112.915 -172.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . . . . . . . . . 24.7 mt -55.11 -60.24 1.78 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.64 0 N-CA-C 112.615 0.598 . . . . 72.5 112.615 179.938 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.784 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.5 pt-20 -61.95 -36.01 80.15 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 120.873 0.368 . . . . 73.53 111.847 -177.506 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -65.44 -48.43 72.78 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-O 120.888 0.375 . . . . 53.35 110.918 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.49 -34.14 77.12 Favored 'General case' 0 CA--C 1.537 0.474 0 CA-C-O 121.065 0.459 . . . . 61.52 111.538 176.173 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.439 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 94.4 m -58.81 -44.59 90.84 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-N 116.442 -0.345 . . . . 73.31 111.22 176.319 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -54.62 -34.54 62.24 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 112.007 0.373 . . . . 73.51 112.007 179.25 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . . . . . . . . . 60.9 t -55.67 -41.75 66.33 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.601 0 N-CA-C 111.821 0.304 . . . . 73.45 111.821 -179.998 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . . . . . . . . . 73.1 m-70 -112.31 17.11 19.7 Favored 'General case' 0 N--CA 1.474 0.735 0 N-CA-C 111.862 0.319 . . . . 71.14 111.862 178.446 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 61.97 23.11 63.29 Favored Glycine 0 CA--C 1.531 1.048 0 C-N-CA 121.123 -0.561 . . . . 74.41 113.763 179.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . . . . . . . . . 48.8 mt -71.1 150.27 9.49 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.538 0 CA-C-O 120.905 0.383 . . . . 71.43 111.639 -178.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 15.4 t70 -85.57 108.3 17.9 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-O 121.125 0.488 . . . . 54.33 110.203 175.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.476 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -75.08 -25.05 58.29 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.384 -0.371 . . . . 73.22 111.962 -176.632 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.424 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 13.9 t70 -60.92 -47.86 84.47 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-O 121.017 0.436 . . . . 74.35 110.621 -179.09 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 58.4 mtpt -72.76 -39.78 66.52 Favored 'General case' 0 N--CA 1.469 0.495 0 CA-C-N 116.127 -0.488 . . . . 64.2 111.659 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 20.9 tp -56.87 -50.47 72.38 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-O 121.08 0.466 . . . . 75.3 111.077 176.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.48 ' HA ' HD12 ' A' ' 59' ' ' LEU . 78.6 t -59.27 -38.5 74.97 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.535 0 CA-C-N 116.217 -0.447 . . . . 73.24 111.442 178.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.424 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 65.0 mttm -57.82 -50.38 73.47 Favored 'General case' 0 CA--C 1.539 0.526 0 N-CA-C 111.544 0.201 . . . . 63.41 111.544 176.005 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.6 mt-10 -58.53 -38.44 77.76 Favored 'General case' 0 N--CA 1.473 0.724 0 CA-C-O 120.826 0.346 . . . . 73.04 111.577 177.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.48 HD12 ' HA ' ' A' ' 56' ' ' VAL . 85.2 mt -61.64 -50.97 70.41 Favored 'General case' 0 CA--C 1.542 0.658 0 CA-C-O 120.734 0.302 . . . . 75.14 111.534 175.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 39.7 m-80 -59.0 -55.78 30.71 Favored 'General case' 0 N--CA 1.472 0.634 0 N-CA-C 111.932 0.345 . . . . 73.34 111.932 179.684 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.49 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 46.3 mt-10 -52.81 -36.79 58.95 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-O 120.728 0.299 . . . . 73.24 111.577 -179.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 90.8 t80 -58.27 -51.68 68.77 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-O 120.87 0.367 . . . . 74.12 111.495 176.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -61.75 -34.76 76.4 Favored 'General case' 0 CA--C 1.538 0.502 0 CA-C-O 120.729 0.299 . . . . 74.23 111.31 178.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.449 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 32.8 mt-10 -65.97 -36.98 84.8 Favored 'General case' 0 CA--C 1.538 0.505 0 CA-C-O 120.881 0.372 . . . . 75.14 110.911 175.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.49 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 73.5 mmtt -63.3 -37.5 87.51 Favored 'General case' 0 N--CA 1.467 0.423 0 CA-C-N 116.235 -0.439 . . . . 73.32 110.928 175.295 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . 0.433 ' HE2' ' HB3' ' A' ' 66' ' ' LYS . 46.2 mtpt -56.13 -44.05 78.8 Favored 'General case' 0 N--CA 1.469 0.493 0 CA-C-O 120.666 0.27 . . . . 61.42 111.418 175.848 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -57.74 -28.98 64.41 Favored 'General case' 0 CA--C 1.541 0.598 0 CA-C-O 120.944 0.402 . . . . 74.33 111.353 178.809 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 84.2 t -85.42 -52.66 11.95 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 CA-C-O 121.284 0.564 . . . . 55.32 111.506 178.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 74.8 mt -64.53 -54.72 27.78 Favored 'General case' 0 CA--C 1.539 0.555 0 CA-C-N 116.071 -0.513 . . . . 63.14 112.35 -177.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.7 mt-10 . . . . . 0 C--O 1.253 1.287 0 CA-C-O 118.605 -0.712 . . . . 74.03 111.894 -179.041 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 87.4 mtp . . . . . 0 N--CA 1.489 1.505 0 CA-C-O 120.768 0.318 . . . . 73.3 111.284 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . 0.509 ' HA ' ' HE2' ' A' ' 2' ' ' LYS . 9.8 mmpt? -74.94 162.82 28.27 Favored 'General case' 0 CA--C 1.541 0.597 0 CA-C-O 120.755 0.312 . . . . 62.52 111.111 178.057 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.402 ' HB ' ' ND2' ' A' ' 60' ' ' ASN . 44.6 mm -74.44 137.99 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.607 0 CA-C-O 120.716 0.293 . . . . 74.24 111.66 -178.206 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.433 ' OG1' ' HG3' ' A' ' 7' ' ' MET . 41.8 p -119.84 160.81 21.93 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 116.554 -0.294 . . . . 72.15 110.553 178.67 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.699 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 22.3 pttp -73.71 -16.77 61.18 Favored 'General case' 0 CA--C 1.54 0.573 0 O-C-N 122.069 -0.394 . . . . 62.24 111.414 -179.865 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 22.3 t70 -71.19 -25.05 62.36 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-N 116.086 -0.506 . . . . 75.53 111.102 175.988 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.433 ' HG3' ' OG1' ' A' ' 4' ' ' THR . 63.0 mtt -62.41 139.86 58.56 Favored 'General case' 0 CA--C 1.538 0.504 0 CA-C-O 121.438 0.637 . . . . 70.05 111.832 -178.691 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.495 ' HB ' ' HB2' ' A' ' 11' ' ' ASP . 44.9 mm -69.53 137.21 24.63 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.585 0 CA-C-N 115.772 -0.649 . . . . 62.33 110.953 179.326 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 39.9 mt -54.04 -46.21 65.7 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.735 0 CA-C-O 120.851 0.357 . . . . 62.21 111.273 179.601 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.482 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -60.2 -36.37 77.52 Favored 'General case' 0 CA--C 1.537 0.442 0 CA-C-O 120.802 0.335 . . . . 64.34 111.426 176.103 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.495 ' HB2' ' HB ' ' A' ' 8' ' ' ILE . 12.0 t70 -63.18 -43.98 96.73 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-O 121.041 0.448 . . . . 73.14 110.516 179.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . 0.454 HG21 HD11 ' A' ' 41' ' ' ILE . 51.6 t -61.19 -40.1 84.77 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.622 0 CA-C-O 121.141 0.496 . . . . 72.13 110.722 175.444 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 93.4 mt -63.23 -33.12 74.8 Favored 'General case' 0 CA--C 1.539 0.557 0 CA-C-N 116.243 -0.435 . . . . 63.24 111.304 174.636 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . 0.45 ' HG3' ' O ' ' A' ' 10' ' ' ALA . 74.0 mt-30 -64.21 -30.33 71.4 Favored 'General case' 0 N--CA 1.472 0.657 0 CA-C-O 120.861 0.362 . . . . 54.41 111.242 175.046 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 34.6 mtt -71.89 -51.59 21.51 Favored 'General case' 0 N--CA 1.466 0.338 0 CA-C-O 121.283 0.563 . . . . 71.15 110.072 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 13.1 t70 -158.29 125.66 5.04 Favored 'General case' 0 CA--C 1.542 0.646 0 CA-C-N 115.55 -0.75 . . . . 70.23 110.693 177.835 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 27.8 mmt180 -71.72 -15.47 62.2 Favored 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 112.006 0.373 . . . . 73.51 112.006 -178.116 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -70.58 -1.75 39.29 Favored Glycine 0 CA--C 1.527 0.834 0 C-N-CA 121.212 -0.518 . . . . 44.21 113.157 176.969 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 68.0 p -82.64 -17.87 43.09 Favored 'General case' 0 N--CA 1.468 0.468 0 O-C-N 122.698 -0.295 . . . . 63.03 111.573 175.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.494 ' N ' ' HD2' ' A' ' 21' ' ' PRO . . . -55.25 -51.06 82.89 Favored Pre-proline 0 CA--C 1.547 0.848 0 N-CA-C 112.223 0.453 . . . . 63.1 112.223 -179.595 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.494 ' HD2' ' N ' ' A' ' 20' ' ' ALA . 18.8 Cg_endo -58.58 -25.76 75.97 Favored 'Trans proline' 0 C--N 1.36 1.177 0 C-N-CA 121.957 1.772 . . . . 60.01 112.554 177.192 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 57.7 mt -71.74 -44.77 68.31 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.52 0 CA-C-O 120.995 0.426 . . . . 53.02 110.812 177.205 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . . . . . . . . . 61.6 m-85 -58.19 -45.82 86.9 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-O 121.03 0.443 . . . . 71.02 110.406 173.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 57.4 mt -59.96 -40.81 84.06 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.603 0 CA-C-O 121.192 0.52 . . . . 63.51 110.911 175.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 47.9 t30 -56.86 -30.06 63.47 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 115.622 -0.717 . . . . 72.34 112.001 179.227 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 23.4 m-80 -96.82 1.47 50.72 Favored 'General case' 0 CA--C 1.54 0.583 0 N-CA-C 112.553 0.575 . . . . 74.2 112.553 -179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 114.92 -3.0 22.84 Favored Glycine 0 CA--C 1.532 1.126 0 C-N-CA 120.476 -0.869 . . . . 22.45 115.11 174.229 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . . . . . . . . . 23.9 mmt -69.03 141.78 54.75 Favored 'General case' 0 N--CA 1.473 0.685 0 CA-C-N 118.251 1.026 . . . . 45.42 112.287 -178.887 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 41.3 t-80 -133.28 143.01 48.79 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 115.763 -0.653 . . . . 74.44 110.882 -178.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 79.3 m -61.53 136.22 57.94 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-O 121.013 0.435 . . . . 75.43 111.679 178.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.525 ' HB3' ' HB3' ' A' ' 36' ' ' SER . 1.2 tm? -135.83 135.78 40.09 Favored 'General case' 0 CA--C 1.54 0.567 0 N-CA-C 109.616 -0.512 . . . . 62.4 109.616 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.481 ' N ' HD13 ' A' ' 31' ' ' LEU . . . -56.87 -46.69 90.22 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 114.177 0.431 . . . . 65.42 114.177 -174.835 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.9 m -56.63 130.25 77.09 Favored Pre-proline 0 CA--C 1.542 0.658 0 CA-C-N 116.915 0.357 . . . . 74.11 111.42 176.818 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -55.99 -23.71 44.85 Favored 'Trans proline' 0 CA--C 1.541 0.83 0 C-N-CA 122.978 2.452 . . . . 65.2 113.59 -176.61 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 80.6 p -49.56 -36.94 25.38 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 112.062 0.393 . . . . 75.55 112.062 178.541 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . 0.525 ' HB3' ' HB3' ' A' ' 31' ' ' LEU . 73.0 p -51.46 -44.52 62.42 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-O 121.307 0.575 . . . . 74.44 111.72 178.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.482 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 4.6 mmt -90.35 -28.27 18.82 Favored 'General case' 0 CA--C 1.538 0.49 0 CA-C-N 115.792 -0.64 . . . . 55.42 111.807 178.619 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -82.55 -21.48 60.0 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 114.891 0.716 . . . . 74.22 114.891 -170.734 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 40.3 mt-10 -92.1 167.78 11.83 Favored 'General case' 0 N--CA 1.471 0.606 0 CA-C-N 117.785 0.793 . . . . 72.52 112.504 -176.947 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . 0.479 ' HA ' ' HA ' ' A' ' 8' ' ' ILE . 90.2 p -75.55 160.12 30.5 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-N 115.928 -0.578 . . . . 54.23 112.207 -175.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.454 HD11 HG21 ' A' ' 12' ' ' VAL . 22.3 mt -54.74 -52.57 40.75 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.404 0 CA-C-N 116.093 -0.503 . . . . 64.14 111.901 178.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.699 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 15.0 pt-20 -62.97 -40.33 97.38 Favored 'General case' 0 N--CA 1.469 0.503 0 N-CA-C 111.877 0.325 . . . . 64.22 111.877 -177.534 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.428 ' O ' HG23 ' A' ' 47' ' ' VAL . 6.7 t70 -62.58 -51.14 68.51 Favored 'General case' 0 CA--C 1.539 0.537 0 CA-C-O 120.991 0.424 . . . . 54.44 110.499 -179.296 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.61 -41.07 94.05 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.01 -0.541 . . . . 52.34 111.632 177.417 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . . . . . . . . . 91.2 m -58.49 -45.82 87.94 Favored 'General case' 0 N--CA 1.47 0.568 0 CA-C-N 116.561 -0.29 . . . . 72.31 111.307 177.028 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -59.24 -35.8 74.32 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 120.753 0.311 . . . . 74.54 111.656 179.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.428 HG23 ' O ' ' A' ' 43' ' ' ASP . 61.2 t -65.98 -43.24 92.76 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.65 0 CA-C-O 121.192 0.52 . . . . 63.15 111.364 178.355 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.46 ' HB3' HG13 ' A' ' 50' ' ' ILE . 61.3 t-80 -86.59 -14.82 41.7 Favored 'General case' 0 CA--C 1.544 0.737 0 CA-C-N 116.2 -0.454 . . . . 75.03 111.435 -179.587 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 78.73 38.61 23.44 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-N 116.455 -0.339 . . . . 71.21 113.13 -177.849 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.46 HG13 ' HB3' ' A' ' 48' ' ' HIS . 27.9 mt -98.02 153.36 4.0 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 C-N-CA 122.927 0.491 . . . . 72.13 111.284 -178.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -79.55 101.92 8.54 Favored 'General case' 0 CA--C 1.54 0.58 0 CA-C-O 121.018 0.437 . . . . 75.25 109.904 173.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -67.45 -34.69 77.71 Favored 'General case' 0 N--CA 1.469 0.489 0 N-CA-C 112.444 0.535 . . . . 55.21 112.444 -176.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 32.5 t70 -57.01 -45.5 82.99 Favored 'General case' 0 CA--C 1.538 0.484 0 CA-C-O 120.829 0.347 . . . . 72.22 111.066 179.607 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 55.7 mtpt -66.26 -47.03 75.03 Favored 'General case' 0 CA--C 1.537 0.443 0 CA-C-N 116.4 -0.363 . . . . 73.2 111.254 177.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.403 ' O ' ' HG ' ' A' ' 59' ' ' LEU . 29.9 tp -57.51 -50.83 71.81 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-N 116.244 -0.435 . . . . 75.13 111.306 -179.391 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.473 HG21 ' HB3' ' A' ' 5' ' ' LYS . 85.4 t -60.79 -39.62 82.4 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.418 0 CA-C-N 116.508 -0.314 . . . . 71.11 111.615 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -63.65 -41.67 98.2 Favored 'General case' 0 N--CA 1.467 0.385 0 N-CA-C 111.454 0.168 . . . . 64.22 111.454 176.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 42.8 mt-10 -61.82 -40.53 95.6 Favored 'General case' 0 N--CA 1.469 0.503 0 CA-C-O 120.706 0.289 . . . . 62.14 111.043 174.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.447 HD12 ' HA ' ' A' ' 56' ' ' VAL . 91.1 mt -59.6 -52.24 66.4 Favored 'General case' 0 CA--C 1.54 0.588 0 CA-C-N 116.617 -0.265 . . . . 55.03 110.971 174.513 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.56 ' O ' ' HG3' ' A' ' 64' ' ' GLU . 39.7 m-80 -54.67 -57.97 9.38 Favored 'General case' 0 N--CA 1.47 0.54 0 CA-C-N 116.622 -0.263 . . . . 44.01 111.537 177.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.617 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 51.3 mt-10 -54.07 -37.78 64.57 Favored 'General case' 0 CA--C 1.536 0.437 0 CA-C-N 116.552 -0.295 . . . . 72.31 111.667 -179.432 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 78.3 t80 -58.4 -51.3 70.4 Favored 'General case' 0 N--CA 1.471 0.608 0 CA-C-O 120.842 0.353 . . . . 63.31 111.31 174.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 65.9 m-85 -61.61 -35.09 76.88 Favored 'General case' 0 CA--C 1.536 0.419 0 CA-C-O 120.695 0.283 . . . . 73.44 110.971 176.755 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . 0.56 ' HG3' ' O ' ' A' ' 60' ' ' ASN . 41.8 mt-10 -69.48 -28.18 65.85 Favored 'General case' 0 CA--C 1.537 0.475 0 CA-C-O 120.657 0.265 . . . . 52.32 111.287 176.462 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.617 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 75.4 mmtt -64.22 -39.52 94.14 Favored 'General case' 0 N--CA 1.467 0.376 0 CA-C-O 121.344 0.592 . . . . 72.35 109.61 170.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 49.2 mtpt -63.43 -44.76 93.64 Favored 'General case' 0 CA--C 1.537 0.478 0 CA-C-N 115.667 -0.697 . . . . 63.1 110.474 173.866 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.4 mt-10 -53.73 -28.49 34.59 Favored 'General case' 0 CA--C 1.543 0.703 0 CA-C-O 120.986 0.422 . . . . 61.34 111.63 175.155 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . 0.466 HG23 ' O ' ' A' ' 64' ' ' GLU . 80.1 t -77.37 -50.22 20.88 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.655 0 CA-C-O 121.087 0.47 . . . . 65.24 111.611 175.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 68.4 mt -75.31 -59.26 2.83 Favored 'General case' 0 CA--C 1.542 0.642 0 N-CA-C 113.339 0.866 . . . . 72.14 113.339 -175.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 36.2 mt-10 . . . . . 0 C--O 1.255 1.371 0 N-CA-C 113.304 0.853 . . . . 61.2 113.304 -173.906 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.412 ' SD ' ' N ' ' A' ' 1' ' ' MET . 1.2 mpt? . . . . . 0 N--CA 1.487 1.41 0 CA-C-O 120.621 0.248 . . . . 70.11 111.171 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' LYS . . . . . . . . . . . . . 4.9 tppp? -69.77 111.78 5.77 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.761 -0.459 . . . . 71.44 109.761 174.357 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' ILE . . . . . 0.519 ' HA ' ' SD ' ' A' ' 7' ' ' MET . 48.8 mm -62.06 130.51 26.49 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 112.426 0.528 . . . . 74.34 112.426 -172.496 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 22.6 p -120.21 167.21 12.49 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-N 115.95 -0.568 . . . . 60.41 110.336 176.289 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.416 ' HB2' ' HB3' ' A' ' 42' ' ' GLU . 16.9 ptpt -74.28 -8.79 57.46 Favored 'General case' 0 CA--C 1.54 0.582 0 CA-C-O 121.134 0.492 . . . . 65.32 110.873 177.196 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ASP . . . . . . . . . . . . . 28.8 t70 -82.91 -24.9 32.92 Favored 'General case' 0 CA--C 1.542 0.661 0 CA-C-N 115.898 -0.592 . . . . 53.24 111.818 -179.535 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.519 ' SD ' ' HA ' ' A' ' 3' ' ' ILE . 62.3 mtt -66.23 156.92 32.82 Favored 'General case' 0 CA--C 1.54 0.575 0 N-CA-C 112.653 0.612 . . . . 73.12 112.653 -175.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.1 mm -81.8 133.78 28.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.614 0 CA-C-N 115.871 -0.604 . . . . 74.13 111.165 179.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ILE . . . . . . . . . . . . . 54.1 mt -57.89 -50.49 77.65 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.681 0 N-CA-C 112.207 0.447 . . . . 73.22 112.207 -177.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.434 ' HB2' ' HB3' ' A' ' 37' ' ' MET . . . -59.74 -38.07 80.73 Favored 'General case' 0 N--CA 1.471 0.592 0 CA-C-O 120.889 0.376 . . . . 70.04 111.655 178.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 31.4 t70 -59.38 -44.3 92.79 Favored 'General case' 0 CA--C 1.539 0.549 0 CA-C-O 121.0 0.429 . . . . 74.14 110.772 178.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' VAL . . . . . . . . . . . . . 60.5 t -60.4 -42.16 89.95 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 CA-C-N 116.112 -0.495 . . . . 73.54 111.105 175.103 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LEU . . . . . . . . . . . . . 95.7 mt -60.39 -34.14 73.48 Favored 'General case' 0 N--CA 1.469 0.524 0 CA-C-N 116.214 -0.448 . . . . 70.11 111.91 177.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' GLN . . . . . . . . . . . . . 92.2 mt-30 -69.23 -22.87 63.83 Favored 'General case' 0 CA--C 1.539 0.522 0 CA-C-O 120.77 0.319 . . . . 74.41 111.719 178.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' MET . . . . . . . . . . . . . 28.6 mtm -83.3 -45.51 13.7 Favored 'General case' 0 N--CA 1.467 0.418 0 CA-C-O 121.048 0.451 . . . . 75.02 110.193 177.548 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ASP . . . . . . . . . . . . . 7.9 t70 -152.08 112.93 4.2 Favored 'General case' 0 CA--C 1.545 0.767 0 CA-C-N 115.901 -0.59 . . . . 73.33 110.889 173.233 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.2 mmt180 -66.3 -11.91 53.42 Favored 'General case' 0 N--CA 1.475 0.819 0 N-CA-C 112.832 0.679 . . . . 74.0 112.832 -179.673 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.469 ' HA3' ' OH ' ' A' ' 62' ' ' TYR . . . -70.16 -9.53 63.87 Favored Glycine 0 CA--C 1.528 0.865 0 C-N-CA 121.175 -0.536 . . . . 74.13 112.916 176.435 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 67.3 p -78.67 -16.36 57.39 Favored 'General case' 0 N--CA 1.468 0.472 0 O-C-N 122.566 -0.373 . . . . 74.14 111.707 176.234 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . 0.597 ' HB3' ' HD3' ' A' ' 21' ' ' PRO . . . -56.62 -52.01 76.86 Favored Pre-proline 0 CA--C 1.546 0.824 0 N-CA-C 112.391 0.515 . . . . 70.41 112.391 -178.558 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' PRO . . . . . 0.597 ' HD3' ' HB3' ' A' ' 20' ' ' ALA . 52.2 Cg_exo -52.63 -38.22 75.84 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 122.011 1.807 . . . . 70.12 112.438 175.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 64.6 mt -62.66 -46.49 96.23 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.516 0 CA-C-N 116.096 -0.502 . . . . 73.13 111.162 177.882 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.536 ' HB3' ' HB2' ' A' ' 28' ' ' MET . 54.4 m-85 -59.03 -46.22 88.77 Favored 'General case' 0 CA--C 1.54 0.559 0 CA-C-O 120.849 0.357 . . . . 74.31 110.836 174.594 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ILE . . . . . . . . . . . . . 71.3 mt -59.83 -37.78 73.24 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.598 0 CA-C-O 120.913 0.387 . . . . 70.33 111.206 177.392 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 37.7 t30 -56.14 -40.31 73.59 Favored 'General case' 0 N--CA 1.47 0.549 0 CA-C-N 116.059 -0.519 . . . . 74.53 111.337 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.465 ' ND2' HD13 ' A' ' 55' ' ' LEU . 39.9 m-80 -87.79 -2.37 58.57 Favored 'General case' 0 CA--C 1.539 0.549 0 N-CA-C 112.389 0.515 . . . . 71.24 112.389 -179.282 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 104.7 11.44 30.66 Favored Glycine 0 CA--C 1.533 1.186 0 N-CA-C 115.011 0.764 . . . . 71.22 115.011 174.264 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' MET . . . . . 0.536 ' HB2' ' HB3' ' A' ' 23' ' ' PHE . 25.4 mmt -76.3 156.57 33.29 Favored 'General case' 0 N--CA 1.473 0.719 0 CA-C-N 117.984 0.892 . . . . 62.03 110.975 175.56 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' HIS . . . . . . . . . . . . . 2.6 p80 -138.54 127.88 24.44 Favored 'General case' 0 N--CA 1.471 0.599 0 N-CA-C 112.686 0.624 . . . . 75.55 112.686 -175.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' CYS . . . . . . . . . . . . . 46.4 t -104.55 4.4 32.91 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-O 121.302 0.573 . . . . 64.23 110.79 174.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -73.58 106.72 5.47 Favored 'General case' 0 CA--C 1.543 0.679 0 CA-C-N 116.183 -0.462 . . . . 64.35 111.2 -176.601 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 84.34 -69.59 3.31 Favored Glycine 0 CA--C 1.525 0.693 0 CA-C-N 116.279 -0.418 . . . . 71.25 113.78 172.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' CYS . . . . . . . . . . . . . 73.8 m -85.77 117.62 69.07 Favored Pre-proline 0 N--CA 1.472 0.661 0 N-CA-C 112.355 0.502 . . . . 60.15 112.355 -174.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -73.96 -4.85 16.09 Favored 'Trans proline' 0 CA--C 1.54 0.786 0 C-N-CA 122.708 2.272 . . . . 71.22 113.009 178.991 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 32.5 t -51.24 -60.41 3.15 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-O 120.556 0.217 . . . . 62.31 111.414 179.002 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' SER . . . . . . . . . . . . . 43.0 t -53.55 -20.27 4.8 Favored 'General case' 0 N--CA 1.476 0.848 0 N-CA-C 112.489 0.551 . . . . 74.03 112.489 -179.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' MET . . . . . 0.434 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 4.2 mmt -84.48 -46.81 11.27 Favored 'General case' 0 CA--C 1.536 0.433 0 CA-C-O 121.01 0.433 . . . . 62.33 111.262 178.526 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -86.75 22.56 13.35 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 114.266 0.466 . . . . 73.2 114.266 -173.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -128.33 170.4 13.12 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-O 121.199 0.524 . . . . 62.34 112.231 177.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' SER . . . . . . . . . . . . . 16.8 m -72.41 147.65 45.97 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 115.864 -0.607 . . . . 64.2 111.805 -176.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ILE . . . . . 0.42 HG23 HD23 ' A' ' 55' ' ' LEU . 32.3 mt -51.41 -52.36 20.35 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.603 0 N-CA-C 112.291 0.478 . . . . 73.44 112.291 178.518 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLU . . . . . 0.416 ' HB3' ' HB2' ' A' ' 5' ' ' LYS . 12.9 pt-20 -62.61 -34.81 77.79 Favored 'General case' 0 N--CA 1.471 0.606 0 N-CA-C 111.741 0.275 . . . . 65.43 111.741 179.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . 0.438 ' O ' HG23 ' A' ' 47' ' ' VAL . 22.0 t70 -65.57 -52.39 52.66 Favored 'General case' 0 CA--C 1.538 0.516 0 CA-C-O 120.914 0.388 . . . . 72.1 110.633 -179.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.29 -38.91 77.94 Favored 'General case' 0 CA--C 1.538 0.517 0 CA-C-O 121.23 0.538 . . . . 72.22 111.077 175.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' CYS . . . . . 0.498 ' SG ' ' HB2' ' A' ' 52' ' ' ALA . 93.0 m -60.18 -49.64 76.82 Favored 'General case' 0 N--CA 1.468 0.465 0 CA-C-N 116.129 -0.487 . . . . 63.34 111.392 175.325 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ALA . . . . . . . . . . . . . . . -56.63 -25.07 52.27 Favored 'General case' 0 N--CA 1.47 0.56 0 N-CA-C 112.264 0.468 . . . . 73.31 112.264 -179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' VAL . . . . . 0.438 HG23 ' O ' ' A' ' 43' ' ' ASP . 48.0 t -65.07 -52.1 57.67 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.531 0 CA-C-O 120.984 0.421 . . . . 65.13 111.716 177.402 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' HIS . . . . . 0.448 ' HB2' HG13 ' A' ' 50' ' ' ILE . 85.4 m-70 -98.87 3.19 47.21 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.021 0.378 . . . . 63.44 112.021 -177.605 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLY . . . . . . . . . . . . . . . 74.13 27.01 67.12 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.008 -0.615 . . . . 73.14 112.944 -177.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ILE . . . . . 0.448 HG13 ' HB2' ' A' ' 48' ' ' HIS . 50.5 mt -73.45 150.43 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.563 0 CA-C-O 120.884 0.373 . . . . 65.21 111.291 -179.466 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' ASP . . . . . . . . . . . . . 9.3 t70 -86.5 97.28 10.4 Favored 'General case' 0 CA--C 1.539 0.545 0 CA-C-O 121.197 0.522 . . . . 72.33 109.766 175.616 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . 0.529 ' O ' HG23 ' A' ' 56' ' ' VAL . . . -64.74 -31.28 72.44 Favored 'General case' 0 C--N 1.329 -0.322 0 N-CA-C 112.407 0.521 . . . . 73.41 112.407 -176.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.501 ' O ' ' HG3' ' A' ' 57' ' ' LYS . 2.9 t70 -63.63 -40.35 96.66 Favored 'General case' 0 CA--C 1.54 0.59 0 CA-C-O 120.663 0.268 . . . . 75.42 110.879 -177.507 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 68.5 mttm -62.32 -47.5 84.0 Favored 'General case' 0 N--CA 1.472 0.641 0 CA-C-O 121.052 0.453 . . . . 72.32 110.668 174.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.465 HD13 ' ND2' ' A' ' 26' ' ' ASN . 20.9 tp -58.05 -48.5 79.92 Favored 'General case' 0 CA--C 1.538 0.482 0 CA-C-N 115.804 -0.635 . . . . 53.03 111.262 179.551 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' VAL . . . . . 0.529 HG23 ' O ' ' A' ' 52' ' ' ALA . 89.6 t -57.12 -42.58 79.9 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 CA-C-N 116.219 -0.446 . . . . 54.42 111.754 178.309 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LYS . . . . . 0.501 ' HG3' ' O ' ' A' ' 53' ' ' ASP . 67.5 mttm -56.5 -52.96 62.75 Favored 'General case' 0 N--CA 1.47 0.562 0 CA-C-O 120.853 0.359 . . . . 73.21 110.812 175.07 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 93.5 mt-10 -55.11 -40.32 70.34 Favored 'General case' 0 CA--C 1.542 0.647 0 CA-C-N 116.081 -0.509 . . . . 54.44 111.622 178.075 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LEU . . . . . 0.407 ' HG ' ' O ' ' A' ' 55' ' ' LEU . 95.4 mt -64.0 -55.41 22.53 Favored 'General case' 0 CA--C 1.542 0.645 0 N-CA-C 112.114 0.413 . . . . 73.45 112.114 178.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.454 ' ND2' ' HB ' ' A' ' 3' ' ' ILE . 51.6 m-80 -55.47 -51.47 66.84 Favored 'General case' 0 N--CA 1.472 0.659 0 CA-C-O 120.72 0.295 . . . . 61.42 111.58 179.607 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . 0.556 ' O ' ' HG2' ' A' ' 65' ' ' LYS . 37.5 mt-10 -59.56 -27.84 66.59 Favored 'General case' 0 CA--C 1.537 0.468 0 CA-C-N 116.434 -0.348 . . . . 54.42 111.68 -179.756 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.469 ' OH ' ' HA3' ' A' ' 18' ' ' GLY . 85.8 t80 -69.66 -47.12 64.45 Favored 'General case' 0 N--CA 1.468 0.435 0 CA-C-N 116.627 -0.261 . . . . 74.45 111.318 175.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 45.4 m-85 -58.16 -33.02 68.77 Favored 'General case' 0 CA--C 1.536 0.425 0 CA-C-O 120.763 0.315 . . . . 61.33 111.23 177.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLU . . . . . . . . . . . . . 37.3 mt-10 -61.01 -40.31 93.08 Favored 'General case' 0 CA--C 1.54 0.587 0 CA-C-O 120.765 0.317 . . . . 61.21 111.22 171.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . 0.556 ' HG2' ' O ' ' A' ' 61' ' ' GLU . 44.3 mmtm -63.19 -34.6 77.99 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 116.453 -0.339 . . . . 61.43 111.482 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LYS . . . . . . . . . . . . . 24.7 mtpp -47.61 -62.29 1.52 Allowed 'General case' 0 N--CA 1.47 0.532 0 N-CA-C 112.336 0.495 . . . . 73.01 112.336 -179.784 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 44.0 mt-10 -66.23 -11.76 52.02 Favored 'General case' 0 CA--C 1.541 0.631 0 N-CA-C 112.428 0.529 . . . . 71.51 112.428 -176.245 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' VAL . . . . . . . . . . . . . 65.9 t -86.56 -54.4 8.32 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.634 0 CA-C-O 120.983 0.421 . . . . 72.43 111.054 175.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LEU . . . . . . . . . . . . . 66.3 mt -70.56 -53.2 16.99 Favored 'General case' 0 CA--C 1.539 0.546 0 CA-C-N 116.132 -0.485 . . . . 44.21 111.977 179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 21.1 mt-10 . . . . . 0 C--O 1.253 1.274 0 CA-C-O 119.115 -0.469 . . . . 55.24 111.977 179.563 . . . . . . . . 0 0 . 1 stop_ save_